data_2mkc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.498 -1.019 0 CA-C-O 121.591 0.71 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.449 HD21 ' OD1' ' A' ' 26' ' ' ASP . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.582 ' OD2' HD21 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.488 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.671 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.7 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.511 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.582 HD21 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 . . . . . 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 113.034 0.359 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.86 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.431 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.716 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.1 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.716 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 106' ' ' LEU . 57.7 mt . . . . . 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 11.1 mm . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 ' OD1' ' A' ' 26' ' ' ASP . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD1' HD21 ' A' ' 22' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 44' ' ' ARG . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.567 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.567 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.408 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.4 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 40' ' ' VAL . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.4 mm . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.416 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.503 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.444 HD23 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.835 0.265 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.493 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.689 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' N ' HD22 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.598 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.406 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.66 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 97' ' ' LYS . 6.5 mt . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--O 1.248 1.007 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . 0.689 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.433 HG23 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 23' ' ' THR . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.588 ' O ' HG13 ' A' ' 66' ' ' ILE . 25.9 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.402 ' CD2' HG21 ' A' ' 69' ' ' VAL . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CD2' HG23 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 106' ' ' LEU . 67.4 mt . . . . . 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.467 HG23 HG13 ' B' ' 208' ' ' ILE . 2.7 mm . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.467 HG13 HG23 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.409 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.507 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo . . . . . 0 C--O 1.245 0.854 0 CA-C-O 120.909 0.295 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.435 -1.186 0 CA-C-O 120.968 0.413 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HA ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD2' HD21 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 60' ' ' GLU . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.4 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 38' ' ' VAL . 59.9 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.419 HG23 HG13 ' B' ' 208' ' ' ILE . 3.5 mm . . . . . 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.419 HG13 HG23 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.622 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.467 HD21 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 CA-C-O 120.922 0.301 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HG ' ' OD1' ' A' ' 19' ' ' ASN . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.411 ' HG1' ' HB3' ' B' ' 211' ' ' ASP . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.6 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD13 ' HD3' ' C' ' 318' ' ' ARG . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 106' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 58' ' ' LYS . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD21 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 66' ' ' ILE . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.614 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG21 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.411 ' HB3' ' HG1' ' A' ' 23' ' ' THR . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.6 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.246 0.9 0 N-CA-C 113.72 0.623 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 p30 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.301 0.572 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.427 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD23 ' OD1' ' A' ' 26' ' ' ASP . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.408 HG22 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD1' HD23 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.415 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD22 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' A' ' 71' ' ' ASN . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.409 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.8 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' HA ' HD11 ' A' ' 110' ' ' ILE . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 18.7 mm . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.405 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.408 ' OD2' HG22 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.404 HD21 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.248 1.001 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.529 HD23 ' OD2' ' A' ' 26' ' ' ASP . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' OD2' HD23 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' CG2' HD23 ' B' ' 218' ' ' LEU . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG11 ' OD1' ' A' ' 39' ' ' ASP . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.546 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.9 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.61 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo . . . . . 0 C--O 1.26 1.586 0 N-CA-C 113.773 0.643 . . . . 0.0 113.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.41 ' CG ' ' HD2' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 HD12 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG23 ' CD1' ' A' ' 31' ' ' PHE . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD11 ' CG ' ' A' ' 44' ' ' ARG . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' CG ' HD11 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.432 ' OG ' HD12 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' O ' HD21 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' HD21 ' A' ' 57' ' ' LEU . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.616 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.56 HG23 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.56 ' NE2' HG23 ' A' ' 69' ' ' VAL . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.501 ' O ' HG21 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.527 ' O ' HG13 ' A' ' 110' ' ' ILE . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.494 HG21 HG13 ' B' ' 208' ' ' ILE . 4.9 mm . . . . . 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.494 HG13 HG21 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.405 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 N-CA-C 114.524 0.932 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.648 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.466 ' OD2' HD23 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 57' ' ' LEU . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 66' ' ' ILE . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.471 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.535 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.7 mt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.478 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . 0.411 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.431 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.466 HD23 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.245 0.846 0 CA-C-O 121.393 0.497 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.498 HD23 ' OD2' ' A' ' 26' ' ' ASP . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' HD23 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.55 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.464 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.409 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt . . . . . 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.453 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.46 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 . . . . . 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 114.617 0.968 . . . . 0.0 114.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.401 ' CB ' ' HB3' ' A' ' 86' ' ' HIS . 10.5 m120 . . . . . 0 N--CA 1.423 -1.796 0 CA-C-O 120.676 0.274 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 57' ' ' LEU . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.572 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.483 HD23 ' OD1' ' A' ' 26' ' ' ASP . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' OD1' HD23 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.591 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 86' ' ' HIS . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.531 ' CD2' HG13 ' A' ' 69' ' ' VAL . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.503 ' O ' HG21 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 110' ' ' ILE . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.404 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.596 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.242 0.71 0 N-CA-C 111.229 -0.335 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.432 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.569 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.651 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' O ' HG22 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 40' ' ' VAL . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.46 HD11 HG12 ' A' ' 38' ' ' VAL . 70.8 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.469 HG21 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.469 HG13 HG21 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.482 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 114.41 0.889 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD13 HD22 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 31' ' ' PHE 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 102' ' ' VAL . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' N ' HD21 ' A' ' 57' ' ' LEU . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.678 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.678 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.442 ' O ' HG11 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.703 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.539 ' O ' HG21 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.403 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.696 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 113.543 0.555 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' OD2' ' A' ' 26' ' ' ASP . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' HD23 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.541 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.541 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.565 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . 0.442 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.425 HD23 ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.246 0.917 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.442 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 13.4 m120 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.442 ' HB ' ' HB1' ' A' ' 55' ' ' ALA . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.583 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 9.3 m120 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD13 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' N ' HD13 ' A' ' 42' ' ' LEU . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.488 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 15' ' ' ILE . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' N ' HD23 ' A' ' 57' ' ' LEU . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.573 HH11 ' ND2' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.491 ' O ' HG21 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.416 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.448 HG21 HG13 ' B' ' 208' ' ' ILE . 4.4 mm . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.448 HG13 HG21 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.466 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.539 0.756 0 N-CA-C 114.157 0.791 . . . . 0.0 114.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.472 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.656 ' O ' ' HB ' ' A' ' 65' ' ' THR . 7.1 tp-100 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' O ' HG21 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.457 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.25 1.104 0 CA-C-O 121.272 0.446 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . 0.439 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.613 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' A' ' 29' ' ' THR . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 60' ' ' GLU . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' N ' HD22 ' A' ' 57' ' ' LEU . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.57 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 106' ' ' LEU . 18.5 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.421 HG23 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.613 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.408 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.434 HD23 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.0 0.334 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.652 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.652 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.437 HG13 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.411 HG22 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.476 ' N ' HD22 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 66' ' ' ILE . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' HE3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.43 HD13 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.3 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' O ' HG21 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CE2' HG22 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD11 HG13 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.402 HD12 HG11 ' A' ' 38' ' ' VAL . 45.0 mt . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 9.1 mm . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.554 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--O 1.243 0.728 0 CA-C-O 121.117 0.382 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 318' ' ' ARG . . . . . 0.572 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 26.21 2.32 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.99 149.58 30.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.808 -174.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 6' ' ' GLU . . . -113.71 69.09 0.24 Allowed Glycine 0 C--N 1.29 -2.007 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -66.52 10.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.128 1.371 . . . . 0.0 113.595 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 4' ' ' GLY . 36.4 mt-10 -69.92 -16.94 63.3 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.34 1.056 . . . . 0.0 110.78 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -141.1 174.0 10.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -123.57 30.0 6.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.65 20.11 19.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.122 -1.853 . . . . 0.0 106.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -83.2 72.51 10.15 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.624 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.449 HD21 ' OD1' ' A' ' 26' ' ' ASP . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.582 ' OD2' HD21 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.536 ' OE1' ' HG2' ' C' ' 324' ' ' ARG . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.488 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.671 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.7 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.81 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -77.84 123.74 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.39 0.614 . . . . 0.0 109.736 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -92.6 120.99 33.59 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 1.1 pptp? -137.52 130.69 30.68 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -91.75 -28.48 17.37 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.92 125.46 25.18 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.41 13.23 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.673 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.63 144.05 39.53 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 47.8 t -84.78 132.97 34.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -124.27 12.35 8.84 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.383 0.611 . . . . 0.0 110.31 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 35.7 t -87.6 -58.14 2.69 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -144.66 159.35 42.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.46 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 3.1 m-85 -69.75 -67.95 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.534 0.683 . . . . 0.0 109.397 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 7.7 mm -124.4 155.93 32.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.511 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.582 HD21 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 -79.43 -29.28 41.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.646 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' C' ' 319' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 47.9 t -165.35 154.94 12.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.237 0.519 . . . . 0.0 110.198 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.09 109.62 14.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -82.29 -61.79 1.8 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.715 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -91.62 127.81 48.89 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -96.72 15.13 0.83 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 123.539 2.826 . . . . 0.0 111.726 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -109.4 113.18 58.64 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.321 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.9 64.88 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.16 2.573 . . . . 0.0 112.61 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.93 -13.06 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 110.226 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.14 134.16 45.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -56.92 -30.75 64.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.627 0.771 . . . . 0.0 110.779 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.65 1.99 56.77 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.958 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.57 20.98 10.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.463 1.105 . . . . 0.0 112.713 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 40.2 mt -81.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.927 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.464 ' HA ' ' HE1' ' C' ' 314' ' ' MET . 2.6 mmt -109.73 139.97 21.75 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.7 131.07 43.9 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 123.867 3.045 . . . . 0.0 113.034 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . 0.496 ' O ' ' HA2' ' C' ' 300' ' ' GLY . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.34 33.48 0.67 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 58.4 t -114.49 100.3 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -77.17 122.8 25.53 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.371 0.419 . . . . 0.0 110.149 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.536 ' HG2' ' OE1' ' A' ' 33' ' ' GLU . 11.5 ptp85 -136.64 143.86 43.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.608 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 68.7 m -158.92 147.21 18.14 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -91.88 -37.14 13.08 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.381 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.22 31.27 8.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 118.852 -1.642 . . . . 0.0 112.067 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.9 OUTLIER -68.96 130.31 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.25 2.71 56.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 0.5 OUTLIER -57.2 -49.05 77.22 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -80.55 118.73 22.39 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 88.6 m95 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.834 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.24 34.39 16.04 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.55 174.39 5.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.322 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.1 76.35 1.25 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.63 -31.59 72.7 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.956 0.903 . . . . 0.0 113.122 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.13 -70.18 0.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.442 0.639 . . . . 0.0 109.833 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -168.03 -141.78 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 10' ' ' ASN . 3.0 mptp? -91.28 -0.38 57.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' HA ' HE22 ' A' ' 62' ' ' GLN . 3.7 m-20 -69.39 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.895 1.678 . . . . 0.0 113.759 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -98.28 110.24 22.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.58 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.602 ' OE1' ' HB3' ' C' ' 324' ' ' ARG . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.431 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.505 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.716 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.1 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.543 ' HB3' ' CE2' ' C' ' 311' ' ' PHE . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.716 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' B' ' 205' ' ' TYR . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' HG11 ' A' ' 111' ' ' VAL . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 106' ' ' LEU . 57.7 mt -55.47 -49.38 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.566 HG11 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -79.26 114.9 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.604 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -66.87 -35.61 80.43 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -168.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -124.22 113.29 18.09 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.808 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.81 169.24 5.89 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.329 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -118.94 86.7 2.59 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.79 145.65 15.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -149.58 -71.78 0.19 Allowed 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.1 m -85.11 158.82 20.3 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 117.026 0.413 . . . . 0.0 110.096 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -107.63 6.28 27.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.456 1.122 . . . . 0.0 108.604 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -72.95 -6.34 44.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.675 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 67.61 111.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.428 1.108 . . . . 0.0 110.441 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.414 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 3.0 m-85 -68.89 -56.34 8.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.942 -169.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 11.1 mm -101.97 146.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.584 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 -97.89 -28.28 13.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.579 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.2 m -128.61 -173.9 3.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -82.08 109.4 16.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.67 -55.62 4.17 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.08 109.52 35.86 Favored Pre-proline 0 C--N 1.318 -0.788 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.996 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.56 -20.23 18.2 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 123.497 2.798 . . . . 0.0 114.099 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.57 103.88 19.53 Favored Pre-proline 0 N--CA 1.427 -1.583 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.928 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.78 162.06 42.17 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.65 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.35 0.99 50.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.657 0.741 . . . . 0.0 110.836 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -86.34 28.81 0.81 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.941 -171.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 65.17 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.837 1.255 . . . . 0.0 113.964 174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 63' ' ' ARG . 43.2 m-85 -91.48 9.86 30.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.38 55.44 3.52 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.49 1.116 . . . . 0.0 110.069 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.06 138.44 23.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.447 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 25.0 mmt -90.65 125.82 58.13 Favored Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.894 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.62 122.84 10.07 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.261 1.974 . . . . 0.0 110.55 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.32 22.12 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.95 104.36 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.79 123.76 22.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.602 ' HB3' ' OE1' ' A' ' 33' ' ' GLU . 43.3 ttm105 -117.75 147.92 42.52 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.835 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 31.0 t -152.28 108.16 3.36 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.76 150.4 8.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.8 30.29 69.13 Favored Glycine 0 C--O 1.224 -0.483 0 O-C-N 124.324 1.015 . . . . 0.0 111.385 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.439 ' C ' ' H ' ' C' ' 330' ' ' GLU . 7.5 t80 -74.29 141.33 45.3 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -69.14 3.61 2.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 126.408 1.883 . . . . 0.0 112.72 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' C' ' 328' ' ' PHE . 0.6 OUTLIER -40.33 -52.35 2.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.623 1.969 . . . . 0.0 113.836 -171.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -87.83 115.37 25.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 N--CA 1.428 -1.527 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.171 173.479 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.64 6.47 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 86' ' ' HIS . 21.1 ptp -110.07 160.18 16.67 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 86' ' ' HIS . . . 69.88 34.5 71.56 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -90.79 -18.27 25.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -32.1 10.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.462 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.86 86.63 2.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.265 175.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -85.72 -9.32 57.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.02 -14.12 61.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.763 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.75 109.36 0.7 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 ' OD1' ' A' ' 26' ' ' ASP . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' OD1' HD21 ' A' ' 22' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.468 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 44' ' ' ARG . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.567 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.567 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.613 ' O ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.506 ' O ' ' HG3' ' A' ' 3' ' ' MET . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.408 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.4 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 40' ' ' VAL . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' O ' HG13 ' A' ' 111' ' ' VAL . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt -90.33 -53.88 8.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -75.8 157.56 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.2 m -85.0 -1.38 56.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.442 0.639 . . . . 0.0 111.599 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -101.35 84.86 2.68 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.91 -38.0 23.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.296 0.569 . . . . 0.0 111.295 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.71 118.53 20.1 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.198 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -148.29 -85.15 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.38 -41.68 24.21 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 175.793 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.433 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -57.17 123.7 16.19 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 117.113 0.457 . . . . 0.0 111.873 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.45 -7.67 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.097 0.951 . . . . 0.0 110.418 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.9 p -87.63 -1.16 57.76 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.47 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.535 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 28.7 tt0 73.01 142.74 0.06 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 124.876 1.27 . . . . 0.0 109.243 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.409 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 10.7 m-85 -77.47 -66.34 0.85 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.849 0.833 . . . . 0.0 110.408 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.4 mm -128.71 154.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . 0.535 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.416 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.503 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.444 HD23 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 -97.66 -55.31 2.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.253 1.238 0 O-C-N 124.896 1.373 . . . . 0.0 110.755 -175.259 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.579 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 17.0 m -100.0 147.04 26.03 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.87 109.08 20.91 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . 0.441 ' HB2' ' HD3' ' C' ' 304' ' ' LYS . 3.1 m-20 -99.16 -51.66 3.76 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.441 ' HD3' ' HB2' ' C' ' 303' ' ' ASP . 2.9 mppt? -70.01 119.99 75.1 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.252 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.57 -42.31 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.603 2.202 . . . . 0.0 110.82 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.41 108.02 19.26 Favored Pre-proline 0 N--CA 1.424 -1.736 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.96 110.88 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.097 1.865 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.79 86.12 4.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 122.804 1.288 . . . . 0.0 110.906 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.33 140.36 22.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' C' ' 310' ' ' ARG . 2.1 tpm_? -46.9 -46.02 20.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.64 9.3 27.21 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.59 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 53.12 60.84 3.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.054 0.942 . . . . 0.0 112.137 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.4 mt -99.78 147.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.4 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 21.6 mmt -87.41 128.71 54.02 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 122.918 0.136 . . . . 0.0 111.207 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 135.79 22.67 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.629 2.219 . . . . 0.0 111.966 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.59 -9.26 41.05 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.77 121.98 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -111.63 139.46 47.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.72 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.94 144.94 50.39 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 8.2 t -157.21 88.66 1.02 Allowed 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 172.39 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.361 1.465 . . . . 0.0 107.646 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.68 65.84 Favored Glycine 0 C--O 1.236 0.238 0 O-C-N 123.316 0.385 . . . . 0.0 112.961 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.84 131.47 37.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.06 1.88 14.35 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.311 1.044 . . . . 0.0 112.985 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.16 -37.13 14.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -84.93 103.05 13.64 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.496 -1.099 0 C-N-CA 127.077 2.151 . . . . 0.0 109.699 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.91 91.83 5.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.383 0.611 . . . . 0.0 109.438 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 tpt -79.59 109.8 14.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.756 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.07 168.09 16.55 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.997 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -71.38 -28.75 64.25 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.234 0.54 . . . . 0.0 109.688 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.53 -3.22 49.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.422 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -83.67 82.19 8.42 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -87.51 -6.06 58.52 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.1 3.62 0.57 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.747 2.019 . . . . 0.0 113.543 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 -82.27 101.15 10.34 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.493 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.689 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' N ' HD22 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.598 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.406 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB2' ' ND2' ' C' ' 326' ' ' ASN . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.66 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 114' ' ' ASN . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.88 -48.78 22.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.4 p -69.09 157.95 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 m -82.15 80.84 8.27 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.193 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.9 tttt 167.46 75.2 0.0 OUTLIER 'General case' 0 C--O 1.251 1.169 0 C-N-CA 127.655 2.382 . . . . 0.0 105.746 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 30.4 p-10 -84.84 169.34 14.24 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -86.07 143.99 27.78 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.417 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.11 -7.8 14.05 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.55 -79.41 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.676 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.679 0 C-N-CA 124.894 1.278 . . . . 0.0 108.477 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.7 m 69.81 -51.13 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.464 1.506 . . . . 0.0 114.444 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -64.23 -18.81 64.88 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.391 0.676 . . . . 0.0 112.754 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.9 p -86.57 11.01 13.7 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.545 0.688 . . . . 0.0 111.255 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 64.47 90.77 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.665 1.586 . . . . 0.0 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -51.74 -60.94 2.6 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.748 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 97' ' ' LYS . 6.5 mt -147.04 158.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 -74.48 -27.23 60.47 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.3 m -150.24 -33.57 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 117.215 0.507 . . . . 0.0 110.678 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.25 109.9 17.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.694 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.15 -49.46 13.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.8 125.82 57.85 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.96 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.05 -29.55 48.38 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.421 2.081 . . . . 0.0 111.741 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -139.52 150.11 62.46 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.28 91.56 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.851 1.701 . . . . 0.0 110.488 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -84.23 95.88 8.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.61 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -179.66 148.15 0.32 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -56.19 -42.33 76.94 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -115.52 17.13 16.48 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.883 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 70.94 26.09 3.68 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.32 131.49 35.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.461 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 4.7 mmt -96.84 138.83 21.34 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.175 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.57 145.99 55.79 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.698 2.932 . . . . 0.0 113.637 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . 0.689 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 95.54 10.91 56.4 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.52 143.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.67 144.64 43.69 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.847 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -128.93 105.81 8.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.807 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 30.3 t -115.93 108.1 15.83 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.425 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 75' ' ' PHE . 16.0 m120 -109.75 -9.1 14.85 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.128 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.14 -6.5 75.93 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -80.25 145.19 32.33 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.712 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -61.25 1.25 0.2 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.66 -21.2 60.35 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 10.1 tmtt? -87.93 129.85 35.11 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . 0.47 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 49.1 m95 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.972 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.48 -66.51 0.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.964 1.305 . . . . 0.0 111.317 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.97 146.74 52.44 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 109.284 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 57.96 4.36 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.83 11.01 14.26 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.432 1.093 . . . . 0.0 112.739 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.36 -71.79 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.05 0.219 . . . . 0.0 111.255 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 86' ' ' HIS . 78.3 m-85 41.52 36.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.556 1.143 . . . . 0.0 113.372 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -17.1 64.68 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.194 0.521 . . . . 0.0 112.087 -172.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.11 11.65 13.39 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.769 1.228 . . . . 0.0 111.638 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.64 113.02 20.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.783 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.433 HG23 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 23' ' ' THR . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.588 ' O ' HG13 ' A' ' 66' ' ' ILE . 25.9 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' C' ' 330' ' ' GLU . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' C' ' 326' ' ' ASN . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.477 ' O ' HG22 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CD2' HG23 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 110' ' ' ILE . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 106' ' ' LEU . 67.4 mt -69.64 -39.27 78.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.62 145.52 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.6 t -92.12 -37.77 12.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -150.81 134.24 16.31 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.499 1.12 . . . . 0.0 108.562 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -68.85 146.26 53.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.758 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -163.53 -25.68 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.629 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.79 101.95 2.73 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.161 0.505 . . . . 0.0 112.215 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.83 -23.87 28.88 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 174.425 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.5 p -100.11 144.93 28.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.056 0.542 . . . . 0.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -117.65 -50.47 2.52 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.459 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 m -56.78 -54.02 51.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.728 0.775 . . . . 0.0 109.818 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.28 148.97 23.84 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.488 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 17.8 m-85 -55.87 -54.18 47.74 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.727 0.642 . . . . 0.0 110.692 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.467 HG23 HG13 ' B' ' 208' ' ' ILE . 2.7 mm -132.63 146.56 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.467 HG13 HG23 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.409 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.507 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 -78.91 -41.46 29.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.256 1.416 0 C-N-CA 125.31 1.444 . . . . 0.0 109.057 -173.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.602 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.6 m -89.49 147.21 24.12 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.8 108.9 20.54 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.624 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 -38.93 14.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 170.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -90.83 111.14 46.43 Favored Pre-proline 0 N--CA 1.423 -1.818 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 -16.89 24.55 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.268 2.646 . . . . 0.0 112.047 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -142.56 166.23 22.16 Favored Pre-proline 0 N--CA 1.419 -2.01 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.2 59.81 3.82 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.684 2.256 . . . . 0.0 111.103 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -91.01 11.66 22.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.368 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -73.6 156.62 37.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -39.06 -48.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -102.68 30.31 4.77 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.195 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 67.37 32.94 5.58 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.375 1.083 . . . . 0.0 110.082 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 74.6 mt -92.78 150.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.148 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.638 ' HE2' ' O ' ' C' ' 314' ' ' MET . 0.0 OUTLIER -116.55 169.04 7.69 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.969 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.59 137.11 24.62 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.678 1.585 . . . . 0.0 111.472 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 132.21 -8.59 5.38 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.21 106.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.876 0 C-N-CA 123.332 0.653 . . . . 0.0 109.829 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -62.76 144.0 56.91 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.698 0.624 . . . . 0.0 111.045 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -109.58 126.66 53.83 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.366 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 45.1 m -73.27 102.1 3.58 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . 0.435 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 33.2 p30 -136.02 -170.51 2.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.858 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.88 31.0 2.01 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.059 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.641 ' CE1' ' HG2' ' C' ' 330' ' ' GLU . 11.0 t80 -82.74 151.6 26.11 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.49 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.5 2.15 56.01 Favored 'General case' 0 CA--C 1.593 2.604 0 C-N-CA 126.892 2.077 . . . . 0.0 115.112 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.641 ' HG2' ' CE1' ' C' ' 328' ' ' PHE . 6.7 mm-40 -62.75 -38.9 92.4 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -73.25 118.62 16.43 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 82.3 m95 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.579 176.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.013 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.86 149.83 30.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.758 0.313 . . . . 0.0 110.637 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ptp -110.27 -179.92 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 90.6 0.11 Allowed Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -110.41 -1.63 17.0 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.134 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -19.54 45.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.426 0.632 . . . . 0.0 109.423 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -111.82 159.03 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.145 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -127.52 23.19 6.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 123.014 1.388 . . . . 0.0 107.309 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.06 5.49 48.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.602 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.19 91.46 8.46 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.298 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HA ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD2' HD21 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' C' ' 324' ' ' ARG . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 60' ' ' GLU . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' C' ' 311' ' ' PHE . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.4 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 111' ' ' VAL . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 38' ' ' VAL . 59.9 mt -90.82 -56.15 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -74.09 132.68 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.288 -172.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -97.01 158.83 15.24 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . 0.333 58.6 mtmt -79.44 75.84 6.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -159.98 168.76 24.92 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 72.68 -39.83 0.46 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.963 0.905 . . . . 0.0 111.863 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.11 92.37 7.89 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.16 -28.64 60.19 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.966 0.888 . . . . 0.0 108.927 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -92.91 138.83 31.14 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -20.93 6.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.953 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 3.7 p -71.11 -29.67 65.56 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.651 0.739 . . . . 0.0 110.213 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.88 178.61 8.75 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.01 -61.23 1.88 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.419 HG23 HG13 ' B' ' 208' ' ' ILE . 3.5 mm -123.29 142.06 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.419 HG13 HG23 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.622 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.467 HD21 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 -76.52 -30.64 57.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.663 178.742 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.336 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 24.0 t -78.25 -43.13 29.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.69 108.92 14.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.69 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.22 -33.39 10.77 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -90.95 144.48 30.17 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.272 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.32 -41.29 9.38 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.31 2.007 . . . . 0.0 109.158 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.9 128.66 23.43 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.17 109.95 0.57 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.652 2.235 . . . . 0.0 112.335 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -84.97 71.13 10.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.949 1.357 . . . . 0.0 109.389 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -144.89 124.66 13.36 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -73.14 -18.07 61.32 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.3 0.572 . . . . 0.0 112.333 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.534 ' CD1' HD11 ' A' ' 67' ' ' LEU . 2.4 m-85 -96.28 -8.81 31.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 57.75 34.88 24.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.895 1.278 . . . . 0.0 112.666 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 27.3 mm -79.48 137.65 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.646 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 23.0 mmt -73.78 136.81 76.95 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 171.85 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.016 2.478 . . . . 0.0 112.729 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.55 45.11 4.4 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.4 170.31 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -106.23 149.93 26.39 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.124 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.535 ' CZ ' ' HA ' ' C' ' 324' ' ' ARG . 0.6 OUTLIER -74.94 99.88 3.96 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.665 0.745 . . . . 0.0 110.95 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.0 t -97.39 137.27 36.63 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 70.95 103.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.599 1.187 . . . . 0.0 110.91 -176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.71 22.45 23.67 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.619 -0.718 . . . . 0.0 113.471 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' C' ' 324' ' ' ARG . 13.7 t80 -100.48 162.81 12.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 117.72 0.76 . . . . 0.0 111.179 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.83 5.12 5.35 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.629 1.572 . . . . 0.0 110.484 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -39.41 -31.39 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.899 2.08 . . . . 0.0 113.038 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -76.29 -155.21 0.06 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.376 0.607 . . . . 0.0 109.56 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.583 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.422 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.84 21.88 11.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.928 0.364 . . . . 0.0 110.62 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.59 ' O ' ' HA ' ' A' ' 87' ' ' THR . 27.0 ptt? -92.98 141.19 28.68 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' A' ' 10' ' ' ASN . . . 171.11 -34.81 0.16 Allowed Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.847 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -72.27 -17.21 61.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.264 1.032 . . . . 0.0 111.698 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.28 4.18 24.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.315 0.578 . . . . 0.0 110.607 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -130.47 171.6 12.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -120.51 -15.5 8.5 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.854 -0.529 . . . . 0.0 112.352 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.58 4.47 46.77 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 110.753 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.8 OUTLIER -87.0 92.67 9.12 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HG ' ' OD1' ' A' ' 19' ' ' ASN . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.411 ' HG1' ' HB3' ' B' ' 211' ' ' ASP . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.6 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD13 ' HD3' ' C' ' 318' ' ' ARG . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' C' ' 324' ' ' ARG . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 106' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 58' ' ' LYS . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD21 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 66' ' ' ILE . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.614 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 3' ' ' MET . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG21 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 114' ' ' ASN . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt -81.05 -39.63 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.434 HG11 ' NH1' ' A' ' 108' ' ' ARG . 1.4 p -78.78 178.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.91 -170.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.5 m -60.96 -44.12 97.78 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -90.2 96.32 10.61 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.318 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 44.7 t30 -73.35 149.23 42.73 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.521 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.87 89.08 1.72 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.526 ' HA ' ' NH2' ' C' ' 318' ' ' ARG . . . -97.17 -47.8 5.61 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 51.72 82.3 0.07 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.176 1.791 . . . . 0.0 113.682 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.314 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 9.3 p -77.2 153.82 33.71 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 123.019 0.528 . . . . 0.0 111.888 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -93.0 -14.12 27.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.2 m -77.43 -4.32 44.77 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.287 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 74.31 145.29 0.08 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.357 1.463 . . . . 0.0 109.068 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.446 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 19.5 m-85 -61.05 -68.29 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.909 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm -123.94 151.38 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.416 ' SD ' ' HD2' ' B' ' 205' ' ' TYR . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.411 ' HB3' ' HG1' ' A' ' 23' ' ' THR . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.6 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 -79.36 -44.71 21.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.598 1.187 . . . . 0.0 109.699 -178.441 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.363 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 16.4 m -93.98 -38.9 10.93 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 0.0 110.164 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -120.27 164.94 15.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.01 -56.94 2.11 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 135.86 28.83 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.126 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.24 -66.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.334 2.022 . . . . 0.0 112.806 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -141.03 142.01 26.06 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.55 159.01 55.31 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.045 1.83 . . . . 0.0 111.063 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.61 -19.87 57.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -71.89 142.6 49.51 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.552 -0.749 . . . . 0.0 108.984 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' C' ' 330' ' ' GLU . 1.0 OUTLIER -72.8 -41.35 65.02 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 67' ' ' LEU . 38.9 m-85 -76.76 -4.93 45.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.417 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 58.61 60.29 2.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.923 0.889 . . . . 0.0 111.447 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 11.5 mm -115.17 146.2 19.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 159.28 50.02 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.37 146.4 68.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.856 2.371 . . . . 0.0 113.72 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -177.87 40.68 0.09 OUTLIER Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . 0.566 HG12 ' NH1' ' C' ' 324' ' ' ARG . 16.4 t -119.8 103.86 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -73.56 148.23 43.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.103 0.961 . . . . 0.0 111.542 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.566 ' NH1' HG12 ' C' ' 322' ' ' VAL . 1.0 OUTLIER -116.92 132.87 56.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 132.15 14.97 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -133.25 -24.35 1.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.301 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.72 30.91 2.88 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.156 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -73.15 141.86 47.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.623 0.249 . . . . 0.0 110.44 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -58.88 1.73 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' C' ' 310' ' ' ARG . 9.4 pt-20 -72.48 -23.69 61.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' C' ' 331' ' ' LYS 0.413 0.0 OUTLIER -82.98 80.4 9.03 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 122.73 1.253 . . . . 0.0 113.949 -175.604 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.521 177.227 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.835 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.0 79.21 8.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.435 ' HA ' ' NE2' ' A' ' 86' ' ' HIS . 26.6 ttt -110.18 126.71 54.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.681 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.554 ' H ' ' CD2' ' A' ' 86' ' ' HIS . . . -77.57 131.52 11.17 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.26 9.76 23.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.77 -52.8 58.69 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.029 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -101.14 104.95 16.06 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -62.79 -30.12 71.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.078 0.466 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -102.46 20.07 17.72 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.532 0.682 . . . . 0.0 111.531 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -78.7 122.34 25.87 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.236 -0.915 . . . . 0.0 109.748 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.427 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD23 ' OD1' ' A' ' 26' ' ' ASP . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.408 HG22 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD1' HD23 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.415 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HB3' ' NH2' ' C' ' 324' ' ' ARG . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD22 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' C' ' 330' ' ' GLU . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.463 HD22 ' NH2' ' C' ' 324' ' ' ARG . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.409 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.461 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 4' ' ' GLY . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.8 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 111' ' ' VAL . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt -75.36 -51.53 20.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 107' ' ' ASP . 5.2 p -84.42 129.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.637 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.0 p -87.97 -36.81 16.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.952 0.882 . . . . 0.0 109.999 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -129.29 95.33 4.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.767 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.67 -46.92 12.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -177.02 -168.0 0.19 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.67 7.24 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.8 91.63 4.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.829 0.347 . . . . 0.0 110.473 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.649 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -82.86 71.24 9.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.505 0.669 . . . . 0.0 111.289 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -89.19 -42.21 11.79 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.605 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.3 m -68.21 -59.9 2.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.649 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.494 ' OE1' ' HG3' ' B' ' 209' ' ' MET . 7.8 tt0 -169.97 158.57 7.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -63.68 -66.02 0.6 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.44 156.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.494 ' HG3' ' OE1' ' B' ' 204' ' ' GLN . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.408 ' OD2' HG22 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.404 HD21 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 -78.06 -30.65 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.256 1.415 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.3 t -132.15 140.17 48.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . 0.404 ' CD2' ' HG3' ' C' ' 314' ' ' MET . 93.0 m-85 -87.23 109.18 19.31 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -94.75 -40.76 9.6 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.053 0.454 . . . . 0.0 111.625 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.83 130.78 45.44 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.479 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -64.03 -36.86 46.26 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.077 2.518 . . . . 0.0 110.688 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -120.88 133.38 24.11 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.96 94.75 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.876 1.717 . . . . 0.0 113.141 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.01 -31.18 56.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.252 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -73.42 87.56 1.56 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 44.48 -91.06 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 116.303 171.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.34 12.32 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 76.26 61.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.671 1.188 . . . . 0.0 113.525 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.29 137.27 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.45 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 6.6 mmt -107.97 159.4 30.65 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.84 151.15 79.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 123.366 2.71 . . . . 0.0 113.885 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 175.13 45.19 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 86.0 t -88.43 109.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -75.92 151.45 37.33 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.836 0.71 . . . . 0.0 110.143 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.483 ' NH2' ' HB3' ' A' ' 33' ' ' GLU . 3.8 tpp180 -89.63 112.9 24.27 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.448 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 24.1 t -149.54 122.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -155.66 -49.74 0.08 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.78 31.11 5.26 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.885 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -70.21 141.56 52.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.411 0.624 . . . . 0.0 110.775 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.2 1.74 0.68 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.583 ' OE1' ' HG2' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -61.35 -63.16 1.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.583 ' HG2' ' OE1' ' C' ' 330' ' ' GLU . 44.5 mmtm -147.77 171.26 15.96 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 . . . . . 0 C--N 1.281 -2.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.482 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.97 100.24 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.067 0.46 . . . . 0.0 109.857 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.523 ' HA ' ' OD1' ' A' ' 85' ' ' ASP . 86.5 mtp -110.21 133.68 52.99 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.728 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.67 31.75 3.54 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -74.04 -11.29 60.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.954 0.901 . . . . 0.0 110.41 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.39 -24.98 42.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.03 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 9' ' ' ASP . 52.3 t80 -122.49 90.85 3.38 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -14.71 56.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 32.9 t70 -56.17 -23.77 37.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.341 0.657 . . . . 0.0 112.236 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 -76.45 100.9 5.38 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.529 HD23 ' OD2' ' A' ' 26' ' ' ASP . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' OD2' HD23 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.405 ' HA ' ' ND2' ' C' ' 309' ' ' ASN . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG11 ' OD1' ' A' ' 39' ' ' ASP . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.546 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CZ ' ' HG3' ' C' ' 324' ' ' ARG . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 3' ' ' MET . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.9 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt -82.64 -44.45 19.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.45 138.31 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -97.56 82.7 3.12 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -147.23 115.2 6.51 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.66 -34.42 19.78 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -114.03 115.59 27.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.51 23.71 9.09 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.74 171.79 13.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.472 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.016 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.3 m -67.32 128.81 37.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 122.868 0.467 . . . . 0.0 110.078 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -130.17 -21.57 2.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.184 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 -12.61 55.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.908 0.861 . . . . 0.0 109.031 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -153.2 152.13 30.88 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -91.51 -64.03 1.18 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.017 0.913 . . . . 0.0 109.27 -175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.79 150.86 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.61 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 -66.54 -48.82 68.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.256 1.438 0 O-C-N 124.87 1.356 . . . . 0.0 111.865 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.9 m -123.38 162.82 22.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -120.62 109.57 15.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -119.95 -19.55 7.83 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -90.38 123.56 65.21 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.124 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.52 -3.73 9.25 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.427 2.751 . . . . 0.0 111.729 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -150.15 152.35 33.5 Favored Pre-proline 0 N--CA 1.423 -1.789 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.23 79.35 0.78 Allowed 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.897 1.731 . . . . 0.0 113.691 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -66.99 -17.06 64.75 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.451 1.101 . . . . 0.0 109.28 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 34' ' ' TYR . 2.7 m-20 -82.16 18.38 1.4 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.475 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 59.75 -73.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.974 1.71 . . . . 0.0 113.915 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.18 17.13 2.12 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.88 0.872 . . . . 0.0 112.308 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.55 32.99 16.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.942 0.897 . . . . 0.0 112.035 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 8.0 mt -79.04 134.85 26.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.44 ' HA ' ' HE1' ' C' ' 314' ' ' MET . 23.9 mmt -90.06 135.53 29.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.21 146.9 16.91 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 124.166 3.244 . . . . 0.0 113.773 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 171.82 34.24 0.03 OUTLIER Glycine 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.33 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -94.2 120.88 35.08 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.06 0.457 . . . . 0.0 111.194 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -100.15 99.81 10.57 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.535 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.6 m -99.73 128.78 45.82 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -164.87 103.91 0.79 Allowed 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.16 31.35 78.64 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 170.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' C' ' 330' ' ' GLU . 54.7 t80 -67.46 137.86 56.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 117.764 0.782 . . . . 0.0 111.807 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.11 3.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.695 2.48 . . . . 0.0 117.695 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.463 ' HB2' ' CE2' ' C' ' 328' ' ' PHE . 4.5 tp10 -66.61 1.12 1.88 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.412 1.006 . . . . 0.0 113.409 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.18 109.52 11.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.947 -1.095 . . . . 0.0 108.813 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.9 m95 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.269 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.92 -37.75 12.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.639 0.257 . . . . 0.0 110.915 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.412 ' HE2' ' HB3' ' A' ' 73' ' ' ASN . 1.7 mpt? -70.73 139.29 51.1 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.423 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 60.65 4.84 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.789 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -79.93 -6.09 56.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -82.39 -26.23 33.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -90.6 137.4 32.39 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -32.21 1.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -101.54 5.22 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.429 0.633 . . . . 0.0 111.581 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 -88.12 101.52 13.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.41 ' CG ' ' HD2' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 HD12 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.484 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 102' ' ' VAL . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD11 ' CG ' ' A' ' 44' ' ' ARG . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' CG ' HD11 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.432 ' OG ' HD12 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' O ' HD21 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' HD21 ' A' ' 57' ' ' LEU . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.616 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.412 ' HB3' ' CD2' ' C' ' 311' ' ' PHE . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.56 HG23 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' CB ' ' HD2' ' C' ' 331' ' ' LYS . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.412 ' HB3' ' HE2' ' A' ' 3' ' ' MET . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.56 ' NE2' HG23 ' A' ' 69' ' ' VAL . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.501 ' O ' HG21 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.527 ' O ' HG13 ' A' ' 110' ' ' ILE . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt -72.42 -52.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.03 135.52 14.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.4 m -78.13 136.92 37.95 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.57 -16.34 63.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.78 93.49 7.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -143.11 90.04 2.16 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.141 0.972 . . . . 0.0 111.158 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.56 118.87 4.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.17 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 81.92 4.22 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.293 1.044 . . . . 0.0 112.567 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.245 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 15.2 m -79.32 121.46 25.13 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.66 -31.09 10.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.9 m -69.27 -56.42 7.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.377 0.608 . . . . 0.0 109.802 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.92 139.26 26.12 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.56 -103.0 0.25 Allowed 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -171.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.494 HG21 HG13 ' B' ' 208' ' ' ILE . 4.9 mm -90.41 132.69 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.494 HG13 HG21 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.405 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 -79.99 -36.64 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 123.633 0.773 . . . . 0.0 112.666 174.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.5 t -132.34 130.84 41.27 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.529 0.681 . . . . 0.0 110.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.03 3.82 15.46 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.234 1.016 . . . . 0.0 109.702 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' C' ' 304' ' ' LYS . 0.0 OUTLIER -81.35 127.0 75.14 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.092 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.46 -33.94 77.55 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.614 2.876 . . . . 0.0 112.362 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -131.68 153.4 81.49 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.01 118.36 5.26 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.956 1.771 . . . . 0.0 109.76 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -30.65 71.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.57 87.09 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -7.11 3.46 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 19.3 m-85 -114.79 11.72 16.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.759 0.79 . . . . 0.0 109.199 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.6 19.94 11.65 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.8 mp -71.67 124.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.454 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 16.4 mmt -85.74 153.65 58.16 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -40.81 140.69 1.05 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.622 3.548 . . . . 0.0 114.524 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.24 -13.29 4.64 Favored Glycine 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.08 114.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 142.2 32.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.572 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 1.5 mpt_? -99.59 107.3 19.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 18.8 m -111.59 118.96 37.13 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -170.65 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.6 33.11 75.61 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.836 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -39.27 112.13 0.23 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.986 1.314 . . . . 0.0 113.015 -168.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.29 -7.44 24.38 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.791 -167.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.18 -36.52 80.07 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.567 -0.708 . . . . 0.0 111.851 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.482 ' HD2' ' CB ' ' A' ' 70' ' ' ASP . 11.8 tmtt? -109.65 137.33 47.62 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . 0.477 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 48.5 p-90 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.77 96.73 1.15 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.975 0.417 . . . . 0.0 110.215 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -102.19 120.9 41.22 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 11.37 0.86 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.469 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 86' ' ' HIS . 9.3 p30 -60.97 -11.54 8.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.851 0.86 . . . . 0.0 112.195 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.4 -41.13 75.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -102.88 91.98 4.38 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -81.98 -2.45 51.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.649 0.738 . . . . 0.0 111.015 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.558 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 6.3 p-10 -76.23 -11.87 59.99 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.076 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -71.86 112.36 7.89 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.648 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.466 ' OD2' HD23 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' C' ' 324' ' ' ARG . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 57' ' ' LEU . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.558 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 5' ' ' ASN . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.471 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.535 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt -83.25 -48.11 17.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.31 -20.26 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.923 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 t -136.81 149.59 47.84 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.755 -0.59 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.466 ' HB3' ' HZ3' ' A' ' 113' ' ' LYS . 3.4 mmmp? -85.64 -5.16 59.3 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -112.04 93.25 4.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.649 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -104.86 91.44 3.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.11 104.8 16.97 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.675 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -145.43 168.56 20.25 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--N 1.29 -1.981 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.0 p -168.19 99.02 0.44 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.028 0.442 . . . . 0.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -104.53 19.86 19.58 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.828 0.823 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.3 p -99.05 10.04 42.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.19 128.42 0.04 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.132 2.173 . . . . 0.0 109.299 -173.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.431 ' HE2' ' SD ' ' B' ' 209' ' ' MET . 2.3 p90 -88.31 -82.05 0.24 Allowed 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.343 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.7 mt -134.26 145.18 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.478 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . 0.411 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.431 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.466 HD23 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 -74.83 -15.45 60.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.182 177.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 39.6 t -74.15 -52.65 11.86 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -113.84 135.79 53.59 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.42 -54.19 6.45 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -90.83 120.02 68.84 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.97 -16.4 45.19 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.969 2.446 . . . . 0.0 110.977 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -132.93 103.66 12.97 Favored Pre-proline 0 N--CA 1.412 -2.373 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.31 106.15 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.445 2.097 . . . . 0.0 110.973 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.92 -31.02 62.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.179 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -60.74 124.41 20.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.485 ' HD3' ' H ' ' C' ' 310' ' ' ARG . 0.0 OUTLIER -57.01 -21.74 33.14 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.174 0.989 . . . . 0.0 113.543 -177.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -77.29 -10.92 59.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.25 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 64.3 26.09 13.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.854 1.262 . . . . 0.0 112.4 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 14.4 mt -104.0 145.64 12.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.456 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 5.0 mmt -120.06 150.32 50.87 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.52 135.18 33.29 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.404 2.736 . . . . 0.0 113.075 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 156.53 -23.82 0.5 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.57 111.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 124.415 0.715 . . . . 0.0 109.789 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.69 140.12 56.69 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.16 98.8 7.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 168.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 50.9 m -87.43 100.93 13.11 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -166.2 -179.62 5.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 99.17 18.85 23.09 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.0 OUTLIER -84.27 173.05 11.3 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.038 -1.081 . . . . 0.0 111.813 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -23.02 63.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.4 0.68 . . . . 0.0 112.655 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.632 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 66.2 mm-40 -78.29 0.16 26.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.111 0.482 . . . . 0.0 112.124 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -109.03 127.71 54.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.107 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.876 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.36 152.0 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.902 0.881 . . . . 0.0 109.108 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.22 109.16 3.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 86' ' ' HIS . . . 73.1 72.22 1.0 Allowed Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -55.27 -43.88 75.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.146 0.578 . . . . 0.0 110.547 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -94.28 -66.73 0.9 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -146.47 175.64 10.41 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -18.4 54.26 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 9.98 5.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.16 97.29 4.08 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD23 ' OD2' ' A' ' 26' ' ' ASP . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' OD2' HD23 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' C' ' 324' ' ' ARG . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.55 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.464 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.434 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.409 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' O ' HG11 ' A' ' 111' ' ' VAL . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt -77.1 -58.02 4.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -65.79 139.27 21.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.994 -173.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -88.07 148.36 24.51 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -85.71 93.13 8.78 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.08 -75.96 0.61 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.486 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -141.23 101.16 3.96 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.227 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.4 65.04 4.45 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.43 -44.26 71.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.095 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 C--N 1.299 -1.593 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.407 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.701 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 27.8 t -130.48 137.38 49.74 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -111.27 -46.22 3.32 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.693 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 8.8 m -49.86 -52.17 34.7 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.212 1.005 . . . . 0.0 111.07 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.92 -179.75 8.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -114.64 -66.6 1.07 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 mm -131.37 139.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.453 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.46 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 -85.53 -17.17 37.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.29 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.495 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.2 t -158.28 -50.58 0.06 Allowed 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -105.21 109.38 21.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.23 -54.87 7.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -90.11 123.2 66.53 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.413 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.95 -26.65 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.142 1.895 . . . . 0.0 110.852 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.49 123.56 35.44 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.95 89.43 0.77 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.112 1.875 . . . . 0.0 113.403 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.42 20.03 16.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.529 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.88 36.96 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 67.02 -47.8 0.47 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.984 1.714 . . . . 0.0 114.96 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -105.46 17.98 23.0 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 122.07 -0.394 . . . . 0.0 110.743 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.88 17.46 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.988 0.915 . . . . 0.0 112.906 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.405 ' O ' ' HE2' ' C' ' 314' ' ' MET . 35.6 mt -86.49 144.62 9.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' C' ' 314' ' ' MET . 2.8 mmt -107.07 136.34 19.49 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -64.19 168.71 12.0 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 124.014 3.143 . . . . 0.0 114.617 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 144.98 51.95 0.03 OUTLIER Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.85 108.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -65.79 150.41 48.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.155 0.91 . . . . 0.0 110.252 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.437 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 1.1 mmp_? -83.2 99.53 10.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.101 0.477 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 2.4 p -86.07 88.34 7.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 178.16 -171.78 0.12 Allowed 'General case' 0 C--O 1.243 0.744 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.15 -40.37 2.21 Favored Glycine 0 C--N 1.29 -2.014 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -90.87 97.07 10.96 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 122.04 0.924 . . . . 0.0 110.833 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.69 -67.58 0.85 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.58 -43.15 6.96 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.014 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -170.79 174.82 4.75 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 . . . . . 0 C--N 1.288 -2.081 0 CA-C-N 119.347 0.976 . . . . 0.0 109.756 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.398 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.86 79.03 0.15 Allowed 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.045 0.938 . . . . 0.0 110.673 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 137.68 56.73 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.087 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.82 83.86 0.49 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.674 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -79.28 -2.87 43.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.848 0.833 . . . . 0.0 109.074 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.26 -32.55 74.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.808 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.607 ' CD2' ' HB2' ' A' ' 86' ' ' HIS . 90.1 m-85 -87.91 137.61 32.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.649 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.73 -50.47 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.856 0.36 . . . . 0.0 111.715 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -81.81 13.16 3.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 7' ' ' TYR . 10.5 m120 -111.03 94.06 4.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.389 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 57' ' ' LEU . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.572 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 HD23 ' OD1' ' A' ' 26' ' ' ASP . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.483 ' OD1' HD23 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.627 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' C' ' 314' ' ' MET . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.591 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 86' ' ' HIS . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' C' ' 329' ' ' GLU . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' C' ' 328' ' ' PHE . 12.8 m120 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CZ ' ' HG2' ' C' ' 324' ' ' ARG . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.607 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' O ' HG21 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 110' ' ' ILE . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt -66.01 -45.0 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.12 142.61 16.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.238 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.6 m -100.17 154.98 18.01 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -61.73 110.03 1.4 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.078 0.466 . . . . 0.0 109.993 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -135.45 143.26 45.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.79 -42.52 24.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.82 126.34 5.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -62.66 -46.65 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.15 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 204' ' ' GLN . 7.7 t -156.19 139.14 15.36 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -74.29 -41.38 61.29 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.9 m -73.99 -58.55 3.23 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.226 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' B' ' 201' ' ' SER . 52.7 tt0 -136.21 120.21 17.59 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.89 -64.95 0.66 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.023 0.929 . . . . 0.0 111.605 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.7 mm -125.89 153.06 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.404 ' HA ' ' HE3' ' B' ' 209' ' ' MET . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.596 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 -81.67 -12.74 58.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.256 1.426 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.426 178.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.9 p -165.25 147.34 7.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.92 171.06 8.7 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -95.86 30.77 2.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.829 0.824 . . . . 0.0 110.344 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -79.2 136.62 56.97 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.876 -0.515 . . . . 0.0 110.306 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.19 -47.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.794 2.329 . . . . 0.0 112.245 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -104.56 125.13 34.85 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -56.78 132.21 50.33 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.195 1.93 . . . . 0.0 110.733 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -72.26 -18.43 61.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.194 0.997 . . . . 0.0 108.576 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.85 93.97 1.76 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -43.15 -46.32 5.85 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -170.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 82.1 m-85 -99.97 21.47 12.65 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.877 -0.515 . . . . 0.0 112.192 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 68.32 28.61 6.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 4.7 mp -78.27 146.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.472 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 19.6 mmt -80.22 136.22 53.57 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.2 150.28 84.99 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.67 2.247 . . . . 0.0 111.229 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 142.8 -21.63 2.33 Favored Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.16 107.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.446 0.698 . . . . 0.0 109.751 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -94.67 137.08 34.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.065 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.627 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 12.3 mtm180 -127.35 143.55 51.2 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 123.438 0.695 . . . . 0.0 109.919 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 38.4 m -155.33 110.25 2.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.17 113.16 7.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.601 0.715 . . . . 0.0 111.962 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.28 31.66 10.44 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.091 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.482 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 70.9 t80 -64.76 145.1 56.72 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.987 0.393 . . . . 0.0 110.753 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . 0.431 ' HG3' ' OD2' ' A' ' 70' ' ' ASP . 29.2 mt-10 -66.1 2.92 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -40.01 -41.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -93.87 113.98 26.11 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.299 0.571 . . . . 0.0 109.572 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 70.9 m95 . . . . . 0 C--N 1.299 -1.629 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.208 -176.122 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.17 99.64 3.42 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -109.6 143.95 38.6 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.97 49.69 3.07 Favored Glycine 0 C--N 1.306 -1.104 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -90.22 -53.53 4.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.176 0.512 . . . . 0.0 110.109 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.64 -21.5 20.77 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.046 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.24 80.13 3.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.244 0.545 . . . . 0.0 109.72 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -119.99 -6.55 10.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.801 0.81 . . . . 0.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.15 -37.63 78.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.768 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -103.9 116.97 33.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.501 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.482 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.432 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.569 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.651 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' C' ' 310' ' ' ARG . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' CG ' ' HZ1' ' C' ' 331' ' ' LYS . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' O ' HG22 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 40' ' ' VAL . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' HG11 ' A' ' 111' ' ' VAL . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.46 HD11 HG12 ' A' ' 38' ' ' VAL . 70.8 mt -69.37 -44.11 80.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 107' ' ' ASP . 10.5 p -68.54 -38.29 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.56 0.695 . . . . 0.0 110.337 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.0 m -156.35 124.59 5.72 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.02 73.21 2.89 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.898 0.856 . . . . 0.0 111.666 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -175.87 -55.37 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -170.76 163.44 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 108' ' ' ARG . . . -100.22 136.03 40.74 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -154.01 -49.41 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' B' ' 204' ' ' GLN . 14.5 m -68.5 145.66 53.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.75 -18.63 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.9 t -71.2 -60.21 2.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' B' ' 201' ' ' SER . 3.8 pm0 -149.85 144.45 25.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.672 ' HE1' ' SD ' ' B' ' 209' ' ' MET . 0.7 OUTLIER -37.71 -56.37 1.07 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.469 HG21 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -126.81 146.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.469 HG13 HG21 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.672 ' SD ' ' HE1' ' B' ' 205' ' ' TYR . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -93.57 -45.4 7.75 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.423 -1.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.163 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 CA-C-O 119.274 -0.737 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 34.9 t -53.86 -71.95 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.424 0.69 . . . . 0.0 110.11 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.72 108.42 18.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -103.62 -51.05 3.28 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.141 -169.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -72.78 147.8 89.28 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.346 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.81 -15.07 21.45 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.652 2.235 . . . . 0.0 111.193 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -127.29 128.93 23.99 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -72.6 45.69 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.196 2.597 . . . . 0.0 112.401 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.72 35.16 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.018 1.327 . . . . 0.0 112.295 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.14 71.0 8.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . 16.1 tpp180 57.2 -79.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.619 2.368 . . . . 0.0 112.594 -177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' C' ' 313' ' ' ILE . 50.7 m-85 -92.13 -6.64 50.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 80.7 61.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.335 1.454 . . . . 0.0 113.953 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 3.7 mp -118.68 128.32 75.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.475 ' HA ' ' HE1' ' C' ' 314' ' ' MET . 4.5 mmt -93.95 153.67 40.86 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.31 156.87 5.11 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.229 3.286 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -174.53 22.89 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 83.9 t -81.52 112.34 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -81.81 133.19 35.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -106.31 141.61 37.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 15.2 m -73.79 95.36 2.39 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -135.5 -169.63 2.43 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.246 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.74 31.62 7.69 Favored Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.003 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.47 166.43 23.53 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.496 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.1 4.24 7.14 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.911 1.684 . . . . 0.0 111.783 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' C' ' 331' ' ' LYS . 0.3 OUTLIER -38.74 -22.1 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.458 ' HB2' ' HZ2' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -139.07 159.51 41.98 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.002 -1.061 . . . . 0.0 110.018 -177.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.742 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.406 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.09 120.97 3.83 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.45 108.39 20.6 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.014 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' HA2' ' CD2' ' A' ' 7' ' ' TYR . . . -166.7 28.48 0.18 Allowed Glycine 0 C--N 1.293 -1.817 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.159 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.44 -15.85 55.8 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.296 0.57 . . . . 0.0 109.468 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -4.17 35.06 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.405 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 67.0 m-85 -82.76 91.99 7.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.489 0.662 . . . . 0.0 109.893 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -20.62 20.25 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.028 -176.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -93.63 -19.49 21.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.764 0.792 . . . . 0.0 110.777 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.63 98.16 10.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.109 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD13 HD22 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.686 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 102' ' ' VAL . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' N ' HD21 ' A' ' 57' ' ' LEU . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.678 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.678 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.442 ' O ' HG11 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.703 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.539 ' O ' HG21 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 111' ' ' VAL . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt -81.31 -62.06 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 107' ' ' ASP . 1.4 p -81.34 135.32 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -69.83 -40.83 75.62 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -147.35 113.93 6.01 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -87.99 131.11 34.75 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -100.89 101.1 11.85 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.033 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.4 105.54 15.62 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.386 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.8 86.71 2.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.035 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 34.3 m -83.51 88.79 7.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.371 0.605 . . . . 0.0 110.424 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -105.81 -2.77 22.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.544 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -57.95 -50.52 73.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -166.22 133.84 2.78 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.417 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 3.7 m-85 -63.99 -60.76 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mt -138.76 152.92 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.403 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.696 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 -76.6 -8.23 56.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.927 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 44.5 m -87.64 54.43 3.12 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.706 0.765 . . . . 0.0 110.579 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -121.29 109.59 15.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.9 -36.07 10.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.435 ' HB3' ' HZ1' ' C' ' 304' ' ' LYS . 2.9 mmmp? -80.02 120.66 80.47 Favored Pre-proline 0 C--N 1.309 -1.155 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.45 -29.43 6.04 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.647 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -148.93 161.0 33.99 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -98.68 109.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.806 2.337 . . . . 0.0 113.883 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' C' ' 304' ' ' LYS . 0.7 OUTLIER -83.46 -36.94 23.79 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -85.94 137.52 32.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -54.61 -36.51 64.55 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.481 0.713 . . . . 0.0 111.561 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -91.44 1.43 57.13 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 63.23 16.79 9.71 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.324 1.05 . . . . 0.0 112.865 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.47 135.37 35.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.378 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.462 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 5.8 mmt -120.9 153.23 57.17 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.67 145.64 22.48 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.646 2.897 . . . . 0.0 113.543 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 133.14 -7.14 5.08 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.27 113.84 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -95.25 136.61 35.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.686 ' NH2' ' HA ' ' A' ' 30' ' ' VAL . 5.8 mpt_? -99.84 149.84 22.97 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.9 p -135.21 89.42 2.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -156.4 132.8 10.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.92 30.83 55.24 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.842 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' C' ' 330' ' ' GLU . 24.1 t80 -86.17 159.44 19.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.268 0.556 . . . . 0.0 110.93 -175.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.85 1.0 48.98 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.479 1.511 . . . . 0.0 113.742 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.415 ' HB2' ' CD2' ' C' ' 328' ' ' PHE . 3.7 tm-20 -55.7 -43.75 76.73 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.6 0.76 . . . . 0.0 111.316 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 9.6 tmtt? -74.61 132.26 41.61 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . 0.549 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 58.1 p-90 . . . . . 0 C--N 1.311 -1.066 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.11 99.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.042 1.337 . . . . 0.0 110.429 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.454 ' O ' HG21 ' A' ' 66' ' ' ILE . 68.8 mtt -82.23 -179.33 7.37 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.009 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.08 34.97 9.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.77 -42.35 97.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.155 -0.522 . . . . 0.0 110.263 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.63 -36.75 11.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -98.72 114.55 27.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -122.21 -20.95 6.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.038 -177.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.92 -27.51 23.32 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.406 0.622 . . . . 0.0 109.853 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.03 107.34 6.18 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.958 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' OD2' ' A' ' 26' ' ' ASP . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' HD23 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.541 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.541 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 3' ' ' MET . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.436 ' O ' HG11 ' A' ' 111' ' ' VAL . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt -64.57 -47.14 90.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 107' ' ' ASP . 9.4 p -79.04 114.59 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 122.646 1.212 . . . . 0.0 108.531 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 p -90.61 174.98 7.22 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.429 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -70.58 113.0 7.25 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 47.7 t30 73.12 88.37 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.705 1.202 . . . . 0.0 108.92 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -154.09 -57.27 0.11 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.916 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -148.2 100.89 3.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.997 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.25 116.82 29.27 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.294 -1.811 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.655 -178.679 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.973 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -77.64 102.57 7.11 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.14 0.495 . . . . 0.0 110.076 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.8 -20.68 11.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.382 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -79.64 -38.88 32.77 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -129.88 147.26 51.62 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -132.72 -69.82 0.56 Allowed 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 122.887 0.475 . . . . 0.0 110.755 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.48 146.04 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.565 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . 0.442 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.425 HD23 ' OD2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 -84.86 -39.37 18.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.413 -2.311 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.718 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.3 t -150.74 154.33 37.18 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -73.84 124.73 26.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -130.7 31.03 4.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.781 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.68 126.15 74.95 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.003 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.03 -39.75 22.97 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.432 2.088 . . . . 0.0 109.165 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.23 46.26 Favored Pre-proline 0 N--CA 1.411 -2.394 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.67 -22.96 63.52 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.566 2.177 . . . . 0.0 112.172 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' C' ' 331' ' ' LYS 0.47 12.1 pt-20 59.58 -56.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.644 2.377 . . . . 0.0 115.223 -175.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -36.46 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.704 2.002 . . . . 0.0 110.473 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -41.81 -48.21 4.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.176 1.79 . . . . 0.0 115.093 -173.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.61 7.68 42.31 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.993 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 49.2 60.35 3.82 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.423 1.089 . . . . 0.0 112.125 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.43 129.47 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.468 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 4.0 mmt -94.23 148.05 34.42 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.736 0.648 . . . . 0.0 111.138 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.27 141.27 50.19 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.366 3.377 . . . . 0.0 114.377 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.442 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 147.67 -19.74 1.47 Allowed Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.12 113.03 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 O-C-N 124.364 0.685 . . . . 0.0 109.489 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -61.24 136.49 58.07 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.562 1.145 . . . . 0.0 112.241 -169.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -108.85 130.09 55.41 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 53.0 m -156.84 130.86 8.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -111.65 -43.29 3.67 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.49 25.89 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -75.64 151.23 37.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.183 -1.008 . . . . 0.0 111.916 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.01 1.37 1.47 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.716 2.407 . . . . 0.0 113.891 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.68 -26.51 60.76 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.59 0.756 . . . . 0.0 112.644 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' C' ' 308' ' ' GLU . 26.6 tptp -90.79 125.06 35.6 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.256 -170.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 74.0 m95 . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.62 29.57 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.615 0.245 . . . . 0.0 110.65 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ttt -72.85 139.81 47.19 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 86' ' ' HIS . . . 160.87 -51.5 0.35 Allowed Glycine 0 CA--C 1.487 -1.698 0 C-N-CA 118.566 -1.778 . . . . 0.0 114.678 175.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -73.09 7.19 2.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.208 1.004 . . . . 0.0 111.288 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -93.66 -31.22 14.55 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.79 -0.569 . . . . 0.0 111.492 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -139.27 148.6 43.23 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -102.58 -17.73 15.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.49 3.86 20.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 13.4 m120 -86.55 99.52 11.76 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.442 ' HB ' ' HB1' ' A' ' 55' ' ' ALA . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.583 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 9.3 m120 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD13 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' N ' HD13 ' A' ' 42' ' ' LEU . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HG2' HD11 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.488 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 15' ' ' ILE . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' N ' HD23 ' A' ' 57' ' ' LEU . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.573 HH11 ' ND2' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HE2' ' CE2' ' B' ' 205' ' ' TYR . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.491 ' O ' HG21 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.416 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt -90.51 -35.59 7.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.74 170.09 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.161 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m -61.4 104.75 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.183 0.516 . . . . 0.0 110.656 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -101.67 -16.11 16.8 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -49.51 111.79 0.55 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.689 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -160.2 120.66 2.96 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.054 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.28 80.03 9.34 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.702 0.763 . . . . 0.0 111.811 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.33 157.5 46.65 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.906 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.889 -178.26 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.745 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.9 p -132.18 113.45 13.3 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.222 0.534 . . . . 0.0 111.854 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.74 -30.0 18.33 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -109.99 -70.42 0.81 Allowed 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 179.38 166.39 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -124.4 -94.5 0.48 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.792 0.269 . . . . 0.0 111.425 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.448 HG21 HG13 ' B' ' 208' ' ' ILE . 4.4 mm -104.05 145.36 12.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.448 HG13 HG21 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.466 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 -81.3 -9.2 59.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.339 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.4 m -80.64 138.24 36.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -83.19 141.63 31.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.86 13.55 13.16 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.0 125.4 78.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.906 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.53 -17.29 12.87 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.568 2.178 . . . . 0.0 111.289 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.51 16.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.74 92.48 1.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.222 1.948 . . . . 0.0 111.699 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.512 0.672 . . . . 0.0 110.201 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -168.12 162.01 12.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -49.46 -52.15 31.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.063 0.945 . . . . 0.0 111.309 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -111.76 17.17 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.25 0.547 . . . . 0.0 110.453 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.22 60.85 1.39 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.7 144.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 3.3 mmt -106.12 154.15 39.8 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.12 155.2 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.14 2.56 . . . . 0.0 114.157 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -159.26 29.09 0.4 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.36 109.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -82.98 148.18 27.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.261 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 99.87 11.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -139.58 110.56 6.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.567 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -129.12 18.37 6.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.808 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.53 -41.55 1.91 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.603 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' C' ' 331' ' ' LYS . 14.1 p90 -103.01 164.41 11.63 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -91.73 -70.37 0.69 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.629 0.728 . . . . 0.0 111.54 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.8 -39.89 6.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . 0.436 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 12.4 tmtt? 82.12 129.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.165 1.386 . . . . 0.0 109.589 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.025 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.501 ' HA2' ' OD1' ' A' ' 73' ' ' ASN . . . . . . . . 0 CA--C 1.488 -1.62 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.8 93.52 3.63 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 117.078 0.439 . . . . 0.0 109.976 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 ptp -110.36 153.15 25.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.01 165.78 37.08 Favored Glycine 0 N--CA 1.415 -2.714 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.055 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -98.81 -14.46 19.67 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.8 -31.98 63.53 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -76.85 86.18 3.43 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.643 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -130.51 -42.57 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.548 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.07 -27.09 48.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.994 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.58 82.46 7.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.759 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.472 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.656 ' O ' ' HB ' ' A' ' 65' ' ' THR . 7.1 tp-100 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' C' ' 311' ' ' PHE . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.501 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' O ' HG21 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.96 -52.25 14.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 114.68 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-O 121.989 0.899 . . . . 0.0 109.375 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m -92.18 -18.78 23.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.645 0.736 . . . . 0.0 109.294 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -99.27 102.66 14.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -178.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -71.26 103.71 2.91 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.862 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.22 100.88 11.48 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.45 1.119 . . . . 0.0 108.717 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.74 47.12 2.56 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.46 80.76 5.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.131 -176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.154 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.266 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.4 p -95.37 148.52 22.36 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 120.72 0.295 . . . . 0.0 110.693 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -97.45 -31.78 12.18 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.786 0.434 . . . . 0.0 111.987 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.5 m -63.45 -64.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.581 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 51.2 tt0 -127.01 167.41 15.95 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -124.29 -66.31 0.99 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.48 155.81 8.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . 0.43 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.457 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 -64.17 -40.98 97.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.256 1.414 0 C-N-CA 125.404 1.481 . . . . 0.0 109.963 -179.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.945 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 3.1 p -105.17 127.21 52.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -53.91 124.35 15.17 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.582 0.706 . . . . 0.0 111.844 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 -54.4 4.63 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.532 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.504 ' HZ3' ' CD2' ' C' ' 323' ' ' HIS . 95.9 mttt -90.87 139.52 26.07 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.08 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.56 -5.1 10.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.551 2.167 . . . . 0.0 114.332 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -134.6 142.8 43.98 Favored Pre-proline 0 C--N 1.309 -1.163 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.16 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.3 84.56 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.372 2.048 . . . . 0.0 110.175 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.53 -4.9 58.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.093 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' C' ' 311' ' ' PHE . 0.4 OUTLIER -89.11 148.65 23.57 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.05 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.404 ' HE ' ' HB3' ' C' ' 310' ' ' ARG . 27.1 ttp180 -49.38 -35.67 19.49 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 128.127 2.571 . . . . 0.0 113.759 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.587 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 21.4 m-85 -89.99 -24.41 21.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.5 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.4 62.2 1.61 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.481 0.712 . . . . 0.0 111.883 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 30.9 mm -104.69 152.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.466 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 17.7 mmt -97.09 142.38 24.44 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 167.14 7.81 Favored 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 123.311 2.674 . . . . 0.0 112.871 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . 0.439 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 177.24 44.08 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.22 108.08 19.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . 0.504 ' CD2' ' HZ3' ' C' ' 304' ' ' LYS . 71.0 t60 -72.83 141.06 47.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 80.8 mtt-85 -128.26 129.3 46.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.639 0.733 . . . . 0.0 112.183 -171.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 65.1 m -148.05 148.83 31.1 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -100.51 -4.18 29.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.051 0.453 . . . . 0.0 110.669 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.52 13.34 30.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.37 165.14 24.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.753 0.311 . . . . 0.0 110.869 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.18 3.87 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.566 2.346 . . . . 0.0 115.169 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -41.03 -32.11 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.975 1.31 . . . . 0.0 114.433 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -76.3 126.76 31.58 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 120.89 -1.131 . . . . 0.0 109.63 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.639 1.576 . . . . 0.0 114.879 -173.447 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.926 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.81 64.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.537 0.685 . . . . 0.0 110.152 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.7 mtt -104.07 109.0 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.354 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.14 166.09 16.09 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -80.8 10.04 5.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.009 0.909 . . . . 0.0 110.762 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.25 -12.15 50.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.656 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' HH ' HG23 ' A' ' 66' ' ' ILE . 12.8 t80 -51.09 -31.09 17.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.573 1.549 . . . . 0.0 114.149 -171.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.25 -28.94 28.84 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.843 0.354 . . . . 0.0 111.576 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -106.05 -4.41 20.48 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 -93.96 86.27 4.99 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.613 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' A' ' 29' ' ' THR . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 60' ' ' GLU . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' N ' HD22 ' A' ' 57' ' ' LEU . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.57 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 106' ' ' LEU . 18.5 mt -75.44 -50.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.493 HG23 ' H ' ' A' ' 113' ' ' LYS . 9.8 p -57.9 138.67 18.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.579 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.444 ' C ' ' HD3' ' A' ' 113' ' ' LYS . 20.0 m -89.42 0.28 56.97 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.377 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 46.48 28.32 0.73 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.119 1.768 . . . . 0.0 113.145 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -92.77 -50.25 5.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.697 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.87 164.27 20.42 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.565 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.43 103.77 15.3 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.79 -6.34 14.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.516 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 10.0 p -132.61 -61.05 0.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.44 9.41 42.46 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.127 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.5 m -54.88 -40.93 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.817 0.847 . . . . 0.0 109.695 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -153.38 136.97 15.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -91.78 -50.44 5.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.381 0.61 . . . . 0.0 109.988 -172.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.421 HG23 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -117.82 142.51 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.613 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.408 ' H ' ' CG ' ' A' ' 26' ' ' ASP . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.434 HD23 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 -77.52 -33.65 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t -118.92 162.11 19.06 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -72.09 112.18 7.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.787 0.804 . . . . 0.0 111.256 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.1 4.82 12.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.712 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -81.56 134.16 51.54 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.007 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.43 -27.58 33.49 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.017 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -135.72 143.26 43.99 Favored Pre-proline 0 N--CA 1.432 -1.374 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.261 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -62.53 -39.16 46.75 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.944 2.429 . . . . 0.0 112.138 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 65.12 32.4 10.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.713 1.205 . . . . 0.0 109.366 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -114.73 146.95 40.36 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.172 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' C' ' 330' ' ' GLU . 8.9 tpt180 -49.45 -42.12 42.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.077 0.951 . . . . 0.0 112.452 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.45 -8.01 39.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 55.89 32.28 19.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.948 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.91 139.77 18.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.97 144.3 82.17 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -73.08 155.8 52.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.989 2.459 . . . . 0.0 111.777 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 129.21 -14.02 5.94 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.28 109.68 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -90.98 118.68 30.55 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 3.7 mpt_? -94.02 147.9 22.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.896 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 11.2 t -137.08 102.27 4.79 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -100.06 9.06 43.45 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.279 -167.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 118.96 -41.47 2.0 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -100.95 95.81 6.84 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -95.96 -66.3 0.92 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 123.127 1.442 . . . . 0.0 108.754 168.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . 0.51 ' O ' ' HD3' ' C' ' 310' ' ' ARG . 12.5 pt-20 -100.82 -30.92 11.43 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.952 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -163.82 153.39 14.55 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.396 -177.385 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.314 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.08 85.72 1.99 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.54 109.48 19.66 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.024 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.24 -13.39 71.26 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -72.68 10.12 0.93 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.979 1.312 . . . . 0.0 112.23 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.4 -39.12 74.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 172.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 t80 57.83 17.16 4.03 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.466 1.906 . . . . 0.0 115.115 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -100.02 -10.68 21.31 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.567 -1.333 . . . . 0.0 112.127 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 25.2 t70 -66.62 -34.48 77.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 109.25 0.94 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.652 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.652 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.638 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.437 HG13 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.411 HG22 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.476 ' N ' HD22 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.645 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD21 ' CE1' ' C' ' 311' ' ' PHE . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' HE3' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.43 HD13 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.3 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' O ' HG21 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CE2' HG22 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD11 HG13 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.402 HD12 HG11 ' A' ' 38' ' ' VAL . 45.0 mt -90.62 -42.6 14.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 113' ' ' LYS . 12.5 p -60.72 147.51 10.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.571 -177.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 t -86.7 37.68 0.76 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 111' ' ' VAL . 35.9 mtmm 61.86 82.92 0.16 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 112.897 -177.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -142.94 93.58 2.52 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.54 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.41 -59.67 2.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.13 30.89 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.079 0.466 . . . . 0.0 110.066 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.1 -51.37 3.27 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 177.114 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.576 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -116.78 123.59 47.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -88.01 -2.54 58.67 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.2 m -65.03 -23.03 67.08 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.763 1.225 . . . . 0.0 113.093 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' B' ' 205' ' ' TYR . 33.5 tt0 -158.73 166.04 32.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.535 ' N ' ' HG2' ' B' ' 204' ' ' GLN . 1.7 m-85 -125.99 -58.76 1.37 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 9.1 mm -120.74 150.61 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.554 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -77.04 -23.32 52.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.264 1.855 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.724 -179.061 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 CA-C-O 120.145 -0.253 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 7.8 p -96.22 -77.17 0.49 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 117.667 0.734 . . . . 0.0 111.132 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.39 109.6 17.55 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -110.92 -52.48 2.78 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.508 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.61 149.21 40.28 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.84 -10.76 11.59 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.327 2.018 . . . . 0.0 114.614 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -126.1 124.9 24.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.036 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.6 96.27 0.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.116 1.877 . . . . 0.0 109.573 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.43 -174.18 4.27 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.89 160.28 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.956 0.902 . . . . 0.0 110.003 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -59.69 -38.2 80.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 311' ' ' PHE . . . . . 0.413 ' CE1' HD21 ' A' ' 67' ' ' LEU . 1.6 m-85 -105.57 20.96 18.03 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.722 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.85 62.44 1.46 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.412 0.625 . . . . 0.0 112.542 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.72 135.64 26.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.872 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 314' ' ' MET . . . . . 0.416 ' HA ' ' HE3' ' C' ' 314' ' ' MET . 2.1 mmt -104.6 111.15 65.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.07 138.99 88.64 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 122.58 2.187 . . . . 0.0 112.581 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.572 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.39 -37.99 0.34 Allowed Glycine 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 26.0 t -51.97 105.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 112.192 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -77.88 135.65 37.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 324' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 79.1 mtt-85 -119.1 118.95 32.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.087 0.47 . . . . 0.0 110.6 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.4 p -136.09 115.54 12.72 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.058 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -136.31 97.71 3.66 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.94 31.04 18.86 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -87.2 156.21 19.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.518 0.675 . . . . 0.0 111.123 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.05 2.44 3.58 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.631 1.573 . . . . 0.0 114.524 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.99 -39.22 25.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.92 0.888 . . . . 0.0 112.076 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -63.63 113.32 3.27 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.027 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 . . . . . 0 C--N 1.292 -1.923 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.119 178.601 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.498 -1.019 0 CA-C-O 121.591 0.71 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.468 HG23 HG23 ' A' ' 65' ' ' THR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.549 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 217' ' ' LEU . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 110' ' ' ILE . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG11 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.458 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.464 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 65' ' ' THR . 62.9 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 40' ' ' VAL . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 38' ' ' VAL . 60.6 mt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.429 HG22 HG13 ' B' ' 208' ' ' ILE . 7.7 mm . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.429 HG13 HG22 ' B' ' 206' ' ' ILE . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.565 HD12 HD21 ' A' ' 22' ' ' LEU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 . . . . . 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 113.034 0.359 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.86 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' LEU . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 15' ' ' ILE . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.444 ' H ' HD12 ' A' ' 22' ' ' LEU . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' B' ' 217' ' ' LEU . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD21 HD12 ' B' ' 217' ' ' LEU . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 28' ' ' LEU . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 42' ' ' LEU . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' C' ' 318' ' ' ARG . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 77' ' ' ILE 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 110' ' ' ILE . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.685 ' O ' HG11 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 50' ' ' GLU . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.1 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 30' ' ' VAL . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 96' ' ' GLN . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 110' ' ' ILE . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' VAL . 57.7 mt . . . . . 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.407 HG22 ' H ' ' B' ' 208' ' ' ILE . 11.1 mm . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.407 ' H ' HG22 ' B' ' 206' ' ' ILE . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.408 ' HZ ' HG13 ' A' ' 102' ' ' VAL . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.514 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 19' ' ' ASN . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD2' HD22 ' B' ' 218' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.421 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.0 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 98' ' ' TYR . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 110' ' ' ILE . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.507 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.507 HG13 HG22 ' B' ' 206' ' ' ILE . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 102' ' ' VAL . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.45 ' HB3' HD23 ' A' ' 22' ' ' LEU . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.478 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.418 ' HG3' ' HG ' ' B' ' 220' ' ' LEU . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.418 ' HG ' ' HG3' ' B' ' 219' ' ' GLU . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.835 0.265 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' C' ' 318' ' ' ARG . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.548 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.4 HG23 ' O ' ' B' ' 213' ' ' SER . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.694 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 28' ' ' LEU . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 44' ' ' ARG . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 42' ' ' LEU . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' B' ' 208' ' ' ILE . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.504 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 38' ' ' VAL . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.416 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.422 HD11 HD12 ' B' ' 208' ' ' ILE . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.517 HG22 HG13 ' B' ' 208' ' ' ILE . 6.5 mt . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.517 HG13 HG22 ' B' ' 206' ' ' ILE . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' THR . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.404 HD22 ' OD2' ' A' ' 26' ' ' ASP . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--O 1.248 1.007 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 319' ' ' TRP . . . . . 0.694 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 37.6 m-80 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.41 HD21 HD12 ' B' ' 217' ' ' LEU . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 42' ' ' LEU . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 110' ' ' ILE . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 50' ' ' GLU . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HD23 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . 98.6 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' B' ' 206' ' ' ILE . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB2' HG12 ' B' ' 206' ' ' ILE . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 40' ' ' VAL . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 38' ' ' VAL . 67.4 mt . . . . . 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.633 HG22 HG13 ' B' ' 208' ' ' ILE . 2.7 mm . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.633 HG13 HG22 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 102' ' ' VAL . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.426 ' HB3' HH12 ' C' ' 318' ' ' ARG . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo . . . . . 0 C--O 1.245 0.854 0 CA-C-O 120.909 0.295 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.426 HH12 ' HB3' ' B' ' 212' ' ' PHE . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 319' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.435 -1.186 0 CA-C-O 120.968 0.413 . . . . 0.0 110.298 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 18' ' ' LEU . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 15' ' ' ILE . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' H ' HD12 ' A' ' 22' ' ' LEU . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' B' ' 217' ' ' LEU . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 19' ' ' ASN . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' HD22 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 110' ' ' ILE . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 28' ' ' LEU . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.572 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.5 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.421 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.9 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 38' ' ' VAL . 59.9 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.554 HG22 HG13 ' B' ' 208' ' ' ILE . 3.5 mm . . . . . 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.554 HG13 HG22 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.484 HD22 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 CA-C-O 120.922 0.301 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' LEU . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 HD12 ' B' ' 217' ' ' LEU . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 42' ' ' LEU . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.61 HD21 HG11 ' A' ' 40' ' ' VAL . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.61 HG11 HD21 ' A' ' 28' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' B' ' 208' ' ' ILE . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' B' ' 208' ' ' ILE . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' ILE . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' HG21 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 65' ' ' THR . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 84' ' ' ILE . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.635 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CD1' HG21 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 40' ' ' VAL . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.482 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.57 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.246 0.9 0 N-CA-C 113.72 0.623 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.554 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 p30 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.301 0.572 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 65' ' ' THR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 HG21 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' HD22 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD22 ' A' ' 28' ' ' LEU . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 60' ' ' GLU . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' A' ' 48' ' ' THR . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' H ' HG21 ' A' ' 38' ' ' VAL . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' A' ' 71' ' ' ASN . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 20.5 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' VAL . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 210' ' ' PRO . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.439 HD11 HG12 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' HA ' HD12 ' A' ' 110' ' ' ILE . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.487 HG22 HG13 ' B' ' 208' ' ' ILE . 18.7 mm . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.487 HG13 HG22 ' B' ' 206' ' ' ILE . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 102' ' ' VAL . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.427 ' OD2' HG21 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.436 HD22 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.248 1.001 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 HD11 ' A' ' 18' ' ' LEU . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD11 HG22 ' A' ' 15' ' ' ILE . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 22' ' ' LEU . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.63 HD21 HD12 ' B' ' 217' ' ' LEU . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' B' ' 218' ' ' LEU . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' C' ' 316' ' ' GLY . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' A' ' 60' ' ' GLU . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 28' ' ' LEU . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 50' ' ' GLU . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 41' ' ' ILE . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 38' ' ' VAL . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 84' ' ' ILE . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.7 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.524 HG22 HG13 ' B' ' 208' ' ' ILE . 13.0 mm . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.524 HG13 HG22 ' B' ' 206' ' ' ILE . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 22' ' ' LEU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo . . . . . 0 C--O 1.26 1.586 0 N-CA-C 113.773 0.643 . . . . 0.0 113.773 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 316' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' C' ' 318' ' ' ARG . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 40' ' ' VAL . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' CD1' ' A' ' 31' ' ' PHE . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.414 ' HA ' HD11 ' A' ' 110' ' ' ILE . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HG2' HD12 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.588 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 24.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 40' ' ' VAL . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.72 HG22 HG13 ' B' ' 208' ' ' ILE . 4.9 mm . . . . . 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.72 HG13 HG22 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 N-CA-C 114.524 0.932 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 94.4 m-20 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD21 HD12 ' B' ' 217' ' ' LEU . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' HD22 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 40' ' ' VAL . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 60' ' ' GLU . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.479 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 38' ' ' VAL . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 66' ' ' ILE . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HB2' HD21 ' A' ' 17' ' ' ASN . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' B' ' 206' ' ' ILE . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 28' ' ' LEU . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.474 HG22 HG13 ' B' ' 208' ' ' ILE . 3.7 mt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.474 HG13 HG22 ' B' ' 206' ' ' ILE . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' B' ' 209' ' ' MET . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.437 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.551 HD12 HD21 ' A' ' 22' ' ' LEU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.443 HD22 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.245 0.846 0 CA-C-O 121.393 0.497 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 15' ' ' ILE . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.561 HD21 HD12 ' B' ' 217' ' ' LEU . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD2' HD22 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 40' ' ' VAL . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' C' ' 315' ' ' PRO . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.595 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HG3' ' CG2' ' B' ' 208' ' ' ILE . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.47 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD11 HD12 ' B' ' 208' ' ' ILE . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt . . . . . 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.425 HG22 HG13 ' B' ' 208' ' ' ILE . 5.3 mm . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 22' ' ' LEU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.442 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 . . . . . 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 315' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 53.5 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 114.617 0.968 . . . . 0.0 114.617 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.417 ' HD3' HD13 ' A' ' 28' ' ' LEU . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.411 ' CB ' ' HB3' ' A' ' 86' ' ' HIS . 15.3 m-80 . . . . . 0 N--CA 1.423 -1.796 0 CA-C-O 120.676 0.274 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 65' ' ' THR . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG12 HD13 ' A' ' 72' ' ' LEU . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.602 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' O ' HG11 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 ' HE ' ' A' ' 44' ' ' ARG . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 42' ' ' LEU . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.602 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.645 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' ILE . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.434 HD13 HG12 ' A' ' 30' ' ' VAL . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 69' ' ' VAL . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.517 ' CD2' HG11 ' A' ' 69' ' ' VAL . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.414 HD11 HD12 ' B' ' 208' ' ' ILE . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 40' ' ' VAL . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.418 HG22 HG13 ' B' ' 208' ' ' ILE . 4.7 mm . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG ' ' A' ' 26' ' ' ASP . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.242 0.71 0 N-CA-C 111.229 -0.335 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.66 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.428 HD21 ' HB2' ' A' ' 80' ' ' ARG . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD21 HD12 ' B' ' 217' ' ' LEU . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.477 HD21 HG11 ' A' ' 40' ' ' VAL . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 HD13 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 106' ' ' LEU . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' HG13 ' A' ' 38' ' ' VAL . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HB2' HD21 ' A' ' 17' ' ' ASN . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD13 HD11 ' A' ' 84' ' ' ILE 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' B' ' 206' ' ' ILE . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 40' ' ' VAL . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.581 HD13 HG12 ' A' ' 38' ' ' VAL . 70.8 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.551 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.551 HG13 HG22 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' B' ' 209' ' ' MET . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.476 ' HB3' HD23 ' A' ' 22' ' ' LEU . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 22' ' ' LEU . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 114.41 0.889 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 65' ' ' THR . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' LEU . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 19' ' ' ASN . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 HG11 ' A' ' 40' ' ' VAL . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 31' ' ' PHE 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HG23 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.565 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.682 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' HG12 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.709 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.716 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.554 HD11 HG12 ' A' ' 40' ' ' VAL . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 108' ' ' ARG . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.454 HG22 HG13 ' B' ' 208' ' ' ILE . 4.0 mt . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.454 HG13 HG22 ' B' ' 206' ' ' ILE . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.459 HD13 ' HA3' ' A' ' 78' ' ' GLY . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.716 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 113.543 0.555 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 65' ' ' THR . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 HD12 ' B' ' 217' ' ' LEU . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.567 ' OD2' HD22 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.463 HD11 HD23 ' A' ' 42' ' ' LEU . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.545 HG22 HG13 ' B' ' 208' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.572 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.484 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.595 HD12 HD21 ' A' ' 22' ' ' LEU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.246 0.917 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.484 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 91.9 m-20 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 5.8 m-80 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.42 HD21 HG11 ' A' ' 40' ' ' VAL . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 110' ' ' ILE . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' HG11 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' HD12 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 69' ' ' VAL . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.4 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' HG12 ' B' ' 206' ' ' ILE . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 40' ' ' VAL . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.642 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.642 HG13 HG22 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 21' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.539 0.756 0 N-CA-C 114.157 0.791 . . . . 0.0 114.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 57' ' ' LEU . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 18' ' ' LEU . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.491 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' C' ' 318' ' ' ARG . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 31' ' ' PHE . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 30' ' ' VAL . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 65' ' ' THR . 59.5 tp60 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 69' ' ' VAL . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 40' ' ' VAL . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.25 1.104 0 CA-C-O 121.272 0.446 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.436 ' HD2' HD13 ' A' ' 28' ' ' LEU . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 319' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.448 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 18' ' ' LEU . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.497 HD11 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' HD12 ' A' ' 22' ' ' LEU . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' B' ' 215' ' ' SER . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' OD2' HD22 ' B' ' 218' ' ' LEU . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 HD21 ' B' ' 218' ' ' LEU . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' HD11 ' A' ' 110' ' ' ILE . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 106' ' ' LEU . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.543 HD12 ' HG2' ' A' ' 44' ' ' ARG . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HG2' HD12 ' A' ' 42' ' ' LEU . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.618 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' VAL . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.569 ' HA ' HD12 ' A' ' 110' ' ' ILE . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 38' ' ' VAL . 18.5 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.559 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.628 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.456 ' HB3' HD23 ' A' ' 22' ' ' LEU . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.458 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.0 0.334 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 57' ' ' LEU . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 15' ' ' ILE . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 HD23 ' A' ' 42' ' ' LEU . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 40' ' ' VAL . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG23 ' CD1' ' A' ' 31' ' ' PHE . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CD1' HG23 ' A' ' 30' ' ' VAL . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' C' ' 316' ' ' GLY . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 58' ' ' LYS . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 27' ' ' ILE . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' B' ' 208' ' ' ILE . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 50' ' ' GLU . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' B' ' 208' ' ' ILE . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD23 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HB2' HG11 ' A' ' 38' ' ' VAL . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 66' ' ' ILE . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.573 ' HE3' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 20.9 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.488 HD11 HG12 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 38' ' ' VAL . 45.0 mt . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.461 HG22 HG13 ' B' ' 208' ' ' ILE . 9.1 mm . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.461 HG13 HG22 ' B' ' 206' ' ' ILE . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.579 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--O 1.243 0.728 0 CA-C-O 121.117 0.382 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 316' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 318' ' ' ARG . . . . . 0.583 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 26.21 2.32 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.99 149.58 30.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.808 -174.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.71 69.09 0.24 Allowed Glycine 0 C--N 1.29 -2.007 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -66.52 10.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.128 1.371 . . . . 0.0 113.595 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -69.92 -16.94 63.3 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.34 1.056 . . . . 0.0 110.78 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -141.1 174.0 10.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -123.57 30.0 6.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.65 20.11 19.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.122 -1.853 . . . . 0.0 106.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -83.2 72.51 10.15 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.624 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.468 HG23 HG23 ' A' ' 65' ' ' THR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.549 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 217' ' ' LEU . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' OE1' ' HG2' ' C' ' 324' ' ' ARG . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 110' ' ' ILE . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG11 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.458 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.464 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.7 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 40' ' ' VAL . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 38' ' ' VAL . 60.6 mt -63.81 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -77.84 123.74 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.39 0.614 . . . . 0.0 109.736 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -92.6 120.99 33.59 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 1.1 pptp? -137.52 130.69 30.68 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -91.75 -28.48 17.37 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.92 125.46 25.18 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.41 13.23 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.673 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.63 144.05 39.53 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.351 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 47.8 t -84.78 132.97 34.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -124.27 12.35 8.84 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.383 0.611 . . . . 0.0 110.31 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 35.7 t -87.6 -58.14 2.69 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -144.66 159.35 42.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.521 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 3.1 m-85 -69.75 -67.95 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.534 0.683 . . . . 0.0 109.397 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.429 HG22 HG13 ' B' ' 208' ' ' ILE . 7.7 mm -124.4 155.93 32.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.429 HG13 HG22 ' B' ' 206' ' ' ILE . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.565 HD12 HD21 ' A' ' 22' ' ' LEU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 -79.43 -29.28 41.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.646 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 300' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' C' ' 319' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 47.9 t -165.35 154.94 12.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.237 0.519 . . . . 0.0 110.198 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.09 109.62 14.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -82.29 -61.79 1.8 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.715 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' C' ' 305' ' ' PRO . 57.3 mtmt -91.62 127.81 48.89 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 305' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' C' ' 304' ' ' LYS . 23.8 Cg_endo -96.72 15.13 0.83 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 123.539 2.826 . . . . 0.0 111.726 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -109.4 113.18 58.64 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.321 -177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 13.9 Cg_exo -69.9 64.88 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.16 2.573 . . . . 0.0 112.61 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.93 -13.06 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 110.226 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.14 134.16 45.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -56.92 -30.75 64.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.627 0.771 . . . . 0.0 110.779 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.65 1.99 56.77 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.958 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.57 20.98 10.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.463 1.105 . . . . 0.0 112.713 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 40.2 mt -81.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.927 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.548 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 2.6 mmt -109.73 139.97 21.75 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.7 131.07 43.9 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 123.867 3.045 . . . . 0.0 113.034 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 319' ' ' TRP . . . . . 0.502 ' O ' ' HA2' ' C' ' 300' ' ' GLY . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.34 33.48 0.67 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 58.4 t -114.49 100.3 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -77.17 122.8 25.53 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.371 0.419 . . . . 0.0 110.149 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.551 ' HG2' ' OE1' ' A' ' 33' ' ' GLU . 11.5 ptp85 -136.64 143.86 43.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.608 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 68.7 m -158.92 147.21 18.14 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -91.88 -37.14 13.08 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.381 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.22 31.27 8.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 118.852 -1.642 . . . . 0.0 112.067 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.9 OUTLIER -68.96 130.31 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.25 2.71 56.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 0.5 OUTLIER -57.2 -49.05 77.22 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.436 ' HB3' ' NZ ' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -80.55 118.73 22.39 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 88.6 m95 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.709 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.834 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.24 34.39 16.04 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.55 174.39 5.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.322 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.1 76.35 1.25 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.63 -31.59 72.7 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.956 0.903 . . . . 0.0 113.122 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.13 -70.18 0.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.442 0.639 . . . . 0.0 109.833 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HB3' ' H ' ' A' ' 8' ' ' LYS . 58.8 m-85 -168.03 -141.78 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 7' ' ' TYR . 3.0 mptp? -91.28 -0.38 57.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.39 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.895 1.678 . . . . 0.0 113.759 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.28 110.24 22.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' LEU . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 15' ' ' ILE . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.444 ' H ' HD12 ' A' ' 22' ' ' LEU . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' B' ' 217' ' ' LEU . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD21 HD12 ' B' ' 217' ' ' LEU . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 28' ' ' LEU . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 42' ' ' LEU . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' C' ' 318' ' ' ARG . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.607 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' C' ' 324' ' ' ARG . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 110' ' ' ILE . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.685 ' O ' HG11 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 50' ' ' GLU . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' HB ' ' A' ' 65' ' ' THR . 25.3 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.558 ' HB3' ' CE2' ' C' ' 311' ' ' PHE . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 30' ' ' VAL . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 96' ' ' GLN . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' CD2' ' B' ' 205' ' ' TYR . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.575 ' O ' HG12 ' A' ' 111' ' ' VAL . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' VAL . 57.7 mt -55.47 -49.38 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -79.26 114.9 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.604 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -66.87 -35.61 80.43 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -168.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -124.22 113.29 18.09 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.808 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.81 169.24 5.89 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.329 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -118.94 86.7 2.59 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.79 145.65 15.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -149.58 -71.78 0.19 Allowed 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.1 m -85.11 158.82 20.3 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 117.026 0.413 . . . . 0.0 110.096 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -107.63 6.28 27.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.456 1.122 . . . . 0.0 108.604 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -72.95 -6.34 44.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.675 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 67.61 111.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.428 1.108 . . . . 0.0 110.441 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.424 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 3.0 m-85 -68.89 -56.34 8.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.942 -169.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.407 HG22 ' H ' ' B' ' 208' ' ' ILE . 11.1 mm -101.97 146.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.407 ' H ' HG22 ' B' ' 206' ' ' ILE . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.408 ' HZ ' HG13 ' A' ' 102' ' ' VAL . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 -97.89 -28.28 13.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.579 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.2 m -128.61 -173.9 3.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -82.08 109.4 16.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.67 -55.62 4.17 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.08 109.52 35.86 Favored Pre-proline 0 C--N 1.318 -0.788 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.996 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.56 -20.23 18.2 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 123.497 2.798 . . . . 0.0 114.099 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.57 103.88 19.53 Favored Pre-proline 0 N--CA 1.427 -1.583 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.928 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.78 162.06 42.17 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.65 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.35 0.99 50.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.657 0.741 . . . . 0.0 110.836 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -86.34 28.81 0.81 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.941 -171.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 65.17 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.837 1.255 . . . . 0.0 113.964 174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 63' ' ' ARG . 43.2 m-85 -91.48 9.86 30.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.38 55.44 3.52 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.49 1.116 . . . . 0.0 110.069 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.06 138.44 23.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 25.0 mmt -90.65 125.82 58.13 Favored Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.894 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.62 122.84 10.07 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.261 1.974 . . . . 0.0 110.55 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.32 22.12 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.95 104.36 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.79 123.76 22.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' A' ' 33' ' ' GLU . 43.3 ttm105 -117.75 147.92 42.52 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.835 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 31.0 t -152.28 108.16 3.36 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.76 150.4 8.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.8 30.29 69.13 Favored Glycine 0 C--O 1.224 -0.483 0 O-C-N 124.324 1.015 . . . . 0.0 111.385 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' C' ' 330' ' ' GLU . 7.5 t80 -74.29 141.33 45.3 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -69.14 3.61 2.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 126.408 1.883 . . . . 0.0 112.72 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.403 ' N ' ' HD1' ' C' ' 328' ' ' PHE . 0.6 OUTLIER -40.33 -52.35 2.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.623 1.969 . . . . 0.0 113.836 -171.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -87.83 115.37 25.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 N--CA 1.428 -1.527 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.171 173.479 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.64 6.47 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 86' ' ' HIS . 21.1 ptp -110.07 160.18 16.67 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 86' ' ' HIS . . . 69.88 34.5 71.56 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -90.79 -18.27 25.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -32.1 10.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.462 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.86 86.63 2.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.265 175.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 8' ' ' LYS . 32.6 tptt -85.72 -9.32 57.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.02 -14.12 61.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.763 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -57.75 109.36 0.7 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.514 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 19' ' ' ASN . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD2' HD22 ' B' ' 218' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.421 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.525 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.0 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 98' ' ' TYR . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' VAL . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt -90.33 -53.88 8.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -75.8 157.56 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.2 m -85.0 -1.38 56.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.442 0.639 . . . . 0.0 111.599 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 116' ' ' ALA . 17.8 tppt? -101.35 84.86 2.68 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.91 -38.0 23.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.296 0.569 . . . . 0.0 111.295 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.71 118.53 20.1 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.198 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . . . -148.29 -85.15 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.38 -41.68 24.21 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 175.793 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 200' ' ' GLY . . . . . 0.576 ' N ' ' HH ' ' B' ' 205' ' ' TYR . . . . . . . . 0 N--CA 1.462 0.433 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -57.17 123.7 16.19 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 117.113 0.457 . . . . 0.0 111.873 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.45 -7.67 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.097 0.951 . . . . 0.0 110.418 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.9 p -87.63 -1.16 57.76 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.47 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 28.7 tt0 73.01 142.74 0.06 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 124.876 1.27 . . . . 0.0 109.243 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.576 ' HH ' ' N ' ' B' ' 200' ' ' GLY . 10.7 m-85 -77.47 -66.34 0.85 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.849 0.833 . . . . 0.0 110.408 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.507 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm -128.71 154.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.507 HG13 HG22 ' B' ' 206' ' ' ILE . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 102' ' ' VAL . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.45 ' HB3' HD23 ' A' ' 22' ' ' LEU . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.478 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.418 ' HG3' ' HG ' ' B' ' 220' ' ' LEU . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.418 ' HG ' ' HG3' ' B' ' 219' ' ' GLU . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 -97.66 -55.31 2.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.253 1.238 0 O-C-N 124.896 1.373 . . . . 0.0 110.755 -175.259 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.579 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 17.0 m -100.0 147.04 26.03 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.87 109.08 20.91 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 303' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' C' ' 304' ' ' LYS . 3.1 m-20 -99.16 -51.66 3.76 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' C' ' 303' ' ' ASP . 2.9 mppt? -70.01 119.99 75.1 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.252 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.57 -42.31 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.603 2.202 . . . . 0.0 110.82 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.41 108.02 19.26 Favored Pre-proline 0 N--CA 1.424 -1.736 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.446 ' HG2' ' HE1' ' C' ' 314' ' ' MET . 13.0 Cg_exo -69.96 110.88 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.097 1.865 . . . . 0.0 110.384 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.79 86.12 4.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 122.804 1.288 . . . . 0.0 110.906 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.33 140.36 22.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' C' ' 310' ' ' ARG . 2.1 tpm_? -46.9 -46.02 20.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.64 9.3 27.21 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.59 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 53.12 60.84 3.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.054 0.942 . . . . 0.0 112.137 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.4 mt -99.78 147.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.446 ' HE1' ' HG2' ' C' ' 307' ' ' PRO . 21.6 mmt -87.41 128.71 54.02 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 122.918 0.136 . . . . 0.0 111.207 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 135.79 22.67 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.629 2.219 . . . . 0.0 111.966 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' C' ' 318' ' ' ARG . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.59 -9.26 41.05 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.77 121.98 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -111.63 139.46 47.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.72 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.94 144.94 50.39 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 8.2 t -157.21 88.66 1.02 Allowed 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 172.39 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.361 1.465 . . . . 0.0 107.646 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.68 65.84 Favored Glycine 0 C--O 1.236 0.238 0 O-C-N 123.316 0.385 . . . . 0.0 112.961 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.84 131.47 37.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.06 1.88 14.35 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.311 1.044 . . . . 0.0 112.985 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.16 -37.13 14.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -84.93 103.05 13.64 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.496 -1.099 0 C-N-CA 127.077 2.151 . . . . 0.0 109.699 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.91 91.83 5.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.383 0.611 . . . . 0.0 109.438 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 tpt -79.59 109.8 14.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.756 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.07 168.09 16.55 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.997 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -71.38 -28.75 64.25 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.234 0.54 . . . . 0.0 109.688 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.53 -3.22 49.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.422 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -83.67 82.19 8.42 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -87.51 -6.06 58.52 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.1 3.62 0.57 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.747 2.019 . . . . 0.0 113.543 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 -82.27 101.15 10.34 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.548 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.4 HG23 ' O ' ' B' ' 213' ' ' SER . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.694 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 28' ' ' LEU . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 44' ' ' ARG . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 42' ' ' LEU . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' B' ' 208' ' ' ILE . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 38' ' ' VAL . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.416 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.422 HD11 HD12 ' B' ' 208' ' ' ILE . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 114' ' ' ASN . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.88 -48.78 22.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.4 p -69.09 157.95 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 m -82.15 80.84 8.27 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.193 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.9 tttt 167.46 75.2 0.0 OUTLIER 'General case' 0 C--O 1.251 1.169 0 C-N-CA 127.655 2.382 . . . . 0.0 105.746 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 30.4 p-10 -84.84 169.34 14.24 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -86.07 143.99 27.78 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.417 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.11 -7.8 14.05 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.55 -79.41 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.676 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.679 0 C-N-CA 124.894 1.278 . . . . 0.0 108.477 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.7 m 69.81 -51.13 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.464 1.506 . . . . 0.0 114.444 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -64.23 -18.81 64.88 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.391 0.676 . . . . 0.0 112.754 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.9 p -86.57 11.01 13.7 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.545 0.688 . . . . 0.0 111.255 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 64.47 90.77 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.665 1.586 . . . . 0.0 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -51.74 -60.94 2.6 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.748 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.517 HG22 HG13 ' B' ' 208' ' ' ILE . 6.5 mt -147.04 158.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.517 HG13 HG22 ' B' ' 206' ' ' ILE . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' THR . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.404 HD22 ' OD2' ' A' ' 26' ' ' ASP . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 -74.48 -27.23 60.47 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.3 m -150.24 -33.57 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 117.215 0.507 . . . . 0.0 110.678 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.25 109.9 17.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.694 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.15 -49.46 13.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.8 125.82 57.85 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.96 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.05 -29.55 48.38 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.421 2.081 . . . . 0.0 111.741 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -139.52 150.11 62.46 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.28 91.56 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.851 1.701 . . . . 0.0 110.488 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -84.23 95.88 8.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.61 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -179.66 148.15 0.32 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' C' ' 310' ' ' ARG . 2.5 tpp180 -56.19 -42.33 76.94 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -115.52 17.13 16.48 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.883 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 70.94 26.09 3.68 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.32 131.49 35.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.7 mmt -96.84 138.83 21.34 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.175 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.57 145.99 55.79 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.698 2.932 . . . . 0.0 113.637 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 319' ' ' TRP . . . . . 0.694 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 95.54 10.91 56.4 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.52 143.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.67 144.64 43.69 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.847 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' C' ' 324' ' ' ARG . 3.8 tpp85 -128.93 105.81 8.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.807 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 30.3 t -115.93 108.1 15.83 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.425 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -109.75 -9.1 14.85 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.128 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.14 -6.5 75.93 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -80.25 145.19 32.33 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.712 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -61.25 1.25 0.2 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.66 -21.2 60.35 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 10.1 tmtt? -87.93 129.85 35.11 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 332' ' ' TRP . . . . . 0.477 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 49.1 m95 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.972 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.48 -66.51 0.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.964 1.305 . . . . 0.0 111.317 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.97 146.74 52.44 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 109.284 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 57.96 4.36 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.83 11.01 14.26 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.432 1.093 . . . . 0.0 112.739 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.36 -71.79 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.05 0.219 . . . . 0.0 111.255 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 86' ' ' HIS . 78.3 m-85 41.52 36.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.556 1.143 . . . . 0.0 113.372 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -17.1 64.68 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.194 0.521 . . . . 0.0 112.087 -172.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.11 11.65 13.39 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.769 1.228 . . . . 0.0 111.638 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 37.6 m-80 -118.64 113.02 20.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.783 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.41 HD21 HD12 ' B' ' 217' ' ' LEU . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 42' ' ' LEU . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 110' ' ' ILE . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 50' ' ' GLU . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HD23 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . 98.6 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' C' ' 330' ' ' GLU . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' C' ' 326' ' ' ASN . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' B' ' 206' ' ' ILE . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 40' ' ' VAL . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 38' ' ' VAL . 67.4 mt -69.64 -39.27 78.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.62 145.52 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.6 t -92.12 -37.77 12.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 39.8 mmtm -150.81 134.24 16.31 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.499 1.12 . . . . 0.0 108.562 174.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -68.85 146.26 53.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.758 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -163.53 -25.68 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.629 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.79 101.95 2.73 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.161 0.505 . . . . 0.0 112.215 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.83 -23.87 28.88 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 174.425 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.5 p -100.11 144.93 28.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.056 0.542 . . . . 0.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -117.65 -50.47 2.52 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.459 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 m -56.78 -54.02 51.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.728 0.775 . . . . 0.0 109.818 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.28 148.97 23.84 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.496 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 17.8 m-85 -55.87 -54.18 47.74 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.727 0.642 . . . . 0.0 110.692 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.633 HG22 HG13 ' B' ' 208' ' ' ILE . 2.7 mm -132.63 146.56 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.633 HG13 HG22 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 102' ' ' VAL . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.426 ' HB3' HH12 ' C' ' 318' ' ' ARG . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 -78.91 -41.46 29.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.256 1.416 0 C-N-CA 125.31 1.444 . . . . 0.0 109.057 -173.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.602 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.6 m -89.49 147.21 24.12 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.8 108.9 20.54 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.624 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 -38.93 14.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 170.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -90.83 111.14 46.43 Favored Pre-proline 0 N--CA 1.423 -1.818 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 -16.89 24.55 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.268 2.646 . . . . 0.0 112.047 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -142.56 166.23 22.16 Favored Pre-proline 0 N--CA 1.419 -2.01 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.2 59.81 3.82 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.684 2.256 . . . . 0.0 111.103 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -91.01 11.66 22.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.368 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -73.6 156.62 37.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -39.06 -48.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -102.68 30.31 4.77 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.195 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 67.37 32.94 5.58 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.375 1.083 . . . . 0.0 110.082 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 74.6 mt -92.78 150.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.148 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.55 169.04 7.69 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.969 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.59 137.11 24.62 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.678 1.585 . . . . 0.0 111.472 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.426 HH12 ' HB3' ' B' ' 212' ' ' PHE . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 319' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 132.21 -8.59 5.38 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.21 106.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.876 0 C-N-CA 123.332 0.653 . . . . 0.0 109.829 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -62.76 144.0 56.91 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.698 0.624 . . . . 0.0 111.045 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -109.58 126.66 53.83 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.366 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 45.1 m -73.27 102.1 3.58 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 326' ' ' ASN . . . . . 0.438 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 33.2 p30 -136.02 -170.51 2.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.858 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.88 31.0 2.01 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.059 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.663 ' CE1' ' HG2' ' C' ' 330' ' ' GLU . 11.0 t80 -82.74 151.6 26.11 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.49 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.5 2.15 56.01 Favored 'General case' 0 CA--C 1.593 2.604 0 C-N-CA 126.892 2.077 . . . . 0.0 115.112 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.663 ' HG2' ' CE1' ' C' ' 328' ' ' PHE . 6.7 mm-40 -62.75 -38.9 92.4 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -73.25 118.62 16.43 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 82.3 m95 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.579 176.778 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.013 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.86 149.83 30.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.758 0.313 . . . . 0.0 110.637 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ptp -110.27 -179.92 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 90.6 0.11 Allowed Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -110.41 -1.63 17.0 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.134 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -19.54 45.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.426 0.632 . . . . 0.0 109.423 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -111.82 159.03 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.145 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -127.52 23.19 6.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 123.014 1.388 . . . . 0.0 107.309 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.06 5.49 48.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.602 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.19 91.46 8.46 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.298 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 18' ' ' LEU . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 15' ' ' ILE . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' H ' HD12 ' A' ' 22' ' ' LEU . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' B' ' 217' ' ' LEU . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 19' ' ' ASN . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' HD22 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' C' ' 324' ' ' ARG . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' C' ' 314' ' ' MET . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 110' ' ' ILE . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 28' ' ' LEU . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.572 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.0 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' C' ' 311' ' ' PHE . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.421 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.9 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 111' ' ' VAL . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 38' ' ' VAL . 59.9 mt -90.82 -56.15 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -74.09 132.68 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.288 -172.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -97.01 158.83 15.24 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . 0.333 58.6 mtmt -79.44 75.84 6.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -159.98 168.76 24.92 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 72.68 -39.83 0.46 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.963 0.905 . . . . 0.0 111.863 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.11 92.37 7.89 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.16 -28.64 60.19 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.966 0.888 . . . . 0.0 108.927 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.267 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -92.91 138.83 31.14 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -20.93 6.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.953 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 3.7 p -71.11 -29.67 65.56 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.651 0.739 . . . . 0.0 110.213 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.88 178.61 8.75 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.01 -61.23 1.88 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.554 HG22 HG13 ' B' ' 208' ' ' ILE . 3.5 mm -123.29 142.06 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.554 HG13 HG22 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.484 HD22 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 -76.52 -30.64 57.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.663 178.742 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.336 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 24.0 t -78.25 -43.13 29.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.69 108.92 14.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.69 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.22 -33.39 10.77 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' C' ' 306' ' ' ALA . 70.3 mmtt -90.95 144.48 30.17 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.272 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.32 -41.29 9.38 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.31 2.007 . . . . 0.0 109.158 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' C' ' 304' ' ' LYS . . . -128.9 128.66 23.43 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.17 109.95 0.57 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.652 2.235 . . . . 0.0 112.335 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -84.97 71.13 10.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.949 1.357 . . . . 0.0 109.389 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -144.89 124.66 13.36 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -73.14 -18.07 61.32 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.3 0.572 . . . . 0.0 112.333 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -96.28 -8.81 31.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 57.75 34.88 24.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.895 1.278 . . . . 0.0 112.666 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 27.3 mm -79.48 137.65 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.661 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 23.0 mmt -73.78 136.81 76.95 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 171.85 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.016 2.478 . . . . 0.0 112.729 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.55 45.11 4.4 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.4 170.31 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -106.23 149.93 26.39 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.124 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.554 ' CZ ' ' HA ' ' C' ' 324' ' ' ARG . 0.6 OUTLIER -74.94 99.88 3.96 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.665 0.745 . . . . 0.0 110.95 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.0 t -97.39 137.27 36.63 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 70.95 103.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.599 1.187 . . . . 0.0 110.91 -176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.71 22.45 23.67 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.619 -0.718 . . . . 0.0 113.471 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' C' ' 324' ' ' ARG . 13.7 t80 -100.48 162.81 12.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 117.72 0.76 . . . . 0.0 111.179 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.83 5.12 5.35 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.629 1.572 . . . . 0.0 110.484 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -39.41 -31.39 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.899 2.08 . . . . 0.0 113.038 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -76.29 -155.21 0.06 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.376 0.607 . . . . 0.0 109.56 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.583 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.422 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.84 21.88 11.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.928 0.364 . . . . 0.0 110.62 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 27.0 ptt? -92.98 141.19 28.68 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' HA2' ' OD1' ' A' ' 10' ' ' ASN . . . 171.11 -34.81 0.16 Allowed Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.847 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -72.27 -17.21 61.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.264 1.032 . . . . 0.0 111.698 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.28 4.18 24.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.315 0.578 . . . . 0.0 110.607 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -130.47 171.6 12.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -120.51 -15.5 8.5 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.854 -0.529 . . . . 0.0 112.352 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.58 4.47 46.77 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 110.753 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.8 OUTLIER -87.0 92.67 9.12 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' LEU . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 HD12 ' B' ' 217' ' ' LEU . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 42' ' ' LEU . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.61 HD21 HG11 ' A' ' 40' ' ' VAL . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 HH21 ' C' ' 324' ' ' ARG . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' C' ' 324' ' ' ARG . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' C' ' 313' ' ' ILE . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.61 HG11 HD21 ' A' ' 28' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' B' ' 208' ' ' ILE . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' B' ' 208' ' ' ILE . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' ILE . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' HG21 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 65' ' ' THR . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 84' ' ' ILE . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.635 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 3' ' ' MET . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CD1' HG21 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 40' ' ' VAL . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.618 ' HA ' HG12 ' A' ' 111' ' ' VAL . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt -81.05 -39.63 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 108' ' ' ARG . 1.4 p -78.78 178.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.91 -170.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.404 ' H ' HG22 ' A' ' 111' ' ' VAL . 47.5 m -60.96 -44.12 97.78 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -90.2 96.32 10.61 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.318 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 44.7 t30 -73.35 149.23 42.73 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.521 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.87 89.08 1.72 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HA ' ' NH2' ' C' ' 318' ' ' ARG . . . -97.17 -47.8 5.61 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 51.72 82.3 0.07 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.176 1.791 . . . . 0.0 113.682 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.314 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 9.3 p -77.2 153.82 33.71 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 123.019 0.528 . . . . 0.0 111.888 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -93.0 -14.12 27.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.2 m -77.43 -4.32 44.77 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.287 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 74.31 145.29 0.08 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.357 1.463 . . . . 0.0 109.068 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 19.5 m-85 -61.05 -68.29 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.909 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm -123.94 151.38 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.482 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' B' ' 205' ' ' TYR . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.57 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 -79.36 -44.71 21.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.598 1.187 . . . . 0.0 109.699 -178.441 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.363 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 16.4 m -93.98 -38.9 10.93 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 0.0 110.164 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -120.27 164.94 15.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.01 -56.94 2.11 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 135.86 28.83 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.126 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.24 -66.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.334 2.022 . . . . 0.0 112.806 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -141.03 142.01 26.06 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 17.3 Cg_exo -68.55 159.01 55.31 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.045 1.83 . . . . 0.0 111.063 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.61 -19.87 57.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -71.89 142.6 49.51 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.552 -0.749 . . . . 0.0 108.984 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' C' ' 330' ' ' GLU . 1.0 OUTLIER -72.8 -41.35 65.02 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 67' ' ' LEU . 38.9 m-85 -76.76 -4.93 45.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.417 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 58.61 60.29 2.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.923 0.889 . . . . 0.0 111.447 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.524 HG22 ' HA2' ' A' ' 35' ' ' GLY . 11.5 mm -115.17 146.2 19.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 159.28 50.02 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.37 146.4 68.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.856 2.371 . . . . 0.0 113.72 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.554 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -177.87 40.68 0.09 OUTLIER Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 322' ' ' VAL . . . . . 0.575 HG12 ' NH1' ' C' ' 324' ' ' ARG . 16.4 t -119.8 103.86 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -73.56 148.23 43.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.103 0.961 . . . . 0.0 111.542 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.575 ' NH1' HG12 ' C' ' 322' ' ' VAL . 1.0 OUTLIER -116.92 132.87 56.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 132.15 14.97 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -133.25 -24.35 1.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.301 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.72 30.91 2.88 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.156 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -73.15 141.86 47.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.623 0.249 . . . . 0.0 110.44 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -58.88 1.73 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' C' ' 310' ' ' ARG . 9.4 pt-20 -72.48 -23.69 61.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' C' ' 331' ' ' LYS 0.413 0.0 OUTLIER -82.98 80.4 9.03 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 122.73 1.253 . . . . 0.0 113.949 -175.604 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.521 177.227 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.835 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.0 79.21 8.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HA ' ' NE2' ' A' ' 86' ' ' HIS . 26.6 ttt -110.18 126.71 54.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.681 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.582 ' H ' ' CD2' ' A' ' 86' ' ' HIS . . . -77.57 131.52 11.17 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.26 9.76 23.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.77 -52.8 58.69 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.029 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 94.7 m-85 -101.14 104.95 16.06 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -62.79 -30.12 71.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.078 0.466 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -102.46 20.07 17.72 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.532 0.682 . . . . 0.0 111.531 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 7' ' ' TYR . 4.4 p30 -78.7 122.34 25.87 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.236 -0.915 . . . . 0.0 109.748 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 65' ' ' THR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 HG21 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' HD22 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HB3' ' NH2' ' C' ' 324' ' ' ARG . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD22 ' A' ' 28' ' ' LEU . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 60' ' ' GLU . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' A' ' 48' ' ' THR . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' H ' HG21 ' A' ' 38' ' ' VAL . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' C' ' 330' ' ' GLU . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.502 HD21 ' NH2' ' C' ' 324' ' ' ARG . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' CD2' ' H ' ' A' ' 4' ' ' GLY . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 20.5 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' VAL . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 210' ' ' PRO . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.439 HD11 HG12 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' HA ' HD12 ' A' ' 110' ' ' ILE . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt -75.36 -51.53 20.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 107' ' ' ASP . 5.2 p -84.42 129.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.637 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.0 p -87.97 -36.81 16.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.952 0.882 . . . . 0.0 109.999 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -129.29 95.33 4.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.767 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.67 -46.92 12.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -177.02 -168.0 0.19 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.67 7.24 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.8 91.63 4.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.829 0.347 . . . . 0.0 110.473 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.649 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -82.86 71.24 9.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.505 0.669 . . . . 0.0 111.289 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -89.19 -42.21 11.79 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.605 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.3 m -68.21 -59.9 2.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.649 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.502 ' OE1' ' HG3' ' B' ' 209' ' ' MET . 7.8 tt0 -169.97 158.57 7.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -63.68 -66.02 0.6 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.487 HG22 HG13 ' B' ' 208' ' ' ILE . 18.7 mm -115.44 156.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.487 HG13 HG22 ' B' ' 206' ' ' ILE . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.502 ' HG3' ' OE1' ' B' ' 204' ' ' GLN . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 102' ' ' VAL . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.427 ' OD2' HG21 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.436 HD22 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 -78.06 -30.65 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.256 1.415 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.3 t -132.15 140.17 48.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 302' ' ' TYR . . . . . 0.414 ' CD2' ' HG3' ' C' ' 314' ' ' MET . 93.0 m-85 -87.23 109.18 19.31 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -94.75 -40.76 9.6 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.053 0.454 . . . . 0.0 111.625 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.83 130.78 45.44 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.479 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -64.03 -36.86 46.26 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.077 2.518 . . . . 0.0 110.688 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -120.88 133.38 24.11 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.96 94.75 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.876 1.717 . . . . 0.0 113.141 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.01 -31.18 56.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.252 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -73.42 87.56 1.56 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 44.48 -91.06 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 116.303 171.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.34 12.32 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 76.26 61.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.671 1.188 . . . . 0.0 113.525 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.29 137.27 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.454 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 6.6 mmt -107.97 159.4 30.65 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.84 151.15 79.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 123.366 2.71 . . . . 0.0 113.885 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 175.13 45.19 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 86.0 t -88.43 109.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -75.92 151.45 37.33 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.836 0.71 . . . . 0.0 110.143 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.502 ' NH2' HD21 ' A' ' 72' ' ' LEU . 3.8 tpp180 -89.63 112.9 24.27 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.448 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 24.1 t -149.54 122.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -155.66 -49.74 0.08 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.78 31.11 5.26 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.885 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -70.21 141.56 52.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.411 0.624 . . . . 0.0 110.775 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.2 1.74 0.68 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.613 ' OE1' ' HG2' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -61.35 -63.16 1.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.613 ' HG2' ' OE1' ' C' ' 330' ' ' GLU . 44.5 mmtm -147.77 171.26 15.96 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 . . . . . 0 C--N 1.281 -2.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.482 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.97 100.24 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.067 0.46 . . . . 0.0 109.857 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.522 ' HA ' ' OD1' ' A' ' 85' ' ' ASP . 86.5 mtp -110.21 133.68 52.99 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.728 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.67 31.75 3.54 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -74.04 -11.29 60.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.954 0.901 . . . . 0.0 110.41 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.39 -24.98 42.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.03 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 9' ' ' ASP . 52.3 t80 -122.49 90.85 3.38 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -14.71 56.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 32.9 t70 -56.17 -23.77 37.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.341 0.657 . . . . 0.0 112.236 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 -76.45 100.9 5.38 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 HD11 ' A' ' 18' ' ' LEU . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD11 HG22 ' A' ' 15' ' ' ILE . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 22' ' ' LEU . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.63 HD21 HD12 ' B' ' 217' ' ' LEU . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' B' ' 218' ' ' LEU . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HA ' ' ND2' ' C' ' 309' ' ' ASN . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' C' ' 316' ' ' GLY . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' A' ' 60' ' ' GLU . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 28' ' ' LEU . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 50' ' ' GLU . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 41' ' ' ILE . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 38' ' ' VAL . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 84' ' ' ILE . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' CZ ' ' HG3' ' C' ' 324' ' ' ARG . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 3' ' ' MET . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.7 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt -82.64 -44.45 19.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.45 138.31 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -97.56 82.7 3.12 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -147.23 115.2 6.51 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.66 -34.42 19.78 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -114.03 115.59 27.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.51 23.71 9.09 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.74 171.79 13.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.472 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.016 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.3 m -67.32 128.81 37.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 122.868 0.467 . . . . 0.0 110.078 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -130.17 -21.57 2.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.184 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 -12.61 55.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.908 0.861 . . . . 0.0 109.031 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -153.2 152.13 30.88 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.416 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 9.7 m-85 -91.51 -64.03 1.18 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.017 0.913 . . . . 0.0 109.27 -175.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.524 HG22 HG13 ' B' ' 208' ' ' ILE . 13.0 mm -110.79 150.86 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.524 HG13 HG22 ' B' ' 206' ' ' ILE . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 22' ' ' LEU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 -66.54 -48.82 68.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.256 1.438 0 O-C-N 124.87 1.356 . . . . 0.0 111.865 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.9 m -123.38 162.82 22.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -120.62 109.57 15.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -119.95 -19.55 7.83 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -90.38 123.56 65.21 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.124 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.52 -3.73 9.25 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.427 2.751 . . . . 0.0 111.729 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -150.15 152.35 33.5 Favored Pre-proline 0 N--CA 1.423 -1.789 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.23 79.35 0.78 Allowed 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.897 1.731 . . . . 0.0 113.691 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -66.99 -17.06 64.75 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.451 1.101 . . . . 0.0 109.28 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 309' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 34' ' ' TYR . 2.7 m-20 -82.16 18.38 1.4 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.475 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 59.75 -73.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.974 1.71 . . . . 0.0 113.915 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.18 17.13 2.12 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.88 0.872 . . . . 0.0 112.308 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.55 32.99 16.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.942 0.897 . . . . 0.0 112.035 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 313' ' ' ILE . 8.0 mt -79.04 134.85 26.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.449 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 23.9 mmt -90.06 135.53 29.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.21 146.9 16.91 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 124.166 3.244 . . . . 0.0 113.773 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 316' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' C' ' 318' ' ' ARG . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 171.82 34.24 0.03 OUTLIER Glycine 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.33 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -94.2 120.88 35.08 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.06 0.457 . . . . 0.0 111.194 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -100.15 99.81 10.57 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.535 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.6 m -99.73 128.78 45.82 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -164.87 103.91 0.79 Allowed 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.16 31.35 78.64 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 170.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' C' ' 330' ' ' GLU . 54.7 t80 -67.46 137.86 56.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 117.764 0.782 . . . . 0.0 111.807 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.11 3.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.695 2.48 . . . . 0.0 117.695 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' C' ' 328' ' ' PHE . 4.5 tp10 -66.61 1.12 1.88 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.412 1.006 . . . . 0.0 113.409 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.18 109.52 11.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.947 -1.095 . . . . 0.0 108.813 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.9 m95 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.269 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.92 -37.75 12.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.639 0.257 . . . . 0.0 110.915 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -70.73 139.29 51.1 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.423 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 60.65 4.84 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.789 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -79.93 -6.09 56.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -82.39 -26.23 33.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 86' ' ' HIS . 75.2 m-85 -90.6 137.4 32.39 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -130.16 -32.21 1.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -173.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -101.54 5.22 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.429 0.633 . . . . 0.0 111.581 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 -88.12 101.52 13.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 40' ' ' VAL . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' HA ' ' HE ' ' C' ' 324' ' ' ARG . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' C' ' 324' ' ' ARG . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.414 ' HA ' HD11 ' A' ' 110' ' ' ILE . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HG2' HD12 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HB3' ' CD2' ' C' ' 311' ' ' PHE . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' ' HD2' ' C' ' 331' ' ' LYS . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.588 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 24.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 40' ' ' VAL . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt -72.42 -52.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.03 135.52 14.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.4 m -78.13 136.92 37.95 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.57 -16.34 63.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.78 93.49 7.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -143.11 90.04 2.16 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.141 0.972 . . . . 0.0 111.158 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.56 118.87 4.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.17 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 81.92 4.22 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.293 1.044 . . . . 0.0 112.567 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.245 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 15.2 m -79.32 121.46 25.13 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.66 -31.09 10.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.9 m -69.27 -56.42 7.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.377 0.608 . . . . 0.0 109.802 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.92 139.26 26.12 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.56 -103.0 0.25 Allowed 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -171.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.72 HG22 HG13 ' B' ' 208' ' ' ILE . 4.9 mm -90.41 132.69 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.72 HG13 HG22 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 -79.99 -36.64 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 123.633 0.773 . . . . 0.0 112.666 174.508 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.5 t -132.34 130.84 41.27 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.529 0.681 . . . . 0.0 110.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.03 3.82 15.46 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.234 1.016 . . . . 0.0 109.702 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' C' ' 304' ' ' LYS . 0.0 OUTLIER -81.35 127.0 75.14 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.092 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.46 -33.94 77.55 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.614 2.876 . . . . 0.0 112.362 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -131.68 153.4 81.49 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.01 118.36 5.26 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.956 1.771 . . . . 0.0 109.76 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 308' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' C' ' 325' ' ' SER . 43.7 mt-10 -65.98 -30.65 71.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.57 87.09 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -7.11 3.46 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 19.3 m-85 -114.79 11.72 16.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.759 0.79 . . . . 0.0 109.199 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.6 19.94 11.65 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.8 mp -71.67 124.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.74 153.65 58.16 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -40.81 140.69 1.05 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.622 3.548 . . . . 0.0 114.524 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.24 -13.29 4.64 Favored Glycine 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.08 114.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 142.2 32.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.588 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 1.5 mpt_? -99.59 107.3 19.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 325' ' ' SER . . . . . 0.404 ' HA ' ' OE2' ' C' ' 308' ' ' GLU . 18.8 m -111.59 118.96 37.13 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -170.65 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.6 33.11 75.61 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.836 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' C' ' 330' ' ' GLU . 32.0 t80 -39.27 112.13 0.23 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.986 1.314 . . . . 0.0 113.015 -168.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.29 -7.44 24.38 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.791 -167.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' C' ' 328' ' ' PHE . 38.2 tt0 -61.18 -36.52 80.07 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.567 -0.708 . . . . 0.0 111.851 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.5 ' HD2' ' CB ' ' A' ' 70' ' ' ASP . 11.8 tmtt? -109.65 137.33 47.62 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 332' ' ' TRP . . . . . 0.471 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 48.5 p-90 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.77 96.73 1.15 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.975 0.417 . . . . 0.0 110.215 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -102.19 120.9 41.22 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 11.37 0.86 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.469 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' A' ' 86' ' ' HIS . 9.3 p30 -60.97 -11.54 8.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.851 0.86 . . . . 0.0 112.195 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.4 -41.13 75.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -102.88 91.98 4.38 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -81.98 -2.45 51.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.649 0.738 . . . . 0.0 111.015 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 6.3 p-10 -76.23 -11.87 59.99 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.076 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 94.4 m-20 -71.86 112.36 7.89 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD21 HD12 ' B' ' 217' ' ' LEU . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' HD22 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 40' ' ' VAL . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' C' ' 324' ' ' ARG . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' O ' HG21 ' C' ' 313' ' ' ILE . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 60' ' ' GLU . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.479 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 38' ' ' VAL . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HB2' HD21 ' A' ' 17' ' ' ASN . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ASN . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' B' ' 206' ' ' ILE . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 28' ' ' LEU . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt -83.25 -48.11 17.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.31 -20.26 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.923 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 t -136.81 149.59 47.84 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.755 -0.59 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -85.64 -5.16 59.3 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -112.04 93.25 4.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.649 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -104.86 91.44 3.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.11 104.8 16.97 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.675 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -145.43 168.56 20.25 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--N 1.29 -1.981 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.542 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.0 p -168.19 99.02 0.44 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.028 0.442 . . . . 0.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -104.53 19.86 19.58 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.828 0.823 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.3 p -99.05 10.04 42.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.19 128.42 0.04 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.132 2.173 . . . . 0.0 109.299 -173.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.433 ' HE2' ' SD ' ' B' ' 209' ' ' MET . 2.3 p90 -88.31 -82.05 0.24 Allowed 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.343 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.474 HG22 HG13 ' B' ' 208' ' ' ILE . 3.7 mt -134.26 145.18 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.474 HG13 HG22 ' B' ' 206' ' ' ILE . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.433 ' SD ' ' HE2' ' B' ' 205' ' ' TYR . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.437 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.551 HD12 HD21 ' A' ' 22' ' ' LEU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.443 HD22 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 -74.83 -15.45 60.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.182 177.534 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 39.6 t -74.15 -52.65 11.86 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -113.84 135.79 53.59 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.42 -54.19 6.45 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -90.83 120.02 68.84 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.97 -16.4 45.19 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.969 2.446 . . . . 0.0 110.977 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -132.93 103.66 12.97 Favored Pre-proline 0 N--CA 1.412 -2.373 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.31 106.15 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.445 2.097 . . . . 0.0 110.973 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.92 -31.02 62.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.179 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -60.74 124.41 20.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.588 ' HD3' ' H ' ' C' ' 310' ' ' ARG . 0.0 OUTLIER -57.01 -21.74 33.14 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.174 0.989 . . . . 0.0 113.543 -177.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -77.29 -10.92 59.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.25 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 64.3 26.09 13.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.854 1.262 . . . . 0.0 112.4 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 34' ' ' TYR . 14.4 mt -104.0 145.64 12.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.55 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 5.0 mmt -120.06 150.32 50.87 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.52 135.18 33.29 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.404 2.736 . . . . 0.0 113.075 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 156.53 -23.82 0.5 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.57 111.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 124.415 0.715 . . . . 0.0 109.789 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.69 140.12 56.69 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.465 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.16 98.8 7.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 168.239 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 50.9 m -87.43 100.93 13.11 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -166.2 -179.62 5.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 99.17 18.85 23.09 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.649 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.0 OUTLIER -84.27 173.05 11.3 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.038 -1.081 . . . . 0.0 111.813 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -23.02 63.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.4 0.68 . . . . 0.0 112.655 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.649 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 66.2 mm-40 -78.29 0.16 26.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.111 0.482 . . . . 0.0 112.124 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -109.03 127.71 54.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.107 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.876 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.36 152.0 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.902 0.881 . . . . 0.0 109.108 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.22 109.16 3.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 86' ' ' HIS . . . 73.1 72.22 1.0 Allowed Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -55.27 -43.88 75.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.146 0.578 . . . . 0.0 110.547 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -94.28 -66.73 0.9 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -146.47 175.64 10.41 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -18.4 54.26 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 9.98 5.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.16 97.29 4.08 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 15' ' ' ILE . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.561 HD21 HD12 ' B' ' 217' ' ' LEU . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD2' HD22 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 40' ' ' VAL . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' C' ' 315' ' ' PRO . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HG3' ' CG2' ' B' ' 208' ' ' ILE . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.47 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD11 HD12 ' B' ' 208' ' ' ILE . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 111' ' ' VAL . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt -77.1 -58.02 4.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -65.79 139.27 21.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.994 -173.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -88.07 148.36 24.51 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -85.71 93.13 8.78 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.08 -75.96 0.61 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.486 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -141.23 101.16 3.96 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.227 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.4 65.04 4.45 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.43 -44.26 71.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.095 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 C--N 1.299 -1.593 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.407 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.701 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 27.8 t -130.48 137.38 49.74 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -111.27 -46.22 3.32 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.693 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 8.8 m -49.86 -52.17 34.7 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.212 1.005 . . . . 0.0 111.07 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.92 -179.75 8.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -114.64 -66.6 1.07 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.425 HG22 HG13 ' B' ' 208' ' ' ILE . 5.3 mm -131.37 139.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 22' ' ' LEU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.442 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 -85.53 -17.17 37.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.29 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.495 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.2 t -158.28 -50.58 0.06 Allowed 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -105.21 109.38 21.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.23 -54.87 7.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -90.11 123.2 66.53 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.413 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.95 -26.65 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.142 1.895 . . . . 0.0 110.852 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.49 123.56 35.44 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.95 89.43 0.77 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.112 1.875 . . . . 0.0 113.403 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.42 20.03 16.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.529 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.88 36.96 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 67.02 -47.8 0.47 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.984 1.714 . . . . 0.0 114.96 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -105.46 17.98 23.0 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 122.07 -0.394 . . . . 0.0 110.743 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.88 17.46 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.988 0.915 . . . . 0.0 112.906 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 35.6 mt -86.49 144.62 9.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.728 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 2.8 mmt -107.07 136.34 19.49 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 315' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 53.5 Cg_endo -64.19 168.71 12.0 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 124.014 3.143 . . . . 0.0 114.617 -172.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.417 ' HD3' HD13 ' A' ' 28' ' ' LEU . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 144.98 51.95 0.03 OUTLIER Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.85 108.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -65.79 150.41 48.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.155 0.91 . . . . 0.0 110.252 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 1.1 mmp_? -83.2 99.53 10.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.101 0.477 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 2.4 p -86.07 88.34 7.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 178.16 -171.78 0.12 Allowed 'General case' 0 C--O 1.243 0.744 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.15 -40.37 2.21 Favored Glycine 0 C--N 1.29 -2.014 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -90.87 97.07 10.96 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 122.04 0.924 . . . . 0.0 110.833 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.69 -67.58 0.85 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.58 -43.15 6.96 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.014 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -170.79 174.82 4.75 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 . . . . . 0 C--N 1.288 -2.081 0 CA-C-N 119.347 0.976 . . . . 0.0 109.756 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.398 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.86 79.03 0.15 Allowed 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.045 0.938 . . . . 0.0 110.673 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 137.68 56.73 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.087 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.82 83.86 0.49 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.674 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -79.28 -2.87 43.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.848 0.833 . . . . 0.0 109.074 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.26 -32.55 74.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.808 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 86' ' ' HIS . 90.1 m-85 -87.91 137.61 32.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.649 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.73 -50.47 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.856 0.36 . . . . 0.0 111.715 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -81.81 13.16 3.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 7' ' ' TYR . 15.3 m-80 -111.03 94.06 4.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.389 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 65' ' ' THR . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.638 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' C' ' 314' ' ' MET . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.602 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' O ' HG11 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 ' HE ' ' A' ' 44' ' ' ARG . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 42' ' ' LEU . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.602 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.645 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' ILE . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' C' ' 329' ' ' GLU . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' C' ' 328' ' ' PHE . 12.8 m120 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.434 HD13 HG12 ' A' ' 30' ' ' VAL . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' C' ' 324' ' ' ARG . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 69' ' ' VAL . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD11 HD12 ' B' ' 208' ' ' ILE . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 40' ' ' VAL . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt -66.01 -45.0 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 108' ' ' ARG . 9.3 p -65.12 142.61 16.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.238 -174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.6 m -100.17 154.98 18.01 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -61.73 110.03 1.4 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.078 0.466 . . . . 0.0 109.993 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -135.45 143.26 45.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.79 -42.52 24.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.82 126.34 5.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -62.66 -46.65 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.15 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' B' ' 204' ' ' GLN . 7.7 t -156.19 139.14 15.36 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -74.29 -41.38 61.29 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.9 m -73.99 -58.55 3.23 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.226 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' B' ' 201' ' ' SER . 52.7 tt0 -136.21 120.21 17.59 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.418 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 5.1 m-85 -53.89 -64.95 0.66 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.023 0.929 . . . . 0.0 111.605 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.418 HG22 HG13 ' B' ' 208' ' ' ILE . 4.7 mm -125.89 153.06 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG ' ' A' ' 26' ' ' ASP . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 -81.67 -12.74 58.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.256 1.426 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.426 178.733 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.9 p -165.25 147.34 7.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.92 171.06 8.7 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -95.86 30.77 2.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.829 0.824 . . . . 0.0 110.344 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' C' ' 305' ' ' PRO . 96.9 mttt -79.2 136.62 56.97 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.876 -0.515 . . . . 0.0 110.306 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 305' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 304' ' ' LYS . 16.8 Cg_exo -63.19 -47.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.794 2.329 . . . . 0.0 112.245 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -104.56 125.13 34.85 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -56.78 132.21 50.33 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.195 1.93 . . . . 0.0 110.733 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -72.26 -18.43 61.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.194 0.997 . . . . 0.0 108.576 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -72.85 93.97 1.76 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.488 ' HB3' HD21 ' A' ' 67' ' ' LEU . 20.9 ttm180 -43.15 -46.32 5.85 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -170.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.489 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 82.1 m-85 -99.97 21.47 12.65 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.877 -0.515 . . . . 0.0 112.192 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 68.32 28.61 6.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 4.7 mp -78.27 146.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.48 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 19.6 mmt -80.22 136.22 53.57 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.2 150.28 84.99 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.67 2.247 . . . . 0.0 111.229 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 142.8 -21.63 2.33 Favored Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.16 107.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.446 0.698 . . . . 0.0 109.751 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -94.67 137.08 34.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.065 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.638 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 12.3 mtm180 -127.35 143.55 51.2 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 123.438 0.695 . . . . 0.0 109.919 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 38.4 m -155.33 110.25 2.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.17 113.16 7.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.601 0.715 . . . . 0.0 111.962 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.28 31.66 10.44 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.091 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.492 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 70.9 t80 -64.76 145.1 56.72 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.987 0.393 . . . . 0.0 110.753 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 329' ' ' GLU . . . . . 0.434 ' HG3' ' OD2' ' A' ' 70' ' ' ASP . 29.2 mt-10 -66.1 2.92 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -40.01 -41.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -93.87 113.98 26.11 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.299 0.571 . . . . 0.0 109.572 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 70.9 m95 . . . . . 0 C--N 1.299 -1.629 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.208 -176.122 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.17 99.64 3.42 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -109.6 143.95 38.6 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.97 49.69 3.07 Favored Glycine 0 C--N 1.306 -1.104 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -90.22 -53.53 4.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.176 0.512 . . . . 0.0 110.109 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.64 -21.5 20.77 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.046 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.24 80.13 3.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.244 0.545 . . . . 0.0 109.72 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -119.99 -6.55 10.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.801 0.81 . . . . 0.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.15 -37.63 78.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.768 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -103.9 116.97 33.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.501 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.428 HD21 ' HB2' ' A' ' 80' ' ' ARG . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD21 HD12 ' B' ' 217' ' ' LEU . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.477 HD21 HG11 ' A' ' 40' ' ' VAL . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.501 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 HD13 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 106' ' ' LEU . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' HG13 ' A' ' 38' ' ' VAL . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' C' ' 310' ' ' ARG . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' C' ' 330' ' ' GLU . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HB2' HD21 ' A' ' 17' ' ' ASN . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD13 HD11 ' A' ' 84' ' ' ILE 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' B' ' 206' ' ' ILE . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 40' ' ' VAL . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' O ' HG12 ' A' ' 111' ' ' VAL . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.621 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.581 HD13 HG12 ' A' ' 38' ' ' VAL . 70.8 mt -69.37 -44.11 80.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 107' ' ' ASP . 10.5 p -68.54 -38.29 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.56 0.695 . . . . 0.0 110.337 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 37.0 m -156.35 124.59 5.72 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.02 73.21 2.89 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.898 0.856 . . . . 0.0 111.666 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -175.87 -55.37 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 112' ' ' SER . 56.9 t30 -170.76 163.44 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 108' ' ' ARG . . . -100.22 136.03 40.74 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -154.01 -49.41 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' SER . . . . . 0.58 ' HB2' ' O ' ' B' ' 204' ' ' GLN . 14.5 m -68.5 145.66 53.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.75 -18.63 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.9 t -71.2 -60.21 2.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' B' ' 201' ' ' SER . 3.8 pm0 -149.85 144.45 25.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.67 ' HE1' ' SD ' ' B' ' 209' ' ' MET . 0.7 OUTLIER -37.71 -56.37 1.07 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.551 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -126.81 146.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.551 HG13 HG22 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.67 ' SD ' ' HE1' ' B' ' 205' ' ' TYR . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.476 ' HB3' HD23 ' A' ' 22' ' ' LEU . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 22' ' ' LEU . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -93.57 -45.4 7.75 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.423 -1.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.163 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 CA-C-O 119.274 -0.737 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 34.9 t -53.86 -71.95 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.424 0.69 . . . . 0.0 110.11 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.72 108.42 18.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -103.62 -51.05 3.28 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.141 -169.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -72.78 147.8 89.28 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.346 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.81 -15.07 21.45 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.652 2.235 . . . . 0.0 111.193 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -127.29 128.93 23.99 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 14.2 Cg_exo -72.6 45.69 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.196 2.597 . . . . 0.0 112.401 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.72 35.16 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.018 1.327 . . . . 0.0 112.295 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.14 71.0 8.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 67' ' ' LEU . 16.1 tpp180 57.2 -79.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.619 2.368 . . . . 0.0 112.594 -177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' C' ' 313' ' ' ILE . 50.7 m-85 -92.13 -6.64 50.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 80.7 61.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.335 1.454 . . . . 0.0 113.953 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 3.7 mp -118.68 128.32 75.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.5 mmt -93.95 153.67 40.86 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.31 156.87 5.11 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.229 3.286 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -174.53 22.89 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 83.9 t -81.52 112.34 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -81.81 133.19 35.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.501 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -106.31 141.61 37.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 15.2 m -73.79 95.36 2.39 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -135.5 -169.63 2.43 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.246 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.74 31.62 7.69 Favored Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.003 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.47 166.43 23.53 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.496 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.1 4.24 7.14 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.911 1.684 . . . . 0.0 111.783 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.479 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -38.74 -22.1 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.461 ' HB2' ' OE1' ' C' ' 330' ' ' GLU . 0.0 OUTLIER -139.07 159.51 41.98 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.002 -1.061 . . . . 0.0 110.018 -177.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.742 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.406 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.09 120.97 3.83 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.45 108.39 20.6 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.014 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.446 ' HA2' ' CD2' ' A' ' 7' ' ' TYR . . . -166.7 28.48 0.18 Allowed Glycine 0 C--N 1.293 -1.817 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.159 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -80.44 -15.85 55.8 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.296 0.57 . . . . 0.0 109.468 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -4.17 35.06 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 67.0 m-85 -82.76 91.99 7.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.489 0.662 . . . . 0.0 109.893 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -93.25 -20.62 20.25 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.028 -176.235 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -93.63 -19.49 21.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.764 0.792 . . . . 0.0 110.777 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.63 98.16 10.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.109 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 65' ' ' THR . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' LEU . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 19' ' ' ASN . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 HG11 ' A' ' 40' ' ' VAL . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.706 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HG23 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.565 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.682 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' HG12 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.709 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.716 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.554 HD11 HG12 ' A' ' 40' ' ' VAL . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' HG12 ' A' ' 111' ' ' VAL . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 108' ' ' ARG . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt -81.31 -62.06 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 107' ' ' ASP . 1.4 p -81.34 135.32 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -69.83 -40.83 75.62 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 113' ' ' LYS . 8.1 tmtm? -147.35 113.93 6.01 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -87.99 131.11 34.75 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -100.89 101.1 11.85 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.033 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.4 105.54 15.62 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.386 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.8 86.71 2.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.035 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 34.3 m -83.51 88.79 7.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.371 0.605 . . . . 0.0 110.424 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -105.81 -2.77 22.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.544 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -57.95 -50.52 73.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -166.22 133.84 2.78 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.44 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 3.7 m-85 -63.99 -60.76 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.454 HG22 HG13 ' B' ' 208' ' ' ILE . 4.0 mt -138.76 152.92 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.454 HG13 HG22 ' B' ' 206' ' ' ILE . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.459 HD13 ' HA3' ' A' ' 78' ' ' GLY . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.716 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 -76.6 -8.23 56.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.927 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 44.5 m -87.64 54.43 3.12 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.706 0.765 . . . . 0.0 110.579 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -121.29 109.59 15.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.9 -36.07 10.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -80.02 120.66 80.47 Favored Pre-proline 0 C--N 1.309 -1.155 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.45 -29.43 6.04 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.647 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -148.93 161.0 33.99 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.44 ' HB3' ' HB2' ' C' ' 312' ' ' ALA . 30.0 Cg_endo -98.68 109.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.806 2.337 . . . . 0.0 113.883 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 308' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' C' ' 308' ' ' GLU . 0.7 OUTLIER -83.46 -36.94 23.79 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -85.94 137.52 32.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -54.61 -36.51 64.55 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.481 0.713 . . . . 0.0 111.561 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -91.44 1.43 57.13 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 312' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' C' ' 307' ' ' PRO . . . 63.23 16.79 9.71 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.324 1.05 . . . . 0.0 112.865 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.47 135.37 35.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.378 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.647 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 5.8 mmt -120.9 153.23 57.17 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.67 145.64 22.48 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.646 2.897 . . . . 0.0 113.543 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 133.14 -7.14 5.08 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.27 113.84 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -95.25 136.61 35.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.706 ' NH2' ' HA ' ' A' ' 30' ' ' VAL . 5.8 mpt_? -99.84 149.84 22.97 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.9 p -135.21 89.42 2.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -156.4 132.8 10.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.92 30.83 55.24 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.842 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' C' ' 330' ' ' GLU . 24.1 t80 -86.17 159.44 19.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.268 0.556 . . . . 0.0 110.93 -175.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.85 1.0 48.98 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.479 1.511 . . . . 0.0 113.742 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' C' ' 328' ' ' PHE . 3.7 tm-20 -55.7 -43.75 76.73 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.6 0.76 . . . . 0.0 111.316 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 9.6 tmtt? -74.61 132.26 41.61 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 332' ' ' TRP . . . . . 0.558 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 58.1 p-90 . . . . . 0 C--N 1.311 -1.066 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.11 99.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.042 1.337 . . . . 0.0 110.429 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.516 ' H ' ' HB2' ' A' ' 70' ' ' ASP . 68.8 mtt -82.23 -179.33 7.37 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.009 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.08 34.97 9.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.77 -42.35 97.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.155 -0.522 . . . . 0.0 110.263 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.63 -36.75 11.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -98.72 114.55 27.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -122.21 -20.95 6.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.038 -177.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.92 -27.51 23.32 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.406 0.622 . . . . 0.0 109.853 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -74.03 107.34 6.18 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.958 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 65' ' ' THR . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 HD12 ' B' ' 217' ' ' LEU . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.567 ' OD2' HD22 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.463 HD11 HD23 ' A' ' 42' ' ' LEU . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 3' ' ' MET . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 111' ' ' VAL . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt -64.57 -47.14 90.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.4 p -79.04 114.59 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 122.646 1.212 . . . . 0.0 108.531 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 p -90.61 174.98 7.22 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.429 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -70.58 113.0 7.25 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 47.7 t30 73.12 88.37 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.705 1.202 . . . . 0.0 108.92 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -154.09 -57.27 0.11 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.916 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -148.2 100.89 3.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.997 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.25 116.82 29.27 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.294 -1.811 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.655 -178.679 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.973 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -77.64 102.57 7.11 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.14 0.495 . . . . 0.0 110.076 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.8 -20.68 11.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.382 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -79.64 -38.88 32.77 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -129.88 147.26 51.62 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -132.72 -69.82 0.56 Allowed 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 122.887 0.475 . . . . 0.0 110.755 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.545 HG22 HG13 ' B' ' 208' ' ' ILE . 3.4 mt -142.48 146.04 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.572 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.484 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.595 HD12 HD21 ' A' ' 22' ' ' LEU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 -84.86 -39.37 18.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.413 -2.311 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.718 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.3 t -150.74 154.33 37.18 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -73.84 124.73 26.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -130.7 31.03 4.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.781 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.68 126.15 74.95 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.003 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.03 -39.75 22.97 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.432 2.088 . . . . 0.0 109.165 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.23 46.26 Favored Pre-proline 0 N--CA 1.411 -2.394 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.67 -22.96 63.52 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.566 2.177 . . . . 0.0 112.172 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 308' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' C' ' 331' ' ' LYS 0.47 12.1 pt-20 59.58 -56.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.644 2.377 . . . . 0.0 115.223 -175.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -36.46 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.704 2.002 . . . . 0.0 110.473 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -41.81 -48.21 4.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.176 1.79 . . . . 0.0 115.093 -173.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.61 7.68 42.31 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.993 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 49.2 60.35 3.82 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.423 1.089 . . . . 0.0 112.125 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.43 129.47 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.0 mmt -94.23 148.05 34.42 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.736 0.648 . . . . 0.0 111.138 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.27 141.27 50.19 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.366 3.377 . . . . 0.0 114.377 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.484 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 147.67 -19.74 1.47 Allowed Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.12 113.03 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 O-C-N 124.364 0.685 . . . . 0.0 109.489 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -61.24 136.49 58.07 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.562 1.145 . . . . 0.0 112.241 -169.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -108.85 130.09 55.41 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 53.0 m -156.84 130.86 8.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -111.65 -43.29 3.67 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.49 25.89 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -75.64 151.23 37.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.183 -1.008 . . . . 0.0 111.916 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.01 1.37 1.47 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.716 2.407 . . . . 0.0 113.891 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.68 -26.51 60.76 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.59 0.756 . . . . 0.0 112.644 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' C' ' 308' ' ' GLU . 26.6 tptp -90.79 125.06 35.6 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.256 -170.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 74.0 m95 . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.62 29.57 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.615 0.245 . . . . 0.0 110.65 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ttt -72.85 139.81 47.19 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 86' ' ' HIS . . . 160.87 -51.5 0.35 Allowed Glycine 0 CA--C 1.487 -1.698 0 C-N-CA 118.566 -1.778 . . . . 0.0 114.678 175.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -73.09 7.19 2.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.208 1.004 . . . . 0.0 111.288 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -93.66 -31.22 14.55 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.79 -0.569 . . . . 0.0 111.492 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.459 ' HB2' ' ND2' ' A' ' 10' ' ' ASN . 99.1 m-85 -139.27 148.6 43.23 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -102.58 -17.73 15.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.49 3.86 20.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 91.9 m-20 -86.55 99.52 11.76 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 5.8 m-80 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.42 HD21 HG11 ' A' ' 40' ' ' VAL . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 110' ' ' ILE . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' HG11 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' HD12 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 69' ' ' VAL . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 28.4 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' HG12 ' B' ' 206' ' ' ILE . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 40' ' ' VAL . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt -90.51 -35.59 7.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.74 170.09 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.161 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m -61.4 104.75 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.183 0.516 . . . . 0.0 110.656 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -101.67 -16.11 16.8 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -49.51 111.79 0.55 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.689 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -160.2 120.66 2.96 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.054 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.28 80.03 9.34 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.702 0.763 . . . . 0.0 111.811 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.33 157.5 46.65 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.906 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.889 -178.26 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.745 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.9 p -132.18 113.45 13.3 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.222 0.534 . . . . 0.0 111.854 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.74 -30.0 18.33 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -109.99 -70.42 0.81 Allowed 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 179.38 166.39 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -124.4 -94.5 0.48 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.792 0.269 . . . . 0.0 111.425 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.642 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm -104.05 145.36 12.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.642 HG13 HG22 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 21' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 -81.3 -9.2 59.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.339 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.4 m -80.64 138.24 36.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -83.19 141.63 31.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.86 13.55 13.16 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.0 125.4 78.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.906 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.53 -17.29 12.87 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.568 2.178 . . . . 0.0 111.289 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.51 16.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.405 ' HB3' ' HG2' ' C' ' 314' ' ' MET . 36.9 Cg_endo -77.74 92.48 1.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.222 1.948 . . . . 0.0 111.699 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.512 0.672 . . . . 0.0 110.201 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -168.12 162.01 12.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -49.46 -52.15 31.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.063 0.945 . . . . 0.0 111.309 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -111.76 17.17 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.25 0.547 . . . . 0.0 110.453 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.22 60.85 1.39 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.7 144.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' C' ' 307' ' ' PRO . 3.3 mmt -106.12 154.15 39.8 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.12 155.2 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.14 2.56 . . . . 0.0 114.157 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -159.26 29.09 0.4 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.36 109.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -82.98 148.18 27.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.261 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 99.87 11.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -139.58 110.56 6.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.567 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -129.12 18.37 6.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.808 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.53 -41.55 1.91 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.603 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 328' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' C' ' 331' ' ' LYS . 14.1 p90 -103.01 164.41 11.63 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -91.73 -70.37 0.69 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.629 0.728 . . . . 0.0 111.54 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.8 -39.89 6.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 331' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 12.4 tmtt? 82.12 129.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.165 1.386 . . . . 0.0 109.589 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.025 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' HA2' ' OD1' ' A' ' 73' ' ' ASN . . . . . . . . 0 CA--C 1.488 -1.62 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.8 93.52 3.63 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 117.078 0.439 . . . . 0.0 109.976 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 ptp -110.36 153.15 25.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.01 165.78 37.08 Favored Glycine 0 N--CA 1.415 -2.714 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.055 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -98.81 -14.46 19.67 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.8 -31.98 63.53 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -76.85 86.18 3.43 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.643 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -130.51 -42.57 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.548 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.07 -27.09 48.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.994 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -81.58 82.46 7.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.759 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 57' ' ' LEU . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 18' ' ' LEU . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.491 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' C' ' 318' ' ' ARG . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 30' ' ' VAL . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 65' ' ' THR . 59.5 tp60 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HG ' ' CD1' ' C' ' 311' ' ' PHE . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 69' ' ' VAL . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 40' ' ' VAL . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.96 -52.25 14.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 114.68 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-O 121.989 0.899 . . . . 0.0 109.375 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m -92.18 -18.78 23.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.645 0.736 . . . . 0.0 109.294 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -99.27 102.66 14.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -178.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -71.26 103.71 2.91 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.862 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.22 100.88 11.48 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.45 1.119 . . . . 0.0 108.717 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.74 47.12 2.56 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.46 80.76 5.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.131 -176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.154 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.266 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.4 p -95.37 148.52 22.36 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 120.72 0.295 . . . . 0.0 110.693 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -97.45 -31.78 12.18 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.786 0.434 . . . . 0.0 111.987 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.5 m -63.45 -64.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.581 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 51.2 tt0 -127.01 167.41 15.95 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -124.29 -66.31 0.99 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.48 155.81 8.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' ASP . . . . . 0.443 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 -64.17 -40.98 97.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.256 1.414 0 C-N-CA 125.404 1.481 . . . . 0.0 109.963 -179.603 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.945 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 3.1 p -105.17 127.21 52.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -53.91 124.35 15.17 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.582 0.706 . . . . 0.0 111.844 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 -54.4 4.63 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.532 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.87 139.52 26.07 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.08 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.56 -5.1 10.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.551 2.167 . . . . 0.0 114.332 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -134.6 142.8 43.98 Favored Pre-proline 0 C--N 1.309 -1.163 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.16 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 5.8 Cg_exo -77.3 84.56 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.372 2.048 . . . . 0.0 110.175 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.53 -4.9 58.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.093 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 309' ' ' ASN . . . . . 0.472 HD21 ' HB2' ' C' ' 311' ' ' PHE . 0.4 OUTLIER -89.11 148.65 23.57 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.05 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' C' ' 310' ' ' ARG . 27.1 ttp180 -49.38 -35.67 19.49 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 128.127 2.571 . . . . 0.0 113.759 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.601 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 21.4 m-85 -89.99 -24.41 21.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.5 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.4 62.2 1.61 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.481 0.712 . . . . 0.0 111.883 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 30.9 mm -104.69 152.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 17.7 mmt -97.09 142.38 24.44 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 167.14 7.81 Favored 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 123.311 2.674 . . . . 0.0 112.871 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.436 ' HD2' HD13 ' A' ' 28' ' ' LEU . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 319' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 177.24 44.08 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.22 108.08 19.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.83 141.06 47.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 80.8 mtt-85 -128.26 129.3 46.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.639 0.733 . . . . 0.0 112.183 -171.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 65.1 m -148.05 148.83 31.1 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -100.51 -4.18 29.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.051 0.453 . . . . 0.0 110.669 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.52 13.34 30.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.37 165.14 24.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.753 0.311 . . . . 0.0 110.869 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.18 3.87 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.566 2.346 . . . . 0.0 115.169 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -41.03 -32.11 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.975 1.31 . . . . 0.0 114.433 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -76.3 126.76 31.58 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 120.89 -1.131 . . . . 0.0 109.63 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.639 1.576 . . . . 0.0 114.879 -173.447 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.926 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.81 64.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.537 0.685 . . . . 0.0 110.152 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.7 mtt -104.07 109.0 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.354 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.14 166.09 16.09 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -80.8 10.04 5.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.009 0.909 . . . . 0.0 110.762 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.25 -12.15 50.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.656 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -51.09 -31.09 17.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.573 1.549 . . . . 0.0 114.149 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.25 -28.94 28.84 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.843 0.354 . . . . 0.0 111.576 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -106.05 -4.41 20.48 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.448 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 -93.96 86.27 4.99 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 18' ' ' LEU . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.497 HD11 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' HD12 ' A' ' 22' ' ' LEU . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' B' ' 215' ' ' SER . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' OD2' HD22 ' B' ' 218' ' ' LEU . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 HD21 ' B' ' 218' ' ' LEU . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' HD11 ' A' ' 110' ' ' ILE . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 106' ' ' LEU . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.543 HD12 ' HG2' ' A' ' 44' ' ' ARG . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HG2' HD12 ' A' ' 42' ' ' LEU . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.618 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' VAL . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.569 ' HA ' HD12 ' A' ' 110' ' ' ILE . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 38' ' ' VAL . 18.5 mt -75.44 -50.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 113' ' ' LYS . 9.8 p -57.9 138.67 18.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.579 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 113' ' ' LYS . 20.0 m -89.42 0.28 56.97 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.377 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 46.48 28.32 0.73 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.119 1.768 . . . . 0.0 113.145 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -92.77 -50.25 5.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.697 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.87 164.27 20.42 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.565 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.43 103.77 15.3 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.79 -6.34 14.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.516 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 10.0 p -132.61 -61.05 0.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.44 9.41 42.46 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.127 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.5 m -54.88 -40.93 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.817 0.847 . . . . 0.0 109.695 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -153.38 136.97 15.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -91.78 -50.44 5.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.381 0.61 . . . . 0.0 109.988 -172.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.559 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -117.82 142.51 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.628 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.456 ' HB3' HD23 ' A' ' 22' ' ' LEU . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.458 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 -77.52 -33.65 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t -118.92 162.11 19.06 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -72.09 112.18 7.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.787 0.804 . . . . 0.0 111.256 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.1 4.82 12.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.712 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -81.56 134.16 51.54 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.007 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.43 -27.58 33.49 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.017 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -135.72 143.26 43.99 Favored Pre-proline 0 N--CA 1.432 -1.374 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.261 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 43.2 Cg_exo -62.53 -39.16 46.75 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.944 2.429 . . . . 0.0 112.138 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 65.12 32.4 10.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.713 1.205 . . . . 0.0 109.366 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -114.73 146.95 40.36 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.172 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 310' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' C' ' 330' ' ' GLU . 8.9 tpt180 -49.45 -42.12 42.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.077 0.951 . . . . 0.0 112.452 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.45 -8.01 39.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 55.89 32.28 19.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.948 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.91 139.77 18.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.97 144.3 82.17 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -73.08 155.8 52.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.989 2.459 . . . . 0.0 111.777 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 129.21 -14.02 5.94 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.28 109.68 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -90.98 118.68 30.55 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.42 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 3.7 mpt_? -94.02 147.9 22.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.896 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 11.2 t -137.08 102.27 4.79 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -100.06 9.06 43.45 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.279 -167.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 118.96 -41.47 2.0 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -100.95 95.81 6.84 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -95.96 -66.3 0.92 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 123.127 1.442 . . . . 0.0 108.754 168.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 330' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' C' ' 310' ' ' ARG . 12.5 pt-20 -100.82 -30.92 11.43 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.952 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -163.82 153.39 14.55 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.396 -177.385 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.314 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.08 85.72 1.99 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.54 109.48 19.66 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.024 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.24 -13.39 71.26 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -72.68 10.12 0.93 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.979 1.312 . . . . 0.0 112.23 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.4 -39.12 74.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 172.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 t80 57.83 17.16 4.03 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.466 1.906 . . . . 0.0 115.115 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -100.02 -10.68 21.31 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.567 -1.333 . . . . 0.0 112.127 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 25.2 t70 -66.62 -34.48 77.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -60.27 109.25 0.94 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 57' ' ' LEU . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 15' ' ' ILE . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 HD23 ' A' ' 42' ' ' LEU . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 40' ' ' VAL . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CD1' HG23 ' A' ' 30' ' ' VAL . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' C' ' 316' ' ' GLY . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 58' ' ' LYS . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 27' ' ' ILE . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' B' ' 208' ' ' ILE . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 50' ' ' GLU . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' B' ' 208' ' ' ILE . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD23 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HB2' HG11 ' A' ' 38' ' ' VAL . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.657 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' C' ' 311' ' ' PHE . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.573 ' HE3' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 20.9 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.488 HD11 HG12 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 38' ' ' VAL . 45.0 mt -90.62 -42.6 14.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.72 147.51 10.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.571 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 t -86.7 37.68 0.76 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm 61.86 82.92 0.16 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 112.897 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -142.94 93.58 2.52 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.54 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.41 -59.67 2.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.13 30.89 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.079 0.466 . . . . 0.0 110.066 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.1 -51.37 3.27 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 177.114 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.576 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -116.78 123.59 47.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -88.01 -2.54 58.67 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.2 m -65.03 -23.03 67.08 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.763 1.225 . . . . 0.0 113.093 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.533 ' HG2' ' N ' ' B' ' 205' ' ' TYR . 33.5 tt0 -158.73 166.04 32.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.533 ' N ' ' HG2' ' B' ' 204' ' ' GLN . 1.7 m-85 -125.99 -58.76 1.37 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.461 HG22 HG13 ' B' ' 208' ' ' ILE . 9.1 mm -120.74 150.61 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.461 HG13 HG22 ' B' ' 206' ' ' ILE . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.579 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -77.04 -23.32 52.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.264 1.855 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.724 -179.061 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 CA-C-O 120.145 -0.253 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 7.8 p -96.22 -77.17 0.49 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 117.667 0.734 . . . . 0.0 111.132 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.39 109.6 17.55 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -110.92 -52.48 2.78 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.508 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.61 149.21 40.28 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.84 -10.76 11.59 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.327 2.018 . . . . 0.0 114.614 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 306' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -126.1 124.9 24.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.036 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 307' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 16.2 Cg_exo -70.6 96.27 0.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.116 1.877 . . . . 0.0 109.573 172.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.43 -174.18 4.27 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.89 160.28 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.956 0.902 . . . . 0.0 110.003 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -59.69 -38.2 80.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 311' ' ' PHE . . . . . 0.435 ' CE1' HD21 ' A' ' 67' ' ' LEU . 1.6 m-85 -105.57 20.96 18.03 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.722 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.85 62.44 1.46 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.412 0.625 . . . . 0.0 112.542 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.427 HD11 ' HB2' ' C' ' 311' ' ' PHE . 2.2 mp -90.72 135.64 26.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.872 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 314' ' ' MET . . . . . 0.446 ' HA ' ' CE ' ' C' ' 314' ' ' MET . 2.1 mmt -104.6 111.15 65.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.07 138.99 88.64 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 122.58 2.187 . . . . 0.0 112.581 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 316' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.583 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.39 -37.99 0.34 Allowed Glycine 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 26.0 t -51.97 105.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 112.192 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -77.88 135.65 37.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 324' ' ' ARG . . . . . 0.646 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 79.1 mtt-85 -119.1 118.95 32.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.087 0.47 . . . . 0.0 110.6 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.4 p -136.09 115.54 12.72 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.058 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -136.31 97.71 3.66 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.94 31.04 18.86 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -87.2 156.21 19.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.518 0.675 . . . . 0.0 111.123 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.05 2.44 3.58 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.631 1.573 . . . . 0.0 114.524 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.99 -39.22 25.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.92 0.888 . . . . 0.0 112.076 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -63.63 113.32 3.27 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.027 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 . . . . . 0 C--N 1.292 -1.923 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.119 178.601 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.498 -1.019 0 CA-C-O 121.591 0.71 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.468 HG23 HG23 ' A' ' 65' ' ' THR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.549 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 217' ' ' LEU . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 110' ' ' ILE . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG11 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.458 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.464 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.7 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 40' ' ' VAL . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 38' ' ' VAL . 60.6 mt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.429 HG22 HG13 ' B' ' 208' ' ' ILE . 7.7 mm . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.429 HG13 HG22 ' B' ' 206' ' ' ILE . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.565 HD12 HD21 ' A' ' 22' ' ' LEU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 . . . . . 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 113.034 0.359 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.86 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' LEU . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 15' ' ' ILE . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.444 ' H ' HD12 ' A' ' 22' ' ' LEU . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' B' ' 217' ' ' LEU . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD21 HD12 ' B' ' 217' ' ' LEU . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 28' ' ' LEU . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 42' ' ' LEU . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' C' ' 318' ' ' ARG . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 77' ' ' ILE 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 110' ' ' ILE . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.685 ' O ' HG11 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 50' ' ' GLU . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.1 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 30' ' ' VAL . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 96' ' ' GLN . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 110' ' ' ILE . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' VAL . 57.7 mt . . . . . 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.407 HG22 ' H ' ' B' ' 208' ' ' ILE . 11.1 mm . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.407 ' H ' HG22 ' B' ' 206' ' ' ILE . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.408 ' HZ ' HG13 ' A' ' 102' ' ' VAL . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.514 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 19' ' ' ASN . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD2' HD22 ' B' ' 218' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.421 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 83' ' ' LYS . 2.8 t-20 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.4 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 98' ' ' TYR . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 110' ' ' ILE . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.507 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.507 HG13 HG22 ' B' ' 206' ' ' ILE . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 102' ' ' VAL . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.45 ' HB3' HD23 ' A' ' 22' ' ' LEU . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.478 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.418 ' HG3' ' HG ' ' B' ' 220' ' ' LEU . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.418 ' HG ' ' HG3' ' B' ' 219' ' ' GLU . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.835 0.265 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' C' ' 318' ' ' ARG . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 . . . . . 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.548 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.4 HG23 ' O ' ' B' ' 213' ' ' SER . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.694 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 28' ' ' LEU . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 44' ' ' ARG . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 42' ' ' LEU . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' B' ' 208' ' ' ILE . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.504 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 38' ' ' VAL . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.416 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.422 HD11 HD12 ' B' ' 208' ' ' ILE . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.517 HG22 HG13 ' B' ' 208' ' ' ILE . 6.5 mt . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.517 HG13 HG22 ' B' ' 206' ' ' ILE . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' THR . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.404 HD22 ' OD2' ' A' ' 26' ' ' ASP . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--O 1.248 1.007 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . 0.694 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 37.6 m-80 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.41 HD21 HD12 ' B' ' 217' ' ' LEU . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 42' ' ' LEU . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 110' ' ' ILE . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 50' ' ' GLU . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HD23 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . 25.9 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' B' ' 206' ' ' ILE . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB2' HG12 ' B' ' 206' ' ' ILE . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 40' ' ' VAL . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 38' ' ' VAL . 67.4 mt . . . . . 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.633 HG22 HG13 ' B' ' 208' ' ' ILE . 2.7 mm . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.633 HG13 HG22 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 102' ' ' VAL . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.426 ' HB3' HH12 ' C' ' 318' ' ' ARG . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo . . . . . 0 C--O 1.245 0.854 0 CA-C-O 120.909 0.295 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.426 HH12 ' HB3' ' B' ' 212' ' ' PHE . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.435 -1.186 0 CA-C-O 120.968 0.413 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 18' ' ' LEU . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 15' ' ' ILE . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' H ' HD12 ' A' ' 22' ' ' LEU . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' B' ' 217' ' ' LEU . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 19' ' ' ASN . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' HD22 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 110' ' ' ILE . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 28' ' ' LEU . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.572 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.0 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.421 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.4 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 38' ' ' VAL . 59.9 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.554 HG22 HG13 ' B' ' 208' ' ' ILE . 3.5 mm . . . . . 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.554 HG13 HG22 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.484 HD22 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 CA-C-O 120.922 0.301 . . . . 0.0 112.729 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' LEU . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 HD12 ' B' ' 217' ' ' LEU . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 42' ' ' LEU . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.61 HD21 HG11 ' A' ' 40' ' ' VAL . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.61 HG11 HD21 ' A' ' 28' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' B' ' 208' ' ' ILE . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' B' ' 208' ' ' ILE . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' ILE . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' HG21 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 65' ' ' THR . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 84' ' ' ILE . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.635 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CD1' HG21 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 40' ' ' VAL . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.482 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.57 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.246 0.9 0 N-CA-C 113.72 0.623 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.554 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 p30 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.301 0.572 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 65' ' ' THR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 HG21 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' HD22 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD22 ' A' ' 28' ' ' LEU . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 60' ' ' GLU . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' A' ' 48' ' ' THR . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' H ' HG21 ' A' ' 38' ' ' VAL . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' A' ' 71' ' ' ASN . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.8 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' VAL . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 210' ' ' PRO . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.439 HD11 HG12 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' HA ' HD12 ' A' ' 110' ' ' ILE . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.487 HG22 HG13 ' B' ' 208' ' ' ILE . 18.7 mm . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.487 HG13 HG22 ' B' ' 206' ' ' ILE . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 102' ' ' VAL . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.427 ' OD2' HG21 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.436 HD22 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.248 1.001 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 HD11 ' A' ' 18' ' ' LEU . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD11 HG22 ' A' ' 15' ' ' ILE . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 22' ' ' LEU . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.63 HD21 HD12 ' B' ' 217' ' ' LEU . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' B' ' 218' ' ' LEU . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' C' ' 316' ' ' GLY . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' A' ' 60' ' ' GLU . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 28' ' ' LEU . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 50' ' ' GLU . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 41' ' ' ILE . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 38' ' ' VAL . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 84' ' ' ILE . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.9 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.524 HG22 HG13 ' B' ' 208' ' ' ILE . 13.0 mm . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.524 HG13 HG22 ' B' ' 206' ' ' ILE . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 22' ' ' LEU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo . . . . . 0 C--O 1.26 1.586 0 N-CA-C 113.773 0.643 . . . . 0.0 113.773 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' C' ' 318' ' ' ARG . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 40' ' ' VAL . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' CD1' ' A' ' 31' ' ' PHE . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.414 ' HA ' HD11 ' A' ' 110' ' ' ILE . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HG2' HD12 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.588 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 40' ' ' VAL . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.72 HG22 HG13 ' B' ' 208' ' ' ILE . 4.9 mm . . . . . 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.72 HG13 HG22 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 . . . . . 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.246 0.906 0 N-CA-C 114.524 0.932 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 94.4 m-20 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD21 HD12 ' B' ' 217' ' ' LEU . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' HD22 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 40' ' ' VAL . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 60' ' ' GLU . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.479 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 38' ' ' VAL . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 66' ' ' ILE . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HB2' HD21 ' A' ' 17' ' ' ASN . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' B' ' 206' ' ' ILE . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 28' ' ' LEU . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.474 HG22 HG13 ' B' ' 208' ' ' ILE . 3.7 mt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.474 HG13 HG22 ' B' ' 206' ' ' ILE . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' B' ' 209' ' ' MET . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.437 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.551 HD12 HD21 ' A' ' 22' ' ' LEU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.443 HD22 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 . . . . . 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 C--O 1.245 0.846 0 CA-C-O 121.393 0.497 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 15' ' ' ILE . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.561 HD21 HD12 ' B' ' 217' ' ' LEU . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD2' HD22 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 40' ' ' VAL . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' C' ' 315' ' ' PRO . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.595 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HG3' ' CG2' ' B' ' 208' ' ' ILE . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.47 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD11 HD12 ' B' ' 208' ' ' ILE . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt . . . . . 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.425 HG22 HG13 ' B' ' 208' ' ' ILE . 5.3 mm . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 22' ' ' LEU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.442 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 . . . . . 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 53.5 Cg_endo . . . . . 0 N--CA 1.482 0.805 0 N-CA-C 114.617 0.968 . . . . 0.0 114.617 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.417 ' HD3' HD13 ' A' ' 28' ' ' LEU . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.411 ' CB ' ' HB3' ' A' ' 86' ' ' HIS . 10.5 m120 . . . . . 0 N--CA 1.423 -1.796 0 CA-C-O 120.676 0.274 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 65' ' ' THR . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG12 HD13 ' A' ' 72' ' ' LEU . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.602 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' O ' HG11 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 ' HE ' ' A' ' 44' ' ' ARG . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 42' ' ' LEU . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.602 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.645 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' ILE . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.434 HD13 HG12 ' A' ' 30' ' ' VAL . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 69' ' ' VAL . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.517 ' CD2' HG11 ' A' ' 69' ' ' VAL . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.414 HD11 HD12 ' B' ' 208' ' ' ILE . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 40' ' ' VAL . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.418 HG22 HG13 ' B' ' 208' ' ' ILE . 4.7 mm . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG ' ' A' ' 26' ' ' ASP . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo . . . . . 0 C--O 1.242 0.71 0 N-CA-C 111.229 -0.335 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.428 HD21 ' HB2' ' A' ' 80' ' ' ARG . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD21 HD12 ' B' ' 217' ' ' LEU . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.477 HD21 HG11 ' A' ' 40' ' ' VAL . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 HD13 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 106' ' ' LEU . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' HG13 ' A' ' 38' ' ' VAL . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HB2' HD21 ' A' ' 17' ' ' ASN . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD13 HD11 ' A' ' 84' ' ' ILE 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' B' ' 206' ' ' ILE . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 40' ' ' VAL . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.581 HD13 HG12 ' A' ' 38' ' ' VAL . 70.8 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.551 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.551 HG13 HG22 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' B' ' 209' ' ' MET . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.476 ' HB3' HD23 ' A' ' 22' ' ' LEU . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 22' ' ' LEU . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 114.41 0.889 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 65' ' ' THR . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' LEU . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 19' ' ' ASN . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 HG11 ' A' ' 40' ' ' VAL . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 31' ' ' PHE 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HG23 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.565 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.682 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' HG12 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.709 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.716 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.554 HD11 HG12 ' A' ' 40' ' ' VAL . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 108' ' ' ARG . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.454 HG22 HG13 ' B' ' 208' ' ' ILE . 4.0 mt . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.454 HG13 HG22 ' B' ' 206' ' ' ILE . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.459 HD13 ' HA3' ' A' ' 78' ' ' GLY . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.716 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 N-CA-C 113.543 0.555 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 65' ' ' THR . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 HD12 ' B' ' 217' ' ' LEU . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.567 ' OD2' HD22 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.463 HD11 HD23 ' A' ' 42' ' ' LEU . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.545 HG22 HG13 ' B' ' 208' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.572 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.484 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.595 HD12 HD21 ' A' ' 22' ' ' LEU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.246 0.917 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.484 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 13.4 m120 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 9.3 m120 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.42 HD21 HG11 ' A' ' 40' ' ' VAL . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 110' ' ' ILE . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' HG11 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' HD12 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.566 HH11 ' ND2' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 69' ' ' VAL . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' HG12 ' B' ' 206' ' ' ILE . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 40' ' ' VAL . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.642 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.642 HG13 HG22 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 21' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo . . . . . 0 CA--C 1.539 0.756 0 N-CA-C 114.157 0.791 . . . . 0.0 114.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 57' ' ' LEU . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 18' ' ' LEU . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.491 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' C' ' 318' ' ' ARG . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 31' ' ' PHE . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 30' ' ' VAL . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 65' ' ' THR . 7.1 tp-100 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 69' ' ' VAL . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 40' ' ' VAL . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.25 1.104 0 CA-C-O 121.272 0.446 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.436 ' HD2' HD13 ' A' ' 28' ' ' LEU . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.448 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 18' ' ' LEU . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.497 HD11 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' HD12 ' A' ' 22' ' ' LEU . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' B' ' 215' ' ' SER . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' OD2' HD22 ' B' ' 218' ' ' LEU . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 HD21 ' B' ' 218' ' ' LEU . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' HD11 ' A' ' 110' ' ' ILE . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 106' ' ' LEU . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.543 HD12 ' HG2' ' A' ' 44' ' ' ARG . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HG2' HD12 ' A' ' 42' ' ' LEU . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.618 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' VAL . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.569 ' HA ' HD12 ' A' ' 110' ' ' ILE . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 38' ' ' VAL . 18.5 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.559 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.628 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.456 ' HB3' HD23 ' A' ' 22' ' ' LEU . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.458 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.0 0.334 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 57' ' ' LEU . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 15' ' ' ILE . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 HD23 ' A' ' 42' ' ' LEU . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 40' ' ' VAL . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG23 ' CD1' ' A' ' 31' ' ' PHE . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CD1' HG23 ' A' ' 30' ' ' VAL . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' C' ' 316' ' ' GLY . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 58' ' ' LYS . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 27' ' ' ILE . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' B' ' 208' ' ' ILE . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 50' ' ' GLU . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' B' ' 208' ' ' ILE . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD23 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HB2' HG11 ' A' ' 38' ' ' VAL . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 66' ' ' ILE . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.573 ' HE3' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.3 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.488 HD11 HG12 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 38' ' ' VAL . 45.0 mt . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.461 HG22 HG13 ' B' ' 208' ' ' ILE . 9.1 mm . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.461 HG13 HG22 ' B' ' 206' ' ' ILE . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.579 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 C--O 1.243 0.728 0 CA-C-O 121.117 0.382 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 316' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 318' ' ' ARG . . . . . 0.583 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 26.21 2.32 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.99 149.58 30.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.808 -174.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.71 69.09 0.24 Allowed Glycine 0 C--N 1.29 -2.007 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -66.52 10.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.128 1.371 . . . . 0.0 113.595 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -69.92 -16.94 63.3 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.34 1.056 . . . . 0.0 110.78 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -141.1 174.0 10.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -123.57 30.0 6.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.65 20.11 19.45 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.122 -1.853 . . . . 0.0 106.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -83.2 72.51 10.15 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.624 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.98 48.53 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.175 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -79.31 137.87 37.51 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.383 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.468 HG23 HG23 ' A' ' 65' ' ' THR . 7.4 pt -126.33 142.14 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.744 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.1 t80 -80.19 123.21 27.72 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.226 -1.806 . . . . 0.0 107.969 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 18.7 mt -116.84 105.32 18.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.7 167.49 12.33 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.019 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 t30 67.7 35.38 4.04 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.906 1.282 . . . . 0.0 109.829 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.99 159.93 26.08 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.284 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.549 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 t30 -93.23 167.16 11.94 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -71.42 -39.79 70.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.58 -0.54 26.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 217' ' ' LEU . 80.3 mt -82.3 120.14 25.01 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.593 0.711 . . . . 0.0 110.552 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.5 t -110.4 176.19 5.14 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.219 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -57.52 -42.37 82.71 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 0.0 110.856 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.22 -27.81 72.82 Favored Glycine 0 C--O 1.227 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.474 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' B' ' 218' ' ' LEU . 12.0 t70 -72.99 -49.13 30.79 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 42' ' ' LEU . 74.0 mt -56.82 -42.66 78.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.207 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.08 -36.21 82.83 Favored 'General case' 0 C--O 1.205 -1.254 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.475 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.0 m -61.86 -44.12 97.47 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 122.753 0.421 . . . . 0.0 111.051 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.25 -38.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -78.88 -23.1 45.08 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 p -70.74 -11.58 61.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.805 0.73 . . . . 0.0 112.364 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' OE1' ' HG2' ' C' ' 324' ' ' ARG . 69.5 tt0 -73.71 -26.4 60.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.757 0.789 . . . . 0.0 109.301 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -101.8 6.45 41.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.851 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 148.65 -165.75 29.18 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.766 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.73 109.53 50.33 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 18.8 Cg_exo -71.23 123.68 9.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.613 2.208 . . . . 0.0 110.728 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 110' ' ' ILE . 33.7 m -97.11 -19.27 6.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.622 0.725 . . . . 0.0 109.497 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 9.3 m-20 -145.21 134.87 23.4 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' HG11 ' A' ' 102' ' ' VAL . 10.8 p -149.24 140.86 17.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.458 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -143.43 133.25 21.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.3 0.571 . . . . 0.0 110.165 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -101.23 124.66 47.28 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -73.67 102.5 3.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 12.4 ptm180 -131.49 147.81 52.58 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.222 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.464 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -61.78 147.21 47.06 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 124.011 0.819 . . . . 0.0 111.642 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -80.12 -21.96 42.65 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.647 0.779 . . . . 0.0 112.655 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -89.49 -61.22 1.75 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.264 0.554 . . . . 0.0 109.773 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -88.25 -25.18 22.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.323 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 77.39 23.76 67.26 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.239 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.86 147.79 25.14 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.299 0.549 . . . . 0.0 110.483 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -55.95 135.13 52.52 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 124.438 1.095 . . . . 0.0 112.101 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.9 -10.69 56.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.2 16.72 42.78 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.933 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.52 151.79 50.69 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.4 165.53 30.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 51.0 m-85 -134.45 127.65 31.91 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 tt -129.75 145.86 51.53 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.989 -0.685 . . . . 0.0 109.805 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 63.4 tttt -131.62 116.16 17.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.189 0.519 . . . . 0.0 110.604 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 83.2 m-85 -77.16 164.79 25.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.728 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.49 -39.64 92.15 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-O 122.412 1.101 . . . . 0.0 108.818 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 63' ' ' ARG . 9.7 t70 -115.53 128.48 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.67 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.7 tt0 -71.04 -20.33 62.39 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.221 0.534 . . . . 0.0 112.235 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 19.0 mtp180 -74.41 -26.35 60.03 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -77.82 -36.76 49.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.9 m -54.9 -49.08 72.1 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.599 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.2 mt -61.07 -42.76 94.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 122.864 0.466 . . . . 0.0 111.215 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.59 -35.12 79.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.915 0.388 . . . . 0.0 110.695 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.94 77.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.103 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 65' ' ' THR . 98.0 t -55.5 -37.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.764 0.825 . . . . 0.0 111.22 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.36 -56.56 3.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -90.48 -17.61 26.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.953 -162.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 tp -97.69 -8.42 28.77 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.8 t30 -75.25 124.33 26.89 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.582 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.85 49.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.578 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -75.42 128.09 34.57 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -88.22 124.41 33.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.448 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.8 mt -133.19 99.67 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 52.93 12.84 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.341 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.53 -18.44 29.36 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 121.258 -0.496 . . . . 0.0 114.261 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -128.75 151.11 49.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.451 0.625 . . . . 0.0 110.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.27 146.98 28.02 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -86.87 149.99 24.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.175 0.512 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 52.6 tptt -116.16 132.34 56.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.369 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -114.97 140.27 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -149.75 165.69 31.68 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' NE2' HG21 ' A' ' 69' ' ' VAL . 65.2 m-70 -92.43 95.64 9.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 119.278 0.945 . . . . 0.0 111.546 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -108.69 156.4 19.62 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -146.16 124.75 12.48 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -141.04 160.43 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -88.79 124.96 64.3 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.85 144.17 99.51 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.331 2.687 . . . . 0.0 112.357 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -75.12 137.45 41.39 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.487 0.66 . . . . 0.0 111.967 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.88 -30.62 35.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -68.47 -34.45 75.96 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.046 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.19 20.69 17.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.3 pt20 -49.34 -39.01 30.05 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -174.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.4 mmmt -65.03 -25.0 67.65 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 102' ' ' VAL . 45.0 t80 -67.89 -44.45 76.95 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD2' HG21 ' A' ' 41' ' ' ILE . 82.3 m-85 -63.44 -53.92 44.59 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.209 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.8 pt-20 -67.36 -34.0 76.39 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.21 73.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.991 0.424 . . . . 0.0 110.184 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 40' ' ' VAL . 68.6 t -69.33 -52.06 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.138 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 18.5 ptpt -64.09 -28.13 69.57 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.489 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 24.4 mm-40 -52.98 -45.82 67.98 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.35 0.406 . . . . 0.0 111.217 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -69.98 -23.42 63.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.37 0.605 . . . . 0.0 111.527 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 40' ' ' VAL . 23.9 mt -88.33 -45.33 10.11 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.66 -28.1 59.99 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.571 1.548 . . . . 0.0 111.423 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 10.3 mmm180 -46.55 -44.04 17.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.158 0.983 . . . . 0.0 111.535 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.34 -38.22 16.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.663 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.513 HD13 HG12 ' A' ' 38' ' ' VAL . 60.6 mt -63.81 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.338 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 p -77.84 123.74 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.39 0.614 . . . . 0.0 109.736 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -92.6 120.99 33.59 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 1.1 pptp? -137.52 130.69 30.68 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -91.75 -28.48 17.37 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.92 125.46 25.18 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.41 13.23 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.673 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.63 144.05 39.53 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.351 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 47.8 t -84.78 132.97 34.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -124.27 12.35 8.84 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.383 0.611 . . . . 0.0 110.31 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 35.7 t -87.6 -58.14 2.69 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -144.66 159.35 42.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.521 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 3.1 m-85 -69.75 -67.95 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.534 0.683 . . . . 0.0 109.397 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.429 HG22 HG13 ' B' ' 208' ' ' ILE . 7.7 mm -124.4 155.93 32.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.42 -15.99 41.23 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 118.684 0.675 . . . . 0.0 111.439 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.429 HG13 HG22 ' B' ' 206' ' ' ILE . 3.2 mt -72.54 -79.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.071 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 64.83 146.58 0.1 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 124.255 1.022 . . . . 0.0 111.373 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.33 156.93 50.35 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 122.07 1.846 . . . . 0.0 112.229 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 59.3 m-20 -95.79 -57.37 2.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.766 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 66.55 87.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.855 0.862 . . . . 0.0 112.418 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 60.3 m -161.66 159.47 22.86 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.44 159.55 22.61 Favored 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 121.08 1.187 . . . . 0.0 109.152 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 80.8 p -89.81 161.91 15.77 Favored 'General case' 0 N--CA 1.381 -3.876 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.512 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.26 -8.52 87.52 Favored Glycine 1 C--N 1.246 -4.464 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.334 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.565 HD12 HD21 ' A' ' 22' ' ' LEU . 20.7 mt -74.94 -52.03 12.23 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 26' ' ' ASP . 5.8 tp -50.3 -44.88 54.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.664 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.77 -28.08 68.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.177 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 mt -95.77 -29.84 14.03 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.216 0.531 . . . . 0.0 110.227 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 18.7 mm-40 -79.43 -29.28 41.81 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.646 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' C' ' 319' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 47.9 t -165.35 154.94 12.71 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.237 0.519 . . . . 0.0 110.198 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.09 109.62 14.72 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -82.29 -61.79 1.8 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.715 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' C' ' 305' ' ' PRO . 57.3 mtmt -91.62 127.81 48.89 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' C' ' 304' ' ' LYS . 23.8 Cg_endo -96.72 15.13 0.83 Allowed 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 123.539 2.826 . . . . 0.0 111.726 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -109.4 113.18 58.64 Favored Pre-proline 0 C--N 1.295 -1.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.321 -177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 13.9 Cg_exo -69.9 64.88 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.16 2.573 . . . . 0.0 112.61 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.93 -13.06 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 110.226 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.14 134.16 45.58 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -56.92 -30.75 64.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.627 0.771 . . . . 0.0 110.779 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.65 1.99 56.77 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.958 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.57 20.98 10.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.463 1.105 . . . . 0.0 112.713 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 40.2 mt -81.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.927 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.548 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 2.6 mmt -109.73 139.97 21.75 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.7 131.07 43.9 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 C-N-CA 123.867 3.045 . . . . 0.0 113.034 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -73.48 163.03 54.76 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.967 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 15.0 m -65.71 10.4 0.1 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -115.62 2.61 13.79 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . 0.502 ' O ' ' HA2' ' C' ' 300' ' ' GLY . 38.7 t90 -85.52 116.86 24.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -68.66 -31.23 70.21 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.074 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.34 33.48 0.67 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.167 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 58.4 t -114.49 100.3 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -77.17 122.8 25.53 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.371 0.419 . . . . 0.0 110.149 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.551 ' HG2' ' OE1' ' A' ' 33' ' ' GLU . 11.5 ptp85 -136.64 143.86 43.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.608 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 68.7 m -158.92 147.21 18.14 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -91.88 -37.14 13.08 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.381 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.22 31.27 8.56 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 118.852 -1.642 . . . . 0.0 112.067 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.9 OUTLIER -68.96 130.31 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.25 2.71 56.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 0.5 OUTLIER -57.2 -49.05 77.22 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.436 ' HB3' ' NZ ' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -80.55 118.73 22.39 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 88.6 m95 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.834 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.24 34.39 16.04 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 110.872 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.55 174.39 5.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.322 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.1 76.35 1.25 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.63 -31.59 72.7 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.956 0.903 . . . . 0.0 113.122 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.13 -70.18 0.55 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.442 0.639 . . . . 0.0 109.833 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' HB3' ' H ' ' A' ' 8' ' ' LYS . 58.8 m-85 -168.03 -141.78 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 7' ' ' TYR . 3.0 mptp? -91.28 -0.38 57.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' HA ' HE22 ' A' ' 62' ' ' GLN . 3.7 m-20 -69.39 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.895 1.678 . . . . 0.0 113.759 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.28 110.24 22.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.08 -11.86 59.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -91.06 141.44 28.83 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.449 0.642 . . . . 0.0 109.979 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.23 138.3 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.387 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 10.2 t80 -80.63 122.97 27.75 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.501 -1.682 . . . . 0.0 108.221 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' LEU . 15.5 mt -112.48 113.17 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.72 157.4 15.01 Favored Glycine 0 C--N 1.277 -2.726 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.671 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 80' ' ' ARG . 65.1 t30 66.74 70.03 0.4 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 124.897 1.279 . . . . 0.0 112.344 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 15' ' ' ILE . 6.2 mp -112.15 156.26 22.58 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.946 175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.444 ' H ' HD12 ' A' ' 22' ' ' LEU . 27.1 t30 -94.4 153.72 17.82 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -47.77 -46.0 29.79 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' B' ' 217' ' ' LEU . 1.3 pm0 -68.23 -28.25 67.07 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD21 HD12 ' B' ' 217' ' ' LEU . 36.0 mt -64.92 117.84 8.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 122.265 1.031 . . . . 0.0 110.174 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -112.19 -172.76 2.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.509 -1.678 . . . . 0.0 109.351 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mp0 -68.27 -39.95 82.0 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.07 0.85 . . . . 0.0 110.384 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 28' ' ' LEU . . . -64.84 -24.88 70.25 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.326 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.97 -46.94 40.85 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 42' ' ' LEU . 81.6 mt -59.04 -39.55 78.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.099 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' C' ' 318' ' ' ARG . 97.6 mt -61.55 -46.84 88.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -55.24 -39.6 69.91 Favored 'General case' 0 C--O 1.255 1.382 0 C-N-CA 123.523 0.729 . . . . 0.0 111.35 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.607 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.272 32.3 m -81.16 -48.27 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.02 -28.39 63.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 t -65.12 -8.55 17.27 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' C' ' 324' ' ' ARG . 44.1 tt0 -72.51 -28.57 62.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.432 0.634 . . . . 0.0 110.105 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 59.7 m-85 -97.95 6.02 48.18 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.5 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.75 -155.64 26.37 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.363 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -112.68 110.43 52.37 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.19 118.39 5.66 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.403 2.069 . . . . 0.0 109.337 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HD11 ' A' ' 110' ' ' ILE . 35.0 m -95.64 -18.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.666 -176.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 28.6 t70 -155.57 132.08 10.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.685 ' O ' HG11 ' A' ' 102' ' ' VAL . 8.6 p -145.37 141.24 22.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -138.87 132.25 39.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-O 121.109 0.481 . . . . 0.0 110.776 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.02 126.11 50.06 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -76.44 102.91 6.18 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -128.21 147.91 50.6 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.68 138.76 58.04 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 123.611 0.569 . . . . 0.0 110.109 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.19 -22.82 66.95 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.797 0.839 . . . . 0.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -99.12 -52.33 3.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.315 0.579 . . . . 0.0 111.194 -172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' HG3' ' A' ' 50' ' ' GLU . 1.5 t -95.73 -18.82 20.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.92 16.47 80.65 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.848 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.5 pp20? -82.07 127.07 32.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 117.403 0.601 . . . . 0.0 111.586 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -61.67 128.1 34.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -77.44 -17.91 57.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.113 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.38 24.93 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.368 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.52 150.95 46.91 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.48 169.63 21.02 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -140.24 146.51 38.73 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -150.36 153.09 35.42 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 19.6 ptmt -138.16 134.35 34.45 Favored 'General case' 0 C--O 1.259 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 65' ' ' THR . 60.5 m-85 -84.69 175.67 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.722 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.95 -39.58 95.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.483 0.659 . . . . 0.0 109.872 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -121.05 146.79 46.34 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.154 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.1 tt0 -69.81 -25.83 63.95 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.558 ' HB3' ' CE2' ' C' ' 311' ' ' PHE . 83.3 mtt180 -83.05 -18.57 39.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.984 . . . . 0.0 111.319 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -75.61 -38.17 59.21 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 29.4 m -59.7 -47.47 85.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 111.926 -2.397 . . . . 0.0 110.402 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 62' ' ' GLN . 67.1 mt -62.7 -35.9 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.74 0.416 . . . . 0.0 110.659 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.15 -45.32 93.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.84 96.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.174 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 65' ' ' THR . 53.5 t -57.49 -41.01 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.334 0.654 . . . . 0.0 111.734 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -87.28 -26.67 23.33 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.51 -55.7 2.53 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.5 -174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 32.1 tp -71.25 -16.78 62.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.131 -170.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 54.8 t30 -65.63 117.87 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.754 0.311 . . . . 0.0 110.581 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.58 -2.99 39.39 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.486 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.57 128.43 36.6 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -86.64 125.18 33.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.088 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 30' ' ' VAL . 60.4 mt -132.42 99.61 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.726 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.05 40.25 72.92 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.479 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.36 -20.15 49.61 Favored Glycine 0 C--N 1.307 -1.055 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.228 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 17' ' ' ASN . 49.2 mtt180 -111.86 142.48 44.19 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.8 122.97 47.84 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.44 145.66 52.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 22.4 tptm -113.75 129.74 56.54 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.822 -175.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -119.27 135.33 60.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -147.0 175.97 10.27 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -98.57 138.48 35.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 118.929 0.786 . . . . 0.0 109.375 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -151.06 160.12 44.1 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -139.19 137.6 36.17 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -150.51 160.17 43.97 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.83 137.0 21.9 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.33 143.47 76.19 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 123.241 2.627 . . . . 0.0 112.864 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -85.95 138.5 31.95 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 93' ' ' ARG . 2.5 tmt_? -70.53 -36.83 73.94 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -61.15 -21.14 63.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.164 0.507 . . . . 0.0 110.988 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.8 mt -107.45 16.8 23.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.484 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 96' ' ' GLN . 3.6 pt20 -55.93 -45.17 78.85 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' CD2' ' B' ' 205' ' ' TYR . 30.1 mmmt -68.8 -24.34 64.39 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.146 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.91 -47.43 59.15 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 41' ' ' ILE . 94.5 m-85 -60.7 -50.1 74.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.441 0.296 . . . . 0.0 111.458 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -65.99 -33.29 75.48 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.196 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.2 83.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -61.27 -52.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.438 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -27.54 68.14 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.636 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -54.19 -51.26 64.93 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.712 0.292 . . . . 0.0 111.132 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.29 -24.78 67.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.322 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 21.8 mt -88.03 -37.17 16.54 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.575 ' O ' HG12 ' A' ' 111' ' ' VAL . 29.1 t70 -62.87 -19.61 64.31 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -59.8 -27.47 66.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.04 -39.83 8.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.826 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 38' ' ' VAL . 57.7 mt -55.47 -49.38 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.563 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -79.26 114.9 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.604 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -66.87 -35.61 80.43 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -168.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -124.22 113.29 18.09 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.808 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.81 169.24 5.89 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.329 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -118.94 86.7 2.59 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.79 145.65 15.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -149.58 -71.78 0.19 Allowed 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? . . . . . 0 N--CA 1.416 -2.162 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.1 m -85.11 158.82 20.3 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 117.026 0.413 . . . . 0.0 110.096 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -107.63 6.28 27.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.456 1.122 . . . . 0.0 108.604 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -72.95 -6.34 44.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.675 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 67.61 111.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.428 1.108 . . . . 0.0 110.441 -173.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.424 ' CD2' ' HE2' ' A' ' 97' ' ' LYS . 3.0 m-85 -68.89 -56.34 8.22 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 113.745 -1.57 . . . . 0.0 111.942 -169.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.407 HG22 ' H ' ' B' ' 208' ' ' ILE . 11.1 mm -101.97 146.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.26 -28.5 47.75 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.407 ' H ' HG22 ' B' ' 206' ' ' ILE . 0.1 OUTLIER -85.94 -72.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 72.27 159.19 0.16 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.558 0.743 . . . . 0.0 109.382 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 159.28 47.4 Favored 'Trans proline' 0 C--O 1.254 1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 114.711 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.22 -70.56 0.77 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.482 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.408 ' HZ ' HG13 ' A' ' 102' ' ' VAL . 79.5 m-85 64.08 90.55 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.706 1.203 . . . . 0.0 112.461 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.4 m -157.34 155.83 28.21 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -95.13 136.1 0.72 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.894 1.729 . . . . 0.0 111.395 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -90.24 127.6 36.18 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.72 9.13 0.06 OUTLIER Glycine 0 C--N 1.279 -2.594 0 C-N-CA 125.422 1.487 . . . . 0.0 115.84 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.603 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 8.2 mt -68.05 -39.82 82.95 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 104.025 -2.584 . . . . 0.0 104.025 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 215' ' ' SER . 9.4 mp -46.35 -54.13 9.6 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.62 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.32 -9.87 58.83 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 69.1 mt -98.23 -20.18 17.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.3 mm-40 -97.89 -28.28 13.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.115 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.579 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.2 m -128.61 -173.9 3.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -82.08 109.4 16.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.67 -55.62 4.17 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -91.08 109.52 35.86 Favored Pre-proline 0 C--N 1.318 -0.788 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.996 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.56 -20.23 18.2 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 123.497 2.798 . . . . 0.0 114.099 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.57 103.88 19.53 Favored Pre-proline 0 N--CA 1.427 -1.583 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.928 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.78 162.06 42.17 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.274 1.983 . . . . 0.0 110.65 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.35 0.99 50.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.657 0.741 . . . . 0.0 110.836 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -86.34 28.81 0.81 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.941 -171.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 65.17 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.837 1.255 . . . . 0.0 113.964 174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 63' ' ' ARG . 43.2 m-85 -91.48 9.86 30.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.38 55.44 3.52 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.49 1.116 . . . . 0.0 110.069 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.06 138.44 23.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 25.0 mmt -90.65 125.82 58.13 Favored Pre-proline 0 C--N 1.293 -1.886 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.894 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.62 122.84 10.07 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.261 1.974 . . . . 0.0 110.55 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.12 171.53 39.21 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.04 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 67.3 m -80.99 20.71 0.76 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.407 0.622 . . . . 0.0 112.056 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 32.4 mmt180 -100.68 0.0 38.22 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.7 0.762 . . . . 0.0 109.237 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -96.76 125.9 41.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.73 -27.87 69.2 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.367 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.32 22.12 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.301 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.95 104.36 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.79 123.76 22.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' A' ' 33' ' ' GLU . 43.3 ttm105 -117.75 147.92 42.52 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.835 -173.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 31.0 t -152.28 108.16 3.36 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.76 150.4 8.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.8 30.29 69.13 Favored Glycine 0 C--O 1.224 -0.483 0 O-C-N 124.324 1.015 . . . . 0.0 111.385 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.403 ' HD1' ' N ' ' C' ' 330' ' ' GLU . 7.5 t80 -74.29 141.33 45.3 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -69.14 3.61 2.04 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 126.408 1.883 . . . . 0.0 112.72 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.403 ' N ' ' HD1' ' C' ' 328' ' ' PHE . 0.6 OUTLIER -40.33 -52.35 2.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.623 1.969 . . . . 0.0 113.836 -171.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -87.83 115.37 25.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 . . . . . 0 N--CA 1.428 -1.527 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.171 173.479 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.27 117.64 6.47 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 86' ' ' HIS . 21.1 ptp -110.07 160.18 16.67 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 86' ' ' HIS . . . 69.88 34.5 71.56 Favored Glycine 0 C--N 1.309 -0.972 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -90.79 -18.27 25.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -32.1 10.97 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.462 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.86 86.63 2.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.265 175.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 8' ' ' LYS . 32.6 tptt -85.72 -9.32 57.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.02 -14.12 61.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.763 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.75 109.36 0.7 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.282 0.563 . . . . 0.0 111.62 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.0 -25.76 48.17 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.581 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 26.4 m-85 -82.31 134.03 35.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.496 0.665 . . . . 0.0 110.296 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.9 pt -124.36 144.72 33.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.789 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.5 t80 -85.9 128.94 34.95 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.783 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 32.7 mt -120.09 114.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.6 167.61 16.9 Favored Glycine 0 C--N 1.286 -2.226 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.339 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 66.5 t30 67.79 52.33 0.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.687 1.195 . . . . 0.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.5 149.23 24.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.483 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.26 159.0 33.07 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.345 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -68.44 -26.57 65.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.836 0.351 . . . . 0.0 111.699 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.514 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -91.23 -0.01 57.61 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 19' ' ' ASN . 91.7 mt -84.96 118.5 24.59 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t -111.94 -175.98 2.82 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -55.9 -45.9 78.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.061 0.944 . . . . 0.0 112.025 -174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.89 -32.45 79.75 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.092 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.478 ' OD2' HD22 ' B' ' 218' ' ' LEU . 15.4 t70 -71.17 -45.17 64.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.03 0.919 . . . . 0.0 109.033 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 42' ' ' LEU . 81.0 mt -57.6 -43.76 83.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.395 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.35 -36.09 82.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 70.3 m -59.51 -42.75 92.93 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.432 0.457 . . . . 0.0 110.344 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 34.2 m -81.13 -43.71 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.21 -22.91 61.95 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.66 -8.49 55.59 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.83 -0.544 . . . . 0.0 112.232 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -75.41 -20.91 58.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.841 0.829 . . . . 0.0 109.614 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -96.8 -6.13 36.83 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.371 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.34 -153.02 24.8 Favored Glycine 0 N--CA 1.416 -2.684 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.742 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.421 ' CG1' HG12 ' A' ' 110' ' ' ILE . 60.6 t -108.36 106.99 59.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.97 126.64 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.675 2.25 . . . . 0.0 109.153 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . 25.2 m -98.41 -25.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.936 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 1.5 t70 -147.33 136.38 22.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 102' ' ' VAL . 13.8 p -148.07 145.71 18.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.1 137.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.966 177.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -115.69 132.69 56.56 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -73.5 105.51 4.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CG ' HD12 ' A' ' 42' ' ' LEU . 74.4 mtp180 -116.7 144.71 44.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.46 137.79 52.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 123.811 0.694 . . . . 0.0 111.305 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -79.01 -5.03 52.94 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 122.665 0.386 . . . . 0.0 111.662 -174.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -102.12 -46.08 4.96 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -120.25 -12.92 8.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.761 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.0 20.71 69.66 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.111 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -82.6 148.11 28.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.934 0.867 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -65.48 133.7 51.82 Favored 'General case' 0 C--O 1.185 -2.32 0 O-C-N 123.337 0.398 . . . . 0.0 110.71 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -90.0 -4.52 57.38 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.067 0.46 . . . . 0.0 110.124 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.72 15.39 70.72 Favored Glycine 0 C--O 1.242 0.615 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.445 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -145.98 169.31 18.89 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.771 0.319 . . . . 0.0 110.883 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 75.6 m-85 -142.63 140.38 31.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 10.1 tt -141.1 153.49 45.45 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 83.3 tttt -134.56 125.34 27.07 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.451 0.7 . . . . 0.0 110.337 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.81 176.88 7.18 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.1 -42.71 72.36 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.74 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 12.0 t70 -124.97 145.46 49.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.18 -4.36 35.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.124 -174.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.9 mmp_? -60.18 -37.66 80.89 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -76.57 -36.31 57.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.4 m -55.57 -55.25 34.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.953 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 62' ' ' GLN . 61.6 mt -60.45 -41.78 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.987 0.422 . . . . 0.0 109.947 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.8 tp -62.71 -43.11 99.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.318 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.88 -43.95 94.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.422 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 65' ' ' THR . 65.0 t -56.62 -48.33 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 123.479 0.487 . . . . 0.0 110.882 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.63 -45.19 54.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.46 -40.36 19.36 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.84 -16.74 59.33 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 83' ' ' LYS . 2.8 t-20 -71.17 109.88 5.49 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.006 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.73 28.63 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.831 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -73.01 124.71 26.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -89.97 129.61 36.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.851 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 mt -134.07 102.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' CD ' ' B' ' 221' ' ' GLU . . . 70.88 39.13 64.96 Favored Glycine 0 C--N 1.308 -0.98 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.707 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.05 -20.27 49.66 Favored Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.458 -0.877 . . . . 0.0 114.069 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -121.99 148.94 44.17 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.383 -0.481 . . . . 0.0 110.892 178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.02 124.7 49.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.261 1.5 pp -70.7 147.75 48.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -175.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 39.6 tptt -110.71 125.44 53.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.591 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -116.85 145.94 21.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.4 t0 -153.29 169.15 23.77 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.525 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 69.0 m-70 -94.9 115.18 27.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.112 0.869 . . . . 0.0 111.011 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -137.17 131.54 32.68 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.857 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -113.59 103.42 11.24 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 119.244 -0.982 . . . . 0.0 108.942 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.412 ' OH ' HG13 ' A' ' 41' ' ' ILE . 10.8 p90 -110.04 160.29 16.57 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -89.2 120.4 69.81 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 137.85 59.78 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.952 2.435 . . . . 0.0 111.267 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -72.2 137.1 46.65 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.51 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -81.93 -28.05 33.0 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.6 t -63.05 -46.19 88.71 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.877 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.26 21.02 9.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.431 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.4 pt20 -49.2 -39.39 29.48 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.9 mmmt -63.77 -24.54 67.8 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' O ' HG23 ' A' ' 102' ' ' VAL . 41.3 t80 -74.11 -44.56 53.44 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -64.13 -46.51 83.82 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.192 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.7 pt-20 -71.15 -40.1 71.53 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.41 76.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.393 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 98' ' ' TYR . 53.6 t -63.81 -48.83 84.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.536 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -26.97 63.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.889 -173.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 74.2 mm-40 -57.98 -28.85 64.75 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.928 0.394 . . . . 0.0 111.257 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -86.5 -39.18 16.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.28 -48.59 17.05 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.221 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 111' ' ' VAL . 7.7 t70 -47.43 -35.62 8.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.128 1.371 . . . . 0.0 113.807 -175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -71.04 -12.96 61.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -103.55 -16.14 15.62 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.924 0.868 . . . . 0.0 109.392 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 38' ' ' VAL . 55.3 mt -90.33 -53.88 8.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.339 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -75.8 157.56 5.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.2 m -85.0 -1.38 56.75 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.442 0.639 . . . . 0.0 111.599 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 116' ' ' ALA . 17.8 tppt? -101.35 84.86 2.68 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.91 -38.0 23.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.296 0.569 . . . . 0.0 111.295 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.71 118.53 20.1 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.198 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB2' ' HD2' ' A' ' 113' ' ' LYS . . . -148.29 -85.15 0.1 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.38 -41.68 24.21 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 175.793 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . 0.576 ' N ' ' HH ' ' B' ' 205' ' ' TYR . . . . . . . . 0 N--CA 1.462 0.433 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -57.17 123.7 16.19 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 117.113 0.457 . . . . 0.0 111.873 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.45 -7.67 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.097 0.951 . . . . 0.0 110.418 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.9 p -87.63 -1.16 57.76 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.47 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 28.7 tt0 73.01 142.74 0.06 Allowed 'General case' 0 C--N 1.349 0.575 0 C-N-CA 124.876 1.27 . . . . 0.0 109.243 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.576 ' HH ' ' N ' ' B' ' 200' ' ' GLY . 10.7 m-85 -77.47 -66.34 0.85 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.849 0.833 . . . . 0.0 110.408 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.507 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm -128.71 154.37 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 10.8 t70 -90.22 -15.73 30.81 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.798 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.507 HG13 HG22 ' B' ' 206' ' ' ILE . 8.2 mt -64.51 -75.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.284 -175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 4.3 mmt 64.23 149.99 0.11 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.088 0.955 . . . . 0.0 112.048 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 102' ' ' VAL . 58.8 Cg_endo -71.9 144.25 42.8 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.814 1.676 . . . . 0.0 112.392 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.31 -55.03 3.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.943 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 61.36 80.2 0.23 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.874 0.87 . . . . 0.0 113.178 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -153.37 155.69 31.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.84 168.67 20.59 Favored 'Trans proline' 0 C--O 1.263 1.745 0 C-N-CA 121.069 1.179 . . . . 0.0 109.413 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.45 ' HB3' HD23 ' A' ' 22' ' ' LEU . 74.8 p -90.62 -178.95 5.43 Favored 'General case' 1 N--CA 1.376 -4.129 0 CA-C-O 122.654 1.216 . . . . 0.0 107.795 167.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -107.17 0.14 35.42 Favored Glycine 1 C--N 1.244 -4.55 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.426 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 16.7 mt -82.59 -47.89 11.59 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.478 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.2 tp -50.17 -39.87 44.97 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 112.056 -2.338 . . . . 0.0 113.454 -171.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.418 ' HG3' ' HG ' ' B' ' 220' ' ' LEU . 9.4 pt-20 -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.845 0.355 . . . . 0.0 111.487 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.418 ' HG ' ' HG3' ' B' ' 219' ' ' GLU . 77.5 mt -93.81 -6.71 45.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.501 . . . . 0.0 110.048 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 40.3 mm-40 -97.66 -55.31 2.85 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.936 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.253 1.238 0 O-C-N 124.896 1.373 . . . . 0.0 110.755 -175.259 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.579 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 17.0 m -100.0 147.04 26.03 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.87 109.08 20.91 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' C' ' 304' ' ' LYS . 3.1 m-20 -99.16 -51.66 3.76 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' C' ' 303' ' ' ASP . 2.9 mppt? -70.01 119.99 75.1 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.252 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.57 -42.31 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.603 2.202 . . . . 0.0 110.82 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -128.41 108.02 19.26 Favored Pre-proline 0 N--CA 1.424 -1.736 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.446 ' HG2' ' HE1' ' C' ' 314' ' ' MET . 13.0 Cg_exo -69.96 110.88 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.097 1.865 . . . . 0.0 110.384 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.79 86.12 4.74 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 122.804 1.288 . . . . 0.0 110.906 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.33 140.36 22.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' C' ' 310' ' ' ARG . 2.1 tpm_? -46.9 -46.02 20.89 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.64 9.3 27.21 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.59 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 53.12 60.84 3.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.054 0.942 . . . . 0.0 112.137 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.4 mt -99.78 147.15 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.446 ' HE1' ' HG2' ' C' ' 307' ' ' PRO . 21.6 mmt -87.41 128.71 54.02 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 122.918 0.136 . . . . 0.0 111.207 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 135.79 22.67 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.629 2.219 . . . . 0.0 111.966 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -81.59 177.11 54.15 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.313 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 23.9 m -83.49 23.2 0.96 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 112.041 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' C' ' 318' ' ' ARG . 0.1 OUTLIER -103.74 0.02 29.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -97.17 115.27 27.26 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.7 -6.9 59.55 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.59 -9.26 41.05 Favored Glycine 0 C--N 1.305 -1.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.459 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.77 121.98 18.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -111.63 139.46 47.06 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.72 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.94 144.94 50.39 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 8.2 t -157.21 88.66 1.02 Allowed 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 172.39 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.361 1.465 . . . . 0.0 107.646 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.68 65.84 Favored Glycine 0 C--O 1.236 0.238 0 O-C-N 123.316 0.385 . . . . 0.0 112.961 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.84 131.47 37.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.06 1.88 14.35 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.311 1.044 . . . . 0.0 112.985 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.16 -37.13 14.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -84.93 103.05 13.64 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.496 -1.099 0 C-N-CA 127.077 2.151 . . . . 0.0 109.699 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.91 91.83 5.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.383 0.611 . . . . 0.0 109.438 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 tpt -79.59 109.8 14.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.756 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.07 168.09 16.55 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.465 -0.874 . . . . 0.0 110.997 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -71.38 -28.75 64.25 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.234 0.54 . . . . 0.0 109.688 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.53 -3.22 49.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.422 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -83.67 82.19 8.42 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -87.51 -6.06 58.52 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.1 3.62 0.57 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.747 2.019 . . . . 0.0 113.543 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 86' ' ' HIS . 7.9 p30 -82.27 101.15 10.34 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.643 1.211 . . . . 0.0 109.055 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.33 10.87 38.43 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.314 -173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -95.79 138.72 33.04 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 8.4 pt -118.41 127.77 75.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.348 0.594 . . . . 0.0 111.574 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 2.7 t80 -83.65 128.79 34.79 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.627 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 3.9 mp -115.53 109.67 29.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -118.8 177.22 16.35 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.324 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.4 t30 67.28 23.38 9.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.015 1.326 . . . . 0.0 109.741 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.9 mt -73.13 147.83 44.5 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.548 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 13.3 m120 -67.77 162.9 22.87 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -76.26 -22.05 55.58 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.264 0.554 . . . . 0.0 110.486 -172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -91.95 -7.32 49.4 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.9 mt -77.47 119.35 20.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.4 HG23 ' O ' ' B' ' 213' ' ' SER . 4.3 t -111.04 173.54 6.29 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.087 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.9 mt-10 -49.16 -46.12 44.89 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.107 1.363 . . . . 0.0 112.397 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -29.08 70.1 Favored Glycine 0 CA--C 1.494 -1.229 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.716 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 29' ' ' THR . 12.3 t70 -75.32 -46.61 32.25 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 3.2 mp -57.92 -42.0 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 88.0 mt -59.92 -38.44 82.34 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.782 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 95.5 m -58.42 -52.71 64.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 123.872 0.732 . . . . 0.0 110.491 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 26.7 m -67.47 -28.38 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.428 0.632 . . . . 0.0 112.568 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 34.8 m-85 -81.1 -23.5 38.37 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 121.62 -0.675 . . . . 0.0 111.731 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 58.2 m -76.59 -9.81 58.93 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.788 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.694 ' HG2' ' CD1' ' C' ' 319' ' ' TRP . 33.0 mt-10 -75.46 -18.47 59.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.739 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 p90 -121.5 -27.9 4.7 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.896 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -157.46 -146.65 4.56 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.183 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.86 140.2 31.57 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -84.52 145.26 10.48 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.906 1.738 . . . . 0.0 112.958 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 52.7 t -109.63 -61.95 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 9.0 m-20 -126.15 137.16 53.56 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 28' ' ' LEU . 8.9 p -141.5 136.26 31.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -135.32 122.71 36.48 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.101 177.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 HD12 ' HG3' ' A' ' 44' ' ' ARG . 2.5 tm? -96.93 123.61 40.68 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.6 t -72.87 96.43 2.09 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 42' ' ' LEU . 72.0 mtt85 -104.67 158.03 16.78 Favored 'General case' 0 CA--C 1.474 -1.95 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.923 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.95 128.21 35.57 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' B' ' 208' ' ' ILE . 41.6 tt0 -61.24 -19.57 61.83 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.873 0.869 . . . . 0.0 112.545 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -95.92 -50.14 5.0 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 2.0 t -93.97 -24.79 17.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 80.64 14.77 79.32 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.445 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 5.2 pt-20 -90.54 152.25 21.0 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.625 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.5 t -65.53 144.07 57.24 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.556 0.742 . . . . 0.0 110.79 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.22 -4.37 32.17 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 24.48 41.85 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.65 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -142.88 145.13 32.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.72 166.13 25.49 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.638 0.256 . . . . 0.0 110.404 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 68.3 m-85 -139.51 145.72 39.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.1 tt -142.99 161.36 38.33 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.131 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' N ' HD23 ' A' ' 57' ' ' LEU . 44.8 mtpt -139.29 142.05 37.74 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.952 0.901 . . . . 0.0 110.946 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -118.29 151.04 38.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 161.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 38' ' ' VAL . 7.8 pt-20 -82.2 29.84 0.41 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -145.78 129.12 16.82 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.7 tt0 -77.79 -17.7 57.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -78.27 -32.26 49.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.615 0.721 . . . . 0.0 109.41 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -78.23 -29.14 48.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 21.4 m -59.81 -45.05 93.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.003 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.34 -37.57 80.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.648 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.9 mt -58.5 -40.97 84.3 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . . . -62.18 -49.19 76.8 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 65' ' ' THR . 51.1 t -56.9 -42.64 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.855 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.03 -20.83 22.76 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -95.77 -60.19 1.7 Allowed 'General case' 0 C--N 1.316 -0.884 0 O-C-N 121.628 -0.67 . . . . 0.0 111.844 -175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.21 -22.36 59.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -171.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 7.6 t30 -60.2 115.43 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 0.0 110.827 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.8 -2.56 36.05 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.132 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' HB2' ' ND2' ' C' ' 326' ' ' ASN . 64.1 t80 -71.34 129.63 39.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.416 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -79.11 114.5 18.1 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.105 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -130.53 115.62 32.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 65.35 28.61 73.77 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.894 -0.193 . . . . 0.0 112.747 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.82 -5.78 84.27 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.933 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.416 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 96.1 mtt180 -115.0 130.85 57.03 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -95.51 111.73 23.58 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.57 149.72 48.25 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 24.1 tptp -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.372 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -110.29 130.62 63.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.52 138.19 27.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 47.3 m-70 -61.65 124.82 21.74 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.352 0.408 . . . . 0.0 110.649 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -141.68 162.55 35.21 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -124.3 99.06 6.03 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -105.81 138.23 42.35 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.758 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -102.16 126.23 34.16 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.39 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.17 138.7 31.11 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.442 2.094 . . . . 0.0 111.931 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.74 138.91 33.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -28.92 37.14 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.706 -0.797 . . . . 0.0 110.964 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.3 m -69.73 -18.38 63.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.685 0.755 . . . . 0.0 109.388 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.422 HD11 HD12 ' B' ' 208' ' ' ILE . 12.7 tp -107.9 7.93 28.29 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.404 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 10.2 pt20 -55.88 -29.46 60.0 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 31.4 mmmt -62.22 -32.18 72.81 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.597 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.08 -45.01 71.38 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CE2' HG21 ' A' ' 41' ' ' ILE . 67.6 m-85 -64.47 -49.92 69.52 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.215 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -63.76 -41.78 97.93 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.887 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.73 80.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.884 0.373 . . . . 0.0 110.082 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.9 t -65.5 -56.99 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.507 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -67.71 -22.31 65.27 Favored 'General case' 0 C--O 1.195 -1.803 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.33 -174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 14.9 mm-40 -57.96 -31.5 66.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.92 -31.52 20.65 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.208 0.528 . . . . 0.0 109.965 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -80.87 -38.12 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.658 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -23.89 63.23 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 124.105 0.962 . . . . 0.0 110.847 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 114' ' ' ASN . 28.6 mmm180 -64.48 -33.1 75.11 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.124 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 13.5 t70 -85.89 -22.97 27.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.549 0.69 . . . . 0.0 109.523 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -77.88 -48.78 22.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.607 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.4 p -69.09 157.95 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 m -82.15 80.84 8.27 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.193 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.9 tttt 167.46 75.2 0.0 OUTLIER 'General case' 0 C--O 1.251 1.169 0 C-N-CA 127.655 2.382 . . . . 0.0 105.746 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 30.4 p-10 -84.84 169.34 14.24 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -171.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -86.07 143.99 27.78 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.417 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.11 -7.8 14.05 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.55 -79.41 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.676 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.679 0 C-N-CA 124.894 1.278 . . . . 0.0 108.477 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.7 m 69.81 -51.13 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.464 1.506 . . . . 0.0 114.444 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -64.23 -18.81 64.88 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.391 0.676 . . . . 0.0 112.754 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 1.9 p -86.57 11.01 13.7 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.545 0.688 . . . . 0.0 111.255 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 64.47 90.77 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.665 1.586 . . . . 0.0 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -51.74 -60.94 2.6 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.748 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.517 HG22 HG13 ' B' ' 208' ' ' ILE . 6.5 mt -147.04 158.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.01 28.36 8.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.988 0.899 . . . . 0.0 110.481 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.517 HG13 HG22 ' B' ' 206' ' ' ILE . 5.6 mt -104.82 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.208 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 8.6 mmt 65.83 159.22 0.13 Allowed Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 123.985 0.914 . . . . 0.0 112.119 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.69 170.16 19.6 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 122.395 2.063 . . . . 0.0 114.101 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.55 -52.88 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.116 0.967 . . . . 0.0 110.496 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.78 29.65 16.71 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 23' ' ' THR . 12.1 m -98.53 160.7 27.4 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -81.48 162.19 19.5 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 168.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.7 p -89.41 -179.67 5.88 Favored 'General case' 0 C--N 1.253 -3.601 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 166.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -104.09 -15.17 22.61 Favored Glycine 1 C--N 1.241 -4.718 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 21' ' ' GLU . 25.9 mt -60.41 -42.01 95.1 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.404 HD22 ' OD2' ' A' ' 26' ' ' ASP . 4.6 tp -56.79 -41.86 78.43 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 112.585 -2.098 . . . . 0.0 112.58 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.33 -9.14 56.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 97.4 mt -90.3 -36.38 14.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.182 0.515 . . . . 0.0 110.011 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 9.1 mm-40 -74.48 -27.23 60.47 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.825 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 20.3 m -150.24 -33.57 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 117.215 0.507 . . . . 0.0 110.678 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -117.25 109.9 17.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.694 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -78.15 -49.46 13.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.8 125.82 57.85 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.96 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.05 -29.55 48.38 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.421 2.081 . . . . 0.0 111.741 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -139.52 150.11 62.46 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.28 91.56 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.851 1.701 . . . . 0.0 110.488 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -84.23 95.88 8.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.61 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -179.66 148.15 0.32 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' C' ' 310' ' ' ARG . 2.5 tpp180 -56.19 -42.33 76.94 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -115.52 17.13 16.48 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.883 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 70.94 26.09 3.68 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.32 131.49 35.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.7 mmt -96.84 138.83 21.34 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.175 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.57 145.99 55.79 Favored 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.698 2.932 . . . . 0.0 113.637 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -82.87 174.92 53.08 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 22.8 t -84.68 0.56 49.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.55 0.675 . . . . 0.0 112.001 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -86.86 3.06 46.98 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.06 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . 0.694 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 18.3 t90 -79.33 119.27 22.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.74 -27.0 58.54 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 125.391 1.476 . . . . 0.0 112.927 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 95.54 10.91 56.4 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.52 143.96 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.67 144.64 43.69 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.847 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' C' ' 324' ' ' ARG . 3.8 tpp85 -128.93 105.81 8.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.807 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 30.3 t -115.93 108.1 15.83 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.425 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 75' ' ' PHE . 16.0 m120 -109.75 -9.1 14.85 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.128 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 93.14 -6.5 75.93 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -80.25 145.19 32.33 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.712 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -61.25 1.25 0.2 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -73.66 -21.2 60.35 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 10.1 tmtt? -87.93 129.85 35.11 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . 0.477 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 49.1 m95 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.972 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.48 -66.51 0.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.964 1.305 . . . . 0.0 111.317 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.97 146.74 52.44 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 109.284 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 57.96 4.36 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.83 11.01 14.26 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.432 1.093 . . . . 0.0 112.739 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.36 -71.79 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.05 0.219 . . . . 0.0 111.255 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 86' ' ' HIS . 78.3 m-85 41.52 36.59 0.57 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.556 1.143 . . . . 0.0 113.372 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -17.1 64.68 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.194 0.521 . . . . 0.0 112.087 -172.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.11 11.65 13.39 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.769 1.228 . . . . 0.0 111.638 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 37.6 m-80 -118.64 113.02 20.58 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.783 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 -23.28 43.02 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.228 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -84.65 139.21 32.2 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.505 0.669 . . . . 0.0 110.716 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 20.4 pt -123.76 137.62 56.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.901 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 20.2 t80 -82.58 130.22 35.08 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 10.4 mt -122.34 115.02 44.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.56 179.35 16.49 Favored Glycine 0 C--N 1.284 -2.313 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.896 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.56 27.36 7.86 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.817 1.247 . . . . 0.0 110.268 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 8.8 mp -75.2 154.47 37.59 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.255 0.55 . . . . 0.0 110.776 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -76.92 152.89 35.15 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.79 -27.01 69.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -168.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.72 9.53 36.64 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 118.989 -1.084 . . . . 0.0 113.037 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.41 HD21 HD12 ' B' ' 217' ' ' LEU . 90.0 mt -82.75 122.52 28.29 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.931 -0.48 . . . . 0.0 111.473 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 6.7 t -112.25 -173.19 2.19 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.405 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -58.22 -42.32 85.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.925 0.49 . . . . 0.0 111.852 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.16 64.61 Favored Glycine 0 C--O 1.245 0.829 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.704 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -68.34 -47.19 68.17 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.931 0.872 . . . . 0.0 109.395 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.474 HD11 HD23 ' A' ' 42' ' ' LEU . 63.0 mt -62.55 -42.19 94.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.944 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.25 -44.44 95.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.411 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.1 m -62.04 -32.77 73.31 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.456 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.49 -53.69 11.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.878 -0.514 . . . . 0.0 111.928 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -77.92 -13.57 59.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -170.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' C' ' 319' ' ' TRP . 70.2 m -69.82 -8.65 50.08 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -80.1 -6.57 57.92 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 64' ' ' SER . 53.5 m-85 -121.21 18.77 11.54 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.774 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.36 -154.89 20.82 Favored Glycine 0 N--CA 1.424 -2.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -126.29 113.93 23.56 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 24.7 Cg_exo -66.69 125.44 13.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.524 2.149 . . . . 0.0 111.415 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 110' ' ' ILE . 16.4 m -90.31 -16.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-O 120.915 0.388 . . . . 0.0 110.243 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 33.1 t70 -158.99 142.56 14.96 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 102' ' ' VAL . 7.5 p -155.44 141.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 ' CD2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -142.84 138.8 27.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 121.063 0.459 . . . . 0.0 110.791 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -108.17 122.24 46.5 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.6 t -73.7 116.49 14.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -144.2 162.01 37.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.429 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.74 141.93 58.59 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.413 0.446 . . . . 0.0 111.677 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.1 tt0 -78.81 -20.63 49.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 122.925 0.49 . . . . 0.0 111.741 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.32 -52.55 4.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 50' ' ' GLU . 5.8 t -105.5 -12.96 15.77 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.753 0.311 . . . . 0.0 111.528 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.48 23.35 73.49 Favored Glycine 0 N--CA 1.435 -1.419 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.971 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -86.24 142.58 28.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 118.101 0.951 . . . . 0.0 109.969 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 m -61.91 139.04 58.41 Favored 'General case' 0 C--O 1.193 -1.897 0 C-N-CA 123.099 0.56 . . . . 0.0 111.844 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -87.8 -19.75 27.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.029 0.442 . . . . 0.0 110.156 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.73 14.63 33.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.701 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -132.99 152.48 51.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.72 170.9 18.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 89.4 m-85 -142.12 149.26 39.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 58' ' ' LYS . 10.0 tt -146.26 153.78 40.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' N ' HD23 ' A' ' 57' ' ' LEU . 81.0 tttt -137.32 119.72 15.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.753 0.821 . . . . 0.0 109.658 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 75.2 m-85 -82.42 169.93 15.86 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.858 0.361 . . . . 0.0 111.476 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.88 -35.37 80.42 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.72 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -132.7 147.35 52.33 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . 25.9 mt-30 -64.52 -23.28 67.22 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -59.7 -38.46 81.65 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.479 0.582 . . . . 0.0 110.669 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 5.2 m -74.07 -37.91 64.09 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -59.47 -49.37 78.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.529 -1.669 . . . . 0.0 110.835 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' GLN . 54.7 mt -64.58 -40.29 88.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 tp -60.62 -47.14 87.54 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.514 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.55 86.37 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.255 0.347 . . . . 0.0 111.02 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 65' ' ' THR . 49.1 t -56.62 -50.32 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.632 0.583 . . . . 0.0 111.614 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' C' ' 330' ' ' GLU . 12.7 t0 -78.79 -45.31 21.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.575 0.702 . . . . 0.0 112.146 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' C' ' 326' ' ' ASN . 46.4 t30 -79.02 -27.28 43.23 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.754 -166.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -99.55 -11.89 20.61 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -67.67 118.03 10.4 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.001 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.32 -7.67 30.59 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.787 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -70.57 129.16 38.46 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -95.99 123.39 39.56 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.091 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -134.24 106.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.5 51.78 19.54 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.453 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.39 -2.02 23.8 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.23 135.28 50.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.308 0.554 . . . . 0.0 109.793 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.3 131.57 38.3 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.252 1.7 pp -77.21 141.04 40.24 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.827 0.822 . . . . 0.0 112.707 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -109.65 120.47 42.6 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.989 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.4 mp -112.55 145.59 18.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.27 146.75 17.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 59.1 m-70 -76.57 132.33 39.43 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.084 0.856 . . . . 0.0 110.976 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -151.78 160.14 43.68 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -132.33 106.36 7.86 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' OH ' ' HE2' ' A' ' 99' ' ' TYR . 11.2 p90 -105.77 160.94 14.84 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.9 125.48 66.47 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.551 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -62.73 130.2 28.8 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.386 2.057 . . . . 0.0 109.005 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -72.24 138.39 47.47 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.649 -0.42 . . . . 0.0 112.029 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -78.08 -31.74 50.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 m -65.59 -29.31 69.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.051 0.453 . . . . 0.0 110.573 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' B' ' 206' ' ' ILE . 86.4 mt -110.31 17.2 21.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.788 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -51.0 -34.92 31.27 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.5 mmmt -66.5 -29.88 70.09 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 102' ' ' VAL . 44.3 t80 -66.23 -44.63 83.24 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD2' HG21 ' A' ' 41' ' ' ILE . 96.8 m-85 -62.28 -52.57 63.19 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 7.7 pt-20 -65.62 -35.33 80.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.07 85.99 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.51 0.195 . . . . 0.0 111.178 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 40' ' ' VAL . 63.7 t -70.75 -52.07 31.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -59.31 -32.04 69.7 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.697 -175.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.2 mm-40 -47.59 -57.53 5.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.119 0.567 . . . . 0.0 111.723 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -52.35 -47.26 66.21 Favored 'General case' 0 CA--C 1.506 -0.742 0 O-C-N 123.698 0.624 . . . . 0.0 112.268 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 40' ' ' VAL . 19.4 mt -70.47 -50.31 39.46 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.009 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -53.45 -37.65 62.82 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.162 1.385 . . . . 0.0 113.336 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 20.3 mmm180 -68.32 -15.54 63.6 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -99.56 -34.91 10.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.681 0.753 . . . . 0.0 109.086 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 38' ' ' VAL . 67.4 mt -69.64 -39.27 78.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.946 -177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.62 145.52 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.6 t -92.12 -37.77 12.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 39.8 mmtm -150.81 134.24 16.31 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.499 1.12 . . . . 0.0 108.562 174.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -68.85 146.26 53.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.758 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -163.53 -25.68 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.629 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.79 101.95 2.73 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.161 0.505 . . . . 0.0 112.215 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.83 -23.87 28.88 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 174.425 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.5 p -100.11 144.93 28.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.056 0.542 . . . . 0.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -117.65 -50.47 2.52 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.459 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 m -56.78 -54.02 51.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.728 0.775 . . . . 0.0 109.818 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.28 148.97 23.84 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.496 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 17.8 m-85 -55.87 -54.18 47.74 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.727 0.642 . . . . 0.0 110.692 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.633 HG22 HG13 ' B' ' 208' ' ' ILE . 2.7 mm -132.63 146.56 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.16 -1.16 54.64 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.316 0.579 . . . . 0.0 110.553 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.633 HG13 HG22 ' B' ' 206' ' ' ILE . 4.4 mt -82.26 -78.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.732 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 7.1 mmt 66.87 148.82 0.12 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.195 0.998 . . . . 0.0 110.345 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 102' ' ' VAL . 60.2 Cg_endo -73.23 156.0 51.34 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 121.832 1.688 . . . . 0.0 113.721 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -92.06 -54.1 3.98 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.426 ' HB3' HH12 ' C' ' 318' ' ' ARG . 58.7 m-85 64.97 20.98 12.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 26.3 m -101.46 159.21 30.11 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.21 157.85 15.03 Favored 'Trans proline' 0 CA--C 1.494 -1.489 0 C-N-CA 120.963 1.108 . . . . 0.0 111.352 172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.6 p -87.01 175.74 7.97 Favored 'General case' 0 N--CA 1.379 -3.995 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 166.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -90.29 -14.82 58.27 Favored Glycine 1 C--N 1.245 -4.516 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.72 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 30.3 mt -64.12 -49.09 73.56 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -41.87 53.86 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 113.668 -1.606 . . . . 0.0 114.069 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.32 -28.07 47.27 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.506 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 95.5 mt -87.15 -39.15 15.78 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.24 -0.288 . . . . 0.0 111.471 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.3 mm-40 -78.91 -41.46 29.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.843 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.256 1.416 0 C-N-CA 125.31 1.444 . . . . 0.0 109.057 -173.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.602 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.6 m -89.49 147.21 24.12 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.8 108.9 20.54 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.624 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 -38.93 14.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 170.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -90.83 111.14 46.43 Favored Pre-proline 0 N--CA 1.423 -1.818 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 -16.89 24.55 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.268 2.646 . . . . 0.0 112.047 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -142.56 166.23 22.16 Favored Pre-proline 0 N--CA 1.419 -2.01 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.2 59.81 3.82 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.684 2.256 . . . . 0.0 111.103 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -91.01 11.66 22.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.368 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -73.6 156.62 37.86 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -39.06 -48.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -102.68 30.31 4.77 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.195 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 67.37 32.94 5.58 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.375 1.083 . . . . 0.0 110.082 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 74.6 mt -92.78 150.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.148 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.55 169.04 7.69 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.969 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.59 137.11 24.62 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.678 1.585 . . . . 0.0 111.472 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -85.15 -154.95 23.38 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.939 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 45.9 t -67.57 -71.63 0.2 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.426 HH12 ' HB3' ' B' ' 212' ' ' PHE . 46.3 mtp180 -89.81 48.07 1.54 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -169.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 23.8 t90 -108.44 109.91 21.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -53.11 -43.59 66.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 132.21 -8.59 5.38 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 59.1 t -56.21 106.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.876 0 C-N-CA 123.332 0.653 . . . . 0.0 109.829 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -62.76 144.0 56.91 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.698 0.624 . . . . 0.0 111.045 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -109.58 126.66 53.83 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.366 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 45.1 m -73.27 102.1 3.58 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . 0.438 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 33.2 p30 -136.02 -170.51 2.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.858 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 115.88 31.0 2.01 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.059 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.663 ' CE1' ' HG2' ' C' ' 330' ' ' GLU . 11.0 t80 -82.74 151.6 26.11 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.49 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.5 2.15 56.01 Favored 'General case' 0 CA--C 1.593 2.604 0 C-N-CA 126.892 2.077 . . . . 0.0 115.112 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.663 ' HG2' ' CE1' ' C' ' 328' ' ' PHE . 6.7 mm-40 -62.75 -38.9 92.4 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -73.25 118.62 16.43 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 82.3 m95 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.579 176.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.013 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.86 149.83 30.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.758 0.313 . . . . 0.0 110.637 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ptp -110.27 -179.92 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.58 90.6 0.11 Allowed Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -110.41 -1.63 17.0 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.134 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -19.54 45.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.426 0.632 . . . . 0.0 109.423 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -111.82 159.03 18.71 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.145 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -127.52 23.19 6.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 123.014 1.388 . . . . 0.0 107.309 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.06 5.49 48.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.602 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.19 91.46 8.46 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.298 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.03 -16.97 53.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.912 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.8 148.45 23.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.521 0.677 . . . . 0.0 110.245 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.5 pt -113.6 142.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.093 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 21.3 t80 -89.9 121.03 31.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.728 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 18' ' ' LEU . 15.4 mt -114.32 113.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.97 172.77 16.57 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 64.53 42.51 4.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.683 1.193 . . . . 0.0 110.243 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 15' ' ' ILE . 7.5 mp -85.94 160.28 19.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' H ' HD12 ' A' ' 22' ' ' LEU . 53.7 t30 -94.98 152.18 18.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 51' ' ' SER . 15.7 tpt180 -51.82 -37.46 51.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' B' ' 217' ' ' LEU . 1.5 pm0 -87.83 -3.13 58.96 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 19' ' ' ASN . 98.0 mt -82.02 118.52 23.06 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.476 0.655 . . . . 0.0 109.72 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -111.46 177.25 4.72 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.408 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.24 -40.88 78.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 0.0 112.31 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.57 -33.24 71.16 Favored Glycine 0 C--N 1.32 -0.35 0 O-C-N 123.297 0.373 . . . . 0.0 112.526 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' HD22 ' B' ' 218' ' ' LEU . 14.7 t70 -74.35 -45.09 49.34 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 24' ' ' GLU . 86.5 mt -57.89 -43.9 85.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.782 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.4 mt -60.18 -39.55 86.87 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.71 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 98.0 m -58.21 -48.12 81.34 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.612 0.57 . . . . 0.0 111.116 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.3 m -81.14 -31.05 11.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -78.7 -15.35 58.57 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 61.3 m -76.63 -8.55 57.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.079 0.466 . . . . 0.0 111.317 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' HD2' ' C' ' 324' ' ' ARG . 12.7 tp10 -53.77 -47.75 70.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.593 1.157 . . . . 0.0 110.294 176.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -97.38 -24.44 15.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.391 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' C' ' 314' ' ' MET . . . -178.5 -167.94 37.05 Favored Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.224 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.35 116.81 61.53 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 117.577 0.688 . . . . 0.0 109.865 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.67 138.05 72.58 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.449 2.099 . . . . 0.0 111.589 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 110' ' ' ILE . 99.3 t -93.89 -50.03 12.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 122.045 0.926 . . . . 0.0 109.825 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -127.85 126.94 42.56 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.229 -1.35 . . . . 0.0 108.392 -177.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 28' ' ' LEU . 13.6 p -139.47 125.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -131.93 127.64 58.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.607 178.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.18 129.01 48.45 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 t -73.13 103.9 4.02 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.44 148.43 46.12 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.578 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' A' ' 50' ' ' GLU . 24.8 t70 -57.14 147.01 25.94 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.258 0.974 . . . . 0.0 111.096 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.02 -16.21 58.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.181 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -102.58 -52.46 3.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.131 0.491 . . . . 0.0 111.725 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.572 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 t -102.21 -15.94 16.49 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.607 -176.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 17.74 76.81 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.232 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HG2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -61.77 114.37 3.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.992 0.396 . . . . 0.0 111.572 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 36.8 m -66.43 113.03 4.37 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.052 0.941 . . . . 0.0 110.823 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -77.64 -10.73 59.67 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 0.0 112.286 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.94 29.36 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.124 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.92 149.96 47.92 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.52 161.18 42.17 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -131.38 138.67 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -143.82 158.74 43.48 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.661 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 1.4 pttm -151.75 144.78 24.53 Favored 'General case' 0 C--O 1.255 1.364 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.015 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 64' ' ' SER . 74.8 t80 -88.08 166.74 14.22 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 163.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 38' ' ' VAL . 1.6 tm-20 -63.48 -55.48 23.75 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.11 143.31 26.37 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 65' ' ' THR . 9.0 tt0 -66.14 -14.63 62.13 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -56.03 -43.07 77.46 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 15.0 m -84.29 -22.75 30.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.732 0.777 . . . . 0.0 109.103 -176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.3 m -64.52 -45.69 86.12 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.526 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.12 -40.02 87.46 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' C' ' 311' ' ' PHE . 62.4 tp -58.63 -48.41 81.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.495 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.1 77.63 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 122.703 0.401 . . . . 0.0 111.635 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 62.1 t -60.5 -40.26 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -86.74 -17.01 34.64 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.268 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.14 -60.6 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -87.94 -9.77 52.57 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 59.2 t30 -65.98 112.73 3.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.78 -0.01 28.89 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.849 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -74.98 128.9 36.66 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.964 -0.695 . . . . 0.0 109.228 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 4.0 tppp? -88.34 119.17 28.51 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 123.651 0.78 . . . . 0.0 110.082 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 33.8 mt -136.45 118.81 20.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.11 35.89 64.24 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -15.38 36.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.116 -0.564 . . . . 0.0 114.155 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -118.6 149.13 41.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.631 0.715 . . . . 0.0 109.916 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -98.79 124.57 43.74 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.33 143.38 50.29 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.759 0.79 . . . . 0.0 112.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 40.0 tptt -110.52 123.42 49.9 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.79 -174.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.5 mp -111.74 140.23 32.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.421 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 3.1 t0 -151.94 -177.44 6.15 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.04 139.76 31.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 118.994 0.815 . . . . 0.0 110.24 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.3 t -151.74 160.34 43.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -148.77 136.55 20.63 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' OH ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -150.42 160.77 43.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -86.47 120.99 72.42 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.36 130.68 17.78 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.502 2.801 . . . . 0.0 110.882 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -68.2 138.07 55.32 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -39.8 25.79 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m -55.3 -36.83 66.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.915 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.76 18.17 19.87 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.68 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.4 pt20 -56.82 -30.09 63.41 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HB2' ' CG1' ' B' ' 206' ' ' ILE . 31.7 mmmt -65.34 -31.87 73.21 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.069 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 102' ' ' VAL . 28.8 t80 -67.49 -43.96 79.69 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -59.53 -54.31 47.98 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.3 pt-20 -64.12 -43.37 95.48 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.303 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.26 69.86 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.22 0.534 . . . . 0.0 110.438 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 98' ' ' TYR . 34.5 t -68.9 -55.54 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.861 175.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 17.7 ptpt -72.95 -20.15 61.11 Favored 'General case' 0 C--O 1.2 -1.524 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mm-40 -52.63 -40.28 62.59 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 118.38 0.537 . . . . 0.0 110.892 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.12 -47.39 24.6 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.734 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.43 -45.34 91.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.074 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' HG12 ' A' ' 111' ' ' VAL . 6.0 t70 -52.11 -35.18 47.29 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 124.98 1.312 . . . . 0.0 112.408 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 22.6 mmm180 -72.5 -17.22 61.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.998 0.428 . . . . 0.0 111.799 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.27 -16.08 22.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.055 0.931 . . . . 0.0 108.834 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 38' ' ' VAL . 59.9 mt -90.82 -56.15 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.508 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 107' ' ' ASP . 8.7 p -74.09 132.68 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.288 -172.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -97.01 158.83 15.24 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . 0.333 58.6 mtmt -79.44 75.84 6.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -159.98 168.76 24.92 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 72.68 -39.83 0.46 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.963 0.905 . . . . 0.0 111.863 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.11 92.37 7.89 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.16 -28.64 60.19 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.966 0.888 . . . . 0.0 108.927 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.1 m -92.91 138.83 31.14 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -20.93 6.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.953 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 3.7 p -71.11 -29.67 65.56 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.651 0.739 . . . . 0.0 110.213 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.88 178.61 8.75 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.01 -61.23 1.88 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.554 HG22 HG13 ' B' ' 208' ' ' ILE . 3.5 mm -123.29 142.06 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -90.63 -6.34 54.71 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.648 0.593 . . . . 0.0 111.676 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.554 HG13 HG22 ' B' ' 206' ' ' ILE . 0.5 OUTLIER -91.76 -80.46 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 119.1 -1.04 . . . . 0.0 109.982 -173.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . 0.274 18.3 mmt 68.43 145.19 0.1 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 147.97 93.81 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 123.116 2.544 . . . . 0.0 116.003 -172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.62 -63.87 1.29 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.571 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 71.22 28.15 3.08 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 77.4 p -127.0 159.78 62.88 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.14 171.8 17.22 Favored 'Trans proline' 0 CA--C 1.485 -1.967 0 CA-C-N 120.508 1.217 . . . . 0.0 111.321 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 63.2 p -87.87 -179.26 6.21 Favored 'General case' 0 N--CA 1.382 -3.838 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -105.43 -6.9 38.1 Favored Glycine 1 C--N 1.243 -4.615 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 26.7 mt -69.74 -47.71 62.06 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.484 HD22 ' OD2' ' A' ' 26' ' ' ASP . 12.0 tp -44.81 -54.65 6.12 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.625 -2.534 . . . . 0.0 113.187 -171.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.26 -19.48 65.99 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -89.86 -31.73 17.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 14.8 mm-40 -76.52 -30.64 57.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.928 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.663 178.742 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.336 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 24.0 t -78.25 -43.13 29.07 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.69 108.92 14.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.69 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.22 -33.39 10.77 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' C' ' 306' ' ' ALA . 70.3 mmtt -90.95 144.48 30.17 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.272 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.32 -41.29 9.38 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.31 2.007 . . . . 0.0 109.158 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' C' ' 304' ' ' LYS . . . -128.9 128.66 23.43 Favored Pre-proline 0 N--CA 1.416 -2.172 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.17 109.95 0.57 Allowed 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.652 2.235 . . . . 0.0 112.335 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -84.97 71.13 10.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 122.949 1.357 . . . . 0.0 109.389 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -144.89 124.66 13.36 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -73.14 -18.07 61.32 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.3 0.572 . . . . 0.0 112.333 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -96.28 -8.81 31.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 57.75 34.88 24.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.895 1.278 . . . . 0.0 112.666 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 27.3 mm -79.48 137.65 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.661 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 23.0 mmt -73.78 136.81 76.95 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 171.85 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.016 2.478 . . . . 0.0 112.729 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -108.36 164.53 12.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.282 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 43.4 m -82.24 -6.34 59.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.9 mtp-105 -95.26 4.36 53.58 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.719 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -73.82 118.87 17.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.47 -19.76 57.72 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.619 1.168 . . . . 0.0 112.707 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.55 45.11 4.4 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.4 170.31 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -106.23 149.93 26.39 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.124 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.554 ' CZ ' ' HA ' ' C' ' 324' ' ' ARG . 0.6 OUTLIER -74.94 99.88 3.96 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.665 0.745 . . . . 0.0 110.95 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.0 t -97.39 137.27 36.63 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 171.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 70.95 103.62 0.06 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.599 1.187 . . . . 0.0 110.91 -176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.71 22.45 23.67 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.619 -0.718 . . . . 0.0 113.471 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' C' ' 324' ' ' ARG . 13.7 t80 -100.48 162.81 12.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 117.72 0.76 . . . . 0.0 111.179 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.83 5.12 5.35 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.629 1.572 . . . . 0.0 110.484 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -39.41 -31.39 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.899 2.08 . . . . 0.0 113.038 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -76.29 -155.21 0.06 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.376 0.607 . . . . 0.0 109.56 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 . . . . . 0 N--CA 1.421 -1.913 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.583 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.422 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.84 21.88 11.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.928 0.364 . . . . 0.0 110.62 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' THR . 27.0 ptt? -92.98 141.19 28.68 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' HA2' ' OD1' ' A' ' 10' ' ' ASN . . . 171.11 -34.81 0.16 Allowed Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.847 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -72.27 -17.21 61.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.264 1.032 . . . . 0.0 111.698 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.28 4.18 24.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.315 0.578 . . . . 0.0 110.607 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -130.47 171.6 12.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -120.51 -15.5 8.5 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.854 -0.529 . . . . 0.0 112.352 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.58 4.47 46.77 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 110.753 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.8 OUTLIER -87.0 92.67 9.12 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.63 -6.62 59.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.1 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -88.49 142.64 27.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 57' ' ' LEU . 27.2 pt -109.2 138.33 37.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.752 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.6 t80 -87.74 119.74 28.37 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.102 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 18' ' ' LEU . 12.2 mt -112.61 111.33 35.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.94 171.98 15.38 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.756 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 t30 67.85 41.75 2.08 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.667 1.187 . . . . 0.0 110.764 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -92.41 159.29 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 22' ' ' LEU . 6.5 p30 -92.98 170.69 9.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' SER . 18.8 tpp180 -65.23 -34.86 79.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.739 0.816 . . . . 0.0 112.318 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 1.7 pm0 -79.07 -13.21 59.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 HD12 ' B' ' 217' ' ' LEU . 86.8 mt -79.73 118.2 21.33 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.487 0.66 . . . . 0.0 110.998 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -112.27 -178.84 3.51 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.44 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -53.95 -45.44 71.31 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 118.521 0.601 . . . . 0.0 112.374 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.4 -33.02 79.31 Favored Glycine 0 N--CA 1.459 0.169 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.069 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD1' HD23 ' B' ' 218' ' ' LEU . 18.4 t70 -71.4 -48.22 51.19 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.873 0.844 . . . . 0.0 109.602 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 HD23 ' A' ' 42' ' ' LEU . 66.3 mt -57.44 -43.48 82.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.664 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.61 HD21 HG11 ' A' ' 40' ' ' VAL . 98.3 mt -61.7 -45.44 93.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.831 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -56.35 -41.69 76.52 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.938 0.774 . . . . 0.0 111.664 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG12 HH21 ' C' ' 324' ' ' ARG . 25.4 m -81.07 -37.41 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -78.86 -14.01 59.48 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.0 p -89.82 -8.75 51.35 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' C' ' 324' ' ' ARG . 2.9 tm-20 -59.56 -44.44 93.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.137 0.494 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -116.45 18.51 15.1 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' C' ' 313' ' ' ILE . . . 179.51 -177.27 48.18 Favored Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.791 -1.671 . . . . 0.0 114.245 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.57 114.11 52.79 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.16 105.06 2.0 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.133 1.888 . . . . 0.0 109.976 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 60' ' ' GLU . 53.8 t -83.77 -38.54 14.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.154 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -142.71 140.07 31.36 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.61 HG11 HD21 ' A' ' 28' ' ' LEU . 11.5 p -151.28 146.83 15.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -147.33 132.25 11.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.303 177.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -99.23 125.14 44.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -74.4 102.6 4.47 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' B' ' 208' ' ' ILE . 10.6 ptm180 -128.08 151.87 48.66 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.983 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.88 136.06 51.72 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 124.096 0.872 . . . . 0.0 111.596 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' B' ' 208' ' ' ILE . 34.2 tt0 -77.95 -12.93 60.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.3 0.571 . . . . 0.0 111.771 -175.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -101.46 -49.21 4.1 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.919 0.39 . . . . 0.0 110.76 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -111.64 -5.15 14.53 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.99 32.36 80.65 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.885 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -89.81 137.65 32.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 117.222 0.511 . . . . 0.0 109.869 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 13.6 m -64.87 126.44 27.98 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.29 -7.68 57.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.785 0.326 . . . . 0.0 111.4 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.45 22.85 45.81 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.723 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -136.12 144.4 45.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.91 161.56 37.78 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 38.9 m-85 -135.88 140.38 44.07 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' O ' HG12 ' A' ' 13' ' ' ILE . 8.2 tt -145.02 157.02 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.603 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 57' ' ' LEU . 79.6 tttt -136.12 125.21 24.43 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 109.52 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -82.37 177.56 8.7 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.82 0.819 . . . . 0.0 112.346 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HA ' HG21 ' A' ' 38' ' ' VAL . 45.0 tt0 -65.92 -19.43 65.86 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.231 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -149.14 144.49 26.66 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.894 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 65' ' ' THR . 32.0 tt0 -50.22 -37.56 36.01 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.815 1.646 . . . . 0.0 111.946 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 43.4 mtm180 -79.91 -22.91 42.21 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.643 -0.661 . . . . 0.0 110.873 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 33.2 t -78.0 -29.22 49.49 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.2 m -63.36 -45.93 88.89 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.577 171.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLN . 74.0 mt -62.94 -41.7 93.76 Favored 'Isoleucine or valine' 0 C--O 1.255 1.38 0 CA-C-O 121.492 0.663 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' SER . 64.1 tp -52.22 -51.26 59.33 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.503 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.88 89.88 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.512 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 65' ' ' THR . 78.5 t -53.09 -39.19 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 124.224 0.953 . . . . 0.0 112.587 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -102.75 -15.4 16.29 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.203 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -83.71 -60.35 2.15 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.15 -3.59 58.86 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.005 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.635 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 9.0 t30 -66.35 114.83 5.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.53 9.86 51.97 Favored Glycine 0 N--CA 1.418 -2.538 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.523 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -79.46 121.78 25.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -81.16 118.41 22.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.379 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.87 105.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.2 56.39 6.99 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.046 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.57 -11.6 25.05 Favored Glycine 0 C--N 1.309 -0.945 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -134.54 144.32 47.93 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 117.529 0.665 . . . . 0.0 110.511 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.82 119.86 38.84 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 84' ' ' ILE . 1.6 pp -71.36 145.55 49.33 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.919 0.866 . . . . 0.0 113.265 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.635 ' HD2' ' OD1' ' A' ' 73' ' ' ASN . 44.1 tptt -103.52 132.0 50.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.885 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -121.42 133.27 68.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.6 t70 -144.86 -173.98 4.22 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -97.42 145.01 26.59 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 3' ' ' MET . 13.8 t -152.04 160.32 43.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -149.01 129.51 13.92 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -139.57 160.31 40.15 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -89.13 123.01 68.26 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.333 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.41 138.28 54.53 Favored 'Trans proline' 0 C--O 1.244 0.775 0 C-N-CA 122.456 2.104 . . . . 0.0 110.872 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -82.83 137.02 34.46 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.2 ptt180 -77.23 -17.33 58.54 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.757 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -64.08 -22.37 66.9 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt -111.47 15.23 21.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.157 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 20.6 pt20 -58.31 -35.98 72.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.2 mmmt -69.45 -24.15 63.77 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.054 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 102' ' ' VAL . 50.2 t80 -72.3 -41.6 66.41 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CD1' HG21 ' A' ' 41' ' ' ILE . 21.9 m-85 -65.92 -46.6 77.65 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.412 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -71.8 -34.5 69.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.614 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.67 74.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.612 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.4 t -73.9 -48.98 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 O-C-N 123.403 0.44 . . . . 0.0 110.547 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -68.38 -19.61 64.63 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 22.5 mm-40 -47.65 -53.79 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.858 0.299 . . . . 0.0 111.689 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.64 -35.08 79.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.287 0.565 . . . . 0.0 110.609 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 40' ' ' VAL . 24.4 mt -72.73 -43.91 62.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.216 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -56.61 -39.19 73.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.964 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.618 ' HA ' HG12 ' A' ' 111' ' ' VAL . 21.0 mmm180 -69.25 -35.2 75.87 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' C' ' 318' ' ' ARG . 6.4 t0 -64.55 -36.87 85.61 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.954 0.883 . . . . 0.0 109.316 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 106' ' ' LEU . 37.1 mt -81.05 -39.63 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.622 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 108' ' ' ARG . 1.4 p -78.78 178.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.91 -170.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.404 ' H ' HG22 ' A' ' 111' ' ' VAL . 47.5 m -60.96 -44.12 97.78 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -90.2 96.32 10.61 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.318 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 44.7 t30 -73.35 149.23 42.73 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.521 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.87 89.08 1.72 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HA ' ' NH2' ' C' ' 318' ' ' ARG . . . -97.17 -47.8 5.61 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 51.72 82.3 0.07 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.176 1.791 . . . . 0.0 113.682 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.314 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 9.3 p -77.2 153.82 33.71 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 123.019 0.528 . . . . 0.0 111.888 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -93.0 -14.12 27.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.2 m -77.43 -4.32 44.77 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.287 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 74.31 145.29 0.08 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.357 1.463 . . . . 0.0 109.068 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 19.5 m-85 -61.05 -68.29 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.909 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 5.9 mm -123.94 151.38 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.56 -19.55 59.22 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.292 0.568 . . . . 0.0 110.012 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.482 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.1 mt -77.24 -76.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.618 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' B' ' 205' ' ' TYR . 1.9 mmt 64.94 152.66 0.12 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.563 1.145 . . . . 0.0 111.388 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 102' ' ' VAL . 56.1 Cg_endo -69.85 156.75 62.31 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 121.946 1.764 . . . . 0.0 112.952 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.4 -51.74 2.96 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.994 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 55.54 73.94 0.4 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.8 m -140.82 152.48 65.76 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.95 160.83 21.03 Favored 'Trans proline' 0 CA--C 1.501 -1.174 0 C-N-CA 121.454 1.436 . . . . 0.0 109.846 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 60.7 p -90.27 162.66 15.09 Favored 'General case' 0 N--CA 1.388 -3.54 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -88.94 -4.84 74.57 Favored Glycine 1 C--N 1.253 -4.065 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.316 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 17.1 mt -73.81 -38.7 64.51 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.57 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -47.41 -44.48 24.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.963 -175.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -68.26 -32.52 72.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.779 0.323 . . . . 0.0 111.775 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.39 -32.17 42.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.353 -176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.1 mm-40 -79.36 -44.71 21.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.95 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.598 1.187 . . . . 0.0 109.699 -178.441 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.363 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 16.4 m -93.98 -38.9 10.93 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 0.0 110.164 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -120.27 164.94 15.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.01 -56.94 2.11 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 135.86 28.83 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.126 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.24 -66.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.334 2.022 . . . . 0.0 112.806 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -141.03 142.01 26.06 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 17.3 Cg_exo -68.55 159.01 55.31 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.045 1.83 . . . . 0.0 111.063 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.61 -19.87 57.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -71.89 142.6 49.51 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.552 -0.749 . . . . 0.0 108.984 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' C' ' 330' ' ' GLU . 1.0 OUTLIER -72.8 -41.35 65.02 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 67' ' ' LEU . 38.9 m-85 -76.76 -4.93 45.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.417 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 58.61 60.29 2.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.923 0.889 . . . . 0.0 111.447 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.524 HG22 ' HA2' ' A' ' 35' ' ' GLY . 11.5 mm -115.17 146.2 19.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 159.28 50.02 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.37 146.4 68.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.856 2.371 . . . . 0.0 113.72 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -88.39 -177.9 47.06 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.113 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 3.7 m -88.94 -15.2 34.86 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.311 0.577 . . . . 0.0 110.906 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.554 ' HG2' ' OD2' ' A' ' 109' ' ' ASP . 9.4 mmp_? -64.82 -21.31 66.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.407 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -76.6 142.78 40.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.772 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.02 -82.5 0.25 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.376 0.608 . . . . 0.0 109.443 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -177.87 40.68 0.09 OUTLIER Glycine 0 CA--C 1.485 -1.805 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . 0.575 HG12 ' NH1' ' C' ' 324' ' ' ARG . 16.4 t -119.8 103.86 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -73.56 148.23 43.18 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 124.103 0.961 . . . . 0.0 111.542 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.575 ' NH1' HG12 ' C' ' 322' ' ' VAL . 1.0 OUTLIER -116.92 132.87 56.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 132.15 14.97 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -133.25 -24.35 1.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.301 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.72 30.91 2.88 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.156 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -73.15 141.86 47.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.623 0.249 . . . . 0.0 110.44 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -58.88 1.73 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' C' ' 310' ' ' ARG . 9.4 pt-20 -72.48 -23.69 61.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' C' ' 331' ' ' LYS 0.413 0.0 OUTLIER -82.98 80.4 9.03 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 122.73 1.253 . . . . 0.0 113.949 -175.604 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 111.066 -2.788 . . . . 0.0 113.521 177.227 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.835 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.0 79.21 8.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HA ' ' NE2' ' A' ' 86' ' ' HIS . 26.6 ttt -110.18 126.71 54.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.681 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.582 ' H ' ' CD2' ' A' ' 86' ' ' HIS . . . -77.57 131.52 11.17 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 173.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -110.26 9.76 23.71 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.77 -52.8 58.69 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.029 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 94.7 m-85 -101.14 104.95 16.06 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -62.79 -30.12 71.23 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.078 0.466 . . . . 0.0 111.487 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -102.46 20.07 17.72 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.532 0.682 . . . . 0.0 111.531 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 7' ' ' TYR . 4.4 p30 -78.7 122.34 25.87 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.236 -0.915 . . . . 0.0 109.748 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.18 -8.62 14.75 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -91.61 145.36 24.66 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.602 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 65' ' ' THR . 15.9 pt -119.82 141.42 40.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 18.3 t80 -86.59 128.18 34.97 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.45 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.23 124.39 72.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.73 -179.9 17.48 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.013 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 64.52 39.89 6.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.528 1.531 . . . . 0.0 110.231 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 146.85 24.83 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.423 0.63 . . . . 0.0 111.481 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 m120 -67.9 168.1 12.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.502 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -78.59 -33.63 47.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.307 0.575 . . . . 0.0 110.386 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 -3.38 45.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 90.3 mt -88.42 117.3 27.26 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 HG21 ' OD2' ' B' ' 211' ' ' ASP . 7.7 t -112.83 -173.83 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.33 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 8.4 mt-10 -51.43 -53.54 35.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.275 1.83 . . . . 0.0 111.383 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.74 -28.09 72.87 Favored Glycine 0 C--O 1.244 0.765 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.019 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' HD22 ' A' ' 22' ' ' LEU . 16.7 t70 -69.1 -52.87 23.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' HD23 ' A' ' 42' ' ' LEU . 77.1 mt -54.96 -37.87 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.151 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -60.1 -48.65 80.82 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.307 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 29.2 m -60.1 -30.09 69.03 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 40.8 t -73.74 -51.51 24.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.02 0.438 . . . . 0.0 110.341 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -73.54 -22.14 60.18 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.8 m -71.41 -8.88 56.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HB3' ' NH2' ' C' ' 324' ' ' ARG . 7.5 tm-20 -68.51 -44.13 75.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -84.02 -30.26 26.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.374 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -170.27 -145.87 4.9 Favored Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.589 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.9 127.89 27.51 Favored Pre-proline 0 C--N 1.297 -1.716 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD22 ' A' ' 28' ' ' LEU . 71.0 Cg_endo -78.02 103.45 1.7 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 121.394 1.396 . . . . 0.0 109.994 174.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 60' ' ' GLU . 36.7 t -77.83 -50.38 20.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.52 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 10.8 t70 -142.59 130.37 21.59 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG11 HD21 ' A' ' 28' ' ' LEU . 8.6 p -144.4 146.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -144.34 126.96 11.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 27' ' ' ILE . 3.4 tm? -102.57 127.47 49.64 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -77.63 97.39 5.08 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -122.16 149.59 43.41 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' OD2' HG22 ' A' ' 48' ' ' THR . 29.6 t70 -56.33 136.62 53.39 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 123.441 0.463 . . . . 0.0 111.7 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.14 -18.25 63.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.529 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -100.31 -53.71 3.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.857 0.361 . . . . 0.0 111.463 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.8 t -92.46 -24.64 18.75 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 12.07 80.56 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.606 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -85.56 138.2 32.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.615 0.708 . . . . 0.0 109.74 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -56.43 138.14 51.82 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 123.887 0.875 . . . . 0.0 110.388 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.36 -13.04 28.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.776 0.798 . . . . 0.0 109.093 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.05 29.34 15.39 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.653 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.34 146.45 40.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.93 169.33 22.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 118.055 0.389 . . . . 0.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 79.2 m-85 -137.87 146.45 43.4 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 58' ' ' LYS . 7.8 tt -150.89 156.64 41.63 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.5 pttm -146.77 140.58 25.94 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.95 0.405 . . . . 0.0 111.041 173.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.71 152.07 19.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 168.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' H ' HG21 ' A' ' 38' ' ' VAL . 2.9 tm-20 -92.21 74.22 5.4 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 161.54 106.31 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 128.552 2.741 . . . . 0.0 104.373 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.579 ' O ' ' HB ' ' A' ' 65' ' ' THR . 52.6 tt0 -60.34 -19.64 56.21 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.522 0.729 . . . . 0.0 112.666 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -69.68 -30.26 67.88 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.252 0.549 . . . . 0.0 110.47 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 t -84.47 -21.01 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 3.7 m -64.69 -47.97 76.43 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.344 171.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 62' ' ' GLN . 42.1 mt -62.69 -42.48 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.38 -43.79 75.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.727 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.35 92.01 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 123.025 0.53 . . . . 0.0 111.158 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.72 -53.92 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 123.721 0.638 . . . . 0.0 109.335 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' C' ' 330' ' ' GLU . 18.2 m-20 -73.96 -7.51 52.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' OD1' ' HG ' ' A' ' 72' ' ' LEU . 22.9 t-20 -100.02 -38.71 8.46 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.502 HD21 ' NH2' ' C' ' 324' ' ' ARG . 62.4 mt -113.16 -18.37 12.15 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -171.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.32 110.57 1.69 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.73 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.9 -0.25 33.9 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.41 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -69.0 129.4 39.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -86.29 116.19 24.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.948 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 71.0 mt -139.83 122.23 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 70.19 27.21 73.19 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.66 76.67 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.613 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -111.48 155.28 23.46 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.06 122.93 47.88 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.259 1.9 pp -73.1 141.49 47.53 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.938 0.875 . . . . 0.0 113.357 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 40.5 tptt -104.76 129.35 53.01 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.421 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.4 mp -117.9 138.84 47.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.0 t70 -145.14 165.12 29.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' CD2' ' H ' ' A' ' 4' ' ' GLY . 35.8 m-70 -83.9 140.52 31.91 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.5 t -151.69 160.97 43.41 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.519 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -141.66 121.36 13.44 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -131.18 161.24 32.61 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -107.18 123.82 37.12 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.39 161.39 23.88 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.95 2.433 . . . . 0.0 113.146 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -86.53 139.26 31.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 93' ' ' ARG . 1.7 ppt_? -77.93 -27.6 49.45 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.335 0.588 . . . . 0.0 109.685 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -69.94 -43.55 71.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.827 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.95 20.31 3.17 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.751 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.8 pt20 -46.72 -39.51 11.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.261 1.024 . . . . 0.0 113.098 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -64.5 -27.15 68.78 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.842 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 102' ' ' VAL . 56.2 t80 -74.49 -43.21 57.02 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.19 -48.7 77.23 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.815 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 7.5 pt-20 -64.7 -49.07 72.35 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.722 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.64 -32.06 68.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 210' ' ' PRO . 82.6 t -74.44 -57.51 6.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.05 0.452 . . . . 0.0 111.056 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -71.95 -21.26 61.62 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -53.57 -39.71 65.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.778 0.323 . . . . 0.0 111.46 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 10.4 mm-40 -74.21 -34.01 63.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.152 0.501 . . . . 0.0 110.888 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.439 HD11 HG12 ' A' ' 40' ' ' VAL . 36.7 mt -79.59 -32.54 41.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.773 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' HA ' HD12 ' A' ' 110' ' ' ILE . 15.4 t70 -62.39 -23.77 67.01 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.702 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 105' ' ' GLU . 50.2 mtp180 -74.56 -12.19 60.4 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.765 0.826 . . . . 0.0 112.319 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.21 -35.01 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 107' ' ' ASP . 24.6 mt -75.36 -51.53 20.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.287 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 107' ' ' ASP . 5.2 p -84.42 129.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.637 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.0 p -87.97 -36.81 16.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.952 0.882 . . . . 0.0 109.999 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -129.29 95.33 4.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.767 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.67 -46.92 12.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -177.02 -168.0 0.19 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.67 7.24 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -77.8 91.63 4.13 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.829 0.347 . . . . 0.0 110.473 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.649 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -82.86 71.24 9.96 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.505 0.669 . . . . 0.0 111.289 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -89.19 -42.21 11.79 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.605 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.3 m -68.21 -59.9 2.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.649 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.502 ' OE1' ' HG3' ' B' ' 209' ' ' MET . 7.8 tt0 -169.97 158.57 7.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -63.68 -66.02 0.6 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.487 HG22 HG13 ' B' ' 208' ' ' ILE . 18.7 mm -115.44 156.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -93.98 7.68 44.17 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.019 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.487 HG13 HG22 ' B' ' 206' ' ' ILE . 4.3 mt -90.04 -77.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.502 ' HG3' ' OE1' ' B' ' 204' ' ' GLN . 4.7 mmt 63.08 150.06 0.1 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 124.666 1.186 . . . . 0.0 111.975 -177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 102' ' ' VAL . 22.3 Cg_endo -60.85 148.33 92.57 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.701 2.267 . . . . 0.0 113.959 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.427 ' OD2' HG21 ' A' ' 23' ' ' THR . 14.8 t70 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.4 1.08 . . . . 0.0 110.173 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 55.53 30.86 15.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.9 m -105.75 158.95 31.21 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.58 172.2 9.29 Favored 'Trans proline' 0 N--CA 1.43 -2.256 0 N-CA-C 109.722 -0.915 . . . . 0.0 109.722 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 53.6 p -90.53 -178.75 5.4 Favored 'General case' 1 C--N 1.242 -4.067 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 164.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -109.89 -7.52 27.19 Favored Glycine 1 C--N 1.245 -4.501 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 23.4 mt -68.96 -42.11 77.09 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.436 HD22 ' OD2' ' A' ' 26' ' ' ASP . 9.3 tp -51.8 -46.01 64.06 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 112.576 -2.102 . . . . 0.0 113.578 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.32 -11.54 60.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.67 -32.33 14.78 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 13.2 mm-40 -78.06 -30.65 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.795 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.256 1.415 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.3 t -132.15 140.17 48.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . 0.414 ' CD2' ' HG3' ' C' ' 314' ' ' MET . 93.0 m-85 -87.23 109.18 19.31 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -94.75 -40.76 9.6 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.053 0.454 . . . . 0.0 111.625 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -87.83 130.78 45.44 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.479 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -64.03 -36.86 46.26 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.077 2.518 . . . . 0.0 110.688 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -120.88 133.38 24.11 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.96 94.75 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.876 1.717 . . . . 0.0 113.141 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.01 -31.18 56.23 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.252 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -73.42 87.56 1.56 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 44.48 -91.06 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.64 1.976 . . . . 0.0 116.303 171.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -101.34 12.32 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 76.26 61.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.671 1.188 . . . . 0.0 113.525 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.29 137.27 54.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.454 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 6.6 mmt -107.97 159.4 30.65 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.84 151.15 79.29 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 123.366 2.71 . . . . 0.0 113.885 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -92.76 176.75 38.21 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.179 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 8.1 m -69.57 -25.48 64.01 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.817 0.447 . . . . 0.0 111.743 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' THR . 1.5 mmp_? -74.77 4.0 7.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -88.34 132.77 34.29 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.34 -68.24 0.8 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 175.13 45.19 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 86.0 t -88.43 109.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -75.92 151.45 37.33 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.836 0.71 . . . . 0.0 110.143 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.502 ' NH2' HD21 ' A' ' 72' ' ' LEU . 3.8 tpp180 -89.63 112.9 24.27 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.448 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 24.1 t -149.54 122.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -155.66 -49.74 0.08 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.78 31.11 5.26 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.885 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -70.21 141.56 52.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.411 0.624 . . . . 0.0 110.775 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.2 1.74 0.68 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.613 ' OE1' ' HG2' ' C' ' 331' ' ' LYS . 0.0 OUTLIER -61.35 -63.16 1.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.613 ' HG2' ' OE1' ' C' ' 330' ' ' GLU . 44.5 mmtm -147.77 171.26 15.96 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 . . . . . 0 C--N 1.281 -2.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.482 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.97 100.24 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.067 0.46 . . . . 0.0 109.857 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.522 ' HA ' ' OD1' ' A' ' 85' ' ' ASP . 86.5 mtp -110.21 133.68 52.99 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.728 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.67 31.75 3.54 Favored Glycine 0 C--N 1.3 -1.442 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -74.04 -11.29 60.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.954 0.901 . . . . 0.0 110.41 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.39 -24.98 42.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.03 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 9' ' ' ASP . 52.3 t80 -122.49 90.85 3.38 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -14.71 56.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 32.9 t70 -56.17 -23.77 37.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.341 0.657 . . . . 0.0 112.236 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 92.5 m-20 -76.45 100.9 5.38 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.55 -16.76 57.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -82.09 134.96 35.37 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 57' ' ' LEU . 14.8 pt -107.57 134.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.351 0.596 . . . . 0.0 111.372 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 23.8 t80 -83.4 127.85 34.02 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.198 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 HD11 ' A' ' 18' ' ' LEU . 11.8 mt -120.02 114.31 43.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 167.21 17.58 Favored Glycine 0 C--N 1.291 -1.934 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.648 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.1 t30 67.75 51.45 0.8 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.953 1.301 . . . . 0.0 110.377 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD11 HG22 ' A' ' 15' ' ' ILE . 8.6 mp -95.63 156.13 16.46 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 22' ' ' LEU . 21.1 t-20 -84.53 143.12 29.54 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -51.61 -32.73 30.03 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.194 1.398 . . . . 0.0 112.232 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -69.63 -29.33 66.79 Favored 'General case' 0 N--CA 1.408 -2.549 0 C-N-CA 125.092 1.357 . . . . 0.0 111.546 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.63 HD21 HD12 ' B' ' 217' ' ' LEU . 71.1 mt -75.46 118.62 18.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.487 0.66 . . . . 0.0 111.799 -174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 3.7 t -111.88 177.13 4.75 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.067 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 17.3 mt-10 -44.73 -49.67 10.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.966 1.706 . . . . 0.0 113.403 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -27.94 72.63 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.489 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 22' ' ' LEU . 18.9 t70 -69.45 -50.45 45.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.94 -41.33 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.593 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 40' ' ' VAL . 88.1 mt -59.87 -46.15 90.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -63.61 -28.58 70.02 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 121.063 0.459 . . . . 0.0 110.794 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' B' ' 218' ' ' LEU . 45.6 t -80.31 -54.15 11.35 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-O 120.912 0.387 . . . . 0.0 110.816 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.8 -12.68 61.41 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 68.9 m -72.01 -8.72 56.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.561 0.22 . . . . 0.0 111.113 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -49.14 -54.18 17.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.509 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HA ' ' ND2' ' C' ' 309' ' ' ASN . 50.7 p90 -95.15 -31.02 13.73 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.772 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -162.3 -176.36 34.3 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.611 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' C' ' 316' ' ' GLY . 34.5 t -86.37 129.05 54.87 Favored Pre-proline 0 C--O 1.207 -1.171 0 C-N-CA 123.397 0.679 . . . . 0.0 109.822 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.31 136.5 34.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.429 1.419 . . . . 0.0 112.199 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' A' ' 60' ' ' GLU . 59.9 t -108.0 -58.95 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.427 0.632 . . . . 0.0 110.556 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.7 m-20 -127.67 126.83 42.67 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 28' ' ' LEU . 8.5 p -136.66 141.11 41.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -141.9 132.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-O 121.511 0.672 . . . . 0.0 109.193 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.22 145.53 25.47 Favored 'General case' 0 C--N 1.267 -2.986 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 11.0 t -91.91 106.11 18.21 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -135.39 155.07 51.18 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.39 135.01 53.71 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.936 0.773 . . . . 0.0 110.261 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 -22.02 64.41 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 123.097 0.559 . . . . 0.0 112.402 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -89.52 -49.94 6.39 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.626 0.251 . . . . 0.0 111.315 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 50' ' ' GLU . 7.8 t -107.58 -8.65 16.11 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -174.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.53 34.55 88.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.782 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.6 pp20? -100.42 138.84 36.95 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.307 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.1 t -65.19 137.7 57.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 111.686 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -98.61 -8.27 26.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.722 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.18 34.22 24.16 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.787 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 97.1 m-85 -144.73 157.92 43.99 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.42 167.6 29.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' HB2' HG12 ' A' ' 41' ' ' ILE . 79.1 m-85 -142.97 146.68 34.16 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.0 tt -151.96 160.73 43.41 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.0 ptmm? -148.42 137.87 22.04 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 120.804 0.335 . . . . 0.0 110.632 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 69.3 t80 -94.6 163.49 13.36 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 166.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.568 ' HG2' HG21 ' A' ' 38' ' ' VAL . 5.5 mm-40 -64.61 -44.85 89.24 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.236 0.541 . . . . 0.0 110.644 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 9.4 t70 -84.25 130.41 34.82 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.467 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 66' ' ' ILE . 58.7 tt0 -70.15 -26.29 63.86 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 125.075 1.35 . . . . 0.0 112.294 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -74.08 -28.61 61.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.456 0.645 . . . . 0.0 109.95 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 t -72.71 -36.99 67.93 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 1.2 m -59.32 -42.87 92.45 Favored 'General case' 0 CA--C 1.572 1.819 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.804 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 62' ' ' GLN . 65.4 mt -61.42 -41.08 88.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.907 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.5 -34.28 77.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.229 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.2 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 84' ' ' ILE . 47.0 t -64.28 -30.48 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.26 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -83.22 -46.44 12.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.98 -46.56 5.86 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.31 -15.38 59.45 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.11 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 83' ' ' LYS . 8.4 t30 -68.57 112.86 5.61 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.05 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.95 8.65 38.92 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' CZ ' ' HG3' ' C' ' 324' ' ' ARG . 45.5 t80 -83.39 124.49 30.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.096 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 5.5 tppp? -80.75 120.22 24.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.892 0.877 . . . . 0.0 110.733 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 61.2 mt -129.98 103.58 8.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 63.47 58.42 11.47 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.204 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.02 -20.16 10.51 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -123.32 138.23 54.66 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 118.254 1.027 . . . . 0.0 111.593 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -100.5 121.46 41.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 pp -76.12 142.9 41.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 32.8 tptt -109.5 126.29 53.37 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.773 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.6 mp -113.62 144.04 22.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 3' ' ' MET . 5.5 t70 -156.05 173.97 16.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 84.6 m-70 -95.44 119.08 33.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -141.92 160.95 39.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -141.88 131.61 24.17 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -141.33 160.59 39.81 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -89.93 121.71 68.59 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.7 143.57 92.47 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.167 1.911 . . . . 0.0 110.339 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -76.96 136.78 38.78 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.846 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 93' ' ' ARG . 4.4 tmm_? -81.4 -32.55 32.74 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -67.7 -25.03 65.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.254 0.55 . . . . 0.0 109.828 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.1 mt -101.43 19.9 16.97 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.131 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 4.9 pt20 -54.21 -39.18 66.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 30.9 mmmt -62.28 -23.62 66.82 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.5 t80 -73.83 -49.12 26.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -62.3 -49.56 75.14 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.772 0.67 . . . . 0.0 111.372 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.5 pt-20 -64.41 -40.22 95.37 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.847 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.62 70.99 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.985 0.422 . . . . 0.0 110.484 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 98' ' ' TYR . 38.3 t -64.23 -53.41 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.765 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.9 ptpt -78.83 -19.84 51.09 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 119.241 -0.984 . . . . 0.0 113.292 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 55.4 mm-40 -63.11 -19.7 64.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.827 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.46 -61.9 1.63 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.512 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.6 -44.96 95.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.268 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.76 -14.46 62.62 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -68.1 -23.91 64.97 Favored 'General case' 0 C--O 1.214 -0.8 0 O-C-N 122.167 -0.333 . . . . 0.0 110.416 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.49 -17.99 20.15 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.252 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.8 mt -82.64 -44.45 19.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.478 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 p -112.45 138.31 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -97.56 82.7 3.12 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -147.23 115.2 6.51 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.66 -34.42 19.78 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -114.03 115.59 27.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.51 23.71 9.09 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.74 171.79 13.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.472 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.016 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.3 m -67.32 128.81 37.8 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 122.868 0.467 . . . . 0.0 110.078 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -130.17 -21.57 2.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.184 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 -12.61 55.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.908 0.861 . . . . 0.0 109.031 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -153.2 152.13 30.88 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.416 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 9.7 m-85 -91.51 -64.03 1.18 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.017 0.913 . . . . 0.0 109.27 -175.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.524 HG22 HG13 ' B' ' 208' ' ' ILE . 13.0 mm -110.79 150.86 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.43 -25.03 60.34 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.515 0.51 . . . . 0.0 111.555 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.524 HG13 HG22 ' B' ' 206' ' ' ILE . 1.0 OUTLIER -78.66 -71.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.875 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.3 mmt 65.99 154.38 0.13 Allowed Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.464 1.106 . . . . 0.0 110.528 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.28 146.81 36.39 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 121.309 1.339 . . . . 0.0 113.094 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -98.32 -60.77 1.49 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.389 0.676 . . . . 0.0 109.328 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 60.08 83.19 0.14 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.29 1.036 . . . . 0.0 113.307 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 14.4 m -147.96 143.33 17.56 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -77.26 159.13 33.31 Favored 'Trans proline' 0 CA--C 1.488 -1.801 0 C-N-CA 121.674 1.583 . . . . 0.0 110.073 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 54.6 p -90.89 166.05 13.27 Favored 'General case' 0 N--CA 1.383 -3.787 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.47 -15.07 74.74 Favored Glycine 1 C--N 1.242 -4.678 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.546 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 22' ' ' LEU . 37.6 mt -65.49 -48.82 71.28 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -44.12 -60.19 1.99 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.656 -2.066 . . . . 0.0 113.255 -174.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.9 -30.76 71.81 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.32 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.41 -31.74 26.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.709 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 12.0 mm-40 -66.54 -48.82 68.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.256 1.438 0 O-C-N 124.87 1.356 . . . . 0.0 111.865 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.9 m -123.38 162.82 22.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -120.62 109.57 15.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -119.95 -19.55 7.83 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -90.38 123.56 65.21 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.124 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -85.52 -3.73 9.25 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.427 2.751 . . . . 0.0 111.729 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -150.15 152.35 33.5 Favored Pre-proline 0 N--CA 1.423 -1.789 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.23 79.35 0.78 Allowed 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.897 1.731 . . . . 0.0 113.691 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -66.99 -17.06 64.75 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.451 1.101 . . . . 0.0 109.28 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 34' ' ' TYR . 2.7 m-20 -82.16 18.38 1.4 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.475 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 59.75 -73.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.974 1.71 . . . . 0.0 113.915 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -83.18 17.13 2.12 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.88 0.872 . . . . 0.0 112.308 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.55 32.99 16.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.942 0.897 . . . . 0.0 112.035 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 313' ' ' ILE . 8.0 mt -79.04 134.85 26.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.449 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 23.9 mmt -90.06 135.53 29.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.21 146.9 16.91 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 124.166 3.244 . . . . 0.0 113.773 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -82.5 164.05 43.17 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 114.373 -1.285 . . . . 0.0 114.851 -173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -54.55 36.75 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 126.273 1.829 . . . . 0.0 112.607 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' C' ' 318' ' ' ARG . 51.4 mtt180 -85.9 15.01 5.26 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -77.75 100.6 6.32 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.66 -70.77 0.13 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.162 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 171.82 34.24 0.03 OUTLIER Glycine 0 CA--C 1.483 -1.907 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.33 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -94.2 120.88 35.08 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.06 0.457 . . . . 0.0 111.194 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -100.15 99.81 10.57 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.535 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.6 m -99.73 128.78 45.82 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -164.87 103.91 0.79 Allowed 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.16 31.35 78.64 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 170.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' C' ' 330' ' ' GLU . 54.7 t80 -67.46 137.86 56.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 117.764 0.782 . . . . 0.0 111.807 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.11 3.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 117.695 2.48 . . . . 0.0 117.695 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' C' ' 328' ' ' PHE . 4.5 tp10 -66.61 1.12 1.88 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.412 1.006 . . . . 0.0 113.409 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.18 109.52 11.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.947 -1.095 . . . . 0.0 108.813 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.9 m95 . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.269 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.92 -37.75 12.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.639 0.257 . . . . 0.0 110.915 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -70.73 139.29 51.1 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.423 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 60.65 4.84 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.789 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -79.93 -6.09 56.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -82.39 -26.23 33.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 86' ' ' HIS . 75.2 m-85 -90.6 137.4 32.39 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -130.16 -32.21 1.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -173.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -101.54 5.22 41.71 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.429 0.633 . . . . 0.0 111.581 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 96.0 m-20 -88.12 101.52 13.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.5 53.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -90.79 148.12 22.75 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 16.6 pt -116.2 133.45 62.67 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.384 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 29.1 t80 -83.62 123.6 29.96 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.685 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 18' ' ' LEU . 12.7 mt -113.51 128.59 70.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.55 170.3 23.1 Favored Glycine 0 C--N 1.292 -1.91 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.06 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.2 t30 70.37 28.6 3.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.543 1.537 . . . . 0.0 111.313 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 HD11 HG22 ' A' ' 15' ' ' ILE . 6.1 mp -77.56 150.97 34.69 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.929 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -75.95 167.44 21.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -67.73 -38.12 83.12 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 110.278 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 pm0 -75.48 -9.29 58.44 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.7 mt -82.38 119.13 23.77 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.754 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -111.85 -174.18 2.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -56.01 -37.04 68.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.324 0.65 . . . . 0.0 112.204 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.33 -35.28 91.29 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.441 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -63.39 -44.85 93.52 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.054 0.93 . . . . 0.0 109.323 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HD23 ' A' ' 42' ' ' LEU . 74.4 mt -61.44 -44.37 98.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 113.155 -1.839 . . . . 0.0 110.35 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 40' ' ' VAL . 95.2 mt -64.3 -41.43 96.87 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.654 0.264 . . . . 0.0 110.704 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.7 m -61.25 -40.84 95.55 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' HA ' ' HE ' ' C' ' 324' ' ' ARG . 34.7 m -80.79 -43.91 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 30' ' ' VAL . 37.0 m-85 -74.93 -22.23 58.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -68.65 -9.14 48.23 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.526 -0.734 . . . . 0.0 111.968 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' C' ' 324' ' ' ARG . 5.9 tp10 -60.57 -34.79 74.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.389 1.075 . . . . 0.0 110.072 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -102.17 -1.88 30.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.539 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.82 -150.52 22.32 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.179 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.07 111.46 42.77 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -68.35 119.4 6.4 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.94 2.427 . . . . 0.0 110.302 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.414 ' HA ' HD11 ' A' ' 110' ' ' ILE . 33.2 m -94.16 -21.62 5.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.531 0.681 . . . . 0.0 110.724 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 4.9 m-20 -142.52 123.84 14.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.37 139.49 22.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -149.14 140.52 17.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD23 HD11 ' A' ' 27' ' ' ILE . 3.3 tm? -103.5 138.6 39.99 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -76.58 97.22 4.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HG2' HD12 ' A' ' 42' ' ' LEU . 18.6 mtp180 -116.46 153.41 32.16 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -87.29 149.98 24.18 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.453 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' HG12 ' B' ' 208' ' ' ILE . 0.8 OUTLIER -79.94 -25.36 40.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.629 0.728 . . . . 0.0 110.546 -175.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.96 -32.48 12.58 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.672 -0.642 . . . . 0.0 111.517 -170.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 t -111.17 -24.1 10.48 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.894 0.378 . . . . 0.0 111.934 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 82.9 -8.42 63.05 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 121.693 -0.289 . . . . 0.0 113.7 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 48' ' ' THR . 11.5 pt-20 -72.2 152.7 42.07 Favored 'General case' 0 C--O 1.254 1.315 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.45 ' OG ' HD11 ' A' ' 42' ' ' LEU . 37.7 t -71.25 136.18 47.85 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.622 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -96.97 -6.52 35.31 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.667 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.62 22.09 51.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.168 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HD22 ' A' ' 42' ' ' LEU . 57.9 m-85 -134.03 152.31 51.79 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -147.82 167.58 24.38 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -139.72 139.27 36.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.3 tt -150.0 159.14 44.62 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.188 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 2.5 ptmm? -152.27 137.26 17.24 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 123.522 0.729 . . . . 0.0 109.772 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.6 178.5 6.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.914 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -61.38 -44.41 97.2 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.817 0.698 . . . . 0.0 110.019 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -113.41 142.33 46.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' O ' ' HB ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -66.99 -25.06 66.12 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.196 0.31 . . . . 0.0 110.759 -175.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HB3' ' CD2' ' C' ' 311' ' ' PHE . 89.5 mtt180 -68.73 -22.42 64.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.886 -1.134 . . . . 0.0 111.594 176.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.5 t -81.98 -34.09 29.86 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 16.7 m -57.63 -48.0 80.64 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.561 172.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.0 -38.53 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.886 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.82 -45.18 86.5 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.944 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.33 87.84 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.708 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 ' NE2' ' A' ' 86' ' ' HIS . 54.8 t -58.45 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.653 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' ' HD2' ' C' ' 331' ' ' LYS . 2.8 p30 -84.75 -14.9 46.85 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.2 -35.84 11.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.447 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.08 -20.19 21.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -65.33 114.39 4.73 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.259 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.97 -9.28 36.83 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.313 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -70.66 131.15 43.48 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -90.58 125.65 35.69 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.528 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.4 mt -133.91 109.56 13.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.26 37.32 94.37 Favored Glycine 0 C--N 1.313 -0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.88 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.78 -17.11 57.63 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.996 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -108.46 136.01 48.8 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 117.452 0.626 . . . . 0.0 110.496 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.56 111.2 23.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 1.6 pp -69.75 150.78 46.55 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -106.2 138.39 42.47 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.654 -177.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -130.27 128.94 64.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.0 165.2 26.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 59.8 m-70 -97.16 127.38 43.08 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 118.493 0.588 . . . . 0.0 110.482 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.42 161.31 39.99 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -138.2 103.49 4.94 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -108.62 157.91 18.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -99.5 128.78 30.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.52 135.68 71.21 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.496 2.131 . . . . 0.0 112.271 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.01 142.22 38.4 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -80.66 -22.74 40.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.2 p -69.89 -50.47 41.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.4 mt -87.32 16.39 5.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.463 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.588 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -44.22 -44.85 8.15 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.929 0.891 . . . . 0.0 112.845 -176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.24 -36.1 79.04 Favored 'General case' 0 C--O 1.206 -1.225 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.867 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 102' ' ' VAL . 51.3 t80 -68.42 -42.46 78.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.163 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -63.88 -49.59 72.13 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.432 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.7 pt-20 -67.04 -42.53 84.68 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.306 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.11 73.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' TYR . 70.0 t -73.75 -48.55 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.578 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 15.9 ptpt -70.33 -19.48 63.06 Favored 'General case' 0 C--O 1.197 -1.684 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 23.5 mm-40 -49.09 -50.39 37.18 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.348 0.405 . . . . 0.0 111.057 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.91 -44.49 96.67 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.206 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 40' ' ' VAL . 15.4 mt -67.9 -40.03 83.53 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.153 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.2 -35.0 70.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.046 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 27.1 mmm180 -66.62 -34.56 78.15 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.56 0.538 . . . . 0.0 109.634 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.58 -39.27 62.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.624 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 106' ' ' LEU . 61.3 mt -72.42 -52.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.816 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.03 135.52 14.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.4 m -78.13 136.92 37.95 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.57 -16.34 63.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.78 93.49 7.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -143.11 90.04 2.16 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.141 0.972 . . . . 0.0 111.158 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.56 118.87 4.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.17 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 81.92 4.22 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.293 1.044 . . . . 0.0 112.567 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.245 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 15.2 m -79.32 121.46 25.13 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.66 -31.09 10.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.9 m -69.27 -56.42 7.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.377 0.608 . . . . 0.0 109.802 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -145.92 139.26 26.12 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.56 -103.0 0.25 Allowed 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -171.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.72 HG22 HG13 ' B' ' 208' ' ' ILE . 4.9 mm -90.41 132.69 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.51 11.79 27.38 Favored 'General case' 0 C--N 1.262 -3.21 0 CA-C-O 121.637 0.732 . . . . 0.0 111.38 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.72 HG13 HG22 ' B' ' 206' ' ' ILE . 2.8 mt -92.8 -77.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.473 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 29.3 mmt 62.31 146.85 0.08 OUTLIER Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.7 1.2 . . . . 0.0 112.125 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.476 ' HB3' HG22 ' A' ' 102' ' ' VAL . 71.8 Cg_endo -78.86 160.35 27.48 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.241 1.961 . . . . 0.0 113.693 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.46 -44.83 6.35 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 52.83 67.73 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.459 0.647 . . . . 0.0 112.23 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 55.1 m -156.19 162.59 27.17 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.66 170.58 4.42 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 120.946 1.097 . . . . 0.0 111.93 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -178.24 5.19 Favored 'General case' 1 N--CA 1.372 -4.357 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.606 168.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -100.63 5.02 56.71 Favored Glycine 1 C--N 1.25 -4.235 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.872 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 27.5 mt -83.31 -49.36 9.46 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.06 -44.02 30.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.754 -2.021 . . . . 0.0 113.348 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -13.09 61.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 78.0 mt -110.73 -4.71 15.21 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.7 mm-40 -79.99 -36.64 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.33 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 123.633 0.773 . . . . 0.0 112.666 174.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 14.5 t -132.34 130.84 41.27 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.529 0.681 . . . . 0.0 110.934 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.03 3.82 15.46 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.234 1.016 . . . . 0.0 109.702 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' C' ' 304' ' ' LYS . 0.0 OUTLIER -81.35 127.0 75.14 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.092 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.46 -33.94 77.55 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.614 2.876 . . . . 0.0 112.362 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -131.68 153.4 81.49 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.01 118.36 5.26 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.956 1.771 . . . . 0.0 109.76 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' C' ' 325' ' ' SER . 43.7 mt-10 -65.98 -30.65 71.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.57 87.09 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.02 -7.11 3.46 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 19.3 m-85 -114.79 11.72 16.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.759 0.79 . . . . 0.0 109.199 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.6 19.94 11.65 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 3.8 mp -71.67 124.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.74 153.65 58.16 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -40.81 140.69 1.05 Allowed 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.622 3.548 . . . . 0.0 114.524 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -77.98 -102.12 0.19 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.286 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 p -134.25 -45.43 0.77 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -88.16 24.65 1.8 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.669 0.747 . . . . 0.0 111.955 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 36.4 t90 -93.85 111.88 23.65 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.65 -38.83 89.17 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.003 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 134.24 -13.29 4.64 Favored Glycine 0 C--N 1.303 -1.296 0 C-N-CA 119.724 -1.227 . . . . 0.0 111.08 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.08 114.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 142.2 32.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.588 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 1.5 mpt_? -99.59 107.3 19.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . 0.404 ' HA ' ' OE2' ' C' ' 308' ' ' GLU . 18.8 m -111.59 118.96 37.13 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -170.65 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.6 33.11 75.61 Favored Glycine 0 C--N 1.355 1.593 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.836 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' C' ' 330' ' ' GLU . 32.0 t80 -39.27 112.13 0.23 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.986 1.314 . . . . 0.0 113.015 -168.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.29 -7.44 24.38 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.791 -167.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' C' ' 328' ' ' PHE . 38.2 tt0 -61.18 -36.52 80.07 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.567 -0.708 . . . . 0.0 111.851 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.5 ' HD2' ' CB ' ' A' ' 70' ' ' ASP . 11.8 tmtt? -109.65 137.33 47.62 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . 0.471 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 48.5 p-90 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.77 96.73 1.15 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.975 0.417 . . . . 0.0 110.215 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -102.19 120.9 41.22 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 11.37 0.86 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.469 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' A' ' 86' ' ' HIS . 9.3 p30 -60.97 -11.54 8.4 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.851 0.86 . . . . 0.0 112.195 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.4 -41.13 75.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -102.88 91.98 4.38 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -81.98 -2.45 51.56 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.649 0.738 . . . . 0.0 111.015 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 6.3 p-10 -76.23 -11.87 59.99 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.076 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 94.4 m-20 -71.86 112.36 7.89 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -77.6 -19.18 55.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.848 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 53.2 m-85 -82.6 140.12 33.4 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.12 0.486 . . . . 0.0 109.773 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' LEU . 18.2 pt -117.46 139.66 43.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.32 0.581 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 10.2 t80 -88.92 124.11 33.92 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.596 177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -115.02 103.16 14.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -124.0 68.86 0.48 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 119.465 -1.35 . . . . 0.0 115.634 -171.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' LEU . 60.3 t30 171.99 69.27 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.782 1.233 . . . . 0.0 108.984 171.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.0 155.07 19.74 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.4 t30 -85.63 159.59 19.81 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 51' ' ' SER . 4.2 tpt180 -51.86 -39.75 59.44 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.6 -2.6 56.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD21 HD12 ' B' ' 217' ' ' LEU . 75.2 mt -75.14 117.88 17.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.051 0.929 . . . . 0.0 111.46 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' B' ' 211' ' ' ASP . 5.3 t -113.18 -179.51 3.66 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.149 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mp0 -58.64 -44.84 90.19 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 212' ' ' PHE . . . -65.6 -26.04 71.79 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.799 -175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD2' HD22 ' B' ' 218' ' ' LEU . 16.4 t70 -73.81 -46.34 45.92 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HD23 ' A' ' 42' ' ' LEU . 63.7 mt -58.61 -38.26 70.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.668 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 40' ' ' VAL . 4.0 mp -63.47 -42.98 98.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.6 175.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -63.32 -30.47 71.6 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.652 0.739 . . . . 0.0 110.542 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 55.8 t -80.76 -55.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.038 0.447 . . . . 0.0 111.394 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.29 -13.77 59.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -71.52 -9.26 57.92 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.058 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' C' ' 324' ' ' ARG . 1.1 tm-20 -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' O ' HG21 ' C' ' 313' ' ' ILE . 73.9 m-85 -114.79 11.08 16.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.279 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.4 -150.48 20.75 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.672 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.63 115.06 39.67 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -65.17 121.94 9.54 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.457 2.104 . . . . 0.0 109.982 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 60' ' ' GLU . 18.5 m -102.44 -20.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.616 0.722 . . . . 0.0 110.225 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -137.03 124.38 21.95 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' HG11 ' A' ' 102' ' ' VAL . 12.8 p -143.9 130.61 16.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.479 HG13 ' OH ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -138.8 127.39 29.31 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-O 121.427 0.632 . . . . 0.0 109.396 177.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 27' ' ' ILE . 3.5 tm? -103.39 124.48 48.77 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -71.44 107.11 4.2 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 11.1 ptm180 -142.4 158.0 44.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.071 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.64 143.48 35.9 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 124.472 1.107 . . . . 0.0 112.54 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.9 tt0 -80.36 -20.33 44.37 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -105.07 -33.1 8.41 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -173.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -120.24 -9.41 9.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.076 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.8 74.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.506 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -86.31 147.78 25.91 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.624 0.712 . . . . 0.0 110.172 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 30.5 t -79.43 133.86 36.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.738 0.78 . . . . 0.0 112.766 -170.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -86.47 -16.3 37.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.099 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.36 27.12 40.81 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.756 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -137.78 147.42 44.65 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.66 168.72 22.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.447 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -137.04 144.34 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.2 tt -148.45 156.35 42.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 4.7 pttm -149.28 141.88 24.44 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.24 0.543 . . . . 0.0 109.919 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -93.81 163.14 13.64 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HB2' HG21 ' A' ' 38' ' ' VAL . 26.5 tt0 -96.77 57.95 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.274 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -176.42 129.6 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 56.4 tt0 -73.04 -22.45 60.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -63.19 -41.03 99.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.0 m -74.54 -33.95 62.86 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.913 0.863 . . . . 0.0 108.751 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -58.55 -50.17 74.77 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.191 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.2 mt -65.55 -39.8 86.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 121.101 0.477 . . . . 0.0 110.488 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.88 -39.03 93.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.683 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.29 -47.58 78.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.552 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 93.0 t -53.97 -45.23 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.452 0.701 . . . . 0.0 112.169 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.38 -39.01 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.2 -38.61 9.23 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.801 -166.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.51 -13.97 53.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.753 0.787 . . . . 0.0 108.921 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 12.8 t30 -66.3 125.88 26.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.885 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.85 9.1 56.57 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.73 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.2 t80 -76.75 131.4 38.71 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -85.23 120.0 26.24 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.128 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.69 108.54 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.5 41.76 57.2 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.05 -11.96 45.95 Favored Glycine 0 C--N 1.319 -0.385 0 C-N-CA 121.179 -0.534 . . . . 0.0 114.41 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' HB2' HD21 ' A' ' 17' ' ' ASN . 15.0 ptp180 -117.52 148.42 41.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.159 -0.612 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.61 120.85 42.28 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -72.02 147.32 46.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 41.3 tptt -109.39 127.71 54.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.208 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.3 mp -118.38 139.21 46.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 1.1 t70 -147.1 175.47 10.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ASN . 72.4 m-70 -94.25 138.67 31.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 119.093 0.86 . . . . 0.0 109.118 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -150.93 159.95 44.23 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -142.63 99.3 3.46 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' OH ' HG13 ' A' ' 41' ' ' ILE . 7.6 p90 -103.86 160.79 14.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -89.45 117.21 67.98 Favored Pre-proline 0 C--N 1.28 -2.418 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 137.66 36.9 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.657 2.905 . . . . 0.0 111.175 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -83.18 135.53 34.76 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.354 -175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -82.19 -25.89 33.86 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' ARG . 4.2 m -68.77 -21.44 64.35 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.733 0.778 . . . . 0.0 109.993 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' B' ' 206' ' ' ILE . 72.0 mt -110.66 20.33 17.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.37 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.2 pt20 -54.24 -35.39 62.42 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -60.96 -30.47 70.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.896 0.379 . . . . 0.0 111.259 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -75.23 -42.94 54.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -62.33 -49.94 73.61 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.292 0.37 . . . . 0.0 111.673 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.0 pt-20 -60.79 -48.38 82.06 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.258 0.348 . . . . 0.0 110.995 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.65 73.6 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 122.615 0.366 . . . . 0.0 111.301 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 40' ' ' VAL . 41.6 t -69.82 -53.86 22.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -66.5 -26.13 67.02 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.393 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 38.0 mm-40 -55.86 -31.74 63.04 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.045 0.45 . . . . 0.0 111.658 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -77.96 -30.63 50.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.582 0.706 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 28' ' ' LEU . 50.2 mt -90.46 -39.92 12.33 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.167 -174.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.96 -33.19 56.21 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 125.264 1.426 . . . . 0.0 112.178 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -57.32 -38.41 74.0 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.482 0.489 . . . . 0.0 111.346 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -86.83 -19.94 28.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.778 0.799 . . . . 0.0 109.857 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.4 mt -83.25 -48.11 17.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.791 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.31 -20.26 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.923 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 t -136.81 149.59 47.84 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.755 -0.59 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -85.64 -5.16 59.3 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -112.04 93.25 4.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.649 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -104.86 91.44 3.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.11 104.8 16.97 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.675 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -145.43 168.56 20.25 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--N 1.29 -1.981 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.842 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 4.0 p -168.19 99.02 0.44 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.028 0.442 . . . . 0.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -104.53 19.86 19.58 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.828 0.823 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.3 p -99.05 10.04 42.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.19 128.42 0.04 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.132 2.173 . . . . 0.0 109.299 -173.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.433 ' HE2' ' SD ' ' B' ' 209' ' ' MET . 2.3 p90 -88.31 -82.05 0.24 Allowed 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.343 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.474 HG22 HG13 ' B' ' 208' ' ' ILE . 3.7 mt -134.26 145.18 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.03 34.63 1.89 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.319 1.057 . . . . 0.0 109.364 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.474 HG13 HG22 ' B' ' 206' ' ' ILE . 25.8 mt -106.32 -75.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.433 ' SD ' ' HE2' ' B' ' 205' ' ' TYR . 9.9 mmt 60.37 152.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.929 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.83 155.56 39.17 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 121.252 1.301 . . . . 0.0 110.971 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 4.3 t70 -107.25 -49.25 3.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.488 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.437 ' HA ' ' N ' ' A' ' 25' ' ' GLY . 54.2 m-85 61.08 30.46 19.48 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 11.3 m -103.53 159.2 30.05 Favored Pre-proline 0 C--N 1.307 -1.247 0 O-C-N 121.045 -1.034 . . . . 0.0 108.237 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.23 156.12 25.75 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 121.039 1.16 . . . . 0.0 110.457 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 52.9 p -88.19 158.26 18.57 Favored 'General case' 0 N--CA 1.389 -3.5 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -87.97 -2.92 80.39 Favored Glycine 1 C--N 1.253 -4.063 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.115 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.551 HD12 HD21 ' A' ' 22' ' ' LEU . 27.7 mt -67.26 -39.09 86.06 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.443 HD22 ' OD2' ' A' ' 26' ' ' ASP . 2.8 mp -57.63 -31.09 65.92 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 112.752 -2.022 . . . . 0.0 115.058 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.71 -9.9 56.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.055 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 85.1 mt -100.03 -39.02 8.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.25 0.547 . . . . 0.0 110.652 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 10.1 mm-40 -74.83 -15.45 60.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.122 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.182 177.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 39.6 t -74.15 -52.65 11.86 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -113.84 135.79 53.59 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.42 -54.19 6.45 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -90.83 120.02 68.84 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.97 -16.4 45.19 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.969 2.446 . . . . 0.0 110.977 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -132.93 103.66 12.97 Favored Pre-proline 0 N--CA 1.412 -2.373 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.31 106.15 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.445 2.097 . . . . 0.0 110.973 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -73.92 -31.02 62.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.179 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -60.74 124.41 20.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.588 ' HD3' ' H ' ' C' ' 310' ' ' ARG . 0.0 OUTLIER -57.01 -21.74 33.14 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.174 0.989 . . . . 0.0 113.543 -177.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -77.29 -10.92 59.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.25 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 64.3 26.09 13.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.854 1.262 . . . . 0.0 112.4 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 34' ' ' TYR . 14.4 mt -104.0 145.64 12.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.55 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 5.0 mmt -120.06 150.32 50.87 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.52 135.18 33.29 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.404 2.736 . . . . 0.0 113.075 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -80.23 173.51 54.92 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.792 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 4.1 m -59.98 -29.25 68.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -96.04 12.91 28.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.451 -0.9 . . . . 0.0 113.252 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -90.64 101.85 14.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.24 -50.59 70.89 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.232 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 156.53 -23.82 0.5 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.57 111.28 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 124.415 0.715 . . . . 0.0 109.789 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -59.69 140.12 56.69 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.465 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.16 98.8 7.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 168.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 50.9 m -87.43 100.93 13.11 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -166.2 -179.62 5.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 99.17 18.85 23.09 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.649 ' CE1' ' HB2' ' C' ' 330' ' ' GLU . 0.0 OUTLIER -84.27 173.05 11.3 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.038 -1.081 . . . . 0.0 111.813 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -23.02 63.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.4 0.68 . . . . 0.0 112.655 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.649 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 66.2 mm-40 -78.29 0.16 26.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.111 0.482 . . . . 0.0 112.124 175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -109.03 127.71 54.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.107 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.876 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.36 152.0 1.05 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.902 0.881 . . . . 0.0 109.108 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.22 109.16 3.95 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 86' ' ' HIS . . . 73.1 72.22 1.0 Allowed Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -55.27 -43.88 75.12 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.146 0.578 . . . . 0.0 110.547 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -94.28 -66.73 0.9 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -146.47 175.64 10.41 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -18.4 54.26 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 9.98 5.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.16 97.29 4.08 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.78 -10.13 59.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.558 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -90.71 127.4 36.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.337 0.589 . . . . 0.0 110.67 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.3 pt -104.68 132.61 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.571 0 CA-C-O 121.772 0.796 . . . . 0.0 110.536 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.1 t80 -80.63 127.27 32.28 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.623 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -113.8 109.56 28.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.34 159.03 14.09 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.656 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.5 t30 62.81 85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.361 1.464 . . . . 0.0 111.146 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 15' ' ' ILE . 7.0 mp -121.7 162.43 20.77 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.814 0.34 . . . . 0.0 110.345 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HB2' ' HD3' ' A' ' 80' ' ' ARG . 58.9 t30 -100.12 141.62 32.71 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 51' ' ' SER . 17.9 tpp180 -48.57 -40.92 28.93 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.909 1.283 . . . . 0.0 114.276 -168.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.49 -14.82 63.27 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.561 HD21 HD12 ' B' ' 217' ' ' LEU . 86.6 mt -78.07 119.32 21.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 111.384 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.33 171.95 7.17 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.1 mp0 -50.36 -40.22 48.67 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.324 1.45 . . . . 0.0 111.776 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.08 79.73 Favored Glycine 0 N--CA 1.461 0.316 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.754 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' OD2' HD22 ' A' ' 22' ' ' LEU . 23.2 t70 -71.29 -45.67 62.55 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 24' ' ' GLU . 70.1 mt -59.42 -42.16 86.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.535 -1.666 . . . . 0.0 109.938 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 40' ' ' VAL . 95.3 mt -62.01 -41.82 98.49 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.563 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.4 m -58.59 -36.21 73.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.653 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.2 -55.33 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 120.78 0.324 . . . . 0.0 111.678 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -71.66 -24.33 61.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -63.94 -8.58 11.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' C' ' 315' ' ' PRO . 31.1 tt0 -72.3 -33.45 67.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.117 0.484 . . . . 0.0 111.127 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.14 1.2 56.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.164 0.507 . . . . 0.0 111.601 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.28 -167.66 28.45 Favored Glycine 0 CA--C 1.474 -2.528 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.53 118.78 57.87 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 120.471 -0.491 . . . . 0.0 109.903 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.23 99.34 0.79 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.176 1.917 . . . . 0.0 108.695 172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.7 m -80.86 -16.8 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.188 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 12.0 t70 -148.4 123.59 10.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.6 p -145.56 138.65 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -143.33 128.09 15.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 CA-C-O 121.453 0.644 . . . . 0.0 110.345 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.97 128.61 44.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 t -74.4 94.98 2.63 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HG3' ' CG2' ' B' ' 208' ' ' ILE . 12.5 ptm180 -123.42 136.52 54.66 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.559 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.65 143.33 36.54 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' B' ' 208' ' ' ILE . 30.4 tt0 -69.81 -24.02 63.41 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -90.63 -54.32 4.04 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -106.99 -15.63 14.65 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.159 -172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.2 19.68 79.55 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.282 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.97 140.88 37.92 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 117.087 0.444 . . . . 0.0 110.459 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 19.6 m -67.92 114.8 6.78 Favored 'General case' 0 C--O 1.208 -1.098 0 O-C-N 123.772 0.67 . . . . 0.0 109.73 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -73.06 -7.51 51.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.997 0.427 . . . . 0.0 111.618 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.53 20.39 48.25 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.735 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -140.22 147.89 40.71 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -145.08 167.21 23.24 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -137.02 140.35 42.03 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.7 tt -143.73 152.06 40.81 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.034 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 35.4 ttpt -137.39 126.52 24.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -80.63 179.71 7.63 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -25.26 63.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.986 0.422 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -144.16 166.42 25.06 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 65' ' ' THR . 51.6 mt-30 -80.33 -14.33 58.45 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -63.54 -42.69 98.38 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.727 0.775 . . . . 0.0 110.637 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 p -77.39 -30.28 53.56 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.428 1.108 . . . . 0.0 108.722 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.8 m -61.16 -48.4 81.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.117 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 62' ' ' GLN . 68.3 mt -66.94 -40.04 84.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.575 0.703 . . . . 0.0 109.591 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.46 -42.83 99.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.323 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.66 -49.08 79.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 p -61.66 -43.24 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.04 -35.92 66.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.044 0.45 . . . . 0.0 111.818 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -90.58 -44.14 9.74 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -170.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.6 mt -83.3 -14.76 52.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 83' ' ' LYS . 63.6 t30 -65.5 119.9 11.9 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.364 -0.935 . . . . 0.0 110.098 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.8 4.25 54.59 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.897 -176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -70.61 120.92 16.95 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 80' ' ' ARG . 3.5 tppp? -84.52 118.64 24.44 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.952 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.47 ' HB ' HH12 ' A' ' 80' ' ' ARG . 74.6 mt -136.29 101.46 2.64 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.603 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 56.16 7.37 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 113.959 0.343 . . . . 0.0 113.959 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.64 -4.77 55.37 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 114.13 0.412 . . . . 0.0 114.13 175.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 19' ' ' ASN . 2.8 ptm180 -140.31 166.68 24.03 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.509 -0.406 . . . . 0.0 110.162 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.54 156.39 30.4 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.548 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 1.1 pp -94.63 147.95 22.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 50.8 tptt -107.14 135.12 49.22 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.659 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 4.0 mp -124.62 147.23 29.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -157.86 178.48 10.19 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 50.7 m-70 -105.53 128.12 53.41 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.8 1.182 . . . . 0.0 111.104 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -140.85 162.03 36.41 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -145.72 135.67 23.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -150.63 160.45 43.81 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -90.97 122.8 66.2 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.5 147.14 90.34 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.541 2.16 . . . . 0.0 110.697 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -78.8 137.54 37.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -27.04 36.26 Favored 'General case' 0 C--O 1.207 -1.184 0 CA-C-O 121.191 0.519 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 m -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.715 0.769 . . . . 0.0 109.681 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD11 HD12 ' B' ' 208' ' ' ILE . 20.2 tp -105.5 14.09 29.13 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.965 -177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.0 pt20 -51.51 -35.41 40.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.782 0.833 . . . . 0.0 112.28 -176.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.15 -30.82 71.31 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.35 0.406 . . . . 0.0 112.064 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.2 t80 -73.11 -45.21 58.35 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 41' ' ' ILE . 97.1 m-85 -62.64 -49.24 75.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.731 -178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.3 pt-20 -65.94 -41.38 91.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.526 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.35 73.75 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 110.16 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 40' ' ' VAL . 25.2 t -66.56 -52.91 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.634 175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.76 -25.4 67.91 Favored 'General case' 0 C--O 1.202 -1.418 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.324 -176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.4 mm-40 -51.6 -40.35 59.67 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.287 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -80.02 -40.81 27.03 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.26 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 20.3 mt -68.9 -41.17 78.63 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.722 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 111' ' ' VAL . 34.1 t70 -61.11 -25.18 66.8 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 26.0 mmm180 -69.67 -22.93 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.558 0.218 . . . . 0.0 111.212 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.09 -28.66 17.78 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 106' ' ' LEU . 41.1 mt -77.1 -58.02 4.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.668 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.3 p -65.79 139.27 21.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.994 -173.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -88.07 148.36 24.51 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -85.71 93.13 8.78 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.08 -75.96 0.61 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.486 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -141.23 101.16 3.96 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.227 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.4 65.04 4.45 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.43 -44.26 71.68 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.095 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 C--N 1.299 -1.593 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.407 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.701 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 27.8 t -130.48 137.38 49.74 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -111.27 -46.22 3.32 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.693 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 8.8 m -49.86 -52.17 34.7 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.212 1.005 . . . . 0.0 111.07 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.92 -179.75 8.43 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -114.64 -66.6 1.07 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.425 HG22 HG13 ' B' ' 208' ' ' ILE . 5.3 mm -131.37 139.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 103.564 -2.754 . . . . 0.0 103.564 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -81.49 4.65 20.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 121.122 0.487 . . . . 0.0 111.917 -170.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mt -80.97 -72.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.1 mmt 59.43 140.99 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.412 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.508 ' HB2' ' CE2' ' B' ' 212' ' ' PHE . 60.8 Cg_endo -72.58 147.18 45.29 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 121.531 1.487 . . . . 0.0 111.159 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.2 -59.53 1.74 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.897 0.379 . . . . 0.0 111.197 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' B' ' 210' ' ' PRO . 70.7 m-85 62.69 83.45 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.637 1.175 . . . . 0.0 113.152 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.1 m -148.92 159.06 38.43 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.94 165.41 24.3 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 CA-C-N 120.433 1.19 . . . . 0.0 110.045 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 70.3 p -90.64 173.24 8.15 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -97.18 -5.41 58.19 Favored Glycine 1 C--N 1.242 -4.684 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 22' ' ' LEU . 15.8 mt -74.27 -47.98 31.5 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.442 HD23 ' OD1' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -43.09 -55.44 3.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.445 -2.161 . . . . 0.0 112.539 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.52 -29.67 66.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.18 -28.03 27.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.373 0.606 . . . . 0.0 110.01 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 9.5 mm-40 -85.53 -17.17 37.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.27 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.29 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.495 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.2 t -158.28 -50.58 0.06 Allowed 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -105.21 109.38 21.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.23 -54.87 7.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -90.11 123.2 66.53 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.413 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.95 -26.65 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.142 1.895 . . . . 0.0 110.852 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.49 123.56 35.44 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.95 89.43 0.77 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.112 1.875 . . . . 0.0 113.403 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.42 20.03 16.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.529 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.88 36.96 0.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 67.02 -47.8 0.47 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.984 1.714 . . . . 0.0 114.96 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -105.46 17.98 23.0 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 122.07 -0.394 . . . . 0.0 110.743 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.31 27.88 17.46 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.988 0.915 . . . . 0.0 112.906 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 35.6 mt -86.49 144.62 9.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.728 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 2.8 mmt -107.07 136.34 19.49 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 53.5 Cg_endo -64.19 168.71 12.0 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 124.014 3.143 . . . . 0.0 114.617 -172.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.1 -151.8 18.53 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 37.0 t -107.77 -23.62 12.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.027 0.914 . . . . 0.0 112.317 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.417 ' HD3' HD13 ' A' ' 28' ' ' LEU . 15.9 mtp180 -72.09 -12.41 61.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.151 -0.62 . . . . 0.0 112.502 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -80.06 104.75 10.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -63.25 -43.73 97.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.828 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 144.98 51.95 0.03 OUTLIER Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.85 108.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -65.79 150.41 48.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.155 0.91 . . . . 0.0 110.252 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 1.1 mmp_? -83.2 99.53 10.0 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.101 0.477 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 2.4 p -86.07 88.34 7.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 178.16 -171.78 0.12 Allowed 'General case' 0 C--O 1.243 0.744 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.15 -40.37 2.21 Favored Glycine 0 C--N 1.29 -2.014 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -90.87 97.07 10.96 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 122.04 0.924 . . . . 0.0 110.833 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.69 -67.58 0.85 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.58 -43.15 6.96 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.014 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -170.79 174.82 4.75 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 . . . . . 0 C--N 1.288 -2.081 0 CA-C-N 119.347 0.976 . . . . 0.0 109.756 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.398 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.86 79.03 0.15 Allowed 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.045 0.938 . . . . 0.0 110.673 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 137.68 56.73 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.087 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.82 83.86 0.49 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.674 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -79.28 -2.87 43.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.848 0.833 . . . . 0.0 109.074 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.26 -32.55 74.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.808 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 86' ' ' HIS . 90.1 m-85 -87.91 137.61 32.18 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.649 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -118.73 -50.47 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.856 0.36 . . . . 0.0 111.715 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -81.81 13.16 3.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.411 ' CB ' ' HB3' ' A' ' 86' ' ' HIS . 10.5 m120 -111.03 94.06 4.8 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.389 -170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -16.81 23.99 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -82.93 143.17 30.88 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.004 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 65' ' ' THR . 7.6 pt -120.94 132.9 69.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 17.8 t80 -79.91 120.34 24.0 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 113.872 -1.513 . . . . 0.0 107.808 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 22.1 mt -110.84 111.71 37.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.16 168.18 18.37 Favored Glycine 0 C--N 1.285 -2.289 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.5 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 7.6 t30 67.61 39.68 2.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.575 1.15 . . . . 0.0 109.484 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.37 162.12 14.72 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.623 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 14.4 m120 -85.29 157.1 20.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -76.61 -21.45 55.52 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 2.0 pm0 -76.81 -7.04 54.69 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 91.4 mt -89.36 118.82 29.31 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 213' ' ' SER . 1.6 t -111.0 172.48 6.85 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.7 mp0 -48.46 -43.32 34.57 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.965 1.306 . . . . 0.0 111.237 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.18 -30.76 78.7 Favored Glycine 0 C--O 1.247 0.941 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.712 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 22' ' ' LEU . 14.4 t70 -76.41 -45.53 31.19 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 76.0 mt -57.34 -38.32 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.71 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 86.1 mt -61.39 -45.65 93.45 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.204 174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.2 m -58.26 -33.43 69.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.453 0.701 . . . . 0.0 110.667 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.638 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 58.9 t -80.53 -53.27 12.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.769 178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -78.07 -10.0 59.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 p -71.79 -8.82 56.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.157 0.503 . . . . 0.0 110.935 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -49.7 -48.15 49.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.061 1.744 . . . . 0.0 111.376 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -103.77 -10.36 18.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' C' ' 314' ' ' MET . . . 174.12 -162.08 32.46 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.087 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.13 119.24 63.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.97 107.6 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.229 1.953 . . . . 0.0 109.681 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -83.07 -37.11 13.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.478 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.602 ' HB3' ' CG ' ' A' ' 58' ' ' LYS . 17.2 t70 -150.01 125.74 10.39 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' O ' HG11 ' A' ' 102' ' ' VAL . 9.2 p -142.45 144.36 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -144.36 126.74 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.594 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 ' HE ' ' A' ' 44' ' ' ARG . 3.4 tm? -94.72 125.48 39.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 t -77.47 97.48 5.0 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.361 1.077 . . . . 0.0 108.981 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 42' ' ' LEU . 8.6 ptp180 -120.68 156.19 32.27 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.697 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 23.8 t70 -62.07 146.35 50.62 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 123.448 0.467 . . . . 0.0 111.359 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 39.5 tt0 -77.31 -22.87 51.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.21 -50.69 5.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -171.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 t -104.08 -19.68 14.1 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 79.46 23.68 62.29 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.088 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -79.78 141.31 36.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.178 0.489 . . . . 0.0 110.436 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -71.61 128.63 36.44 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.34 -11.14 56.87 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.332 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.79 52.99 Favored Glycine 0 C--O 1.241 0.534 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.253 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -136.55 148.32 47.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.33 169.83 19.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 72.9 m-85 -135.24 144.18 46.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.9 tt -148.34 157.32 43.41 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.602 ' CG ' ' HB3' ' A' ' 39' ' ' ASP . 21.4 ptmt -145.86 136.56 24.3 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 122.964 0.506 . . . . 0.0 109.637 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -86.75 -179.85 6.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.308 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.37 -56.84 5.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.27 132.45 43.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.929 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.645 ' O ' ' HB ' ' A' ' 65' ' ' THR . 64.8 tt0 -65.45 -18.86 65.65 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.54 1.136 . . . . 0.0 112.995 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -74.74 -20.42 59.83 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.257 -0.902 . . . . 0.0 111.145 178.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -83.51 -29.17 28.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 5.7 m -59.31 -42.26 90.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.69 -1.596 . . . . 0.0 109.42 171.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.2 mt -65.94 -37.08 79.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.874 177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 81.7 mt -60.11 -39.53 86.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.942 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.11 -44.7 83.56 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.212 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 84' ' ' ILE . 12.7 m -68.49 -19.87 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' C' ' 329' ' ' GLU . 32.1 t70 -105.04 -37.78 6.82 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' C' ' 328' ' ' PHE . 12.8 m120 -101.74 -22.66 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -168.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.434 HD13 HG12 ' A' ' 30' ' ' VAL . 46.5 mt -100.78 -14.15 18.15 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.224 0.535 . . . . 0.0 110.374 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -65.76 109.88 2.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.341 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.28 2.21 31.32 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' C' ' 324' ' ' ARG . 58.3 t80 -71.11 134.71 47.22 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -87.24 119.82 27.89 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.395 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.5 mt -136.59 115.34 15.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 70.19 40.58 71.08 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.55 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.18 1.62 80.9 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.906 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 1.0 OUTLIER -135.91 154.1 51.24 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -104.94 129.55 53.31 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -78.42 150.23 33.13 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.285 0.564 . . . . 0.0 112.338 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -115.4 131.08 57.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.733 -179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 69' ' ' VAL . 3.8 mp -122.61 121.2 62.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -141.66 137.87 32.08 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 48.0 m-70 -60.99 135.84 57.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.846 0.748 . . . . 0.0 110.955 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.7 t -149.35 161.3 42.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -141.31 105.66 4.84 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -106.93 160.85 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -94.29 119.92 65.96 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.42 130.4 39.77 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 123.126 2.551 . . . . 0.0 110.853 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.51 138.14 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.224 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -69.48 -43.84 72.37 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -66.51 -12.9 59.8 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.51 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD11 HD12 ' B' ' 208' ' ' ILE . 17.2 tp -111.32 10.65 21.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.912 0.387 . . . . 0.0 110.4 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -50.57 -42.71 55.94 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HG3' ' HB3' ' B' ' 205' ' ' TYR . 31.3 mmmt -66.29 -25.9 67.07 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 102' ' ' VAL . 67.1 t80 -73.68 -41.15 63.04 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' A' ' 41' ' ' ILE . 20.6 m-85 -62.07 -53.5 54.62 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 pt-20 -66.28 -36.85 84.04 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.57 -32.31 73.91 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 40' ' ' VAL . 69.4 t -68.21 -47.81 76.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.207 0.527 . . . . 0.0 110.103 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -68.79 -18.62 64.22 Favored 'General case' 0 C--O 1.197 -1.678 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.473 -177.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 38.5 mm-40 -54.1 -27.45 33.0 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.917 0.389 . . . . 0.0 111.606 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.29 -47.47 7.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.176 0.512 . . . . 0.0 109.885 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 40' ' ' VAL . 29.4 mt -60.94 -42.69 98.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.157 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -56.58 -33.38 66.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.51 0.724 . . . . 0.0 111.288 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.7 mmm180 -79.07 -9.75 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.116 0.484 . . . . 0.0 110.671 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.81 -40.26 9.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 106' ' ' LEU . 62.5 mt -66.01 -45.0 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.15 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 108' ' ' ARG . 9.3 p -65.12 142.61 16.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.238 -174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.6 m -100.17 154.98 18.01 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -61.73 110.03 1.4 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.078 0.466 . . . . 0.0 109.993 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -135.45 143.26 45.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.125 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.79 -42.52 24.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.82 126.34 5.56 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -62.66 -46.65 87.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.15 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' B' ' 204' ' ' GLN . 7.7 t -156.19 139.14 15.36 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -74.29 -41.38 61.29 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.9 m -73.99 -58.55 3.23 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.226 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' B' ' 201' ' ' SER . 52.7 tt0 -136.21 120.21 17.59 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.418 ' HB3' ' HG3' ' A' ' 97' ' ' LYS . 5.1 m-85 -53.89 -64.95 0.66 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.023 0.929 . . . . 0.0 111.605 -174.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.418 HG22 HG13 ' B' ' 208' ' ' ILE . 4.7 mm -125.89 153.06 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.61 -21.79 35.01 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.071 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -67.04 -76.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.267 -172.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mmt 62.75 151.93 0.11 Allowed Pre-proline 0 CA--C 1.574 1.887 0 C-N-CA 124.393 1.077 . . . . 0.0 111.806 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.52 163.5 19.11 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 122.25 1.967 . . . . 0.0 113.573 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.97 -61.71 1.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.492 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 67.84 72.23 0.32 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.05 0.94 . . . . 0.0 113.244 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 23' ' ' THR . 55.3 m -145.03 164.05 29.35 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.96 168.58 9.26 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.386 1.39 . . . . 0.0 111.23 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 60.3 p -90.77 -178.36 5.23 Favored 'General case' 0 N--CA 1.388 -3.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 166.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -112.61 -0.03 26.13 Favored Glycine 1 C--N 1.242 -4.691 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 37.1 mt -75.05 -50.22 17.18 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG ' ' A' ' 26' ' ' ASP . 3.8 tp -54.83 -37.51 66.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.238 -2.255 . . . . 0.0 113.649 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.51 -17.17 63.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.798 0.332 . . . . 0.0 111.783 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.39 -18.53 14.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.934 0.397 . . . . 0.0 110.175 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.0 mm-40 -81.67 -12.74 58.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.835 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.256 1.426 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.426 178.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 13.9 p -165.25 147.34 7.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.92 171.06 8.7 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -95.86 30.77 2.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.829 0.824 . . . . 0.0 110.344 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' C' ' 305' ' ' PRO . 96.9 mttt -79.2 136.62 56.97 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.876 -0.515 . . . . 0.0 110.306 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 304' ' ' LYS . 16.8 Cg_exo -63.19 -47.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.794 2.329 . . . . 0.0 112.245 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -104.56 125.13 34.85 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -56.78 132.21 50.33 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.195 1.93 . . . . 0.0 110.733 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -72.26 -18.43 61.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.194 0.997 . . . . 0.0 108.576 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.85 93.97 1.76 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.488 ' HB3' HD21 ' A' ' 67' ' ' LEU . 20.9 ttm180 -43.15 -46.32 5.85 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -170.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.489 ' CD2' ' HB3' ' A' ' 63' ' ' ARG . 82.1 m-85 -99.97 21.47 12.65 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.877 -0.515 . . . . 0.0 112.192 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 68.32 28.61 6.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 4.7 mp -78.27 146.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.48 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 19.6 mmt -80.22 136.22 53.57 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.2 150.28 84.99 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.67 2.247 . . . . 0.0 111.229 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -69.82 160.74 53.06 Favored Glycine 0 C--O 1.248 0.982 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.017 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.6 t -74.08 -9.39 58.58 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 122.664 -0.315 . . . . 0.0 111.119 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -101.32 10.43 40.64 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.796 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -79.77 100.86 8.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -51.97 -42.14 62.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.672 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 142.8 -21.63 2.33 Favored Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.279 -0.963 . . . . 0.0 110.846 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.16 107.52 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.446 0.698 . . . . 0.0 109.751 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -94.67 137.08 34.22 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.065 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.638 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 12.3 mtm180 -127.35 143.55 51.2 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 123.438 0.695 . . . . 0.0 109.919 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 38.4 m -155.33 110.25 2.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.17 113.16 7.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.601 0.715 . . . . 0.0 111.962 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 90.28 31.66 10.44 Favored Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 119.194 -1.479 . . . . 0.0 113.091 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.492 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 70.9 t80 -64.76 145.1 56.72 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.987 0.393 . . . . 0.0 110.753 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . 0.434 ' HG3' ' OD2' ' A' ' 70' ' ' ASP . 29.2 mt-10 -66.1 2.92 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -40.01 -41.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -93.87 113.98 26.11 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.299 0.571 . . . . 0.0 109.572 173.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 70.9 m95 . . . . . 0 C--N 1.299 -1.629 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.208 -176.122 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.17 99.64 3.42 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -109.6 143.95 38.6 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.97 49.69 3.07 Favored Glycine 0 C--N 1.306 -1.104 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -90.22 -53.53 4.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.176 0.512 . . . . 0.0 110.109 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.64 -21.5 20.77 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.046 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.24 80.13 3.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.244 0.545 . . . . 0.0 109.72 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -119.99 -6.55 10.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.801 0.81 . . . . 0.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.15 -37.63 78.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.768 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -103.9 116.97 33.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.501 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.76 1.99 56.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.42 141.76 37.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.285 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 14.6 pt -105.79 134.05 48.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.64 0.734 . . . . 0.0 111.957 177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 19.3 t80 -88.29 120.13 29.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.356 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 23.7 mt -108.6 107.42 22.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 174.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 14' ' ' TYR . . . -116.67 27.26 8.03 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 119.199 -1.477 . . . . 0.0 115.873 -171.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.428 HD21 ' HB2' ' A' ' 80' ' ' ARG . 65.7 t30 -154.86 72.78 0.86 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.744 0.783 . . . . 0.0 110.583 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.99 164.04 14.73 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -100.56 170.63 8.24 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' NH1' ' HA ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -68.57 -11.35 59.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -87.23 -37.15 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.485 0.66 . . . . 0.0 109.415 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD21 HD12 ' B' ' 217' ' ' LEU . 88.8 mt -64.05 118.32 8.33 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.029 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.1 t -111.98 174.83 5.69 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.841 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 7.6 mt-10 -47.15 -46.56 23.5 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.047 1.739 . . . . 0.0 111.941 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.44 89.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.918 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' B' ' 215' ' ' SER . 10.8 t70 -80.41 -34.66 36.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.653 0.739 . . . . 0.0 109.88 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.53 -36.43 69.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.18 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.477 HD21 HG11 ' A' ' 40' ' ' VAL . 96.0 mt -66.16 -40.46 90.57 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.581 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -57.4 -35.62 70.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.393 0.616 . . . . 0.0 110.55 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.501 ' HA ' ' NH1' ' C' ' 324' ' ' ARG . 56.0 t -80.27 -57.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.57 -19.84 60.78 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t -70.48 -8.41 50.89 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.309 -0.869 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.42 -24.64 65.33 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.122 0.569 . . . . 0.0 110.435 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -116.73 23.62 11.85 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 122.199 -0.313 . . . . 0.0 111.309 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 133.21 -165.95 23.89 Favored Glycine 0 C--N 1.31 -0.878 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.57 177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.95 116.47 51.77 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 32.1 Cg_exo -64.24 128.01 20.56 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.75 2.3 . . . . 0.0 112.554 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 HD13 ' A' ' 110' ' ' ILE . 32.9 m -92.03 -16.76 7.81 Favored 'Isoleucine or valine' 0 C--O 1.251 1.16 0 CA-C-O 122.439 1.114 . . . . 0.0 108.959 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 m-20 -143.48 125.38 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.647 -177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 106' ' ' LEU . 7.1 p -150.44 129.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -141.61 126.12 17.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-O 121.474 0.654 . . . . 0.0 109.403 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 130.77 36.52 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 t -83.05 102.29 11.69 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -124.87 163.19 22.74 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.692 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -63.23 146.13 54.04 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.934 0.771 . . . . 0.0 110.494 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.04 -22.61 42.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.034 0.445 . . . . 0.0 112.016 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.94 -46.47 5.61 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.081 0.467 . . . . 0.0 111.613 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 t -97.72 -24.8 15.32 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.15 86.71 Favored Glycine 0 C--N 1.321 -0.275 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.909 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.31 147.76 36.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.834 -0.215 . . . . 0.0 111.038 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.39 121.14 14.16 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 123.422 0.689 . . . . 0.0 110.39 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 18.8 mm-40 -76.91 -14.47 59.87 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.338 0.59 . . . . 0.0 110.732 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.31 5.37 54.49 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.504 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 65.4 m-85 -124.31 143.15 50.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.87 163.37 38.23 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 47.2 m-85 -131.09 136.36 48.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.8 tt -140.51 156.17 46.41 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.542 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 61.1 tttt -148.75 128.4 13.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.861 0.864 . . . . 0.0 109.386 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 27.4 m-85 -80.9 -179.35 7.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' HG13 ' A' ' 38' ' ' VAL . 34.3 tt0 -47.33 -41.13 18.69 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.235 1.814 . . . . 0.0 110.06 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -140.74 -177.91 5.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 65' ' ' THR . 47.0 tt0 -90.06 -18.17 26.42 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.548 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 -74.52 -27.23 60.45 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.453 -0.78 . . . . 0.0 110.842 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -81.0 -30.59 34.93 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.717 1.246 . . . . 0.0 107.664 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 24.3 m -61.31 -42.31 98.45 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.568 172.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 62' ' ' GLN . 93.3 mt -66.33 -37.78 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.218 177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' C' ' 310' ' ' ARG . 86.4 mt -60.06 -39.02 84.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.32 -56.71 14.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.807 0.692 . . . . 0.0 111.18 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.28 -43.74 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 123.438 0.461 . . . . 0.0 111.944 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' C' ' 330' ' ' GLU . 1.1 m-20 -68.63 -41.43 79.48 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -97.15 -34.92 10.95 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.16 -21.41 36.59 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.75 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.14 114.92 4.03 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 120.975 0.417 . . . . 0.0 110.238 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.38 -7.73 34.75 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.215 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -73.38 131.25 41.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -81.58 119.5 23.86 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.4 105.51 5.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.182 0.515 . . . . 0.0 110.318 175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 71.0 48.81 30.87 Favored Glycine 0 CA--C 1.497 -1.05 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.913 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 -13.87 57.3 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.947 -0.644 . . . . 0.0 114.445 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HB2' HD21 ' A' ' 17' ' ' ASN . 16.6 ptp180 -131.61 147.66 52.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.549 0.675 . . . . 0.0 111.277 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.25 118.6 33.14 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD13 HD11 ' A' ' 84' ' ' ILE 0.271 2.1 pp -69.7 139.81 53.48 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -109.29 122.55 47.58 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.517 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.5 mp -115.63 151.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -154.56 -178.7 7.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.34 139.84 40.2 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 119.011 0.823 . . . . 0.0 108.985 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.7 t -148.01 157.19 43.38 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -132.55 138.08 47.35 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -148.85 161.58 41.54 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -107.45 128.01 26.75 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.56 145.99 95.4 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 122.574 2.182 . . . . 0.0 112.169 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -79.06 136.96 37.32 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.639 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -19.8 44.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.67 0.748 . . . . 0.0 110.181 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 m -75.28 -22.58 57.67 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.808 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' B' ' 206' ' ' ILE . 92.6 mt -110.69 15.77 21.78 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.086 -178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.5 pt20 -51.1 -36.3 39.7 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.98 -31.33 72.43 Favored 'General case' 0 C--O 1.207 -1.183 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 102' ' ' VAL . 55.2 t80 -68.94 -45.37 70.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 41' ' ' ILE . 98.2 m-85 -61.95 -46.37 89.58 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 8.9 pt-20 -66.64 -47.82 71.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.195 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.69 -35.66 68.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.998 0.519 . . . . 0.0 112.07 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' B' ' 210' ' ' PRO . 93.2 t -70.97 -53.2 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.627 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -24.72 64.1 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.568 -174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 16.3 mm-40 -50.37 -53.1 31.57 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 123.423 0.452 . . . . 0.0 110.76 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -67.99 -21.1 65.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.259 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 40' ' ' VAL . 20.8 mt -85.33 -49.71 7.93 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' O ' HG12 ' A' ' 111' ' ' VAL . 17.2 t70 -58.42 -28.66 65.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.79 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.621 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 22.0 mmt180 -57.9 -20.58 38.08 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 123.564 0.54 . . . . 0.0 111.248 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.19 -29.33 6.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.344 0.592 . . . . 0.0 110.662 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.581 HD13 HG12 ' A' ' 38' ' ' VAL . 70.8 mt -69.37 -44.11 80.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.766 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 107' ' ' ASP . 10.5 p -68.54 -38.29 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.56 0.695 . . . . 0.0 110.337 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 37.0 m -156.35 124.59 5.72 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -76.02 73.21 2.89 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.898 0.856 . . . . 0.0 111.666 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -175.87 -55.37 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 112' ' ' SER . 56.9 t30 -170.76 163.44 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 108' ' ' ARG . . . -100.22 136.03 40.74 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -154.01 -49.41 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . 0.58 ' HB2' ' O ' ' B' ' 204' ' ' GLN . 14.5 m -68.5 145.66 53.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.75 -18.63 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.9 t -71.2 -60.21 2.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' B' ' 201' ' ' SER . 3.8 pm0 -149.85 144.45 25.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.67 ' HE1' ' SD ' ' B' ' 209' ' ' MET . 0.7 OUTLIER -37.71 -56.37 1.07 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.551 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -126.81 146.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.77 -7.04 47.66 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.189 0.519 . . . . 0.0 110.412 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.551 HG13 HG22 ' B' ' 206' ' ' ILE . 6.3 mt -76.65 -76.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.67 ' SD ' ' HE1' ' B' ' 205' ' ' TYR . 8.1 mmt 66.26 150.96 0.12 Allowed Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.661 1.185 . . . . 0.0 113.09 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -66.15 151.18 84.29 Favored 'Trans proline' 0 C--O 1.256 1.421 0 C-N-CA 122.323 2.016 . . . . 0.0 112.442 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.11 -57.39 2.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.606 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 56.3 83.55 0.09 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.539 0.736 . . . . 0.0 112.87 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 16.5 m -146.93 158.86 44.63 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.5 167.87 10.12 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 121.46 1.44 . . . . 0.0 110.989 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.476 ' HB3' HD23 ' A' ' 22' ' ' LEU . 45.0 p -92.13 -177.4 4.67 Favored 'General case' 0 N--CA 1.382 -3.862 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -131.01 17.44 5.16 Favored Glycine 1 C--N 1.236 -4.989 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 22' ' ' LEU . 24.5 mt -88.96 -42.18 11.95 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.19 -44.95 53.24 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.2 -1.818 . . . . 0.0 113.906 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.32 -18.2 65.21 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.537 0.735 . . . . 0.0 112.302 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.83 -17.14 19.49 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -93.57 -45.4 7.75 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.414 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.423 -1.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.163 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 CA-C-O 119.274 -0.737 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 34.9 t -53.86 -71.95 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.424 0.69 . . . . 0.0 110.11 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.72 108.42 18.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -103.62 -51.05 3.28 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.141 -169.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -72.78 147.8 89.28 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.346 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.81 -15.07 21.45 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.652 2.235 . . . . 0.0 111.193 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -127.29 128.93 23.99 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 14.2 Cg_exo -72.6 45.69 0.9 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.196 2.597 . . . . 0.0 112.401 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.72 35.16 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.018 1.327 . . . . 0.0 112.295 -176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.14 71.0 8.11 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 67' ' ' LEU . 16.1 tpp180 57.2 -79.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.619 2.368 . . . . 0.0 112.594 -177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' C' ' 313' ' ' ILE . 50.7 m-85 -92.13 -6.64 50.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 80.7 61.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.335 1.454 . . . . 0.0 113.953 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' C' ' 311' ' ' PHE . 3.7 mp -118.68 128.32 75.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.5 mmt -93.95 153.67 40.86 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.31 156.87 5.11 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.229 3.286 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -100.67 -176.28 29.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 115.129 -0.941 . . . . 0.0 114.131 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 10.2 m -70.35 -9.66 56.84 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -114.82 5.4 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.978 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -84.21 105.27 14.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.18 -77.6 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.391 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -174.53 22.89 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.409 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 83.9 t -81.52 112.34 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -81.81 133.19 35.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.501 ' NH1' ' HA ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -106.31 141.61 37.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 15.2 m -73.79 95.36 2.39 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -135.5 -169.63 2.43 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.246 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.74 31.62 7.69 Favored Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.003 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.47 166.43 23.53 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.496 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.1 4.24 7.14 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.911 1.684 . . . . 0.0 111.783 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.479 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -38.74 -22.1 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.461 ' HB2' ' OE1' ' C' ' 330' ' ' GLU . 0.0 OUTLIER -139.07 159.51 41.98 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.002 -1.061 . . . . 0.0 110.018 -177.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 43.9 p-90 . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.742 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.406 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.09 120.97 3.83 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.45 108.39 20.6 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.014 175.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.446 ' HA2' ' CD2' ' A' ' 7' ' ' TYR . . . -166.7 28.48 0.18 Allowed Glycine 0 C--N 1.293 -1.817 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.159 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.44 -15.85 55.8 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.296 0.57 . . . . 0.0 109.468 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -4.17 35.06 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 67.0 m-85 -82.76 91.99 7.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.489 0.662 . . . . 0.0 109.893 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -93.25 -20.62 20.25 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.028 -176.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -93.63 -19.49 21.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.764 0.792 . . . . 0.0 110.777 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.63 98.16 10.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.109 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -17.01 38.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.874 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' CZ ' ' HD3' ' A' ' 58' ' ' LYS . 52.0 m-85 -91.5 157.65 16.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.361 0.6 . . . . 0.0 109.694 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 65' ' ' THR . 3.7 pt -127.07 133.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.776 175.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.4 t80 -84.43 134.33 34.46 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.573 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' LEU . 10.7 mt -122.68 116.22 48.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.8 167.8 19.14 Favored Glycine 0 C--N 1.285 -2.288 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.877 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.2 t30 67.86 41.25 2.18 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.299 1.04 . . . . 0.0 110.417 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -84.37 162.12 20.13 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.491 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.4 t30 -83.17 171.0 14.13 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -73.83 -37.09 64.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -74.65 -26.54 59.94 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 19' ' ' ASN . 46.8 mt -62.97 117.36 6.32 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 122.042 0.925 . . . . 0.0 111.058 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 t -113.18 -172.15 2.01 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.641 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.59 -45.11 95.17 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.37 -24.09 72.06 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.478 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.91 -48.2 47.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 42' ' ' LEU . 70.3 mt -61.21 -39.31 82.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.928 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 HG11 ' A' ' 40' ' ' VAL . 92.7 mt -63.7 -41.55 98.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.425 175.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.2 m -60.67 -34.08 73.79 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 120.891 0.377 . . . . 0.0 111.482 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.706 ' HA ' ' NH2' ' C' ' 324' ' ' ARG 0.277 31.2 m -81.06 -47.09 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 175.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HG23 ' A' ' 30' ' ' VAL . 49.9 m-85 -77.18 -16.41 59.11 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 8.5 t -69.77 -8.64 49.83 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.962 0.41 . . . . 0.0 111.971 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.23 -24.48 64.92 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 26.99 9.52 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.583 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 116.05 -145.99 18.77 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.472 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' N ' ' HE1' ' A' ' 59' ' ' TYR . 13.6 t -122.07 111.24 32.41 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.16 137.86 70.81 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.46 2.773 . . . . 0.0 113.614 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.2 t -89.82 -39.73 12.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.049 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 28.2 m-20 -135.52 128.27 31.05 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 HD11 ' A' ' 106' ' ' LEU . 8.8 p -145.34 126.56 8.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -137.96 125.0 28.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.173 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -95.76 129.01 43.12 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.97 106.57 5.73 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.61 153.92 47.6 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.127 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 21.2 t70 -67.34 146.59 53.92 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.702 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' ' CD1' ' B' ' 208' ' ' ILE . 34.6 tt0 -81.0 -22.82 39.14 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -102.89 -46.64 4.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.565 HG23 ' HG3' ' A' ' 50' ' ' GLU . 3.6 t -101.68 -9.34 20.98 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.157 0.503 . . . . 0.0 110.729 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 59.91 31.94 73.63 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 114.221 177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -100.14 157.97 16.19 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.164 0.482 . . . . 0.0 110.004 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 m -72.77 133.4 44.51 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.285 0.564 . . . . 0.0 112.135 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -82.01 -16.49 50.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.309 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.23 18.28 43.33 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.767 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.96 157.15 47.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.09 168.31 27.83 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.719 0.407 . . . . 0.0 110.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -137.01 145.45 44.11 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.4 tt -144.51 158.11 43.92 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 25.1 ttpt -144.15 131.04 20.34 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HE1' ' N ' ' A' ' 36' ' ' VAL . 57.2 t80 -99.61 165.23 11.72 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.25 -62.17 2.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.784 1.233 . . . . 0.0 108.679 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.82 130.67 34.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.682 ' O ' ' HB ' ' A' ' 65' ' ' THR . 65.3 tt0 -71.86 -12.7 61.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.42 0.628 . . . . 0.0 111.854 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -78.25 -16.95 57.31 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.503 -0.748 . . . . 0.0 111.526 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 59' ' ' TYR . 47.1 t -84.59 -32.49 23.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 32.9 m -55.4 -40.46 71.44 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.388 172.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' HG12 ' A' ' 69' ' ' VAL . 86.1 mt -69.19 -43.36 81.56 Favored 'Isoleucine or valine' 0 C--O 1.257 1.453 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.14 -53.57 56.82 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.197 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.46 83.1 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.596 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 66' ' ' ILE . 13.1 p -63.26 -46.86 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.212 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.709 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 22.1 t70 -98.05 -8.5 27.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 117.147 -1.821 . . . . 0.0 113.998 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.06 -19.82 19.14 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.622 -0.674 . . . . 0.0 112.351 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.23 -13.89 14.81 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.05 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 70' ' ' ASP . 8.9 p30 -70.95 128.41 35.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.118 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.1 64.4 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.756 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 125.94 29.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.8 118.64 23.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.549 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.2 mt -132.6 103.89 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.716 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.18 50.14 23.67 Favored Glycine 0 C--N 1.3 -1.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.883 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.78 -20.47 6.37 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -121.18 160.04 24.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 117.511 0.655 . . . . 0.0 110.298 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.07 143.04 40.69 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE 0.253 0.9 OUTLIER -88.9 147.76 24.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.365 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -108.63 115.01 29.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.757 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -105.01 146.67 11.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -153.94 170.76 20.27 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -88.37 137.95 31.87 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 118.902 0.774 . . . . 0.0 111.107 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.4 t -150.64 163.4 38.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -134.88 99.66 4.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -100.16 125.65 46.32 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.329 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -89.58 130.98 41.4 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 139.95 60.33 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.787 2.325 . . . . 0.0 113.759 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -91.71 138.8 31.27 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.651 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 -24.7 40.04 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 m -66.37 -25.05 66.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.638 0.732 . . . . 0.0 110.489 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.1 mt -111.68 17.36 19.98 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.019 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 17.4 pt20 -58.81 -42.37 88.98 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG3' ' CB ' ' B' ' 205' ' ' TYR . 31.1 mmmt -63.07 -28.18 69.9 Favored 'General case' 0 C--O 1.205 -1.248 0 O-C-N 123.225 0.328 . . . . 0.0 111.507 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 102' ' ' VAL . 40.8 t80 -70.3 -47.02 63.03 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' HG21 ' A' ' 41' ' ' ILE . 12.1 m-30 -64.75 -49.89 68.99 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.977 -176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 10.7 pt-20 -65.56 -37.64 87.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.736 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.95 74.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.69 0.281 . . . . 0.0 110.725 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 98' ' ' TYR . 90.8 t -69.63 -49.52 57.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.031 0.443 . . . . 0.0 110.033 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 16.5 ptpt -69.12 -18.24 63.94 Favored 'General case' 0 C--O 1.206 -1.204 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 10.0 mm-40 -51.0 -51.66 50.77 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -64.19 -45.3 88.94 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.51 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.554 HD11 HG12 ' A' ' 40' ' ' VAL . 24.2 mt -63.08 -50.79 69.18 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.56 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' HG12 ' A' ' 111' ' ' VAL . 23.7 t70 -58.66 -40.83 84.61 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.616 0.366 . . . . 0.0 110.933 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 108' ' ' ARG . 0.0 OUTLIER -70.16 -25.52 63.49 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.07 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.7 -39.29 24.5 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.446 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 106' ' ' LEU . 59.1 mt -81.31 -62.06 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.658 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 107' ' ' ASP . 1.4 p -81.34 135.32 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -69.83 -40.83 75.62 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 113' ' ' LYS . 8.1 tmtm? -147.35 113.93 6.01 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -87.99 131.11 34.75 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -100.89 101.1 11.85 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.033 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.4 105.54 15.62 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.386 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.8 86.71 2.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.035 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 34.3 m -83.51 88.79 7.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.371 0.605 . . . . 0.0 110.424 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -105.81 -2.77 22.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.544 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -57.95 -50.52 73.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -166.22 133.84 2.78 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.44 ' CB ' ' HG3' ' A' ' 97' ' ' LYS . 3.7 m-85 -63.99 -60.76 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.454 HG22 HG13 ' B' ' 208' ' ' ILE . 4.0 mt -138.76 152.92 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.58 -7.38 52.97 Favored 'General case' 0 C--N 1.287 -2.127 0 O-C-N 123.679 0.612 . . . . 0.0 111.758 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.454 HG13 HG22 ' B' ' 206' ' ' ILE . 7.1 mt -80.35 -77.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.324 -171.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.81 152.31 0.12 Allowed Pre-proline 0 CA--C 1.575 1.909 0 C-N-CA 123.884 0.873 . . . . 0.0 110.811 -173.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.89 172.69 15.82 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.376 2.051 . . . . 0.0 113.963 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -138.87 53.71 1.76 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.981 0.512 . . . . 0.0 110.365 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -41.79 111.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.433 0.693 . . . . 0.0 112.588 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.9 p -178.5 154.79 0.89 Allowed Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -93.68 146.53 2.14 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.03 1.82 . . . . 0.0 111.519 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -91.88 128.64 37.8 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -60.99 4.79 0.25 Allowed Glycine 0 C--N 1.278 -2.643 0 C-N-CA 125.396 1.474 . . . . 0.0 116.045 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.459 HD13 ' HA3' ' A' ' 78' ' ' GLY . 0.7 OUTLIER -72.26 -36.25 68.98 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' B' ' 215' ' ' SER . 7.4 tp -50.93 -47.44 61.02 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.162 -171.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.47 -9.55 59.69 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 87.6 mt -102.9 -44.24 5.31 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.38 0.609 . . . . 0.0 110.368 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.716 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 31.1 mm-40 -76.6 -8.23 56.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.248 -174.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 -179.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.927 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 44.5 m -87.64 54.43 3.12 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.706 0.765 . . . . 0.0 110.579 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -121.29 109.59 15.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.9 -36.07 10.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -80.02 120.66 80.47 Favored Pre-proline 0 C--N 1.309 -1.155 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.45 -29.43 6.04 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.647 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -148.93 161.0 33.99 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.44 ' HB3' ' HB2' ' C' ' 312' ' ' ALA . 30.0 Cg_endo -98.68 109.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.806 2.337 . . . . 0.0 113.883 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' C' ' 308' ' ' GLU . 0.7 OUTLIER -83.46 -36.94 23.79 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 171.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -85.94 137.52 32.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -54.61 -36.51 64.55 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.481 0.713 . . . . 0.0 111.561 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -91.44 1.43 57.13 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' C' ' 307' ' ' PRO . . . 63.23 16.79 9.71 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.324 1.05 . . . . 0.0 112.865 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.47 135.37 35.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.378 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.647 ' HA ' ' HE2' ' C' ' 314' ' ' MET . 5.8 mmt -120.9 153.23 57.17 Favored Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.67 145.64 22.48 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.646 2.897 . . . . 0.0 113.543 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -89.07 179.01 45.22 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.826 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.5 t -75.3 -3.22 32.11 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -108.17 6.89 27.19 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.05 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -79.1 119.04 21.65 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.48 -37.28 79.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.343 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 133.14 -7.14 5.08 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.536 -176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.27 113.84 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -95.25 136.61 35.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.706 ' NH2' ' HA ' ' A' ' 30' ' ' VAL . 5.8 mpt_? -99.84 149.84 22.97 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.561 0.696 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 12.9 p -135.21 89.42 2.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -156.4 132.8 10.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.92 30.83 55.24 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.842 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' C' ' 330' ' ' GLU . 24.1 t80 -86.17 159.44 19.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.268 0.556 . . . . 0.0 110.93 -175.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.85 1.0 48.98 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.479 1.511 . . . . 0.0 113.742 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' C' ' 328' ' ' PHE . 3.7 tm-20 -55.7 -43.75 76.73 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.6 0.76 . . . . 0.0 111.316 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' C' ' 332' ' ' TRP . 9.6 tmtt? -74.61 132.26 41.61 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . 0.558 ' N ' ' HD3' ' C' ' 331' ' ' LYS . 58.1 p-90 . . . . . 0 C--N 1.311 -1.066 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.11 99.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.042 1.337 . . . . 0.0 110.429 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.516 ' H ' ' HB2' ' A' ' 70' ' ' ASP . 68.8 mtt -82.23 -179.33 7.37 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.009 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.08 34.97 9.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.77 -42.35 97.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.155 -0.522 . . . . 0.0 110.263 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -94.63 -36.75 11.64 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -98.72 114.55 27.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -122.21 -20.95 6.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.038 -177.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.92 -27.51 23.32 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.406 0.622 . . . . 0.0 109.853 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -74.03 107.34 6.18 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.958 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 -18.68 29.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -85.66 145.48 27.29 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.608 0.718 . . . . 0.0 110.169 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 65' ' ' THR . 7.8 pt -113.71 135.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.35 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.4 t80 -79.68 125.66 29.92 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.712 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mt -115.06 118.97 60.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.86 167.58 21.58 Favored Glycine 0 C--N 1.284 -2.354 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.757 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 65.9 t30 67.17 44.46 1.89 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.511 1.125 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.933 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -72.99 157.76 36.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -67.49 -27.31 66.91 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.01 -4.71 59.23 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 HD12 ' B' ' 217' ' ' LEU . 78.6 mt -77.14 121.93 24.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.747 0.784 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 1.1 t -111.0 175.31 5.47 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.371 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -57.06 -41.08 78.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.19 0.996 . . . . 0.0 111.199 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.82 -26.28 74.58 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.567 ' OD2' HD22 ' A' ' 22' ' ' LEU . 21.9 t70 -73.19 -46.5 50.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.463 HD11 HD23 ' A' ' 42' ' ' LEU . 67.9 mt -58.36 -41.11 80.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.166 176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.65 -41.08 97.01 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.275 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.6 m -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 110.241 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.95 -55.28 9.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.592 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.12 -13.33 61.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -71.23 -9.67 58.49 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -81.52 -15.86 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.876 0.846 . . . . 0.0 108.878 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -108.69 17.97 21.33 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.38 -161.64 22.13 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.693 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.71 110.32 57.42 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.52 143.83 93.6 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.704 2.27 . . . . 0.0 111.324 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 110' ' ' ILE . 96.9 t -104.56 -42.88 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.98 0.895 . . . . 0.0 109.491 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 58' ' ' LYS . 1.2 m-20 -128.36 123.1 33.06 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.409 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.45 114.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 121.48 58.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.929 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 27' ' ' ILE . 3.4 tm? -90.66 120.58 31.84 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 t -70.03 113.41 7.21 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -143.84 155.87 44.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.95 134.52 57.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.457 0.473 . . . . 0.0 110.771 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.3 tt0 -71.63 -11.64 60.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -103.91 -55.9 2.29 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.504 -0.748 . . . . 0.0 111.485 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -97.5 -11.27 23.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.614 0.721 . . . . 0.0 111.214 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.73 79.68 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.731 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -75.43 129.73 37.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.368 0.584 . . . . 0.0 112.032 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.9 m -60.57 131.09 49.64 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.026 0.93 . . . . 0.0 112.423 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -86.91 -21.08 26.52 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.826 0.346 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.9 13.76 48.71 Favored Glycine 0 C--O 1.241 0.565 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.849 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.99 157.58 45.7 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.62 26.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -134.42 145.39 48.86 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 58' ' ' LYS . 8.5 tt -147.85 152.94 38.47 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 19.2 ptmt -147.83 142.55 26.69 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.196 0.522 . . . . 0.0 110.235 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.8 176.46 6.34 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.507 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -56.45 13.12 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -95.28 130.85 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.462 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 65' ' ' THR . 34.2 mt-30 -61.99 -19.72 63.12 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -71.03 -22.38 62.15 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.877 -0.515 . . . . 0.0 111.714 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 m -82.23 -34.68 28.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 8.7 m -59.74 -48.26 82.37 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.803 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 62' ' ' GLN . 94.7 mt -61.0 -39.08 80.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 123.686 0.794 . . . . 0.0 110.894 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.39 -43.61 76.95 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.934 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.41 95.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.5 -41.28 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 3' ' ' MET . 35.7 t70 -81.07 -30.02 34.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.102 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -90.14 -43.42 10.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.06 -10.97 57.42 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.573 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -63.3 113.15 3.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.09 3.8 44.94 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.604 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.61 128.61 36.08 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.35 115.5 24.81 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.434 -172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -136.02 107.89 7.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 71.34 49.07 27.58 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 116.051 -0.522 . . . . 0.0 114.002 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 -18.35 27.77 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.477 -0.392 . . . . 0.0 114.023 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' A' ' 17' ' ' ASN . 4.6 ptp85 -125.68 152.18 45.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 116.916 0.358 . . . . 0.0 111.109 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.37 125.77 50.88 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.17 143.83 48.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 85' ' ' ASP . 37.1 tptt -109.93 132.22 54.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.309 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.9 mp -123.09 147.09 27.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 4.7 t70 -155.24 -178.11 7.02 Favored 'General case' 0 C--O 1.208 -1.109 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -104.48 130.86 52.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 119.451 1.023 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.79 161.56 42.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.97 144.02 38.79 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -136.9 160.62 38.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -93.48 118.45 67.56 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.22 122.58 10.32 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 123.348 2.699 . . . . 0.0 111.624 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 95' ' ' LEU . 56.2 mtpt -73.48 138.99 45.45 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 15.3 tpp180 -73.03 -29.52 63.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.786 0.803 . . . . 0.0 109.108 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.86 -23.97 58.5 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.187 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 17.3 tp -111.42 11.84 21.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -175.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 17.5 pt20 -59.49 -36.54 76.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -65.19 -31.31 72.43 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.354 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 59.7 t80 -70.02 -37.97 75.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 23.7 m-85 -66.57 -50.79 61.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 121.161 0.505 . . . . 0.0 110.507 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.4 pt-20 -64.22 -41.57 96.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.955 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.46 79.47 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.484 0.183 . . . . 0.0 111.429 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 98' ' ' TYR . 44.3 t -63.25 -55.72 21.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 CA-C-O 121.115 0.483 . . . . 0.0 110.911 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 15.5 ptpt -72.31 -20.83 61.43 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.483 -175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.8 mm-40 -61.09 -19.4 61.4 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -88.34 -47.3 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 109.688 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.33 -44.91 58.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.252 -171.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 111' ' ' VAL . 7.9 t70 -56.16 -28.32 57.66 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.127 0.971 . . . . 0.0 111.864 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.99 -23.63 66.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -86.93 -40.04 15.19 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 38' ' ' VAL . 59.8 mt -64.57 -47.14 90.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.951 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 107' ' ' ASP . 9.4 p -79.04 114.59 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 122.646 1.212 . . . . 0.0 108.531 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 p -90.61 174.98 7.22 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.429 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -70.58 113.0 7.25 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 47.7 t30 73.12 88.37 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.705 1.202 . . . . 0.0 108.92 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -154.09 -57.27 0.11 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.916 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -148.2 100.89 3.21 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.997 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.25 116.82 29.27 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 C--N 1.294 -1.811 0 CA-C-O 118.726 -0.654 . . . . 0.0 109.655 -178.679 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.973 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.0 m -77.64 102.57 7.11 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.14 0.495 . . . . 0.0 110.076 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.8 -20.68 11.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.382 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 13.0 m -79.64 -38.88 32.77 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -129.88 147.26 51.62 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -132.72 -69.82 0.56 Allowed 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 122.887 0.475 . . . . 0.0 110.755 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.545 HG22 HG13 ' B' ' 208' ' ' ILE . 3.4 mt -142.48 146.04 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.55 48.27 1.08 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-O 122.049 0.928 . . . . 0.0 110.34 -173.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 3.1 mt -121.73 -75.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.8 mmt 58.17 148.08 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.956 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.43 137.44 43.08 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 121.741 1.627 . . . . 0.0 112.276 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.572 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 66.8 m-20 -78.23 -45.0 24.09 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.484 ' HB3' HH12 ' C' ' 318' ' ' ARG . 10.3 m-85 58.17 33.97 23.69 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.2 m -106.48 167.63 9.29 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.33 164.6 9.66 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 CA-C-N 120.387 1.174 . . . . 0.0 109.934 170.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 59.1 p -90.24 178.6 6.11 Favored 'General case' 0 N--CA 1.388 -3.571 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -103.05 -10.02 37.98 Favored Glycine 1 C--N 1.247 -4.363 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.595 HD12 HD21 ' A' ' 22' ' ' LEU . 17.0 mt -69.72 -45.26 68.61 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.85 -60.11 1.96 Allowed 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.704 -2.044 . . . . 0.0 112.922 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.02 -9.82 58.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.04 -32.66 11.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.117 0.484 . . . . 0.0 109.885 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 30.2 mm-40 -84.86 -39.37 18.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.648 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.413 -2.311 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.718 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 32.3 t -150.74 154.33 37.18 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -73.84 124.73 26.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -130.7 31.03 4.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.781 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.68 126.15 74.95 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.003 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.03 -39.75 22.97 Favored 'Trans proline' 0 CA--C 1.513 -0.555 0 C-N-CA 122.432 2.088 . . . . 0.0 109.165 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.23 46.26 Favored Pre-proline 0 N--CA 1.411 -2.394 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.67 -22.96 63.52 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.566 2.177 . . . . 0.0 112.172 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' C' ' 331' ' ' LYS 0.47 12.1 pt-20 59.58 -56.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.644 2.377 . . . . 0.0 115.223 -175.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -36.46 103.39 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.704 2.002 . . . . 0.0 110.473 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -41.81 -48.21 4.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.176 1.79 . . . . 0.0 115.093 -173.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -92.61 7.68 42.31 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.993 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 49.2 60.35 3.82 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.423 1.089 . . . . 0.0 112.125 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 35.9 mm -94.43 129.47 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 4.0 mmt -94.23 148.05 34.42 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.736 0.648 . . . . 0.0 111.138 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.27 141.27 50.19 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 124.366 3.377 . . . . 0.0 114.377 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -95.29 -147.7 23.05 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.555 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -56.55 10.84 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -171.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.484 HH12 ' HB3' ' B' ' 212' ' ' PHE . 22.8 mtp180 -91.82 29.18 1.61 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -89.42 99.79 12.72 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -46.36 -51.99 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.728 1.211 . . . . 0.0 112.507 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 147.67 -19.74 1.47 Allowed Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 85.0 t -51.12 113.03 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 O-C-N 124.364 0.685 . . . . 0.0 109.489 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -61.24 136.49 58.07 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.562 1.145 . . . . 0.0 112.241 -169.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -108.85 130.09 55.41 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 53.0 m -156.84 130.86 8.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -111.65 -43.29 3.67 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.49 25.89 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -75.64 151.23 37.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 114.183 -1.008 . . . . 0.0 111.916 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.01 1.37 1.47 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.716 2.407 . . . . 0.0 113.891 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.68 -26.51 60.76 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.59 0.756 . . . . 0.0 112.644 -174.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' C' ' 308' ' ' GLU . 26.6 tptp -90.79 125.06 35.6 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.256 -170.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 74.0 m95 . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 171.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.62 29.57 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.615 0.245 . . . . 0.0 110.65 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ttt -72.85 139.81 47.19 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 86' ' ' HIS . . . 160.87 -51.5 0.35 Allowed Glycine 0 CA--C 1.487 -1.698 0 C-N-CA 118.566 -1.778 . . . . 0.0 114.678 175.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -73.09 7.19 2.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.208 1.004 . . . . 0.0 111.288 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -93.66 -31.22 14.55 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.79 -0.569 . . . . 0.0 111.492 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -139.27 148.6 43.23 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -102.58 -17.73 15.58 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -80.49 3.86 20.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.604 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 13.4 m120 -86.55 99.52 11.76 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.52 -21.11 63.68 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -84.22 135.36 34.39 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 57' ' ' LEU . 24.8 pt -105.92 139.94 25.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 121.408 0.623 . . . . 0.0 111.165 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 13.7 t80 -86.81 123.34 31.84 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -116.21 117.93 57.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.91 171.9 21.18 Favored Glycine 0 C--N 1.29 -1.998 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.295 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.4 t30 69.64 32.52 3.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.081 1.352 . . . . 0.0 109.855 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 15' ' ' ILE . 6.6 mp -82.71 153.19 25.45 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.582 0.706 . . . . 0.0 111.094 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 9.3 m120 -65.37 144.98 56.74 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.415 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -70.24 -22.72 62.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 1.3 pm0 -85.17 -2.23 57.79 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 83.5 mt -89.4 131.53 35.42 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -111.34 -172.13 1.97 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -62.46 -41.05 98.48 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.935 -0.478 . . . . 0.0 110.717 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.13 -35.75 65.78 Favored Glycine 0 CA--C 1.511 -0.182 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.081 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.73 -45.73 91.36 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 122.118 0.961 . . . . 0.0 109.764 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 HD23 ' A' ' 42' ' ' LEU . 65.9 mt -62.6 -43.39 98.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.625 -1.625 . . . . 0.0 110.534 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.42 HD21 HG11 ' A' ' 40' ' ' VAL . 3.5 mm? -62.36 -40.96 98.12 Favored 'General case' 0 C--O 1.209 -1.058 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.007 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' C' ' 318' ' ' ARG . 31.6 m -58.72 -38.99 79.54 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.08 -54.3 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.064 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -70.82 -17.34 62.76 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t -72.02 -8.33 53.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.235 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -62.46 -22.27 66.09 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -109.1 28.95 7.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.6 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.23 -145.28 17.95 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.284 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 110' ' ' ILE . 9.2 t -127.83 109.37 20.35 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -60.13 143.48 99.54 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.264 2.643 . . . . 0.0 112.182 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 110' ' ' ILE . 16.9 m -91.74 -26.09 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.416 0.627 . . . . 0.0 110.713 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 1.5 m-20 -136.54 128.42 29.25 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.496 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' O ' HG11 ' A' ' 102' ' ' VAL . 4.7 p -155.76 121.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.83 131.85 50.41 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.516 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' HG2' ' A' ' 44' ' ' ARG . 2.2 tm? -92.45 136.07 33.52 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 t -75.17 91.44 2.61 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' HD12 ' A' ' 42' ' ' LEU . 56.0 mtp180 -104.22 151.18 23.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.71 146.38 36.02 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.08 -25.51 59.85 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -90.01 -52.93 4.71 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.924 0.869 . . . . 0.0 110.514 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 50' ' ' GLU . 2.3 t -90.02 -23.15 21.56 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.492 -174.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.33 6.82 76.57 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.445 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 48' ' ' THR . 13.8 pt-20 -89.48 158.94 17.5 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 117.806 0.803 . . . . 0.0 111.039 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.0 m -67.75 133.97 50.2 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 124.395 1.078 . . . . 0.0 112.01 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.27 9.76 34.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.812 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.87 5.37 87.97 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -127.68 156.68 41.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.541 0.671 . . . . 0.0 109.956 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -149.09 162.47 39.89 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.208 0.603 . . . . 0.0 109.58 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -137.29 141.89 41.92 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.5 tt -148.5 155.63 41.41 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 39' ' ' ASP . 5.7 pttm -148.95 131.55 15.86 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.399 0.618 . . . . 0.0 109.798 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HE2' ' N ' ' A' ' 36' ' ' VAL . 45.6 t80 -95.88 151.36 19.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.47 74.62 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.063 0.935 . . . . 0.0 108.649 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 162.09 113.16 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 128.387 2.675 . . . . 0.0 105.383 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 66' ' ' ILE . 1.2 tm0? -68.98 -19.77 64.16 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 5.4 mpt_? -80.04 -33.34 39.14 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.758 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -75.54 -28.77 59.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 17.9 m -63.94 -48.44 76.51 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 112.675 -2.057 . . . . 0.0 109.732 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLN . 85.4 mt -64.63 -34.68 71.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.045 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.27 98.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 84' ' ' ILE . 44.5 t -61.52 -44.19 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.803 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -72.63 -39.83 66.91 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -100.58 -39.04 8.1 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.979 -1.088 . . . . 0.0 113.216 -169.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.65 -17.42 48.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.41 111.73 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.56 -6.6 29.9 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.023 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -70.04 134.06 47.87 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -95.2 131.73 40.92 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.223 -174.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.7 mt -139.91 117.0 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' B' ' 217' ' ' LEU . . . 66.13 35.65 90.79 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 121.209 -0.52 . . . . 0.0 114.078 172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.19 -0.18 89.42 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 121.045 -0.597 . . . . 0.0 113.594 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.566 HH11 ' ND2' ' A' ' 19' ' ' ASN . 63.1 mtt85 -124.64 146.28 49.18 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 123.23 47.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.88 147.79 36.84 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.69 0.757 . . . . 0.0 112.482 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 20.5 tptm -111.76 127.58 55.84 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.477 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 69' ' ' VAL . 4.3 mp -114.54 133.95 59.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.9 -173.19 3.83 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 10' ' ' ASN . 69.2 m-70 -106.23 148.28 28.13 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 118.653 0.661 . . . . 0.0 109.895 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 12.6 t -152.1 160.63 43.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.611 -0.68 . . . . 0.0 109.188 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -120.94 99.47 6.52 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -124.76 135.89 53.38 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.68 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -97.02 130.46 29.86 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.12 127.85 22.35 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.306 2.004 . . . . 0.0 110.272 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.16 137.27 57.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.89 -18.3 47.71 Favored 'General case' 0 C--O 1.201 -1.449 0 CA-C-O 121.514 0.674 . . . . 0.0 110.444 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 p -77.3 -29.35 53.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.675 0.75 . . . . 0.0 110.324 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 tp -107.13 17.99 22.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 3.8 pt20 -52.63 -34.34 50.85 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' HG12 ' B' ' 206' ' ' ILE . 30.6 mmmt -61.92 -33.23 73.87 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 123.389 0.431 . . . . 0.0 111.961 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 102' ' ' VAL . 32.2 t80 -68.14 -43.62 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -66.01 -48.93 69.53 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 8.4 pt-20 -64.61 -44.24 91.19 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.19 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.15 -30.23 69.18 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.143 0.277 . . . . 0.0 111.28 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.531 HG11 ' O ' ' A' ' 40' ' ' VAL . 55.1 t -68.31 -60.92 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 103' ' ' LYS . 16.8 ptpt -70.45 -19.09 62.99 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 52.6 mm-40 -58.64 -33.36 69.99 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.258 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.04 -31.64 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.569 0.699 . . . . 0.0 109.924 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 40' ' ' VAL . 37.8 mt -75.21 -47.89 26.08 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.95 -24.41 38.02 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.519 1.127 . . . . 0.0 112.584 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -58.87 -32.14 69.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.358 0.663 . . . . 0.0 111.596 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -102.23 -7.18 22.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.007 0.908 . . . . 0.0 110.158 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 36' ' ' VAL . 66.4 mt -90.51 -35.59 7.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.266 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.74 170.09 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.161 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m -61.4 104.75 0.44 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.183 0.516 . . . . 0.0 110.656 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -101.67 -16.11 16.8 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -49.51 111.79 0.55 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.689 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -160.2 120.66 2.96 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.054 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.28 80.03 9.34 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.702 0.763 . . . . 0.0 111.811 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.33 157.5 46.65 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.906 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.889 -178.26 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.745 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.9 p -132.18 113.45 13.3 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.222 0.534 . . . . 0.0 111.854 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.74 -30.0 18.33 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -109.99 -70.42 0.81 Allowed 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 179.38 166.39 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -124.4 -94.5 0.48 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.792 0.269 . . . . 0.0 111.425 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.642 HG22 HG13 ' B' ' 208' ' ' ILE . 4.4 mm -104.05 145.36 12.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -114.03 29.47 7.99 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.038 0.923 . . . . 0.0 110.646 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.642 HG13 HG22 ' B' ' 206' ' ' ILE . 2.6 mt -98.22 -72.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 6.7 mmt 65.69 141.6 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.626 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.0 139.41 24.26 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.134 1.889 . . . . 0.0 112.24 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.15 -42.56 13.77 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 52.93 70.06 0.62 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.714 0.769 . . . . 0.0 112.279 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 20.2 m -158.18 155.68 26.43 Favored Pre-proline 0 C--N 1.288 -2.104 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -85.56 166.35 10.45 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 121.069 1.179 . . . . 0.0 111.446 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.7 p -90.8 -179.17 5.44 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . -84.84 -17.34 63.63 Favored Glycine 1 C--N 1.244 -4.547 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.863 177.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 21' ' ' GLU . 45.3 mt -64.58 -43.62 93.26 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.46 -46.01 73.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 113.274 -1.785 . . . . 0.0 112.403 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.08 -22.37 59.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.889 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 78.0 mt -83.37 -35.25 25.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.645 0.736 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.9 mm-40 -81.3 -9.2 59.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.005 -178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.339 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 19.4 m -80.64 138.24 36.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -83.19 141.63 31.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.86 13.55 13.16 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.0 125.4 78.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.906 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.53 -17.29 12.87 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.568 2.178 . . . . 0.0 111.289 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.51 16.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.405 ' HB3' ' HG2' ' C' ' 314' ' ' MET . 36.9 Cg_endo -77.74 92.48 1.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.222 1.948 . . . . 0.0 111.699 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.45 111.94 19.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.512 0.672 . . . . 0.0 110.201 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -168.12 162.01 12.81 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -49.46 -52.15 31.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 124.063 0.945 . . . . 0.0 111.309 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -111.76 17.17 20.09 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.25 0.547 . . . . 0.0 110.453 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 62.22 60.85 1.39 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.7 144.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' C' ' 307' ' ' PRO . 3.3 mmt -106.12 154.15 39.8 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.12 155.2 46.62 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.14 2.56 . . . . 0.0 114.157 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -105.28 -174.45 24.24 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.646 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 42.2 t -64.53 -21.79 66.79 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' C' ' 318' ' ' ARG . 7.8 mmp_? -87.61 -7.87 56.95 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -88.84 129.04 35.66 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.908 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.45 -86.34 0.19 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.92 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . -159.26 29.09 0.4 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.738 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.36 109.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -82.98 148.18 27.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.261 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 99.87 11.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -139.58 110.56 6.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.567 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -129.12 18.37 6.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.808 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 120.53 -41.55 1.91 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.603 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' C' ' 331' ' ' LYS . 14.1 p90 -103.01 164.41 11.63 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 172.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -91.73 -70.37 0.69 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.629 0.728 . . . . 0.0 111.54 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.8 -39.89 6.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' C' ' 328' ' ' PHE . 12.4 tmtt? 82.12 129.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.165 1.386 . . . . 0.0 109.589 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.025 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' HA2' ' OD1' ' A' ' 73' ' ' ASN . . . . . . . . 0 CA--C 1.488 -1.62 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.8 93.52 3.63 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 117.078 0.439 . . . . 0.0 109.976 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 ptp -110.36 153.15 25.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.01 165.78 37.08 Favored Glycine 0 N--CA 1.415 -2.714 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.055 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -98.81 -14.46 19.67 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.8 -31.98 63.53 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -76.85 86.18 3.43 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.643 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -130.51 -42.57 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.548 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.07 -27.09 48.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.994 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.58 82.46 7.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.759 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -90.03 0.85 56.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.249 0.547 . . . . 0.0 112.007 -177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -105.26 137.68 42.67 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 57' ' ' LEU . 16.9 pt -108.66 138.92 33.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 CA-C-O 121.394 0.616 . . . . 0.0 111.494 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 14.8 t80 -84.93 121.56 27.93 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.076 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 18' ' ' LEU . 16.5 mt -116.7 113.98 44.59 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.98 170.93 19.32 Favored Glycine 0 C--N 1.286 -2.235 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.464 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 71.42 33.03 1.99 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.712 1.205 . . . . 0.0 110.116 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 15' ' ' ILE . 6.8 mp -83.93 167.26 17.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.591 0.71 . . . . 0.0 110.809 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.491 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -78.62 170.5 16.56 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.796 174.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -81.13 -32.65 33.65 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.114 0.483 . . . . 0.0 109.9 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -86.96 -4.23 59.16 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD12 ' H ' ' A' ' 19' ' ' ASN . 96.6 mt -80.86 124.44 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.874 0.369 . . . . 0.0 110.042 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 t -110.64 175.66 5.34 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.68 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 2.2 mp0 -49.38 -38.83 30.06 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.295 1.438 . . . . 0.0 110.465 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.9 92.65 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.586 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 30' ' ' VAL . 19.6 m-20 -66.64 -45.23 79.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-O 121.727 0.775 . . . . 0.0 109.516 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 24' ' ' GLU . 60.5 mt -60.57 -38.84 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.778 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.436 HD13 ' HD2' ' C' ' 318' ' ' ARG . 95.4 mt -67.86 -43.42 79.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.9 m -58.36 -37.19 74.7 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.5 0.667 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 15.7 m -81.28 -41.68 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 30' ' ' VAL . 3.1 m-30 -85.41 -14.78 45.19 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -79.04 -7.69 58.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.853 -0.529 . . . . 0.0 111.562 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HG2' ' NE1' ' C' ' 319' ' ' TRP . 1.9 tm-20 -62.07 -52.88 62.12 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 0.0 110.87 -178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 38.2 p90 -113.57 26.72 10.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.738 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.05 -175.92 42.13 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.704 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -115.85 113.16 42.29 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.666 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -73.61 126.65 11.01 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.589 2.193 . . . . 0.0 109.021 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.7 -20.62 5.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.292 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 10.9 t0 -149.61 138.9 21.39 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.5 p -146.45 122.13 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-O 121.59 0.71 . . . . 0.0 110.391 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -127.34 114.14 35.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-O 121.69 0.757 . . . . 0.0 110.891 -178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB2' ' HG3' ' A' ' 24' ' ' GLU . 3.1 tm? -85.35 120.31 26.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.0 t -69.73 106.59 3.15 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -127.89 144.73 51.09 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.66 135.12 56.5 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 123.451 0.469 . . . . 0.0 111.766 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.62 -17.07 61.71 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 112.285 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -95.47 -60.41 1.67 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.198 0.523 . . . . 0.0 109.67 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 t -96.18 -16.16 21.63 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.719 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.63 36.45 67.64 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.532 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 139.2 34.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.005 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -63.12 126.65 28.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.499 0.719 . . . . 0.0 109.079 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.6 -14.75 47.85 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.86 17.56 59.51 Favored Glycine 0 C--N 1.319 -0.366 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.036 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -137.2 151.52 48.85 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.3 162.78 39.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 39.5 m-85 -131.82 143.43 50.19 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 13' ' ' ILE . 9.7 tt -141.86 153.24 44.31 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.393 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 81.0 tttt -125.54 125.15 42.76 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 3.5 m-85 -87.22 167.35 14.19 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.723 0.773 . . . . 0.0 112.756 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.12 -46.22 33.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.088 -1.869 . . . . 0.0 112.161 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -143.59 163.06 34.27 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 65' ' ' THR . 7.1 tp-100 -61.16 -29.0 69.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.998 0.519 . . . . 0.0 111.337 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -65.31 -35.92 82.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.622 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.3 m -81.12 -24.21 37.81 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.78 1.276 . . . . 0.0 107.803 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 18.4 m -65.43 -55.88 15.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.432 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.21 -36.37 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.692 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HG ' ' CD1' ' C' ' 311' ' ' PHE . 0.7 OUTLIER -56.62 -48.7 76.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.529 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -59.76 -46.9 87.72 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 84' ' ' ILE . 48.8 t -58.53 -36.59 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.485 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -95.7 -25.24 16.18 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -99.79 -28.39 13.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.6 mt -109.48 -1.96 17.97 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 118.454 -1.299 . . . . 0.0 113.235 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -63.58 121.32 13.6 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.13 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.44 58.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.961 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 71.3 t80 -69.08 129.64 40.46 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -88.19 123.5 32.89 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.092 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HA ' ' HG3' ' B' ' 221' ' ' GLU . 52.2 mt -140.66 114.73 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.86 43.01 76.43 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.788 -0.72 . . . . 0.0 114.135 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.97 1.64 87.72 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.215 -0.516 . . . . 0.0 114.011 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.1 155.67 46.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 122.246 -0.561 . . . . 0.0 110.635 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -107.08 136.36 47.07 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.42 144.11 28.19 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.772 0.796 . . . . 0.0 112.529 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 19.9 tptm -107.92 124.36 50.01 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.549 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 69' ' ' VAL . 4.1 mp -111.47 135.64 50.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.97 -176.58 5.2 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.42 138.54 39.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.276 0.489 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 t -147.83 160.79 42.38 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -123.72 98.83 6.0 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -104.48 124.18 48.8 Favored 'General case' 0 C--N 1.265 -3.075 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.566 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.99 121.24 78.91 Favored Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.691 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.93 136.9 55.08 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.864 1.71 . . . . 0.0 109.879 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -78.49 137.88 38.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -20.84 59.16 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.944 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -71.88 -18.41 62.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.911 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.0 mt -111.34 20.38 17.35 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.649 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 16.7 pt20 -58.87 -37.93 77.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.476 -177.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -63.99 -31.05 72.1 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 120.987 0.422 . . . . 0.0 111.105 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.5 t80 -71.46 -44.94 63.84 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' HG21 ' A' ' 41' ' ' ILE . 22.0 m-85 -66.88 -43.49 83.33 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.012 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.1 pt-20 -65.69 -44.32 86.54 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.48 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.42 68.08 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.364 0.415 . . . . 0.0 111.72 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 58.2 t -66.6 -61.51 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -66.84 -25.36 66.39 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.555 -175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -59.1 -19.07 41.18 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -89.41 -52.41 5.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.328 0.585 . . . . 0.0 110.193 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 40' ' ' VAL . 35.2 mt -68.85 -46.21 69.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.448 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -58.88 -25.97 63.83 Favored 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 124.07 0.948 . . . . 0.0 112.629 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -76.49 -11.9 59.95 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.117 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.07 -28.11 20.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.477 1.132 . . . . 0.0 108.399 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.96 -52.25 14.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.934 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 114.68 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-O 121.989 0.899 . . . . 0.0 109.375 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m -92.18 -18.78 23.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.645 0.736 . . . . 0.0 109.294 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -99.27 102.66 14.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -178.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -71.26 103.71 2.91 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.862 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -84.22 100.88 11.48 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.45 1.119 . . . . 0.0 108.717 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.74 47.12 2.56 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.46 80.76 5.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.131 -176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.154 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.266 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.4 p -95.37 148.52 22.36 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 120.72 0.295 . . . . 0.0 110.693 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -97.45 -31.78 12.18 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.786 0.434 . . . . 0.0 111.987 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.5 m -63.45 -64.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.581 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' B' ' 207' ' ' ASP . 51.2 tt0 -127.01 167.41 15.95 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -124.29 -66.31 0.99 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.48 155.81 8.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . 0.443 ' HA ' ' NE2' ' B' ' 204' ' ' GLN . 31.2 t70 -91.54 -13.02 32.8 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.242 -173.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.76 -80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mmt 68.88 151.74 0.13 Allowed Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 123.705 0.628 . . . . 0.0 109.604 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.41 153.97 45.25 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 121.597 1.531 . . . . 0.0 111.3 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -104.69 -47.84 3.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 56.3 84.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.091 0.869 . . . . 0.0 112.636 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.5 m -146.23 169.75 9.07 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -94.33 162.37 2.0 Allowed 'Trans proline' 0 CA--C 1.498 -1.299 0 C-N-CA 121.135 1.223 . . . . 0.0 110.783 168.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 81.1 p -91.38 -178.85 5.24 Favored 'General case' 1 N--CA 1.379 -4.013 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -111.92 -1.07 27.13 Favored Glycine 1 C--N 1.227 -5.484 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 22.4 mt -77.61 -43.22 32.28 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.39 -36.78 76.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 112.027 -2.352 . . . . 0.0 112.412 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.27 -20.33 60.19 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 65.3 mt -83.88 -50.15 8.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 8.3 mm-40 -64.17 -40.98 97.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.476 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.256 1.414 0 C-N-CA 125.404 1.481 . . . . 0.0 109.963 -179.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.945 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 3.1 p -105.17 127.21 52.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -53.91 124.35 15.17 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.582 0.706 . . . . 0.0 111.844 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.24 -54.4 4.63 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.532 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.87 139.52 26.07 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.08 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.56 -5.1 10.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.551 2.167 . . . . 0.0 114.332 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -134.6 142.8 43.98 Favored Pre-proline 0 C--N 1.309 -1.163 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.16 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 5.8 Cg_exo -77.3 84.56 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.372 2.048 . . . . 0.0 110.175 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.53 -4.9 58.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.093 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . 0.472 HD21 ' HB2' ' C' ' 311' ' ' PHE . 0.4 OUTLIER -89.11 148.65 23.57 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.05 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' C' ' 310' ' ' ARG . 27.1 ttp180 -49.38 -35.67 19.49 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 128.127 2.571 . . . . 0.0 113.759 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.601 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 21.4 m-85 -89.99 -24.41 21.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.5 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.4 62.2 1.61 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.481 0.712 . . . . 0.0 111.883 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 30.9 mm -104.69 152.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 17.7 mmt -97.09 142.38 24.44 Favored Pre-proline 0 C--N 1.312 -1.045 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.08 167.14 7.81 Favored 'Trans proline' 0 C--O 1.25 1.104 0 C-N-CA 123.311 2.674 . . . . 0.0 112.871 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -109.49 -163.0 19.74 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.886 -0.673 . . . . 0.0 114.122 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 47.6 t -74.01 -60.88 2.06 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.089 0.955 . . . . 0.0 113.012 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.436 ' HD2' HD13 ' A' ' 28' ' ' LEU . 76.8 mtt180 -83.23 25.98 0.67 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -169.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 33' ' ' GLU . 33.9 t90 -96.97 124.65 41.0 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -71.45 -74.72 0.14 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 120.693 0.282 . . . . 0.0 111.588 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 177.24 44.08 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.441 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.22 108.08 19.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.83 141.06 47.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 80.8 mtt-85 -128.26 129.3 46.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.639 0.733 . . . . 0.0 112.183 -171.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 65.1 m -148.05 148.83 31.1 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -100.51 -4.18 29.25 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.051 0.453 . . . . 0.0 110.669 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 102.52 13.34 30.62 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.37 165.14 24.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.753 0.311 . . . . 0.0 110.869 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.18 3.87 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.566 2.346 . . . . 0.0 115.169 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -41.03 -32.11 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.975 1.31 . . . . 0.0 114.433 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -76.3 126.76 31.58 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 120.89 -1.131 . . . . 0.0 109.63 172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.639 1.576 . . . . 0.0 114.879 -173.447 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.926 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.81 64.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.537 0.685 . . . . 0.0 110.152 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.7 mtt -104.07 109.0 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.354 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.14 166.09 16.09 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -80.8 10.04 5.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.009 0.909 . . . . 0.0 110.762 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.25 -12.15 50.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.656 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -51.09 -31.09 17.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.573 1.549 . . . . 0.0 114.149 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -83.25 -28.94 28.84 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.843 0.354 . . . . 0.0 111.576 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -106.05 -4.41 20.48 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.448 ' CG ' ' HB3' ' A' ' 86' ' ' HIS . 28.9 p30 -93.96 86.27 4.99 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.786 0.803 . . . . 0.0 111.849 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' A' ' 65' ' ' THR . . . -82.9 -7.72 59.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.814 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 87' ' ' THR . 91.4 m-85 -89.09 151.07 22.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -126.51 132.45 70.26 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-O 121.312 0.577 . . . . 0.0 110.654 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 28.3 t80 -79.98 121.62 25.71 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.292 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 18' ' ' LEU . 13.5 mt -110.91 117.78 55.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.56 165.81 19.6 Favored Glycine 0 C--N 1.287 -2.173 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.932 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.44 40.89 2.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.906 1.282 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.497 HD11 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -82.79 168.82 16.79 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.406 0.622 . . . . 0.0 109.497 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' HD12 ' A' ' 22' ' ' LEU . 42.9 t30 -100.48 146.76 26.66 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' SER . 14.3 tpt180 -50.62 -39.52 50.54 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.935 1.294 . . . . 0.0 113.052 -171.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.59 -4.91 55.87 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' B' ' 215' ' ' SER . 86.5 mt -77.56 119.7 21.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.613 0.721 . . . . 0.0 110.538 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' B' ' 211' ' ' ASP . 0.5 OUTLIER -109.39 170.21 8.2 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.607 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 43.7 mp0 -50.55 -41.64 54.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.122 1.369 . . . . 0.0 111.213 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.3 82.21 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.443 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' OD2' HD22 ' B' ' 218' ' ' LEU . 5.4 t70 -80.31 -34.36 36.84 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 122.262 1.029 . . . . 0.0 108.608 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HD23 ' A' ' 42' ' ' LEU . 79.5 mt -61.98 -42.8 96.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.622 175.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 24' ' ' GLU . 96.0 mt -60.45 -41.65 94.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.27 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 60.3 m -52.97 -45.08 67.61 Favored 'General case' 0 C--O 1.25 1.084 0 O-C-N 123.62 0.575 . . . . 0.0 111.185 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG13 HD21 ' B' ' 218' ' ' LEU . 29.9 m -80.36 -37.12 16.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -73.45 -27.43 61.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 42.3 m -67.03 -8.63 31.65 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.031 0.443 . . . . 0.0 111.827 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -53.65 -45.7 70.3 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.806 1.243 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -130.32 25.9 5.14 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.626 -170.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 168.69 -175.51 43.21 Favored Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 119.205 -1.474 . . . . 0.0 112.128 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.92 107.43 40.04 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.98 124.15 13.92 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.14 2.56 . . . . 0.0 111.859 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' HD11 ' A' ' 110' ' ' ILE . 95.3 t -91.26 -40.2 12.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.722 0.772 . . . . 0.0 110.902 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 4.9 m-20 -138.76 137.96 37.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 106' ' ' LEU . 12.3 p -147.49 137.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.83 122.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.543 HD12 ' HG2' ' A' ' 44' ' ' ARG . 3.4 tm? -91.1 129.3 37.12 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.1 t -73.86 97.28 2.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HG2' HD12 ' A' ' 42' ' ' LEU . 20.9 mtp180 -110.78 143.2 41.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -62.62 134.99 57.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.618 ' HA ' HD11 ' B' ' 208' ' ' ILE . 35.8 tt0 -63.23 -34.03 76.78 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.618 0.767 . . . . 0.0 112.846 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.18 -47.26 6.12 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 t -99.0 -9.47 23.92 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.251 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' B' ' 208' ' ' ILE . . . 62.82 43.56 98.75 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.319 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.42 136.77 39.79 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.438 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 44.1 m -76.43 104.8 7.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.273 0.559 . . . . 0.0 111.065 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -65.0 -16.27 63.23 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.877 0.871 . . . . 0.0 113.167 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 22.6 50.67 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.591 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.96 149.42 51.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.96 31.21 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -131.83 142.31 49.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.1 tt -139.23 157.04 46.62 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' ASP . 20.7 ttpt -141.23 126.68 18.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.24 170.25 10.15 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 38' ' ' VAL . 33.6 tt0 -84.18 -28.58 27.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -108.81 124.13 50.12 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.687 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 65' ' ' THR . 50.5 tp60 -61.91 -21.54 64.82 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.943 0.897 . . . . 0.0 112.362 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -75.51 -26.53 58.18 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.189 -0.945 . . . . 0.0 110.574 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.9 t -80.57 -32.22 36.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 62' ' ' GLN . 11.1 m -58.01 -50.35 73.72 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.386 172.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 62' ' ' GLN . 90.0 mt -61.73 -48.72 87.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.6 tp -53.12 -46.4 68.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.275 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.46 -46.72 83.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.512 0.725 . . . . 0.0 111.77 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 86' ' ' HIS . 76.8 t -55.98 -45.89 80.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.501 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.62 -5.39 25.13 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -96.33 -44.56 7.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 117.862 -1.535 . . . . 0.0 113.732 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.66 -9.3 50.11 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.714 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.89 114.54 3.12 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.02 46.42 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.774 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.98 126.3 30.74 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -81.08 121.09 25.65 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.0 mt -137.01 110.15 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 72.03 43.68 47.98 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.98 -14.73 25.15 Favored Glycine 0 C--O 1.225 -0.452 0 CA-C-N 115.249 -0.475 . . . . 0.0 113.82 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -122.6 142.48 50.59 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.125 0.463 . . . . 0.0 110.553 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.68 130.85 39.47 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -80.46 155.29 27.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.3 133.18 55.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.869 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.7 mp -120.91 128.92 76.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -136.3 157.83 45.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.215 0.606 . . . . 0.0 109.392 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 69' ' ' VAL . 63.8 m-70 -76.46 129.48 36.59 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.867 0.303 . . . . 0.0 110.223 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 5.8 t -151.22 161.07 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.429 0.559 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -142.23 125.48 16.48 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -126.41 156.83 39.96 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -91.52 123.12 64.66 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.48 128.87 29.97 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.648 2.232 . . . . 0.0 111.331 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -81.69 137.48 35.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.646 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -26.92 58.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.004 0.43 . . . . 0.0 111.412 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 m -68.85 -23.42 64.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.613 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.2 mt -110.45 17.11 21.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.037 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.5 pt20 -60.86 -33.07 72.51 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.68 -34.91 78.9 Favored 'General case' 0 C--O 1.211 -0.96 0 O-C-N 123.243 0.339 . . . . 0.0 111.148 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 102' ' ' VAL . 53.1 t80 -66.74 -44.67 80.87 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -58.13 -55.41 35.28 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.293 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 10.9 pt-20 -62.29 -43.23 99.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.365 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.85 69.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 98' ' ' TYR . 84.8 t -74.5 -49.34 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.222 0.534 . . . . 0.0 110.209 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' A' ' 106' ' ' LEU . 17.8 ptpt -70.59 -18.88 62.89 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 17.6 mm-40 -55.81 -29.02 59.09 Favored 'General case' 0 C--O 1.197 -1.707 0 O-C-N 123.195 0.31 . . . . 0.0 111.118 176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' ARG . 24.0 mm-40 -90.72 -40.59 11.76 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.016 0.436 . . . . 0.0 109.839 174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' VAL . 35.8 mt -61.92 -42.12 98.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.554 -173.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.569 ' HA ' HD12 ' A' ' 110' ' ' ILE . 18.0 t70 -60.21 -18.51 48.9 Favored 'General case' 0 C--O 1.206 -1.233 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.396 -177.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -71.83 -27.22 62.76 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.08 0.952 . . . . 0.0 110.874 178.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -89.2 -32.12 17.6 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 38' ' ' VAL . 18.5 mt -75.44 -50.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.74 -176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 113' ' ' LYS . 9.8 p -57.9 138.67 18.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.579 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 113' ' ' LYS . 20.0 m -89.42 0.28 56.97 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.377 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.593 ' H ' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 46.48 28.32 0.73 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.119 1.768 . . . . 0.0 113.145 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -92.77 -50.25 5.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.697 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.87 164.27 20.42 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.565 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.43 103.77 15.3 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.79 -6.34 14.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.516 -174.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 10.0 p -132.61 -61.05 0.86 Allowed 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.44 9.41 42.46 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.127 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 14.5 m -54.88 -40.93 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.817 0.847 . . . . 0.0 109.695 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -153.38 136.97 15.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -91.78 -50.44 5.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.381 0.61 . . . . 0.0 109.988 -172.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.559 HG22 HG13 ' B' ' 208' ' ' ILE . 2.8 mm -117.82 142.51 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -93.94 9.64 36.62 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 122.113 0.958 . . . . 0.0 111.998 -172.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 46' ' ' GLU . 2.2 mt -89.54 -76.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 21.2 mmt 62.24 146.4 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.14 157.98 49.77 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.224 1.95 . . . . 0.0 113.64 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.628 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.9 m-20 -98.04 -51.19 4.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.566 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 67.83 21.2 9.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 50.9 m -97.1 166.8 13.12 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.13 164.96 17.24 Favored 'Trans proline' 0 N--CA 1.43 -2.263 0 N-CA-C 109.935 -0.833 . . . . 0.0 109.935 168.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.456 ' HB3' HD23 ' A' ' 22' ' ' LEU . 58.2 p -86.94 -176.96 5.94 Favored 'General case' 0 N--CA 1.388 -3.554 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -119.63 1.72 13.81 Favored Glycine 1 C--N 1.23 -5.32 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 15.5 mt -80.38 -48.94 12.17 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.458 HD22 ' OD2' ' A' ' 26' ' ' ASP . 8.9 tp -51.6 -42.61 62.08 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.809 -168.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.72 -21.1 62.59 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.174 0.59 . . . . 0.0 112.532 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.55 -31.77 10.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.396 0.617 . . . . 0.0 109.919 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 15.0 mm-40 -77.52 -33.65 54.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.6 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 23.0 t -118.92 162.11 19.06 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -72.09 112.18 7.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.787 0.804 . . . . 0.0 111.256 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.1 4.82 12.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.712 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -81.56 134.16 51.54 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.007 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.43 -27.58 33.49 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.017 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -135.72 143.26 43.99 Favored Pre-proline 0 N--CA 1.432 -1.374 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.261 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 43.2 Cg_exo -62.53 -39.16 46.75 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.944 2.429 . . . . 0.0 112.138 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 65.12 32.4 10.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.713 1.205 . . . . 0.0 109.366 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -114.73 146.95 40.36 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.172 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' C' ' 330' ' ' GLU . 8.9 tpt180 -49.45 -42.12 42.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.077 0.951 . . . . 0.0 112.452 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.45 -8.01 39.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 55.89 32.28 19.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.948 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 22.6 mm -77.91 139.77 18.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.97 144.3 82.17 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -73.08 155.8 52.19 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.989 2.459 . . . . 0.0 111.777 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . . . . . . . . . . . -86.16 176.13 48.51 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.194 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 14.2 t -81.41 -28.61 34.24 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 16.9 mtp-105 -82.57 11.53 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.462 0.649 . . . . 0.0 112.62 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -83.0 116.93 22.47 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.97 -36.55 75.04 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.321 0.582 . . . . 0.0 111.697 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 129.21 -14.02 5.94 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.28 109.68 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -90.98 118.68 30.55 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.42 ' N ' ' HD2' ' C' ' 324' ' ' ARG . 3.7 mpt_? -94.02 147.9 22.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.189 0.519 . . . . 0.0 110.896 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 11.2 t -137.08 102.27 4.79 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -100.06 9.06 43.45 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.279 -167.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 118.96 -41.47 2.0 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -100.95 95.81 6.84 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 171.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -95.96 -66.3 0.92 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 123.127 1.442 . . . . 0.0 108.754 168.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' C' ' 310' ' ' ARG . 12.5 pt-20 -100.82 -30.92 11.43 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 112.542 -2.117 . . . . 0.0 110.952 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -163.82 153.39 14.55 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.396 -177.385 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.314 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.08 85.72 1.99 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.54 109.48 19.66 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.024 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.24 -13.39 71.26 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -72.68 10.12 0.93 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.979 1.312 . . . . 0.0 112.23 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.4 -39.12 74.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 172.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 t80 57.83 17.16 4.03 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.466 1.906 . . . . 0.0 115.115 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -100.02 -10.68 21.31 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.567 -1.333 . . . . 0.0 112.127 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 25.2 t70 -66.62 -34.48 77.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 109.25 0.94 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.847 0.832 . . . . 0.0 112.584 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.7 -11.03 54.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.43 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.27 127.61 32.56 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 57' ' ' LEU . 21.7 pt -116.4 139.33 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.589 0.709 . . . . 0.0 111.981 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 31.6 t80 -83.67 131.88 34.91 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.067 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 18' ' ' LEU . 12.0 mt -121.08 125.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.28 172.64 26.82 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.548 -1.31 . . . . 0.0 113.196 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 t30 68.05 29.24 6.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.75 1.22 . . . . 0.0 109.819 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 15' ' ' ILE . 10.8 mp -80.34 162.59 24.44 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 114.876 -1.057 . . . . 0.0 110.4 177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 15.2 m120 -71.03 166.69 20.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.025 176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.73 -24.01 41.92 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.4 pm0 -88.51 -2.38 58.56 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 19' ' ' ASN . 87.9 mt -87.05 123.13 31.8 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.285 0.564 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -112.53 -175.67 2.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.354 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.85 -38.45 72.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.02 1.328 . . . . 0.0 111.801 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.78 -36.44 92.75 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.638 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.9 -45.74 70.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 121.711 0.767 . . . . 0.0 109.528 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 HD23 ' A' ' 42' ' ' LEU . 80.4 mt -59.43 -41.76 85.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.724 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 40' ' ' VAL . 96.1 mt -66.42 -43.74 84.87 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.5 m -61.46 -32.78 72.78 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.224 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' ' NE ' ' C' ' 324' ' ' ARG . 20.9 m -81.59 -46.65 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CD1' HG23 ' A' ' 30' ' ' VAL . 64.9 m-85 -77.1 -16.82 59.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' C' ' 318' ' ' ARG . 63.5 m -69.13 -9.0 50.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.44 -21.43 66.65 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.23 20.52 14.85 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.747 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 127.74 -157.08 20.88 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.239 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' C' ' 316' ' ' GLY . 40.6 t -110.72 105.43 57.14 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.94 124.91 16.64 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.365 . . . . 0.0 110.881 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 110' ' ' ILE . 10.6 m -94.6 -24.43 4.89 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.755 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 58' ' ' LYS . 25.1 t70 -149.05 125.79 11.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 106' ' ' LEU . 10.7 p -143.11 139.88 27.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG21 ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -140.49 135.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.186 176.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 27' ' ' ILE . 3.2 tm? -104.92 126.94 52.51 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -79.13 102.18 8.32 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -125.36 155.6 40.04 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.131 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.93 137.74 57.93 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.075 0.86 . . . . 0.0 110.572 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' B' ' 208' ' ' ILE . 35.3 mt-10 -78.59 -1.34 33.64 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -106.49 -61.17 1.56 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.676 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 50' ' ' GLU . 4.2 t -94.08 -17.03 23.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.657 -175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' B' ' 208' ' ' ILE . . . 85.37 4.93 85.64 Favored Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.802 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 48' ' ' THR . 1.1 pp20? -73.53 132.15 42.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.419 -177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 m -61.12 150.72 33.22 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.028 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -100.23 -6.08 26.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.502 0.668 . . . . 0.0 110.277 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.53 57.8 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.306 -177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -134.03 146.39 50.32 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.53 171.41 18.15 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -141.0 142.08 34.3 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 58' ' ' LYS . 9.6 tt -147.5 157.35 43.53 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' N ' HD23 ' A' ' 57' ' ' LEU . 20.8 ptmt -145.48 137.69 25.65 Favored 'General case' 0 C--O 1.261 1.682 0 CA-C-O 121.596 0.712 . . . . 0.0 110.519 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 61' ' ' ASP . 29.1 t80 -100.75 149.56 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HB2' HG11 ' A' ' 38' ' ' VAL . 31.7 tt0 -84.52 65.38 8.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.406 1.098 . . . . 0.0 110.452 -177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . 15.3 t70 175.66 118.78 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 127.876 2.471 . . . . 0.0 106.684 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.657 ' NE2' ' HA ' ' A' ' 9' ' ' ASP . 29.2 tt0 -68.19 -29.78 68.72 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.465 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 2.3 mpt_? -85.96 -31.04 22.3 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 121.599 -0.688 . . . . 0.0 112.812 -171.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 t -79.99 -23.94 41.21 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.8 m -62.41 -40.84 97.82 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.834 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 62' ' ' GLN . 87.7 mt -61.14 -41.86 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.019 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD21 ' CE1' ' C' ' 311' ' ' PHE . 75.5 mt -57.24 -46.6 82.83 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.857 176.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.68 82.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' THR . 53.6 t -66.4 -54.04 30.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 CA-C-O 121.429 0.633 . . . . 0.0 110.473 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.46 -36.13 76.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -171.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.6 -48.12 6.77 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.894 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.4 -15.26 60.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -62.01 109.16 1.19 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.924 0.392 . . . . 0.0 110.175 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.96 34.11 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.25 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -69.19 126.77 30.83 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -86.32 121.86 29.48 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 123.853 0.861 . . . . 0.0 111.474 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -142.3 117.23 5.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.02 37.99 73.8 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.036 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.88 -2.19 88.39 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.848 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD2' ' CG ' ' A' ' 19' ' ' ASN . 13.6 ptp180 -137.62 161.99 34.98 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.267 0.533 . . . . 0.0 110.095 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.21 132.48 53.6 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.54 142.34 34.23 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.612 0.72 . . . . 0.0 112.179 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -107.94 134.15 51.27 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.719 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 3.8 mp -125.05 141.69 44.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -149.7 173.4 13.73 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -100.54 128.18 46.68 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 118.443 0.565 . . . . 0.0 110.337 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -150.45 133.33 15.98 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -102.02 99.0 9.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.322 -1.351 . . . . 0.0 107.477 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.12 160.66 15.15 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.3 119.41 57.78 Favored Pre-proline 0 C--N 1.297 -1.675 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.68 139.59 90.76 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.067 2.512 . . . . 0.0 111.367 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.573 ' HE3' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.97 138.45 36.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.617 0.722 . . . . 0.0 112.22 -175.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -79.42 -30.33 42.3 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 m -61.42 -31.49 71.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.824 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 92' ' ' LYS . 53.9 mt -110.8 16.53 21.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.212 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 2.3 pt20 -55.72 -35.45 66.14 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -67.23 -24.88 65.87 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.175 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 102' ' ' VAL . 27.5 t80 -72.68 -47.37 47.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 41' ' ' ILE . 73.1 m-85 -57.34 -50.95 71.32 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.269 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 9.6 pt-20 -64.79 -43.76 92.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.898 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.28 -34.63 72.5 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.688 0.28 . . . . 0.0 111.396 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 98' ' ' TYR . 91.3 t -70.08 -52.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 121.065 0.459 . . . . 0.0 110.619 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -65.15 -24.0 67.28 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -175.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.1 mm-40 -60.98 -19.91 61.75 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -89.77 -31.38 17.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.543 0.687 . . . . 0.0 110.622 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.488 HD11 HG12 ' A' ' 40' ' ' VAL . 29.3 mt -86.29 -43.69 12.71 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.5 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -58.28 -27.07 63.7 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.002 -173.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -59.2 -35.98 74.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.286 0.634 . . . . 0.0 111.172 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.37 -20.58 29.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 38' ' ' VAL . 45.0 mt -90.62 -42.6 14.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.563 -174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.72 147.51 10.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.571 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 t -86.7 37.68 0.76 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm 61.86 82.92 0.16 Allowed 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 112.897 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -142.94 93.58 2.52 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.54 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -80.41 -59.67 2.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.13 30.89 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.079 0.466 . . . . 0.0 110.066 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.1 -51.37 3.27 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 177.114 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.576 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 18.9 m -116.78 123.59 47.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -88.01 -2.54 58.67 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 10.2 m -65.03 -23.03 67.08 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 124.763 1.225 . . . . 0.0 113.093 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.533 ' HG2' ' N ' ' B' ' 205' ' ' TYR . 33.5 tt0 -158.73 166.04 32.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.533 ' N ' ' HG2' ' B' ' 204' ' ' GLN . 1.7 m-85 -125.99 -58.76 1.37 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.461 HG22 HG13 ' B' ' 208' ' ' ILE . 9.1 mm -120.74 150.61 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -95.89 -10.24 29.32 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.47 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.461 HG13 HG22 ' B' ' 206' ' ' ILE . 0.0 OUTLIER -87.3 -76.23 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.899 -177.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.579 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 21.6 mmt 72.94 144.43 0.1 Allowed Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.579 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 1.5 Cg_endo -45.25 139.36 8.98 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.82 3.68 . . . . 0.0 115.06 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.11 -55.81 2.67 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.403 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 58.17 26.18 13.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 4.4 m -95.92 164.76 17.92 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -86.24 157.13 9.66 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 109.501 -1.0 . . . . 0.0 109.501 167.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 88.8 p -86.0 170.99 11.76 Favored 'General case' 0 N--CA 1.382 -3.859 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.98 -20.31 65.51 Favored Glycine 1 C--N 1.241 -4.712 0 CA-C-N 113.263 -1.79 . . . . 0.0 109.585 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.3 -42.31 88.52 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.92 -29.2 70.6 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.048 -1.433 . . . . 0.0 114.159 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -89.95 -9.68 47.9 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.388 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.48 -37.18 6.27 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -77.04 -23.32 52.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.264 1.855 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.724 -179.061 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 300' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 CA-C-O 120.145 -0.253 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 301' ' ' SER . . . . . . . . . . . . . 7.8 p -96.22 -77.17 0.49 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 117.667 0.734 . . . . 0.0 111.132 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 302' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.39 109.6 17.55 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 303' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -110.92 -52.48 2.78 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.508 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.61 149.21 40.28 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 305' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.84 -10.76 11.59 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.327 2.018 . . . . 0.0 114.614 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 306' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 307' ' ' PRO . . . -126.1 124.9 24.68 Favored Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.036 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 307' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 306' ' ' ALA . 16.2 Cg_exo -70.6 96.27 0.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.116 1.877 . . . . 0.0 109.573 172.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 308' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.43 -174.18 4.27 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 309' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.89 160.28 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.956 0.902 . . . . 0.0 110.003 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 310' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -59.69 -38.2 80.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 311' ' ' PHE . . . . . 0.435 ' CE1' HD21 ' A' ' 67' ' ' LEU . 1.6 m-85 -105.57 20.96 18.03 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.722 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 312' ' ' ALA . . . . . . . . . . . . . . . 60.85 62.44 1.46 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.412 0.625 . . . . 0.0 112.542 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.427 HD11 ' HB2' ' C' ' 311' ' ' PHE . 2.2 mp -90.72 135.64 26.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.872 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 314' ' ' MET . . . . . 0.446 ' HA ' ' CE ' ' C' ' 314' ' ' MET . 2.1 mmt -104.6 111.15 65.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 315' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.07 138.99 88.64 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 122.58 2.187 . . . . 0.0 112.581 -176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 316' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . -78.17 163.8 50.84 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.862 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 317' ' ' SER . . . . . . . . . . . . . 35.1 t -74.87 -13.28 60.53 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.359 0.6 . . . . 0.0 110.225 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.583 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.6 mmp_? -79.48 -11.94 59.89 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 319' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -81.01 107.5 13.88 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -96.04 69.13 2.77 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.785 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 321' ' ' GLY . . . . . . . . . . . . . . . 69.39 -37.99 0.34 Allowed Glycine 0 CA--C 1.538 1.476 0 N-CA-C 117.964 1.946 . . . . 0.0 117.964 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 322' ' ' VAL . . . . . . . . . . . . . 26.0 t -51.97 105.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 112.192 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -77.88 135.65 37.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 324' ' ' ARG . . . . . 0.646 ' NE ' ' HA ' ' A' ' 30' ' ' VAL . 79.1 mtt-85 -119.1 118.95 32.79 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.087 0.47 . . . . 0.0 110.6 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 325' ' ' SER . . . . . . . . . . . . . 28.4 p -136.09 115.54 12.72 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.058 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 326' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -136.31 97.71 3.66 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 327' ' ' GLY . . . . . . . . . . . . . . . 86.94 31.04 18.86 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 328' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -87.2 156.21 19.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.518 0.675 . . . . 0.0 111.123 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 329' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.05 2.44 3.58 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.631 1.573 . . . . 0.0 114.524 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 330' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.99 -39.22 25.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.92 0.888 . . . . 0.0 112.076 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 331' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -63.63 113.32 3.27 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.027 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 332' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 . . . . . 0 C--N 1.292 -1.923 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.119 178.601 . . . . . . . . 0 0 . 1 stop_ save_